{
  "url": "https://dx.doi.org/10.1186/s12879-018-3565-z?utm_medium=email&utm_source=transaction",
  "cached_at": 1749607921.339298,
  "cache_key": "url_aceed0b31cdf7949",
  "content": {
    "success": true,
    "url": "https://dx.doi.org/10.1186/s12879-018-3565-z?utm_medium=email&utm_source=transaction",
    "title": "Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective | BMC Infectious Diseases | Full Text",
    "description": "Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.",
    "status_code": 200,
    "crawl_time": 5.132751703262329,
    "timestamp": "2025-06-11T05:12:01.338297",
    "cache_hit": false,
    "raw_html": "<!DOCTYPE html><html lang=\"en\" class=\"js webfonts-loaded\"><head>\n        <meta charset=\"UTF-8\">\n        <meta http-equiv=\"X-UA-Compatible\" content=\"IE=edge\">\n        <meta name=\"applicable-device\" content=\"pc,mobile\">\n        <meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n\n        <title>Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective | BMC Infectious Diseases | Full Text</title>\n\n        \n    \n    <meta name=\"citation_abstract\" content=\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta name=\"journal_id\" content=\"12879\">\n    <meta name=\"dc.title\" content=\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\">\n    <meta name=\"dc.source\" content=\"BMC Infectious Diseases 2018 18:1\">\n    <meta name=\"dc.format\" content=\"text/html\">\n    <meta name=\"dc.publisher\" content=\"BioMed Central\">\n    <meta name=\"dc.date\" content=\"2018-12-18\">\n    <meta name=\"dc.type\" content=\"OriginalPaper\">\n    <meta name=\"dc.language\" content=\"En\">\n    <meta name=\"dc.copyright\" content=\"2018 The Author(s).\">\n    <meta name=\"dc.rights\" content=\"2018 The Author(s).\">\n    <meta name=\"dc.rightsAgent\" content=\"reprints@biomedcentral.com\">\n    <meta name=\"dc.description\" content=\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &amp;lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta name=\"prism.issn\" content=\"1471-2334\">\n    <meta name=\"prism.publicationName\" content=\"BMC Infectious Diseases\">\n    <meta name=\"prism.publicationDate\" content=\"2018-12-18\">\n    <meta name=\"prism.volume\" content=\"18\">\n    <meta name=\"prism.number\" content=\"1\">\n    <meta name=\"prism.section\" content=\"OriginalPaper\">\n    <meta name=\"prism.startingPage\" content=\"1\">\n    <meta name=\"prism.endingPage\" content=\"11\">\n    <meta name=\"prism.copyright\" content=\"2018 The Author(s).\">\n    <meta name=\"prism.rightsAgent\" content=\"reprints@biomedcentral.com\">\n    <meta name=\"prism.url\" content=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    <meta name=\"prism.doi\" content=\"doi:10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_pdf_url\" content=\"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_fulltext_html_url\" content=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_journal_title\" content=\"BMC Infectious Diseases\">\n    <meta name=\"citation_journal_abbrev\" content=\"BMC Infect Dis\">\n    <meta name=\"citation_publisher\" content=\"BioMed Central\">\n    <meta name=\"citation_issn\" content=\"1471-2334\">\n    <meta name=\"citation_title\" content=\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\">\n    <meta name=\"citation_volume\" content=\"18\">\n    <meta name=\"citation_issue\" content=\"1\">\n    <meta name=\"citation_publication_date\" content=\"2018/12\">\n    <meta name=\"citation_online_date\" content=\"2018/12/18\">\n    <meta name=\"citation_firstpage\" content=\"1\">\n    <meta name=\"citation_lastpage\" content=\"11\">\n    <meta name=\"citation_article_type\" content=\"Research article\">\n    <meta name=\"citation_fulltext_world_readable\" content=\"\">\n    <meta name=\"citation_language\" content=\"en\">\n    <meta name=\"dc.identifier\" content=\"doi:10.1186/s12879-018-3565-z\">\n    <meta name=\"DOI\" content=\"10.1186/s12879-018-3565-z\">\n    <meta name=\"size\" content=\"226948\">\n    <meta name=\"citation_doi\" content=\"10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_springer_api_url\" content=\"http://api.springer.com/xmldata/jats?q=doi:10.1186/s12879-018-3565-z&amp;api_key=\">\n    <meta name=\"description\" content=\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &amp;lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta name=\"dc.creator\" content=\"Gramegna, Andrea\">\n    <meta name=\"dc.creator\" content=\"Sotgiu, Giovanni\">\n    <meta name=\"dc.creator\" content=\"Di Pasquale, Marta\">\n    <meta name=\"dc.creator\" content=\"Radovanovic, Dejan\">\n    <meta name=\"dc.creator\" content=\"Terraneo, Silvia\">\n    <meta name=\"dc.creator\" content=\"Reyes, Luis F.\">\n    <meta name=\"dc.creator\" content=\"Vendrell, Ester\">\n    <meta name=\"dc.creator\" content=\"Neves, Joao\">\n    <meta name=\"dc.creator\" content=\"Menzella, Francesco\">\n    <meta name=\"dc.creator\" content=\"Blasi, Francesco\">\n    <meta name=\"dc.creator\" content=\"Aliberti, Stefano\">\n    <meta name=\"dc.creator\" content=\"Restrepo, Marcos I.\">\n    <meta name=\"dc.subject\" content=\"Infectious Diseases\">\n    <meta name=\"dc.subject\" content=\"Parasitology\">\n    <meta name=\"dc.subject\" content=\"Medical Microbiology\">\n    <meta name=\"dc.subject\" content=\"Tropical Medicine\">\n    <meta name=\"dc.subject\" content=\"Internal Medicine\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults; citation_author=LA Mandell, RG Wunderink, A Anzueto; citation_volume=44; citation_issue=suppl 2; citation_publication_date=2007; citation_pages=S27-S72; citation_doi=10.1086/511159; citation_id=CR1\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality; citation_author=JA Ramirez, TL Wiemken, P Peyrani, FW Arnold, R Kelley, WA Mattingly, R Nakamatsu, S Pena, BE Guinn, SP Furmanek, AK Persaud, A Raghuram, F Fernandez, L Beavin, R Bosson, R Fernandez-Botran, R Cavallazzi, J Bordon, C Valdivieso, J Schulte, RM Carrico; citation_volume=65; citation_issue=11; citation_publication_date=2017; citation_pages=1806-1812; citation_doi=10.1093/cid/cix647; citation_id=CR2\">\n    <meta name=\"citation_reference\" content=\"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\">\n    <meta name=\"citation_reference\" content=\"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Chin Med J; citation_title=Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China; citation_author=LL Tao, BJ Hu, LX He, L Wei, HM Xie, BQ Wang, HY Li, XH Chen, CM Zhou, WW Deng; citation_volume=125; citation_issue=17; citation_publication_date=2012; citation_pages=2967-2972; citation_id=CR5\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Am J Respir Crit Care Med; citation_title=Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia; citation_author=FW Arnold, JT Summersgill, AS Lajoie, P Peyrani, TJ Marrie, P Rossi, F Blasi, P Fernandez, TM File, J Rello, R Menendez, L Marzoratti, CM Luna, JA Ramirez; citation_volume=175; citation_issue=10; citation_publication_date=2007; citation_pages=1086-1093; citation_doi=10.1164/rccm.200603-350OC; citation_id=CR6\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Microbiol Infect; citation_title=Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version; citation_author=M Woodhead, F Blasi, S Ewig, J Garau, G Huchon, M Ieven, A Ortqvist, T Schaberg, A Torres, G Heijden, R Read, TJ Verheij; citation_volume=17; citation_issue=Suppl 6; citation_publication_date=2011; citation_pages=E1-59; citation_doi=10.1111/j.1469-0691.2011.03672.x.; citation_id=CR7\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Lancet Infect Dis; citation_title=Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study; citation_author=S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, MI Restrepo, GLIMP investigators; citation_volume=16; citation_issue=12; citation_publication_date=2016; citation_pages=1364-1376; citation_doi=10.1016/S1473-3099(16)30267-5; citation_id=CR8\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=J Med Microbiol; citation_title=Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology; citation_author=MA Martinez, M Ruiz, E Zunino, V Luchsinger, LF Avendano; citation_volume=57; citation_issue=Pt 12; citation_publication_date=2008; citation_pages=1491-1495; citation_doi=10.1099/jmm.0.2008/003814-0; citation_id=CR9\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Infect Dis; citation_title=Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ); citation_author=BH von, T Welte, R Marre, N Suttorp, C Luck, S Ewig; citation_volume=9; citation_publication_date=2009; citation_pages=62; citation_doi=10.1186/1471-2334-9-62; citation_id=CR10\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks; citation_author=KA Thurman, ND Walter, SB Schwartz; citation_volume=48; citation_publication_date=2009; citation_pages=1244-1249; citation_doi=10.1086/597775; citation_id=CR11\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Infection; citation_title=CAPNETZ: community-acquired pneumonia competence network; citation_author=T Welte, N Suttorp, R Marre; citation_volume=32; citation_publication_date=2004; citation_pages=234-238; citation_doi=10.1007/s15010-004-3107-z; citation_id=CR12\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Infect Dis; citation_title=Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts; citation_author=VM Raeven, SM Spoorenberg, WG Boersma, EM Garde, SC Cannegieter, GP Voorn, WJ Bos, JE Steenbergen; citation_volume=16; citation_publication_date=2016; citation_pages=299; citation_doi=10.1186/s12879-016-1641-9.; citation_id=CR13\">\n    <meta name=\"citation_reference\" content=\"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Int J Antimicrob Agents; citation_title=Japanese guidelines for the management of community-acquired pneumonia; citation_author=K Yanagihara, S Kohno, T Matsusima; citation_volume=18; citation_issue=Suppl. 1; citation_publication_date=2001; citation_pages=S45-S48; citation_doi=10.1016/S0924-8579(01)00402-2; citation_id=CR15\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=S Afr Med J; citation_title=Management of community-acquired pneumonia in adults; citation_author=; citation_volume=97; citation_publication_date=2007; citation_pages=1296-1306; citation_id=CR16\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Eur Respir J; citation_title=Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia; citation_author=A Singanayagam, S Aliberti, C Cillóniz; citation_volume=50; citation_publication_date=2017; citation_pages=1602306; citation_doi=10.1183/13993003.02306-2016; citation_id=CR17\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Medicine; citation_title=Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years; citation_author=D Viasus, S Yacovo, C Garcia-Vidal, R Verdaguer, F Manresa, J Dorca, F Gudiol, J Carratalà; citation_volume=92; citation_publication_date=2012; citation_pages=51-60; citation_doi=10.1097/MD.0b013e31827f6104; citation_id=CR18\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Arch Intern Med; citation_title=Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial; citation_author=EN Vergis, A Indorf, TM File, J Phillips, J Bates, J Tan, GA Sarosi, JT Grayston, J Summersgill, VL Yu; citation_volume=160; citation_issue=9; citation_publication_date=2000; citation_pages=1294-1300; citation_doi=10.1001/archinte.160.9.1294; citation_id=CR19\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Thorax; citation_title=Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria; citation_author=V Luchsinger, M Ruiz, E Zunino, MA Martínez, C Machado, PA Piedra, R Fasce, MT Ulloa, MC Fink, P Lara, M Gebauer, F Chávez, LF Avendaño; citation_volume=68; citation_publication_date=2013; citation_pages=1000-1006; citation_doi=10.1136/thoraxjnl-2013-203551; citation_id=CR20\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Infect Dis; citation_title=Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis; citation_author=SM Spoorenberg, WJ Bos, R Heijligenberg, PG Voorn, JC Grutters, GT Rijkers, EM Garde; citation_volume=14; citation_publication_date=2014; citation_pages=335-343; citation_doi=10.1186/1471-2334-14-335; citation_id=CR21\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Isr Med Assoc J; citation_title=Etiology of community-acquired pneumonia in hospitalized patients in northern Israel; citation_author=F Shibli, B Chazan, O Nitzan, E Flatau, H Edelstein, O Blondheim, R Raz, R Colodner; citation_volume=12; citation_publication_date=2010; citation_pages=477-482; citation_id=CR22\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Public Health; citation_title=The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season; citation_author=K Chen, R Jia, L Li, C Yang, Y Shi; citation_volume=15; citation_publication_date=2015; citation_pages=113-118; citation_doi=10.1186/s12889-015-1422-1; citation_id=CR23\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Chile Chest; citation_title=Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago; citation_author=F Arancibia, CP Cortes, M Valdés, J Cerda, A Hernández, L Soto, A Torres; citation_volume=145; citation_publication_date=2014; citation_pages=290-296; citation_doi=10.1378/chest.13-0162; citation_id=CR24\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction; citation_author=KE Templeton, SA Scheltinga, WC Eeden, AW Graffelman, PJ Broek, EC Claas; citation_volume=41; citation_publication_date=2005; citation_pages=345-351; citation_doi=10.1086/431588; citation_id=CR25\">\n    <meta name=\"citation_author\" content=\"Gramegna, Andrea\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Sotgiu, Giovanni\">\n    <meta name=\"citation_author_institution\" content=\"Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy\">\n    <meta name=\"citation_author\" content=\"Di Pasquale, Marta\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Radovanovic, Dejan\">\n    <meta name=\"citation_author_institution\" content=\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Terraneo, Silvia\">\n    <meta name=\"citation_author_institution\" content=\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Reyes, Luis F.\">\n    <meta name=\"citation_author_institution\" content=\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\">\n    <meta name=\"citation_author\" content=\"Vendrell, Ester\">\n    <meta name=\"citation_author_institution\" content=\"Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Barcelona, Spain\">\n    <meta name=\"citation_author\" content=\"Neves, Joao\">\n    <meta name=\"citation_author_institution\" content=\"Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal\">\n    <meta name=\"citation_author\" content=\"Menzella, Francesco\">\n    <meta name=\"citation_author_institution\" content=\"Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy\">\n    <meta name=\"citation_author\" content=\"Blasi, Francesco\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Aliberti, Stefano\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Restrepo, Marcos I.\">\n    <meta name=\"citation_author_institution\" content=\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\">\n    \n\n\n        <meta name=\"format-detection\" content=\"telephone=no\">\n\n        \n        \n\n        \n\n        <link rel=\"apple-touch-icon\" sizes=\"180x180\" href=\"/static/img/favicons/bmc/apple-touch-icon-582ef1d0f5.png\">\n<link rel=\"icon\" type=\"image/png\" sizes=\"192x192\" href=\"/static/img/favicons/bmc/android-chrome-192x192-9625b7cdba.png\">\n<link rel=\"icon\" type=\"image/png\" sizes=\"32x32\" href=\"/static/img/favicons/bmc/favicon-32x32-5d7879efe1.png\">\n<link rel=\"icon\" type=\"image/png\" sizes=\"16x16\" href=\"/static/img/favicons/bmc/favicon-16x16-c241ac1a2f.png\">\n<link rel=\"shortcut icon\" data-test=\"shortcut-icon\" href=\"/static/img/favicons/bmc/favicon-1886637b78.ico\">\n\n    <link rel=\"manifest\" href=\"/static/app-bmc/manifest-3bb9ad383b.json\">\n    <meta name=\"msapplication-config\" content=\"/static/app-bmc/browserconfig-ecd9aa8205.xml\">\n    <meta name=\"msapplication-TileColor\" content=\"#1b3051\">\n    <meta name=\"msapplication-TileImage\" content=\"/static/img/favicons/bmc/app-icon-144x144.png\">\n\n<meta name=\"theme-color\" content=\"#1b3051\">\n\n        \n        <script type=\"text/javascript\" async=\"\" src=\"https://pagead2.googlesyndication.com/tag/js/gpt.js\"></script><script async=\"\" src=\"//cdn.jsdelivr.net/npm/mathjax@2.7.5/MathJax.js?config=TeX-AMS-MML_SVG.js\"></script><script async=\"\" src=\"https://sgtm.biomedcentral.com/gtm.js?id=GTM-MRVXSHQ\"></script><script>(function(H){H.className=H.className.replace(/\\bno-js\\b/,'js')})(document.documentElement)</script><script src=\"https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-42.js\" onload=\"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\"></script>\n\n        \n\n\n    <link rel=\"stylesheet\" media=\"screen\" href=\"/static/app-bmc/css/core-article-f3872e738d.css\">\n\n\n<link rel=\"stylesheet\" media=\"screen\" href=\"/static/app-bmc/css/core-eac3097aa4.css\">\n<link rel=\"stylesheet\" media=\"print\" href=\"/static/app-bmc/css/print-b8af42253b.css\">\n\n\n\n\n    <!-- This template is only used by BMC for now -->\n\n\n    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,form,input,p{margin:0;padding:0}body{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.61803;padding:16px 0}.c-navbar--with-submit-button{padding-bottom:24px}@media only screen and (min-width:540px){.c-navbar--with-submit-button{padding-bottom:16px}}.c-navbar__container{display:flex;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__content{display:flex;flex:0 1 auto}.c-navbar__nav{align-items:center;display:flex;flex-wrap:wrap;gap:16px 16px;list-style:none;margin:0;padding:0}.c-navbar__item{flex:0 0 auto}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad--728x90 iframe{height:90px;max-width:970px}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad iframe{border:0;overflow:auto;vertical-align:top}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}.c-dropdown__button:after{border-color:transparent transparent transparent #fff;border-style:solid;border-width:4px 0 4px 14px;content:\"\";display:block;height:0;margin-left:3px;width:0}.c-dropdown{display:inline-block;position:relative}.c-dropdown__button{background-color:transparent;border:0;display:inline-block;padding:0;white-space:nowrap}.c-dropdown__button:after{border-color:currentcolor transparent transparent;border-width:5px 4px 0 5px;display:inline-block;margin-left:8px;vertical-align:middle}.c-dropdown__menu{background-color:#fff;border:1px solid #d9d9d9;border-radius:3px;box-shadow:0 2px 6px rgba(0,0,0,.1);font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.4;list-style:none;margin:0;padding:8px 0;position:absolute;top:100%;transform:translateY(8px);width:180px;z-index:100}.c-dropdown__menu:after,.c-dropdown__menu:before{border-style:solid;bottom:100%;content:\"\";display:block;height:0;left:16px;position:absolute;width:0}.c-dropdown__menu:before{border-color:transparent transparent #d9d9d9;border-width:0 9px 9px;transform:translateX(-1px)}.c-dropdown__menu:after{border-color:transparent transparent #fff;border-width:0 8px 8px}.c-dropdown__menu--right{left:auto;right:0}.c-dropdown__menu--right:after,.c-dropdown__menu--right:before{left:auto;right:16px}.c-dropdown__menu--right:before{transform:translateX(1px)}.c-dropdown__link{background-color:transparent;color:#004b83;display:block;padding:4px 16px}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container,.c-header__menu{align-items:center;display:flex;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu{gap:2em 2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}@supports not (gap:2em){.c-header__item{margin-left:24px}}.c-header__container{justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}@supports not (gap:2em){.c-header__brand{margin-right:48px}}.c-header__brand a{display:block;text-decoration:none}.c-header__link{color:#fff}.c-journal-title a{text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-form-field{margin-bottom:1em}.c-form-field__label{color:#666;display:block;font-size:14px;margin-bottom:.4em}.c-form-field__input{border:1px solid #a6a6a6;border-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);font-size:14px;line-height:1.28571;padding:.75em 1em;vertical-align:middle;width:100%}.c-popup-search{background-color:#25426f;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.c-logo img{display:block}.ctx-search .c-form-field{margin-bottom:0}.ctx-search .c-form-field__label{color:#fff}.ctx-search .c-form-field__input{border-bottom-right-radius:0;border-top-right-radius:0;margin-right:0}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-header__identity--default{background:url(/static/images/bmc/identities/patterns/default-7e3a6b1388.svg) 0 0 no-repeat #04caa8}.c-journal-title{color:#1b3051;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#0061a9;color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-logo{display:block}html.webfonts-loaded .u-h3,html.webfonts-loaded .u-h4{font-family:Europa,Trebuchet MS}.u-button{align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button svg,.u-button--primary svg,.u-button--tertiary svg{fill:currentcolor}.u-button{color:#004b83}.u-button--primary,.u-button--tertiary{background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);color:#fff}.u-button--tertiary{font-weight:400}.u-button--full-width{display:flex;width:100%}.u-clearfix:after,.u-clearfix:before{content:\"\";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-display-none{display:none}.js .u-js-hide{display:none;visibility:hidden}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3,.u-h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}.u-h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.u-h4{color:#1b3051;font-size:18px;font-style:italic;font-weight:700;margin-bottom:.7em}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}.u-hide-at-lt-lg:first-child+*{margin-block-start:0}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-button--tertiary{font-size:.875rem;padding:8px 16px}@media only screen and (max-width:539px){.u-button--alt-colour-on-mobile{background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;color:#004b83}}body{font-size:1.125rem}.c-header__navigation{display:flex;gap:.5rem .5rem} }</style>\n    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,form,input,p{margin:0;padding:0}body{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}p{overflow-wrap:break-word;word-break:break-word}.u-h3{font-size:1.5rem}.u-h3,.u-h4{font-weight:700}.u-h4{font-size:1.25rem}.c-reading-companion__figure-title{font-size:1.25rem;font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#173962;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;margin-top:0;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:24px 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article__sub-heading:first-child{margin-top:0}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#0067c5;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-article-associated-content__container a,.c-card__summary a{text-decoration:underline}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}.c-article-associated-content__container .c-article-associated-content__collection.collection~.c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__title{display:none}.c-article-associated-content__container .c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label{display:block}.c-article-associated-content__container .c-article-associated-content__collection.collection,.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.collection{margin-top:28px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif} }</style>\n\n    <link rel=\"stylesheet\" data-test=\"critical-css-handler\" data-inline-css-source=\"critical-css\" href=\"/static/app-bmc/css/enhanced-9894e8f787.css\" media=\"only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)\" onload=\"this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null\">\n\n    <link rel=\"stylesheet\" data-test=\"critical-css-handler\" data-inline-css-source=\"critical-css\" href=\"/static/app-bmc/css/enhanced-article-568f59de28.css\" media=\"only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)\" onload=\"this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null\">\n\n\n\n        \n\n        \n    <script type=\"text/javascript\">\n        config = {\n            env: 'live',\n            site: 'bmcinfectdis.biomedcentral.com',\n            siteWithPath: 'bmcinfectdis.biomedcentral.com' + window.location.pathname,\n            twitterHashtag: '',\n            cmsPrefix: 'https://studio-cms.springernature.com/studio/',\n            \n            doi: '10.1186/s12879-018-3565-z',\n            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',\n            hasFigshareInvoked: false,\n            publisherBrand: 'BioMed Central',\n            mustardcut: false\n        };\n    </script>\n\n        \n    <script type=\"text/javascript\" data-test=\"dataLayer\">\n        window.dataLayer = [{\"content\":{\"article\":{\"doi\":\"10.1186/s12879-018-3565-z\",\"articleType\":\"Research article\",\"peerReviewType\":\"Open\",\"supplement\":null,\"keywords\":\"CAP;Atypical pathogens;Epidemiology\"},\"contentInfo\":{\"imprint\":\"BioMed Central\",\"title\":\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\",\"publishedAt\":1545091200000,\"publishedAtDate\":\"2018-12-18\",\"author\":[\"Andrea Gramegna\",\"Giovanni Sotgiu\",\"Marta Pasquale\",\"Dejan Radovanovic\",\"Silvia Terraneo\",\"Luis F. Reyes\",\"Ester Vendrell\",\"Joao Neves\",\"Francesco Menzella\",\"Francesco Blasi\",\"Stefano Aliberti\",\"Marcos I. Restrepo\"],\"collection\":[]},\"attributes\":{\"deliveryPlatform\":\"oscar\",\"template\":\"rebrand\",\"cms\":null,\"copyright\":{\"creativeCommonsType\":\"CC BY + CC0\",\"openAccess\":true},\"environment\":\"live\"},\"journal\":{\"siteKey\":\"bmcinfectdis.biomedcentral.com\",\"volume\":\"18\",\"issue\":\"1\",\"title\":\"BMC Infectious Diseases\",\"type\":\"SERIES\",\"journalID\":12879,\"section\":[{\"sectionId\":\"AC_57613ed1ce2f7fd9e438c2e3f22a5de7\",\"sectionName\":\"Bacterial and fungal diseases\"}]},\"category\":{\"pmc\":{\"primarySubject\":\"Medicine & Public Health\"},\"contentType\":\"Research article\",\"publishingSegment\":\"BMC Series 2\",\"snt\":[\"Diseases\",\"Parasitology\",\"Medical Microbiology\",\"Tropical Medicine\",\"Internal Medicine\"]}},\"session\":{\"authentication\":{\"authenticationID\":[]}},\"version\":\"1.0.0\",\"page\":{\"category\":{\"pageType\":\"article\"},\"attributes\":{\"featureFlags\":[],\"environment\":\"live\",\"darwin\":false}},\"japan\":false,\"event\":\"dataLayerCreated\",\"collection\":null,\"publisherBrand\":\"BioMed Central\"}];\n    </script>\n\n        \n        \n        \n            <script>\n                window.dataLayer = window.dataLayer || [];\n                window.dataLayer.push({\n                    ga4MeasurementId: 'G-PJCTJWPV25',\n                    ga360TrackingId: 'UA-54492316-9',\n                    twitterId: 'o47a2',\n                    baiduId: 'd1b4bc3b5ada4eb7290535e72899bac1',\n                    ga4ServerUrl: 'https://collect.biomedcentral.com',\n                    imprint: 'biomedcentral'\n                });\n            </script>\n        \n        \n\n        \n\n        <script>\n    (function(w, d) {\n        w.config = w.config || {};\n        w.config.mustardcut = false;\n\n        \n        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {\n            w.config.mustardcut = true;\n            d.classList.add('js');\n            d.classList.remove('grade-c');\n            d.classList.remove('no-js');\n        }\n    })(window, document.documentElement);\n</script>\n\n\n        \n<script>\n    (function () {\n        if ( typeof window.CustomEvent === \"function\" ) return false;\n        function CustomEvent ( event, params ) {\n            params = params || { bubbles: false, cancelable: false, detail: null };\n            var evt = document.createEvent( 'CustomEvent' );\n            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );\n            return evt;\n        }\n\n        CustomEvent.prototype = window.Event.prototype;\n\n        window.CustomEvent = CustomEvent;\n    })();\n</script>\n\n        <script class=\"js-entry\">\n    if (window.config.mustardcut) {\n        (function(w, d) {\n            \n            \n            \n                window.Component = {};\n                window.suppressShareButton = true;\n                window.onArticlePage = true;\n            \n\n            var currentScript = d.currentScript || d.head.querySelector('script.js-entry');\n\n            \n            function catchNoModuleSupport() {\n                var scriptEl = d.createElement('script');\n                return (!('noModule' in scriptEl) && 'onbeforeload' in scriptEl)\n            }\n\n            var headScripts = [\n                {'src': '/static/js/polyfill-es5-bundle-b4356fa7f5.js', 'async': false}\n            ];\n\n            var bodyScripts = [\n                \n                    {'src': '/static/js/app-es5-bundle-fe9cce56e1.js', 'async': false, 'module': false},\n                    {'src': '/static/js/app-es6-bundle-fed4944a50.js', 'async': false, 'module': true}\n                \n                \n                    \n                        , {'src': '/static/js/global-article-es5-bundle-d1124b54a9.js', 'async': false, 'module': false},\n                        {'src': '/static/js/global-article-es6-bundle-798832bcce.js', 'async': false, 'module': true}\n                    \n                \n                \n                \n            ];\n\n            function createScript(script) {\n                var scriptEl = d.createElement('script');\n                scriptEl.src = script.src;\n                scriptEl.async = script.async;\n                if (script.module === true) {\n                    scriptEl.type = \"module\";\n                    if (catchNoModuleSupport()) {\n                        scriptEl.src = '';\n                    }\n                } else if (script.module === false) {\n                    scriptEl.setAttribute('nomodule', true)\n                }\n                if (script.charset) {\n                    scriptEl.setAttribute('charset', script.charset);\n                }\n\n                return scriptEl;\n            }\n\n            for (var i = 0; i < headScripts.length; ++i) {\n                var scriptEl = createScript(headScripts[i]);\n                currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);\n            }\n\n            d.addEventListener('DOMContentLoaded', function() {\n                for (var i = 0; i < bodyScripts.length; ++i) {\n                    var scriptEl = createScript(bodyScripts[i]);\n                    d.body.appendChild(scriptEl);\n                }\n            });\n\n            // Webfont repeat view\n            var config = w.config;\n            if (config && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {\n                d.documentElement.className += ' webfonts-loaded';\n            }\n        })(window, document);\n    }\n</script><script src=\"/static/js/polyfill-es5-bundle-b4356fa7f5.js\"></script>\n\n\n        \n            \n            \n                \n<script data-test=\"gtm-head\">\n    window.initGTM = function() {\n        (function (w, d, s, l, i) {\n            w[l] = w[l] || [];\n            w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});\n            var f = d.getElementsByTagName(s)[0],\n                j = d.createElement(s),\n                dl = l != 'dataLayer' ? '&l=' + l : '';\n            j.async = true;\n            j.src = 'https://sgtm.biomedcentral.com/gtm.js?id=' + i + dl;\n            f.parentNode.insertBefore(j, f);\n        })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');\n    }\n</script>\n\n            \n            \n        \n\n        \n            <meta name=\"360-site-verification\" content=\"2e1d87196f82c9ac5454a21aede69eda\">\n        \n\n        <script>\n(function (w, d, t) {\n    function cc() {\n        var h = w.location.hostname;\n        var e = d.createElement(t),\n        s = d.getElementsByTagName(t)[0];\n\n        \n        if (h.indexOf('springer.com') > -1 && h.indexOf('biomedcentral.com') === -1 && h.indexOf('springeropen.com') === -1) {\n            if (h.indexOf('link-qa.springer.com') > -1 || h.indexOf('test-www.springer.com') > -1) {\n                e.src = 'https://cmp.springer.com/production_live/en/consent-bundle-17-57.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            } else {\n                e.src = 'https://cmp.springer.com/production_live/en/consent-bundle-17-57.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            }\n        } else if (h.indexOf('biomedcentral.com') > -1) {\n            if (h.indexOf('biomedcentral.com.qa') > -1) {\n                e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-42.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            } else {\n                e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-42.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            }\n        } else if (h.indexOf('springeropen.com') > -1) {\n            if (h.indexOf('springeropen.com.qa') > -1) {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-38.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            } else {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-38.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            }\n        } else if (h.indexOf('springernature.com') > -1) {\n            if (h.indexOf('beta-qa.springernature.com') > -1) {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-43.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-NK22KLS')\");\n            } else {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-43.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-NK22KLS')\");\n            }\n        } else {\n            e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';\n            e.setAttribute('data-consent', h);\n        }\n        s.insertAdjacentElement('afterend', e);\n    }\n\n    cc();\n})(window, document, 'script');\n</script>\n\n\n        \n    \n        \n    \n\n\n        \n    \n    <link rel=\"canonical\" href=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    \n\n        \n        \n        \n    \n    <meta property=\"og:url\" content=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    <meta property=\"og:type\" content=\"article\">\n    <meta property=\"og:site_name\" content=\"BioMed Central\">\n    <meta property=\"og:title\" content=\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective - BMC Infectious Diseases\">\n    <meta property=\"og:description\" content=\"Background Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Results Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Conclusions Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta property=\"og:image\" content=\"https://static-content.springer.com/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\">\n    \n\n        \n\n        \n    <script type=\"application/ld+json\">{\"mainEntity\":{\"headline\":\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\",\"description\":\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\",\"datePublished\":\"2018-12-18T00:00:00Z\",\"dateModified\":\"2020-10-13T00:00:00Z\",\"pageStart\":\"1\",\"pageEnd\":\"11\",\"license\":\"http://creativecommons.org/publicdomain/zero/1.0/\",\"sameAs\":\"https://doi.org/10.1186/s12879-018-3565-z\",\"keywords\":[\"CAP\",\"Atypical pathogens\",\"Epidemiology\",\"Infectious Diseases\",\"Parasitology\",\"Medical Microbiology\",\"Tropical Medicine\",\"Internal Medicine\"],\"image\":[\"https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\"],\"isPartOf\":{\"name\":\"BMC Infectious Diseases\",\"issn\":[\"1471-2334\"],\"volumeNumber\":\"18\",\"@type\":[\"Periodical\",\"PublicationVolume\"]},\"publisher\":{\"name\":\"BioMed Central\",\"logo\":{\"url\":\"https://www.springernature.com/app-sn/public/images/logo-springernature.png\",\"@type\":\"ImageObject\"},\"@type\":\"Organization\"},\"author\":[{\"name\":\"Andrea Gramegna\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Giovanni Sotgiu\",\"affiliation\":[{\"name\":\"Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari\",\"address\":{\"name\":\"Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Marta Di Pasquale\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Dejan Radovanovic\",\"affiliation\":[{\"name\":\"University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco\",\"address\":{\"name\":\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Silvia Terraneo\",\"affiliation\":[{\"name\":\"University of Milan\",\"address\":{\"name\":\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Luis F. Reyes\",\"affiliation\":[{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\",\"address\":{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Ester Vendrell\",\"affiliation\":[{\"name\":\"Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme\",\"address\":{\"name\":\"Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Barcelona, Spain\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Joao Neves\",\"affiliation\":[{\"name\":\"Internal Medicine Department, Centro Hospitalar do Porto\",\"address\":{\"name\":\"Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Francesco Menzella\",\"affiliation\":[{\"name\":\"Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova\",\"address\":{\"name\":\"Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Francesco Blasi\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Stefano Aliberti\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"email\":\"stefano.aliberti@unimi.it\",\"@type\":\"Person\"},{\"name\":\"Marcos I. Restrepo\",\"affiliation\":[{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\",\"address\":{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"}],\"isAccessibleForFree\":true,\"@type\":\"ScholarlyArticle\"},\"@context\":\"https://schema.org\",\"@type\":\"WebPage\"}</script>\n\n        \n\n    <style type=\"text/css\">.cc-banner{background-color:#01324b;border:none!important;bottom:0;box-sizing:border-box;color:#fff!important;left:0;line-height:1.3;margin:auto 0 0;max-width:100%;outline:0;overflow:visible;padding:0;position:fixed;right:0;width:100%;z-index:99999}.cc-banner::backdrop{background-color:#0000004d}.cc-banner *{color:inherit!important}.cc-banner:focus{box-shadow:none;outline:0}.cc-banner a{color:#fff!important;text-decoration:underline}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{color:inherit;text-decoration:none}.cc-banner a:focus{outline:3px solid #08c!important}.cc-banner h2,.cc-banner h3,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-banner .cc-h2,.cc-banner h2{font-size:18px}.cc-banner .cc-h3,.cc-banner h3{font-size:16px}.cc-banner .cc-h4,.cc-banner .cc-h5,.cc-banner .cc-h6,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-size:14px}.cc-banner .cc-button{font-size:16px}.cc-banner__content{background-color:#01324b;display:flex;flex-direction:column;margin:0 auto;max-height:90vh;max-width:100%;padding:16px;position:relative}.cc-banner__content:focus{outline:0}@media (min-width:680px){.cc-banner__content{padding:12px}}@media (min-width:980px){.cc-banner__content{max-height:60vh;padding-bottom:20px;padding-top:20px}}@media (min-width:1320px){.cc-banner__content{padding-bottom:40px;padding-top:40px}}.cc-banner__container{display:flex;flex-direction:column;margin:auto;max-width:1320px;overflow:auto}.cc-banner__title{background:none!important;border:0;flex-shrink:0;font-size:18px!important;font-size:22px!important;font-weight:700!important;letter-spacing:normal;margin:0 0 12px!important;padding:0}@media (min-width:680px){.cc-banner__title{font-size:24px!important;margin:0 0 16px!important}}@media (min-width:1320px){.cc-banner__title{font-size:26px!important;margin:0 0 24px!important}}.cc-banner__body{display:flex;flex-direction:column;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;overflow-x:hidden;overflow-y:auto;padding:3px 3px 16px}@media (min-width:980px){.cc-banner__body{flex-direction:row}}.cc-banner__policy p{font-size:16px!important;margin:0;max-width:none;padding:0}.cc-banner__policy p:not(:last-child){margin:0 0 16px}@media (min-width:980px){.cc-banner__policy p:not(:last-child){margin:0 0 24px}}.cc-banner__policy p a{font-size:16px!important;font-weight:700}.cc-banner__footer{box-shadow:none;flex-shrink:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif !important!important;margin:0;padding:12px 0 3px 3px;position:relative}@media (min-width:380px){.cc-banner__footer{align-items:stretch;display:flex;flex-wrap:wrap}}@media (min-width:680px){.cc-banner__footer{box-shadow:none;flex-wrap:nowrap;width:40%}}.cc-banner__footer .cc-banner__button{flex:1 1 auto;font-weight:700;overflow:hidden;padding:.5em 1em;width:100%}@media (min-width:680px){.cc-banner__footer .cc-banner__button{max-width:275px}}.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:12px}@media (min-width:680px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:0;margin-right:16px}}@media (min-width:980px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-right:24px}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-break{display:block}}@media (min-width:680px){.cc-banner--is-tcf .cc-banner__footer{width:auto}}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__footer{padding-right:48px;width:66%}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px!important}.cc-banner--is-tcf .cc-banner__stacks{margin:16px 0 0}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__stacks{display:flex;flex:0 0 33%;flex-direction:column;margin:0 0 0 48px;overflow:auto}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px;margin:0 0 12px}.cc-banner--is-tcf .cc-banner__stacks-details{padding:0 3px}.cc-banner--is-tcf .cc-banner .cc-details{border-color:#fff3!important}.cc-box{border-radius:10px;padding:12px}.cc-box--info{background-color:#eff6fb}.cc-box--light{background-color:#faf9f6}.cc-button{border:2px solid #0000;border-radius:32px!important;color:inherit;cursor:pointer;font-size:14px;font-weight:700!important;left:auto;line-height:1.2;margin:0;padding:.5em 1em;right:auto;text-transform:none!important;transition:all .2s}@media (min-width:680px){.cc-button{font-size:14px;padding:.75em 1em}}.cc-button--sm{font-size:12px;padding:2px 8px!important}.cc-button--primary{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--primary:focus{outline:3px solid #08c}.cc-button--primary:focus,.cc-button--primary:hover,.cc-button--secondary{background-color:#fff!important;border-color:#025e8d!important;color:#025e8d!important}.cc-button--secondary:focus{background-color:#025e8d!important;border-color:#fff!important;color:#fff!important;outline:3px solid #08c!important}.cc-button--secondary:hover{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--secondary:active{border:2px solid #01324b!important}.cc-button--secondary.cc-button--contrast{border-color:#fff!important}.cc-button--secondary.cc-button--contrast:hover{background-color:initial!important;color:#fff!important}.cc-button--tertiary{background-color:#f0f7fc!important;background-image:none;border:2px solid #f0f7fc;color:#025e8d!important;text-decoration:underline!important;text-underline-offset:.25em}.cc-button--tertiary:focus{outline:3px solid #08c!important}.cc-button--tertiary:hover{text-decoration-thickness:.25em}.cc-button--tertiary:active{color:#013c5b}.cc-button--link{background-color:initial!important;border-color:#0000!important;border-radius:0!important;color:inherit!important;padding:0!important;text-decoration:underline!important;width:inherit!important}.cc-button--link:focus{outline:3px solid #08c}.cc-button--link:hover{background-color:initial!important;box-shadow:none;text-decoration:none}.cc-button--text{border-radius:0;padding:0}.cc-button--details{padding-right:24px!important;position:relative;width:auto}.cc-button--details:after,.cc-button--details:before{background-color:currentColor;content:\"\";position:absolute;transition:transform .25s ease-out}.cc-button--details:before{height:10px;margin-top:-5px;right:12px;top:50%;width:2px}.cc-button--details:after{height:2px;margin-top:-1px;right:8px;top:50%;width:10px}.cc-button--details.cc-active:before{transform:rotate(90deg);transform-origin:center}.cc-button--details.cc-active:after{display:none}.cc-details{border-bottom:1px solid #0000001a;padding:12px 0;position:relative;width:100%}.cc-details__summary{align-items:center;display:flex;font-size:14px;font-weight:700;list-style-type:none}.cc-details__summary:focus,.cc-details__summary:focus-visible{outline:3px solid #08c!important;will-change:auto}.cc-details__title{align-items:baseline;display:flex}.cc-details__title h2,.cc-details__title h3,.cc-details__title h4,.cc-details__title h5{line-height:1.4;margin:0!important;padding:0!important}.cc-details__title svg{flex-shrink:0;height:auto;margin-right:8px;position:relative;top:-1px;transition:all .2s;width:auto}.cc-details[open] .cc-details__title svg{top:2px;transform:rotate(90deg)}.cc-details__switch{margin-left:auto}.cc-details__section{padding:16px 0 0 18px}.cc-details__section p{margin:0}.cc-details__section p:not(:last-child){margin-bottom:12px}details summary::-webkit-details-marker{display:none}.cc-radio{align-items:center;display:flex;position:relative}.cc-radio *{cursor:pointer}.cc-radio__input{height:22px;left:0;position:absolute;top:0;width:22px}.cc-radio__input:focus{outline:none}.cc-radio__label{color:inherit;font-size:14px;font-weight:700;line-height:23px;margin:0;padding-left:28px}.cc-radio__label:after,.cc-radio__label:before{background-color:#fff;content:\"\";display:block;position:absolute;transition:transform .25s ease-out}.cc-radio__label:before{border:1px solid #777;border-radius:50%;height:22px;left:0;top:0;width:22px}.cc-radio__label:after{border:7px solid #025e8d;border-radius:50%;height:0;left:4px;opacity:0;top:4px;width:0}.cc-radio__input:focus+.cc-radio__label:before{box-shadow:0 0 0 2px #08c;outline:none}.cc-radio__label--hidden{display:none}.cc-radio__input:checked+.cc-radio__label:after{opacity:1}.cc-radio__input:disabled{cursor:default}.cc-radio__input:disabled+.cc-radio__label{cursor:default;opacity:.5}.cc-switch *{cursor:pointer}.cc-switch{align-items:center;display:flex;line-height:1}.cc-switch__label{cursor:pointer;display:inline-block;font-size:14px;font-weight:700;margin:0;-webkit-user-select:none;user-select:none}.cc-switch__input[type=checkbox]{-webkit-appearance:none;appearance:none;background-color:#fff!important;background-image:url(\"data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='rgba(0, 0, 0, 0.25)'/%3E%3C/svg%3E\")!important;background-position:0!important;background-repeat:no-repeat!important;border:1px solid #777!important;border-radius:16px!important;height:18px!important;margin:0 8px 0 0!important;transition:background-position .2s ease-in-out!important;width:32px!important}.cc-switch__input[type=checkbox]:focus{background-image:url(\"data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%2380b3cc'/%3E%3C/svg%3E\")!important}.cc-switch__input[type=checkbox]:checked{background-color:#025e8d!important;background-image:url(\"data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%23fff'/%3E%3C/svg%3E\")!important;background-position:100%!important}.cc-switch__input[type=checkbox]:checked~.cc-switch__label>.cc-switch__text-off,.cc-switch__input[type=checkbox]:not(:checked)~.cc-switch__label>.cc-switch__text-on{display:none}.cc-switch__input[type=checkbox]:hover{cursor:pointer;outline:none}.cc-switch__input[type=checkbox]:focus-visible{cursor:pointer;outline:3px solid #fc0}.cc-switch__input[type=checkbox]:checked:before{background-color:none!important;color:#0000!important}.cc-list>ul,ul.cc-list{list-style-type:disc;margin-left:0;padding-left:0}.cc-list>ul>li,ul.cc-list>li{margin-left:1em}.cc-list>ul>li:not(:last-child),ul.cc-list>li:not(:last-child){margin-bottom:4px}.cc-list__title{margin-bottom:8px!important}.cc-list--inline>ul,ul.cc-list--inline{display:flex;flex-wrap:wrap;list-style-type:none}.cc-list--inline>ul>li,ul.cc-list--inline>li{margin:0 .5em .5em 0}.cc-overlay{background-color:#0000004d;z-index:99998}.cc-overlay,.cc-preferences{bottom:0;left:0;position:fixed;right:0;top:0}.cc-preferences{background-color:#050a14f2!important;border:0;box-sizing:border-box;color:#111;font-family:sans-serif!important;line-height:1.4;margin:auto;max-height:100vh;overflow:auto;padding:0;z-index:100000}.cc-preferences:focus{outline:none}.cc-preferences *,.cc-preferences :after,.cc-preferences :before{box-sizing:inherit!important}.cc-preferences h2,.cc-preferences h3,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-preferences .cc-h2,.cc-preferences h2{font-size:18px}.cc-preferences .cc-h3,.cc-preferences h3{font-size:16px}.cc-preferences .cc-h4,.cc-preferences .cc-h5,.cc-preferences .cc-h6,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-size:14px}.cc-preferences a{color:#025e8d;text-decoration:underline}.cc-preferences a:hover{color:inherit;text-decoration:none}.cc-preferences h3{background:none;color:#111;padding:0;text-transform:none}dialog.cc-preferences{background-color:initial}dialog.cc-preferences::backdrop{background-color:#000000e6}.cc-preferences__dialog{display:flex;flex-direction:column;margin:auto;max-height:100vh;max-width:860px;padding:12px;position:relative}.cc-preferences__dialog>:last-child{border-bottom-left-radius:10px;border-bottom-right-radius:10px}@media (min-width:980px){.cc-preferences__dialog{padding:16px}}.cc-preferences__close{background:#0000!important;border:1px solid #ececec;border-radius:50%;color:#111!important;cursor:pointer;font-family:Times New Roman,serif;font-size:40px;height:40px;left:auto;line-height:1;margin-top:-20px;padding:0!important;position:absolute;right:20px;top:50%;width:40px}.cc-preferences__close:focus{outline:3px solid #08c}.cc-preferences__close-label{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__header{background:#fff!important;border-bottom:1px solid #0000001a;border-top-left-radius:10px;border-top-right-radius:10px;padding:16px;position:relative;text-align:center}.cc-preferences__title{background:none!important;color:#111!important;font-family:sans-serif!important;font-size:18px!important;font-weight:700!important;margin:0!important;padding:0 16px 0 0!important}@media (min-width:480px){.cc-preferences__title{padding-right:0!important}}@media (min-width:980px){.cc-preferences__title{font-size:22px!important}}.cc-preferences__body{background:#fff!important;flex:1 1 auto;min-height:200px;overflow-x:hidden;overflow-y:auto;padding:16px}.cc-preferences__footer{background:#fff!important;border-top:1px solid #d0d0d0;box-shadow:0 0 5px 0 #0003;margin-bottom:0;padding:12px;position:relative}@media (min-width:480px){.cc-preferences__footer{align-items:stretch;display:flex}}.cc-preferences__footer>.cc-button{display:block;width:100%}@media (min-width:480px){.cc-preferences__footer>.cc-button{flex:1 1 auto}}@media (min-width:980px){.cc-preferences__footer>.cc-button{flex-basis:auto}}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:first-child){margin-left:12px}}.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:8px}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:0}}.cc-preferences__categories{list-style:none;margin:0;padding:0}.cc-preferences__category:not(:last-child){border-bottom:1px solid #0000001a;margin-bottom:12px;padding-bottom:12px}.cc-preferences__category-description{font-size:14px;margin:0 0 8px;padding:0}.cc-preferences__category-footer{align-items:center;display:flex;justify-content:space-between}.cc-preferences__status{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__controls{display:flex;margin:0}.cc-preferences__controls>:not(:last-child){margin-right:12px}.cc-preferences__always-on{font-size:14px;font-weight:700;padding-left:26px;position:relative}.cc-preferences__always-on:before{background:#0000!important;border:solid;border-top-color:#0000;border-width:0 0 4px 4px;content:\"\";display:block;height:10px;left:0;position:absolute;top:2px;transform:rotate(-45deg);width:18px}.cc-preferences__details{background-color:#eff6fb!important;border-radius:10px;font-size:14px;margin:12px 0 0;padding:12px}.cc-preferences__cookie-list,.cc-preferences__provider-list{list-style:none;margin:0;padding:0}.cc-preferences__provider-list{columns:170px}.cc-preferences__cookie-title{font-size:1em;margin:0}.cc-preferences__cookie-description{font-size:1em;margin:0 0 8px}.cc-preferences__cookie-domain,.cc-preferences__cookie-lifespan{border-left:1px solid #999;color:#666;margin-left:8px;padding-left:4px}body.cc-has-preferences-open{overflow:hidden;position:relative}.cc-table{border-collapse:collapse;width:100%}.cc-table tbody tr{border-top:1px solid #0000001a}.cc-table td,.cc-table th{font-size:14px;padding:4px 8px;vertical-align:top}.cc-table+.cc-table{margin-top:8px}.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:70%}@media (min-width:680px){.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:80%}}.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{padding-left:8px;width:40%}@media (min-width:680px){.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{width:30%}}.cc-tabs,.cc-tabs>ul{background-color:#faf9f6;display:flex;list-style:none;margin:0;padding:0}.cc-tabs__panel{border-top:1px solid #ececec;margin-top:-1px}.cc-tabs__button{background-color:initial;border:0;border-left:1px solid #0000;border-right:1px solid #0000;color:#111;font-size:16px;font-weight:700;margin:0;padding:15px 16px 12px;position:relative}.cc-tabs__button:before{background-color:initial;content:\"\";display:block;height:3px;left:0;position:absolute;top:0;width:100%}.cc-tabs__button.cc-active{background-color:#fff;border-color:#025e8d #ececec #ececec;color:#111}.cc-tabs__button.cc-active:before{background-color:#025e8d}.cc-tabs__content{background-color:#fff;display:none;font-size:14px;padding:16px}.cc-tabs__section:not(:first-child){padding-top:24px}.cc-tcf{font-size:14px;margin-top:16px}.cc-tcf__list{list-style:none;margin:0;padding:0}.cc-vendor-count{color:#666;font-size:16px;margin:0 0 8px}.cc-hide{display:none!important}.cc-show{display:block!important}.cc-external-link{background-color:#ececec;background-image:url(\"data:image/svg+xml;base64,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\");background-position:right 8px center;background-repeat:no-repeat;background-size:10px auto;border-radius:3px;box-shadow:0 1px 0 #0003;color:#111!important;display:inline-block;font-size:12px;padding:4px 26px 4px 8px;text-decoration:none!important}.cc-external-link:hover{text-decoration:underline!important}.cc-m-0{margin:0!important}.cc-grey{color:#666}</style><style type=\"text/css\">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}\n.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}\n.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}\n.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}\n.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}\n</style><style type=\"text/css\">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}\n#MathJax_About.MathJax_MousePost {outline: none}\n.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}\n.MathJax_MenuItem {padding: 2px 2em; background: transparent}\n.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}\n.MathJax_MenuActive .MathJax_MenuArrow {color: white}\n.MathJax_MenuArrow.RTL {left: .5em; right: auto}\n.MathJax_MenuCheck {position: absolute; left: .7em}\n.MathJax_MenuCheck.RTL {right: .7em; left: auto}\n.MathJax_MenuRadioCheck {position: absolute; left: 1em}\n.MathJax_MenuRadioCheck.RTL {right: 1em; left: auto}\n.MathJax_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic}\n.MathJax_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px}\n.MathJax_MenuDisabled {color: GrayText}\n.MathJax_MenuActive {background-color: Highlight; color: HighlightText}\n.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}\n.MathJax_ContextMenu:focus {outline: none}\n.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}\n#MathJax_AboutClose {top: .2em; right: .2em}\n.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}\n.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}\n.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}\n.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}\n.MathJax_MenuClose:hover span {background-color: #CCC!important}\n.MathJax_MenuClose:hover:focus {outline: none}\n</style><style type=\"text/css\">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}\n.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}\n</style><style type=\"text/css\">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}\n#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}\n#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}\n#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}\n</style><style type=\"text/css\">.MathJax_Preview {color: #888}\n#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}\n#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}\n.MathJax_Error {color: #CC0000; font-style: italic}\n</style><style type=\"text/css\">.MJXp-script {font-size: .8em}\n.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}\n.MJXp-bold {font-weight: bold}\n.MJXp-italic {font-style: italic}\n.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-largeop {font-size: 150%}\n.MJXp-largeop.MJXp-int {vertical-align: -.2em}\n.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}\n.MJXp-display {display: block; text-align: center; margin: 1em 0}\n.MJXp-math span {display: inline-block}\n.MJXp-box {display: block!important; text-align: center}\n.MJXp-box:after {content: \" \"}\n.MJXp-rule {display: block!important; margin-top: .1em}\n.MJXp-char {display: block!important}\n.MJXp-mo {margin: 0 .15em}\n.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}\n.MJXp-denom {display: inline-table!important; width: 100%}\n.MJXp-denom > * {display: table-row!important}\n.MJXp-surd {vertical-align: top}\n.MJXp-surd > * {display: block!important}\n.MJXp-script-box > *  {display: table!important; height: 50%}\n.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}\n.MJXp-script-box > *:last-child > * {vertical-align: bottom}\n.MJXp-script-box > * > * > * {display: block!important}\n.MJXp-mphantom {visibility: hidden}\n.MJXp-munderover, .MJXp-munder {display: inline-table!important}\n.MJXp-over {display: inline-block!important; text-align: center}\n.MJXp-over > * {display: block!important}\n.MJXp-munderover > *, .MJXp-munder > * {display: table-row!important}\n.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}\n.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}\n.MJXp-mtr {display: table-row!important}\n.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}\n.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}\n.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}\n.MJXp-mlabeledtr {display: table-row!important}\n.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}\n.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}\n.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}\n.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}\n.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}\n.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}\n.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}\n.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}\n.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}\n.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}\n.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}\n.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}\n.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}\n.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}\n</style></head>\n\n    <body class=\"journal journal-fulltext\"><div id=\"MathJax_Message\" style=\"display: none;\"></div><dialog class=\"cc-banner\" data-cc-banner=\"\" data-nosnippet=\"\" aria-labelledby=\"cc-banner-label\" open=\"\">\n\t\t<div class=\"cc-banner__content\" autofocus=\"\" tabindex=\"-1\">\n\t\t\t<div class=\"cc-banner__container\">\n\t\t\t\t<div class=\"cc-banner__header\">\n\t\t\t\t\t<h2 class=\"cc-banner__title\" id=\"cc-banner-label\">Your privacy, your choice</h2>\n\t\t\t\t</div>\n\t\t\t\t<div class=\"cc-banner__body\">\n\t\t\t\t\t<div class=\"cc-banner__policy\">\n\t\t\t\t\t\t<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href=\"https://www.biomedcentral.com/privacy-statement\" data-cc-action=\"privacy\">privacy policy</a> for more information on the use of your personal data.</p><p><button type=\"button\" data-cc-action=\"preferences\" class=\"cc-button cc-button--link cc-button--text\">Manage preferences</button> for further information and to change your choices.</p>\n\t\t\t\t\t</div>\n\t\t\t\t\t\n\t\t\t\t</div>\n\t\t\t\t<div class=\"cc-banner__footer\">\n\t\t\t\t\t\n\t\t\t<button data-cc-action=\"accept\" class=\"cc-button cc-button--secondary cc-button--contrast cc-banner__button cc-banner__button-accept\">Accept all cookies</button>\n\t\t\t\n\t\t\n\t\t\t\t</div>\n\t\t\t</div>\n\t\t</div>\n\t</dialog>\n        <div class=\"ctm\"></div> \n        \n    \n        \n            <!-- Google Tag Manager (noscript) -->\n            <noscript>\n                <iframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ\"\n                        height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"></iframe>\n            </noscript>\n            <!-- End Google Tag Manager (noscript) -->\n        \n    \n\n        <div class=\"u-visually-hidden\" aria-hidden=\"true\">\n    \n    <!--?xml version=\"1.0\" encoding=\"UTF-8\"?--><svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><defs><path id=\"a\" d=\"M0 .74h56.72v55.24H0z\"></path></defs><symbol id=\"icon-access\" viewBox=\"0 0 18 18\"><path d=\"m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-account\" viewBox=\"0 0 18 18\"><path d=\"m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-alert\" viewBox=\"0 0 18 18\"><path d=\"m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-broad\" viewBox=\"0 0 16 16\"><path d=\"m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 14 15)\"></path></symbol><symbol id=\"icon-arrow-down\" viewBox=\"0 0 16 16\"><path d=\"m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-left\" viewBox=\"0 0 16 16\"><path d=\"m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-right\" viewBox=\"0 0 16 16\"><path d=\"m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-sub\" viewBox=\"0 0 16 16\"><path d=\"m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-up\" viewBox=\"0 0 16 16\"><path d=\"m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-article\" viewBox=\"0 0 18 18\"><path d=\"m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-audio\" viewBox=\"0 0 18 18\"><path d=\"m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-block\" viewBox=\"0 0 24 24\"><path d=\"m0 0h24v24h-24z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-book\" viewBox=\"0 0 18 18\"><path d=\"m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-broad\" viewBox=\"0 0 24 24\"><path d=\"m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 20.182742 24.805206)\"></path></symbol><symbol id=\"icon-calendar\" viewBox=\"0 0 18 18\"><path d=\"m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-cart\" viewBox=\"0 0 18 18\"><path d=\"m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z\"></path></symbol><symbol id=\"icon-chevron-less\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 -1 0 9 9)\"></path></symbol><symbol id=\"icon-chevron-more\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 1)\"></path></symbol><symbol id=\"icon-chevron-right\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-circle-fill\" viewBox=\"0 0 16 16\"><path d=\"m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-circle\" viewBox=\"0 0 16 16\"><path d=\"m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-citation\" viewBox=\"0 0 18 18\"><path d=\"m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-close\" viewBox=\"0 0 16 16\"><path d=\"m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-collections\" viewBox=\"0 0 18 18\"><path d=\"m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-compare\" viewBox=\"0 0 18 18\"><path d=\"m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download-file\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download\" viewBox=\"0 0 16 16\"><path d=\"m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-editors\" viewBox=\"0 0 18 18\"><path d=\"m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-email\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-error\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-ethics\" viewBox=\"0 0 18 18\"><path d=\"m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-expand\"><path d=\"M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-explore\" viewBox=\"0 0 18 18\"><path d=\"m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-filter\" viewBox=\"0 0 16 16\"><path d=\"m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z\"></path></symbol><symbol id=\"icon-home\" viewBox=\"0 0 18 18\"><path d=\"m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-image\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-info\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-institution\" viewBox=\"0 0 18 18\"><path d=\"m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-location\" viewBox=\"0 0 18 18\"><path d=\"m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-minus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-newsletter\" viewBox=\"0 0 18 18\"><path d=\"m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-orcid\" viewBox=\"0 0 18 18\"><path d=\"m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-plus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-print\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-search\" viewBox=\"0 0 22 22\"><path d=\"M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-facebook\" viewBox=\"0 0 24 24\"><path d=\"m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-twitter\" viewBox=\"0 0 24 24\"><path d=\"m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-youtube\" viewBox=\"0 0 24 24\"><path d=\"m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-subject-medicine\" viewBox=\"0 0 18 18\"><path d=\"m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-success\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-table\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick-circle\" viewBox=\"0 0 24 24\"><path d=\"m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick\" viewBox=\"0 0 16 16\"><path d=\"m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-update\" viewBox=\"0 0 18 18\"><path d=\"m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-upload\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-video\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-warning\" viewBox=\"0 0 18 18\"><path d=\"m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-left-bullet\" viewBox=\"0 0 8 16\"><path d=\"M3 8l5 5v3L0 8l8-8v3L3 8z\"></path></symbol><symbol id=\"icon-chevron-down\" viewBox=\"0 0 16 16\"><path d=\"m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 3)\"></path></symbol><symbol id=\"icon-download-rounded\"><path d=\"M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z\"></path></symbol><symbol id=\"icon-ext-link\" viewBox=\"0 0 16 16\"><path d=\"M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z\"></path><path d=\"M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z\"></path><path d=\"M9.7 0L16 6.2V0z\"></path></symbol><symbol id=\"icon-remove\" viewBox=\"-296 388 18 18\"><path d=\"M-291.7 396.1h9v2h-9z\"></path><path d=\"M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z\"></path></symbol><symbol id=\"icon-rss\" viewBox=\"0 0 18 18\"><path d=\"m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-springer-arrow-left\"><path d=\"M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z\"></path></symbol><symbol id=\"icon-springer-arrow-right\"><path d=\"M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z\"></path></symbol><symbol id=\"icon-springer-collections\" viewBox=\"3 3 32 32\"><path fill-rule=\"evenodd\" d=\"M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z\"></path></symbol><symbol id=\"icon-springer-download\" viewBox=\"-301 390 9 14\"><path d=\"M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z\"></path></symbol><symbol id=\"icon-springer-info\" viewBox=\"0 0 24 24\"><!--Generator: Sketch 63.1 (92452) - https://sketch.com--><g id=\"V&amp;I\" stroke=\"none\" stroke-width=\"1\" fill-rule=\"evenodd\"><g id=\"info\" fill-rule=\"nonzero\"><path d=\"M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z\" id=\"Combined-Shape\"></path></g></g></symbol><symbol id=\"icon-springer-tick-circle\" viewBox=\"0 0 24 24\"><g id=\"Page-1\" stroke=\"none\" stroke-width=\"1\" fill-rule=\"evenodd\"><g id=\"springer-tick-circle\" fill-rule=\"nonzero\"><path d=\"M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z\" id=\"path-1\"></path></g></g></symbol><symbol id=\"icon-updates\" viewBox=\"0 0 18 18\"><g fill-rule=\"nonzero\"><path d=\"M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z\"></path><path d=\"M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z\"></path></g></symbol><symbol id=\"icon-checklist-banner\" viewBox=\"0 0 56.69 56.69\"><path style=\"fill:none\" d=\"M0 0h56.69v56.69H0z\"></path><clipPath id=\"b\"><use xlink:href=\"#a\" style=\"overflow:visible\"></use></clipPath><path d=\"M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round\"></path><path d=\"M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round\"></path></symbol><symbol id=\"icon-submit-closed\" viewBox=\"0 0 18 18\"><path d=\"m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-3.03756612 2.46243388-5.5 5.5-5.5zm0 1c-2.4852814 0-4.5 2.0147186-4.5 4.5s2.0147186 4.5 4.5 4.5 4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5zm2.3087379 2.1912621c.2550161.2550162.2550161.668479 0 .9234952l-1.3859024 1.3845831 1.3859024 1.3859023c.2550161.2550162.2550161.668479 0 .9234952-.2550162.2550161-.668479.2550161-.9234952 0l-1.3859023-1.3859024-1.3845831 1.3859024c-.2550162.2550161-.668479.2550161-.9234952 0-.25501614-.2550162-.25501614-.668479 0-.9234952l1.3845831-1.3859023-1.3845831-1.3845831c-.25501614-.2550162-.25501614-.668479 0-.9234952.2550162-.25501614.668479-.25501614.9234952 0l1.3845831 1.3845831 1.3859023-1.3845831c.2550162-.25501614.668479-.25501614.9234952 0zm-9.8087379-8.7782621-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z\"></path></symbol><symbol id=\"icon-submit-open\" viewBox=\"0 0 18 18\"><path d=\"m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\"></path></symbol><symbol id=\"icon-submit-upcoming\" viewBox=\"0 0 18 18\"><path d=\"m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-1.6607442.73606908-3.14957021 1.89976608-4.15803695l-1.51549374.02214397c-.27613212.00263356-.49998143-.22483432-.49998143-.49020681 0-.24299316.17766103-.44509007.40961587-.48700057l.08928713-.00797472h2.66407569c.2449213 0 .4486219.17766776.490865.40963137l.008038.08929051v2.6642143c0 .275547-.2296028.4989219-.4949753.4989219-.24299317 0-.44342617-.1744719-.4830969-.4093269l-.00710993-.0906783.01983146-1.46576707c-.96740882.82538117-1.58082193 2.05345007-1.58082193 3.42478927 0 2.4852814 2.0147186 4.5 4.5 4.5s4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5c-.7684937 0-.7684937-1 0-1zm0 2.85c.3263501 0 .5965265.2405082.6429523.5539478l.0070477.0960522v1.731l.8096194.8093806c.2284567.2284567.2513024.5846637.068537.8386705l-.068537.0805683c-.2284567.2284567-.5846637.2513024-.8386705.068537l-.0805683-.068537-.9707107-.9707107c-.1125218-.1125218-.1855975-.257116-.2103268-.412296l-.0093431-.1180341v-1.9585786c0-.3589851.2910149-.65.65-.65zm-7.5-8.437-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z\"></path></symbol><symbol id=\"icon-facebook-bordered\" viewBox=\"463.812 263.868 32 32\"><path d=\"M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z\n\t M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z\"></path><path d=\"M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213\n\tc-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354\n\tL483.025,280.48L483.025,280.48z\"></path></symbol><symbol id=\"icon-twitter-bordered\" viewBox=\"463.812 263.868 32 32\"><g><path d=\"M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502\n\t\tc-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71\n\t\tc0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361\n\t\tc0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656\n\t\tc-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883\n\t\tc-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215\n\t\tc4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z\"></path></g><path d=\"M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z\n\t M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z\"></path></symbol><symbol id=\"icon-weibo-bordered\" viewBox=\"463.812 263.868 32 32\"><path d=\"M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z\n\t M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z\"></path><g><path d=\"M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588\n\t\tc2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63\n\t\tc-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021\n\t\tc0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027\n\t\tc-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493\n\t\tC485.697,280.594,484.689,279.911,483.782,279.63\"></path><path d=\"M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72\n\t\tc0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0\n\t\tc-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833\n\t\t\"></path><path d=\"M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621\n\t\tc0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0\n\t\tc-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276\"></path><path d=\"M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389\n\t\tc0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301\n\t\tc-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393\n\t\tC477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396\n\t\tc-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437\"></path></g></symbol></svg>\n</div>\n\n\n        \n\n        \n\n    <div class=\"u-vh-full\">\n        <a class=\"c-skip-link\" href=\"#main-content\">Skip to main content</a>\n        \n            \n    \n        <div class=\"u-hide u-show-following-ad\"></div>\n    \n    <aside class=\"adsbox c-ad c-ad--728x90\" data-component-mpu=\"\">\n        <div class=\"c-ad__inner\">\n            <p class=\"c-ad__label\">Advertisement</p>\n            <div id=\"div-gpt-ad-LB1\" data-ad-type=\"LB1\" data-test=\"LB1-ad\" data-pa11y-ignore=\"\" data-gpt=\"\" data-gpt-unitpath=\"/270604982/bmc/bmcinfectdis/articles\" data-gpt-sizes=\"728x90,970x90\" data-gpt-targeting=\"pos=LB1;doi=10.1186/s12879-018-3565-z;type=article;kwrd=CAP,Atypical pathogens,Epidemiology;pmc=H33096,B19002,B16003,H61006,H33002;\">\n                <noscript>\n                    <a href=\"//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\">\n                        <img data-test=\"gpt-advert-fallback-img\"\n                            src=\"//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\"\n                            alt=\"Advertisement\"\n                            width=\"728\"\n                            height=\"90\">\n                    </a>\n                </noscript>\n            </div>\n        </div>\n    </aside>\n\n        \n        \n\n         \n    \n        <div id=\"membership-message-loader-desktop\" class=\"placeholder\" data-placeholder=\"/placeholder/v1/membership/message\"></div>\n    \n    \n        <div id=\"top\" class=\"u-position-relative\">\n    <header class=\"c-header\" data-test=\"publisher-header\">\n        <div class=\"c-header__container\">\n            <div class=\"c-header__brand u-mr-48\" itemscope=\"\" itemtype=\"http://schema.org/Organization\" data-test=\"navbar-logo-header\">\n                <div class=\"c-logo\">\n    <a href=\"https://www.biomedcentral.com\" itemprop=\"url\">\n        <img alt=\"BMC\" itemprop=\"logo\" width=\"76\" height=\"18\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-series-d1f4e4f0a7.svg\">\n        <div class=\"c-logo__strapline\">\n            <img alt=\"Part of Springer Nature\" width=\"173\" height=\"16\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg\">\n        </div>\n    </a>\n</div>\n\n            </div>\n            <div class=\"c-header__navigation\">\n                <button type=\"button\" class=\"c-header__link u-button-reset u-mr-24\" data-expander=\"\" data-expander-target=\"#publisher-header-search\" data-expander-autofocus=\"firstTabbable\" data-test=\"header-search-button\" aria-controls=\"publisher-header-search\" aria-expanded=\"false\" aria-haspopup=\"true\">\n                    <span class=\"u-display-flex u-align-items-center\">\n                        <span>Search</span>\n                        <svg class=\"u-icon u-flex-static u-ml-8\" aria-hidden=\"true\" focusable=\"false\">\n                            <use xlink:href=\"#icon-search\"></use>\n                        </svg>\n                    </span>\n                </button>\n                <nav>\n                    <ul class=\"c-header__menu u-hide-at-lt-lg\" data-enhanced-menu=\"\" data-test=\"publisher-navigation\">\n                        \n                            \n                                <li class=\"c-header__item u-hide-at-lt-lg\">\n                                    <a class=\"c-header__link\" href=\"//www.biomedcentral.com/journals\">\n                                        Explore journals\n                                    </a>\n                                </li>\n                            \n                                <li class=\"c-header__item u-hide-at-lt-lg\">\n                                    <a class=\"c-header__link\" href=\"//www.biomedcentral.com/getpublished\">\n                                        Get published\n                                    </a>\n                                </li>\n                            \n                                <li class=\"c-header__item u-hide-at-lt-lg\">\n                                    <a class=\"c-header__link\" href=\"//www.biomedcentral.com/about\">\n                                        About BMC\n                                    </a>\n                                </li>\n                            \n                        \n                        <li class=\"c-header__item\">\n                            <a href=\"/login\" class=\"c-header__link\">Login</a>\n                        </li>\n                    </ul><div class=\"c-dropdown u-hide-at-lg\"><button class=\"c-dropdown__button c-header__item\" aria-expanded=\"false\" aria-haspopup=\"true\">Menu</button><ul class=\"c-dropdown__menu u-hide c-dropdown__menu--right\"><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://www.biomedcentral.com/journals\">\n                                        Explore journals\n                                    </a></li><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://www.biomedcentral.com/getpublished\">\n                                        Get published\n                                    </a></li><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://www.biomedcentral.com/about\">\n                                        About BMC\n                                    </a></li><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://bmcinfectdis.biomedcentral.com/login\">Login</a></li></ul></div>\n                </nav>\n            </div>\n        </div>\n    </header>\n    <div class=\"c-popup-search u-js-hide\" id=\"publisher-header-search\" hidden=\"\">\n        <div class=\"u-container\">\n            <div class=\"c-popup-search__container\">\n                <div class=\"ctx-search\">\n    <form role=\"search\" class=\"c-form-field js-skip-validation\" method=\"GET\" action=\"//www.biomedcentral.com/search\" data-track=\"search\" data-track-context=\"pop out website-wide search in bmc website header\" data-track-category=\"Search and Results\" data-track-action=\"Submit search\" data-dynamic-track-label=\"\" data-track-label=\"\" data-test=\"global-search\">\n        <label for=\"publisherSearch\" class=\"c-form-field__label\">Search all BMC articles</label>\n        <div class=\"u-display-flex\">\n            <input id=\"publisherSearch\" class=\"c-form-field__input\" data-search-input=\"\" autocomplete=\"off\" role=\"textbox\" data-test=\"search-input\" name=\"query\" type=\"text\" value=\"\">\n            <div>\n                <button class=\"u-button\" type=\"submit\" data-test=\"search-submit-button\">\n    <span class=\"u-visually-hidden\">Search</span>\n    <svg class=\"u-icon u-flex-static\" width=\"16\" height=\"16\" aria-hidden=\"true\" focusable=\"false\">\n        <use xlink:href=\"#icon-search\"></use>\n    </svg>\n</button>\n\n\n            </div>\n        </div>\n        <input type=\"hidden\" name=\"searchType\" value=\"publisherSearch\">\n    </form>\n</div>\n\n            </div>\n        </div>\n    </div>\n</div>\n\n    \n\n        \n            <header class=\"c-journal-header c-journal-header--bmc-infectious-diseases ctx-journal-header\">\n                <div class=\"u-container\">\n                    <div class=\"c-journal-header__inner \">\n                        \n                        <div class=\"c-journal-title\" id=\"journalTitle\">\n                            <a href=\"/\">\n    \n        \n    \n    <span class=\"c-journal-title__text \">BMC Infectious Diseases</span>\n    \n</a>\n                        </div>\n                        \n                    </div>\n                </div>\n                <div class=\"c-navbar c-navbar--with-submit-button\">\n                    <div class=\"c-navbar__container\">\n                        \n                            <div class=\"c-navbar__content\">\n                                <nav class=\"c-navbar__nav\">\n                                    <ul class=\"c-navbar__nav c-navbar__nav--journal\" role=\"menu\" data-test=\"site-navigation\">\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Home\" data-track-action=\"Clicked journal navigation link\" href=\"/\">Home</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"About\" data-track-action=\"Clicked journal navigation link\" href=\"/about\">About</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link c-navbar__link--is-shown\" data-track=\"click\" data-track-category=\"Articles\" data-track-action=\"Clicked journal navigation link\" href=\"/articles\">Articles</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Submission Guidelines\" data-track-action=\"Clicked journal navigation link\" href=\"/submission-guidelines\">Submission Guidelines</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Join the board\" data-track-action=\"Clicked journal navigation link\" href=\"/join-our-editorial-board\">Join the board</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Collections\" data-track-action=\"Clicked journal navigation link\" href=\"/articles/collections\">Collections</a>\n                                            </li>\n                                        \n                                        \n                                            \n                                                <li class=\"c-navbar__item\" role=\"menuitem\" data-test=\"journal-header-submit-button\">\n                                                    \n    \n\n    \n        <div class=\"\">\n            \n        <a class=\"u-button u-button--tertiary u-button--alt-colour-on-mobile\" href=\"https://submission.nature.com/new-submission/12879/3\" data-track=\"click_submit_manuscript\" data-track-action=\"manuscript submission\" data-track-category=\"article\" data-track-label=\"button in journal nav\" data-track-context=\"journal header on article page\" data-track-external=\"\" data-gtm-criteo=\"submit-manuscript\" data-test=\"submit-manuscript-button\">Submit manuscript<svg class=\"u-ml-8\" width=\"15\" height=\"16\" aria-hidden=\"true\" focusable=\"false\"><use xlink:href=\"#icon-submit-open\"></use></svg></a>\n    \n        </div>\n    \n\n\n                                                </li>\n                                            \n                                        \n                                    </ul>\n                                </nav>\n                            </div>\n                        \n                    </div>\n                </div>\n                <div class=\"c-journal-header__identity c-journal-header__identity--default\">\n                    \n                </div>\n            </header>\n            \n        \n\n        <div class=\"u-container u-mt-32 u-mb-32 u-clearfix\" id=\"main-content\" data-component=\"article-container\">\n            <main class=\"c-article-main-column u-float-left js-main-column\" data-track-component=\"article body\">\n                <div class=\"c-context-bar u-hide\" data-test=\"context-bar\" data-context-bar=\"\" aria-hidden=\"true\">\n                    <div class=\"c-context-bar__container u-container\" data-track-context=\"sticky banner\">\n                        <div class=\"c-context-bar__title\">\n                            Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\n                        </div>\n                        <div class=\"c-pdf-container\">\n                            \n    <div class=\"c-pdf-download u-clear-both\">\n        <a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\" class=\"u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link\" data-article-pdf=\"true\" data-readcube-pdf-url=\"true\" data-test=\"pdf-link\" data-draft-ignore=\"true\" data-track=\"content_download\" data-track-type=\"article pdf download\" data-track-action=\"download pdf\" data-track-label=\"link\" data-track-external=\"\" download=\"\">\n            <span class=\"c-pdf-download__text\">Download PDF</span>\n            <svg aria-hidden=\"true\" focusable=\"false\" width=\"16\" height=\"16\" class=\"u-icon\"><use xlink:href=\"#icon-download\"></use></svg>\n        </a>\n    </div>\n\n                            \n                        </div>\n                    </div>\n                </div>\n\n                <div class=\"c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile\">\n                    <div class=\"c-pdf-container\" data-track-context=\"article body\">\n                        \n    <div class=\"c-pdf-download u-clear-both\">\n        <a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\" class=\"u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link\" data-article-pdf=\"true\" data-readcube-pdf-url=\"true\" data-test=\"pdf-link\" data-draft-ignore=\"true\" data-track=\"content_download\" data-track-type=\"article pdf download\" data-track-action=\"download pdf\" data-track-label=\"link\" data-track-external=\"\" download=\"\">\n            <span class=\"c-pdf-download__text\">Download PDF</span>\n            <svg aria-hidden=\"true\" focusable=\"false\" width=\"16\" height=\"16\" class=\"u-icon\"><use xlink:href=\"#icon-download\"></use></svg>\n        </a>\n    </div>\n\n                        \n                    </div>\n                </div>\n                <article lang=\"en\">\n                    <div class=\"c-article-header\">\n                        \n    \n\n\n                        <ul class=\"c-article-identifiers\" data-test=\"article-identifier\">\n                            \n        <li class=\"c-article-identifiers__item\" data-test=\"article-category\">Research article</li>\n    \n        <li class=\"c-article-identifiers__item\">\n            <a href=\"https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research\" data-track=\"click\" data-track-action=\"open access\" data-track-label=\"link\" class=\"u-color-open-access\" data-test=\"open-access\">Open access</a>\n        </li>\n    \n    \n\n                            <li class=\"c-article-identifiers__item\">Published: <time datetime=\"2018-12-18\">18 December 2018</time></li>\n                        </ul>\n\n                        <h1 class=\"c-article-title\" data-test=\"article-title\" data-article-title=\"\">Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective</h1>\n                        <ul class=\"c-article-author-list c-article-author-list--short js-no-scroll\" data-test=\"authors-list\" data-component-authors-activator=\"authors-list\"><li class=\"c-article-author-list__item\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Andrea-Gramegna-Aff1\" data-author-popup=\"auth-Andrea-Gramegna-Aff1\" data-author-search=\"Gramegna, Andrea\" data-track-context=\"researcher popup with no profile\" data-track-index=\"1_13\">Andrea Gramegna</a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup>, </li><li class=\"c-article-author-list__item\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Giovanni-Sotgiu-Aff2\" data-author-popup=\"auth-Giovanni-Sotgiu-Aff2\" data-author-search=\"Sotgiu, Giovanni\" data-track-context=\"researcher popup with no profile\" data-track-index=\"2_13\">Giovanni Sotgiu</a><sup class=\"u-js-hide\"><a href=\"#Aff2\" tabindex=\"-1\">2</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Marta-Pasquale-Aff1\" data-author-popup=\"auth-Marta-Pasquale-Aff1\" data-author-search=\"Di Pasquale, Marta\" data-track-context=\"researcher popup with no profile\" data-track-index=\"3_13\">Marta Di Pasquale</a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Dejan-Radovanovic-Aff3\" data-author-popup=\"auth-Dejan-Radovanovic-Aff3\" data-author-search=\"Radovanovic, Dejan\" data-track-context=\"researcher popup with no profile\" data-track-index=\"4_13\">Dejan Radovanovic</a><sup class=\"u-js-hide\"><a href=\"#Aff3\" tabindex=\"-1\">3</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Silvia-Terraneo-Aff4\" data-author-popup=\"auth-Silvia-Terraneo-Aff4\" data-author-search=\"Terraneo, Silvia\" data-track-context=\"researcher popup with no profile\" data-track-index=\"5_13\">Silvia Terraneo</a><sup class=\"u-js-hide\"><a href=\"#Aff4\" tabindex=\"-1\">4</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Luis_F_-Reyes-Aff5\" data-author-popup=\"auth-Luis_F_-Reyes-Aff5\" data-author-search=\"Reyes, Luis F.\" data-track-context=\"researcher popup with no profile\" data-track-index=\"6_13\">Luis F. Reyes</a><sup class=\"u-js-hide\"><a href=\"#Aff5\" tabindex=\"-1\">5</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Ester-Vendrell-Aff6\" data-author-popup=\"auth-Ester-Vendrell-Aff6\" data-author-search=\"Vendrell, Ester\" data-track-context=\"researcher popup with no profile\" data-track-index=\"7_13\">Ester Vendrell</a><sup class=\"u-js-hide\"><a href=\"#Aff6\" tabindex=\"-1\">6</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Joao-Neves-Aff7\" data-author-popup=\"auth-Joao-Neves-Aff7\" data-author-search=\"Neves, Joao\" data-track-context=\"researcher popup with no profile\" data-track-index=\"8_13\">Joao Neves</a><sup class=\"u-js-hide\"><a href=\"#Aff7\" tabindex=\"-1\">7</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Francesco-Menzella-Aff8\" data-author-popup=\"auth-Francesco-Menzella-Aff8\" data-author-search=\"Menzella, Francesco\" data-track-context=\"researcher popup with no profile\" data-track-index=\"9_13\">Francesco Menzella</a><sup class=\"u-js-hide\"><a href=\"#Aff8\" tabindex=\"-1\">8</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Francesco-Blasi-Aff1\" data-author-popup=\"auth-Francesco-Blasi-Aff1\" data-author-search=\"Blasi, Francesco\" data-track-context=\"researcher popup with no profile\" data-track-index=\"10_13\">Francesco Blasi</a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Stefano-Aliberti-Aff1\" data-author-popup=\"auth-Stefano-Aliberti-Aff1\" data-author-search=\"Aliberti, Stefano\" data-corresp-id=\"c1\" data-track-context=\"researcher popup with no profile\" data-track-index=\"11_13\">Stefano Aliberti<svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-mail-medium\"></use></svg></a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup> &amp; </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Marcos_I_-Restrepo-Aff5\" data-author-popup=\"auth-Marcos_I_-Restrepo-Aff5\" data-author-search=\"Restrepo, Marcos I.\" data-track-context=\"researcher popup with no profile\" data-track-index=\"12_13\">Marcos I. Restrepo</a><sup class=\"u-js-hide\"><a href=\"#Aff5\" tabindex=\"-1\">5</a></sup> </li><li class=\"c-article-author-list__item\"><a data-test=\"author-name\" data-author-popup=\"group-1\" href=\"#group-1\" data-track-context=\"researcher popup with no profile\" data-track-index=\"13_13\">on behalf of the GLIMP Study Group</a></li></ul><button aria-expanded=\"false\" class=\"c-article-author-list__button\"><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-down-medium\"></use></svg><span>Show authors</span></button>\n                        <p class=\"c-article-info-details\" data-container-section=\"info\">\n                            \n    <a data-test=\"journal-link\" href=\"/\" data-track=\"click\" data-track-action=\"journal homepage\" data-track-category=\"article body\" data-track-label=\"link\"><i data-test=\"journal-title\">BMC Infectious Diseases</i></a>\n\n                            <b data-test=\"journal-volume\"><span class=\"u-visually-hidden\">volume</span>&nbsp;18</b>, Article&nbsp;number:&nbsp;<span data-test=\"article-number\">677</span> (<span data-test=\"article-publication-year\">2018</span>)\n            <a href=\"#citeas\" class=\"c-article-info-details__cite-as u-hide-print\" data-track=\"click\" data-track-action=\"cite this article\" data-track-label=\"link\">Cite this article</a>\n                        </p>\n                        \n        <div class=\"c-article-metrics-bar__wrapper u-clear-both\">\n            <ul class=\"c-article-metrics-bar u-list-reset\">\n                \n                    <li class=\" c-article-metrics-bar__item\" data-test=\"access-count\">\n                        <p class=\"c-article-metrics-bar__count\">8117 <span class=\"c-article-metrics-bar__label\">Accesses</span></p>\n                    </li>\n                \n                \n                    <li class=\"c-article-metrics-bar__item\" data-test=\"citation-count\">\n                        <p class=\"c-article-metrics-bar__count\">37 <span class=\"c-article-metrics-bar__label\">Citations</span></p>\n                    </li>\n                \n                \n                    \n                        <li class=\"c-article-metrics-bar__item\" data-test=\"altmetric-score\">\n                            <p class=\"c-article-metrics-bar__count\">4 <span class=\"c-article-metrics-bar__label\">Altmetric</span></p>\n                        </li>\n                    \n                \n                <li class=\"c-article-metrics-bar__item\">\n                    <p class=\"c-article-metrics-bar__details\"><a href=\"/articles/10.1186/s12879-018-3565-z/metrics\" data-track=\"click\" data-track-action=\"view metrics\" data-track-label=\"link\" rel=\"nofollow\">Metrics <span class=\"u-visually-hidden\">details</span></a></p>\n                </li>\n            </ul>\n        </div>\n    \n                        \n                        \n    \n    \n        <div class=\"u-mb-8 c-status-message c-status-message--boxed c-status-message--info\">\n            \n                <span class=\"c-status-message__icon\">\n                    <svg class=\"u-icon\" width=\"18\" height=\"18\" aria-hidden=\"true\" focusable=\"false\">\n                        <use xlink:href=\"#icon-eds-i-info-filled-medium\"></use>\n                    </svg>\n                </span>\n            \n            \n                \n                    <p class=\"u-mt-0\">A <a href=\"/articles/10.1186/s12879-020-05472-y\" class=\"relation-link\" data-track=\"click\" data-track-action=\"view linked article\" data-track-label=\"link\">Correction</a> to this article was published on 13 October 2020</p>\n                \n            \n        </div>\n    \n\n    \n        <div class=\"u-mb-8 c-status-message c-status-message--boxed c-status-message--info\">\n            \n                <span class=\"c-status-message__icon\">\n                    <svg class=\"u-icon\" width=\"18\" height=\"18\" aria-hidden=\"true\" focusable=\"false\">\n                        <use xlink:href=\"#icon-eds-i-info-filled-medium\"></use>\n                    </svg>\n                </span>\n            \n            <p class=\"u-mt-0\">This article has been <a href=\"#change-history\">updated</a></p>\n        </div>\n    \n    \n\n                        \n                    </div>\n\n                    <section aria-labelledby=\"Abs1\" data-title=\"Abstract\" lang=\"en\"><div class=\"c-article-section\" id=\"Abs1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Abs1\">Abstract</h2><div class=\"c-article-section__content\" id=\"Abs1-content\"><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Background</h3><p>Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity.</p><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Methods</h3><p>A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including <i>L. pneumophila</i>, <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis.</p><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Results</h3><p>Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, <i>p</i> &lt; 0.0001). Detection of <i>L. pneumophila</i> urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, <i>p</i> = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, <i>p</i> = 0.003) than the rest of the population. Similarly, <i>L. pneumophila</i> testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including <i>M. pneumoniae</i> (26/251 patients, 10.3%), <i>L. pneumophila</i> (30/1186 patients, 2.5%), and <i>C. pneumoniae</i> (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP.</p><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Conclusions</h3><p>Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.</p></div></div></section>\n                    \n    \n        <p class=\"c-status-message c-status-message--info c-status-message--boxed u-mb-32\">\n            <svg class=\"c-status-message__icon\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\"><use xlink:href=\"#icon-eds-i-info-filled-medium\"></use></svg>\n            <a href=\"/articles/10.1186/s12879-018-3565-z/peer-review\" data-track=\"click\" data-track-category=\"article body\" data-track-action=\"open peer review reports\" data-track-label=\"10.1186/s12879-018-3565-z\">Peer Review reports</a>\n        </p>\n    \n\n\n                    <section data-title=\"Background\"><div class=\"c-article-section\" id=\"Sec1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec1\">Background</h2><div class=\"c-article-section__content\" id=\"Sec1-content\"><p>Community-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e799\">1</a>]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 2\" title=\"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR2\" id=\"ref-link-section-d56842855e802\">2</a>]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including <i>Mycoplasma pneumoniae</i>, <i>Chlamydia pneumoniae</i>, and <i>Legionella pneumophila</i>, is still a matter of debate [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 3\" title=\"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR3\" id=\"ref-link-section-d56842855e815\">3</a>].</p><p>Several Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 4\" title=\"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR4\" id=\"ref-link-section-d56842855e821\">4</a>]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding <i>Streptococcus pneumoniae</i> [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 5\" title=\"Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR5\" id=\"ref-link-section-d56842855e827\">5</a>]. Other studies described similar prevalences of atypical pathogens [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e830\">6</a>].</p><p>Epidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e836\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n                    https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n                    \n                  \n                        \" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" id=\"ref-link-section-d56842855e839\">7</a>]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e842\">6</a>].</p><p>The aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens.</p></div></div></section><section data-title=\"Methods\"><div class=\"c-article-section\" id=\"Sec2-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec2\">Methods</h2><div class=\"c-article-section__content\" id=\"Sec2-content\"><h3 class=\"c-article__sub-heading\" id=\"Sec3\">Study design and population</h3><p>The present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n                    https://doi.org/10.1016/S1473-3099(16)30267-5\n                    \n                  .\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" id=\"ref-link-section-d56842855e860\">8</a>]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n                    https://doi.org/10.1016/S1473-3099(16)30267-5\n                    \n                  .\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" id=\"ref-link-section-d56842855e863\">8</a>]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015.</p><p>All adults (&gt; 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature &lt; 36 °C); 3) systemic inflammation (e.g., white blood cell count &gt; 10,000/cm<sup>3</sup> or &lt; 4000/cm<sup>3</sup>, C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded.</p><h3 class=\"c-article__sub-heading\" id=\"Sec4\">Data collection and microbiology for atypical pathogens</h3><p>Data were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results.</p><p>Physicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for <i>L. pneumophila</i> were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and <i>L. pneumophila</i>.</p><h3 class=\"c-article__sub-heading\" id=\"Sec5\">Study groups</h3><p>Definition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for <i>L. pneumophila,</i> serology for <i>L. Pneumophila</i>, <i>C. pneumoniae,</i> and <i>M. pneumoniae</i>.</p><h3 class=\"c-article__sub-heading\" id=\"Sec6\">Study definitions</h3><p>CAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission.</p><p>Definition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions.</p><h3 class=\"c-article__sub-heading\" id=\"Sec7\">Statistical analysis</h3><p>Testing frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for <i>L. pneumophila</i> performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was &lt; 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software.</p></div></div></section><section data-title=\"Results\"><div class=\"c-article-section\" id=\"Sec8-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec8\">Results</h2><div class=\"c-article-section__content\" id=\"Sec8-content\"><h3 class=\"c-article__sub-heading\" id=\"Sec9\">Testing for atypical pathogens</h3><p>A total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for <i>L. pneumophila</i> (either urinary antigen or serology), 251 (6.8%) for <i>M. pneumoniae</i> (serology), and 228 (6.1%) for <i>C. pneumoniae</i> (serology). Distribution of testing frequencies across countries is showed in Fig.&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"figure anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1a</a>.</p><div class=\"c-article-section__figure js-c-reading-companion-figures-item\" data-test=\"figure\" data-container-section=\"figure\" id=\"figure-1\" data-title=\"Fig. 1\"><figure><figcaption><b id=\"Fig1\" class=\"c-article-section__figure-caption\" data-test=\"figure-caption-text\">Fig. 1</b></figcaption><div class=\"c-article-section__figure-content\"><div class=\"c-article-section__figure-item\"><a class=\"c-article-section__figure-link\" data-test=\"img-link\" data-track=\"click\" data-track-label=\"image\" data-track-action=\"view figure\" href=\"/articles/10.1186/s12879-018-3565-z/figures/1\" rel=\"nofollow\"><picture><source type=\"image/webp\" srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png?as=webp\"><img aria-describedby=\"Fig1\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\" alt=\"figure 1\" loading=\"lazy\" width=\"685\" height=\"815\"></picture></a></div><div class=\"c-article-section__figure-description\" data-test=\"bottom-caption\" id=\"figure-1-desc\"><p><b>a</b>) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. <b>b</b>) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"figure anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1</a> is original and it was created using Stat Planet software with the information created from the study</p></div></div><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"article-link\" data-track=\"click\" data-track-label=\"button\" data-track-action=\"view figure\" href=\"/articles/10.1186/s12879-018-3565-z/figures/1\" data-track-dest=\"link:Figure1 Full size image\" aria-label=\"Full size image figure 1\" rel=\"nofollow\"><span>Full size image</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><p>The frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, <i>P</i> &lt; 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling &gt; 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab1\">1</a>). Data on testing for <i>L. pneumophila</i>, <i>M. pneumoniae</i>, and <i>C. pneumoniae</i> are reported in the additional files (Additional&nbsp;file&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"/articles/10.1186/s12879-018-3565-z#MOESM1\">1</a>: Table A). Detection of <i>L. pneumophila</i> urinary antigen was the most prevalent test performed worldwide (32.0%).</p><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-1\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab1\" data-test=\"table-caption\">Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries</b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/1\" aria-label=\"Full size table 1\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><p>The frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than <i>L. pneumophila</i>, <i>P</i> = 0.009; 28.3% VS. 33.5% for <i>L. pneumophila</i>, <i>P</i> = 0.003). <i>L. pneumophila</i> testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column A.</p><h3 class=\"c-article__sub-heading\" id=\"Sec10\">Prevalence of atypical pathogens</h3><p>At least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. <i>L. pneumophila</i> was detected in 30 (2.5%), <i>M. pneumoniae</i> in 26 (10.3%), and <i>C. pneumoniae</i> in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"figure anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1b</a>. Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, <i>P</i> = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, <i>P</i> = 0.001)&nbsp;(Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab2\">2</a>).</p><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-2\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab2\" data-test=\"table-caption\">Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents</b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/2\" aria-label=\"Full size table 2\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><p>Patients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column B and Table&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab4\">4</a>).</p><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-3\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab3\" data-test=\"table-caption\">Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B)</b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/3\" aria-label=\"Full size table 3\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-4\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab4\" data-test=\"table-caption\">Table 4 \n                          <span class=\"u-sans-serif\">Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia</span>\n                        </b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/4\" aria-label=\"Full size table 4\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div></div></div></section><section data-title=\"Discussion\"><div class=\"c-article-section\" id=\"Sec11-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec11\">Discussion</h2><div class=\"c-article-section__content\" id=\"Sec11-content\"><p>This secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, <i>L. pneumophila</i> testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals.</p><p>The most frequent test for atypical pathogens performed in hospitalized patients with CAP was the <i>Legionella</i> urinary antigen (32.0%), followed by <i>Legionella</i> serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for <i>M. pneumoniae</i> and <i>C. pneumoniae</i>, respectively).</p><p>However, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4850\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n                    https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n                    \n                  \n                        \" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" id=\"ref-link-section-d56842855e4853\">7</a>]. Although molecular techniques was found helpful in the diagnosis of CAP caused by <i>L. pneumophila</i>, findings from different studies showed that single available tests were not reliable for the detection of <i>M. pneumoniae</i> and <i>C. pneumoniae</i> in CAP patients [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\" href=\"#ref-CR9\" id=\"ref-link-section-d56842855e4866\">9</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\" href=\"#ref-CR10\" id=\"ref-link-section-d56842855e4866_1\">10</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 11\" title=\"Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR11\" id=\"ref-link-section-d56842855e4869\">11</a>]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e4872\">6</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 12\" title=\"Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR12\" id=\"ref-link-section-d56842855e4875\">12</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 13\" title=\"Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n                    https://doi.org/10.1186/s12879-016-1641-9.\n                    \n                  \n                        \" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR13\" id=\"ref-link-section-d56842855e4878\">13</a>]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for <i>Legionella</i>, is not routinely prescribed.</p><p>One of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain.</p><p>Furthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4891\">1</a>]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4894\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\" href=\"#ref-CR14\" id=\"ref-link-section-d56842855e4897\">14</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\" href=\"#ref-CR15\" id=\"ref-link-section-d56842855e4897_1\">15</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 16\" title=\"Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR16\" id=\"ref-link-section-d56842855e4900\">16</a>]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, <i>L. pneumophila</i> testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" id=\"ref-link-section-d56842855e4907\">17</a>].</p><p>The present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. <i>L. pneumophila</i> and <i>M. pneumoniae</i> seem to be the most frequent pathogens worldwide. The prevalence of <i>M. pneumoniae</i> is highest in South America, whereas <i>L. pneumophila</i> did show a homogeneous geographical distribution. <i>L. pneumophila</i> prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 18\" title=\"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR18\" id=\"ref-link-section-d56842855e4929\">18</a>]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 19\" title=\"Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR19\" id=\"ref-link-section-d56842855e4932\">19</a>].</p><p>The CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e4938\">6</a>]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\" href=\"#ref-CR20\" id=\"ref-link-section-d56842855e4941\">20</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\" href=\"#ref-CR21\" id=\"ref-link-section-d56842855e4941_1\">21</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\" href=\"#ref-CR22\" id=\"ref-link-section-d56842855e4941_2\">22</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\" href=\"#ref-CR23\" id=\"ref-link-section-d56842855e4941_3\">23</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" id=\"ref-link-section-d56842855e4944\">24</a>]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" id=\"ref-link-section-d56842855e4947\">17</a>]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" id=\"ref-link-section-d56842855e4950\">17</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\" href=\"#ref-CR20\" id=\"ref-link-section-d56842855e4954\">20</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\" href=\"#ref-CR21\" id=\"ref-link-section-d56842855e4954_1\">21</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\" href=\"#ref-CR22\" id=\"ref-link-section-d56842855e4954_2\">22</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\" href=\"#ref-CR23\" id=\"ref-link-section-d56842855e4954_3\">23</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" id=\"ref-link-section-d56842855e4957\">24</a>].</p><p>The prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for <i>Legionella</i> [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4966\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 25\" title=\"Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR25\" id=\"ref-link-section-d56842855e4969\">25</a>]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up.</p><p>Second, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology.</p><p>However, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians.</p><p>Potential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others.</p></div></div></section><section data-title=\"Conclusions\"><div class=\"c-article-section\" id=\"Sec12-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec12\">Conclusions</h2><div class=\"c-article-section__content\" id=\"Sec12-content\"><p>In conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide.</p><p>Testing for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations.</p></div></div></section>\n                    <section data-title=\"Change history\"><div class=\"c-article-section\" id=\"change-history-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"change-history\">Change history</h2><div class=\"c-article-section__content\" id=\"change-history-content\"><ul class=\"c-article-change-list\"><li class=\"c-article-change-list__item u-mb-24\" id=\"chg1\"><ins datetime=\"2020-10-13\"><h3 class=\"c-article-change-list__heading u-h3 u-pr-8 u-display-inline\">13 October 2020</h3><div class=\"c-article-change-list__details\"><p>An amendment to this paper has been published and can be accessed via the original article.</p></div></ins></li></ul></div></div></section><section data-title=\"Abbreviations\"><div class=\"c-article-section\" id=\"abbreviations-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"abbreviations\">Abbreviations</h2><div class=\"c-article-section__content\" id=\"abbreviations-content\"><dl class=\"c-abbreviation_list\"><dt class=\"c-abbreviation_list__term u-text-bold u-float-left u-pr-16\" style=\"min-width:50px;\"><dfn>CAP:</dfn></dt><dd class=\"c-abbreviation_list__description u-mb-24\">\n                    <p>Community-acquired pneumonia</p>\n                  </dd><dt class=\"c-abbreviation_list__term u-text-bold u-float-left u-pr-16\" style=\"min-width:50px;\"><dfn>GLIMP:</dfn></dt><dd class=\"c-abbreviation_list__description u-mb-24\">\n                    <p>Global Initiative for MRSA Pneumonia</p>\n                  </dd><dt class=\"c-abbreviation_list__term u-text-bold u-float-left u-pr-16\" style=\"min-width:50px;\"><dfn>ICU:</dfn></dt><dd class=\"c-abbreviation_list__description u-mb-24\">\n                    <p>Intensive care unit</p>\n                  </dd></dl></div></div></section><div id=\"MagazineFulltextArticleBodySuffix\"><section aria-labelledby=\"Bib1\" data-title=\"References\"><div class=\"c-article-section\" id=\"Bib1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Bib1\">References</h2><div class=\"c-article-section__content\" id=\"Bib1-content\"><div data-container-section=\"references\"><ol class=\"c-article-references\" data-track-component=\"outbound reference\" data-track-context=\"references section\"><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"1.\"><p class=\"c-article-references__text\" id=\"ref-CR1\">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1086/511159\" data-track-item_id=\"10.1086/511159\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1086%2F511159\" aria-label=\"Article reference 1\" data-doi=\"10.1086/511159\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\" aria-label=\"CAS reference 1\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 1\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Infectious%20Diseases%20Society%20of%20America%3B%20American%20Thoracic%20Society.%20Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F511159&amp;volume=44&amp;issue=suppl%202&amp;pages=S27-S72&amp;publication_year=2007&amp;author=Mandell%2CLA&amp;author=Wunderink%2CRG&amp;author=Anzueto%2CA\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"2.\"><p class=\"c-article-references__text\" id=\"ref-CR2\">Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1093/cid/cix647\" data-track-item_id=\"10.1093/cid/cix647\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1093%2Fcid%2Fcix647\" aria-label=\"Article reference 2\" data-doi=\"10.1093/cid/cix647\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 2\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=University%20of%20Louisville%20Pneumonia%20Study%20Group.%20Adults%20hospitalized%20with%20pneumonia%20in%20the%20United%20States%3A%20incidence%2C%20epidemiology%2C%20and%20mortality&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1093%2Fcid%2Fcix647&amp;volume=65&amp;issue=11&amp;pages=1806-1812&amp;publication_year=2017&amp;author=Ramirez%2CJA&amp;author=Wiemken%2CTL&amp;author=Peyrani%2CP&amp;author=Arnold%2CFW&amp;author=Kelley%2CR&amp;author=Mattingly%2CWA&amp;author=Nakamatsu%2CR&amp;author=Pena%2CS&amp;author=Guinn%2CBE&amp;author=Furmanek%2CSP&amp;author=Persaud%2CAK&amp;author=Raghuram%2CA&amp;author=Fernandez%2CF&amp;author=Beavin%2CL&amp;author=Bosson%2CR&amp;author=Fernandez-Botran%2CR&amp;author=Cavallazzi%2CR&amp;author=Bordon%2CJ&amp;author=Valdivieso%2CC&amp;author=Schulte%2CJ&amp;author=Carrico%2CRM\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"3.\"><p class=\"c-article-references__text\" id=\"ref-CR3\">Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"4.\"><p class=\"c-article-references__text\" id=\"ref-CR4\">Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"5.\"><p class=\"c-article-references__text\" id=\"ref-CR5\">Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22932165\" aria-label=\"PubMed reference 5\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 5\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20and%20antimicrobial%20resistance%20of%20community-acquired%20pneumonia%20in%20adult%20patients%20in%20China&amp;journal=Chin%20Med%20J&amp;volume=125&amp;issue=17&amp;pages=2967-2972&amp;publication_year=2012&amp;author=Tao%2CLL&amp;author=Hu%2CBJ&amp;author=He%2CLX&amp;author=Wei%2CL&amp;author=Xie%2CHM&amp;author=Wang%2CBQ&amp;author=Li%2CHY&amp;author=Chen%2CXH&amp;author=Zhou%2CCM&amp;author=Deng%2CWW\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"6.\"><p class=\"c-article-references__text\" id=\"ref-CR6\">Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1164/rccm.200603-350OC\" data-track-item_id=\"10.1164/rccm.200603-350OC\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1164%2Frccm.200603-350OC\" aria-label=\"Article reference 6\" data-doi=\"10.1164/rccm.200603-350OC\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 6\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-acquired%20pneumonia%20organization%20%28CAPO%29%20investigators.%20A%20worldwide%20perspective%20of%20atypical%20pathogens%20in%20community-acquired%20pneumonia&amp;journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;doi=10.1164%2Frccm.200603-350OC&amp;volume=175&amp;issue=10&amp;pages=1086-1093&amp;publication_year=2007&amp;author=Arnold%2CFW&amp;author=Summersgill%2CJT&amp;author=Lajoie%2CAS&amp;author=Peyrani%2CP&amp;author=Marrie%2CTJ&amp;author=Rossi%2CP&amp;author=Blasi%2CF&amp;author=Fernandez%2CP&amp;author=File%2CTM&amp;author=Rello%2CJ&amp;author=Menendez%2CR&amp;author=Marzoratti%2CL&amp;author=Luna%2CCM&amp;author=Ramirez%2CJA\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"7.\"><p class=\"c-article-references__text\" id=\"ref-CR7\">Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. <a href=\"https://doi.org/10.1111/j.1469-0691.2011.03672.x.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\">https://doi.org/10.1111/j.1469-0691.2011.03672.x.</a>\n                        </p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\" data-track-item_id=\"10.1111/j.1469-0691.2011.03672.x.\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1111%2Fj.1469-0691.2011.03672.x.\" aria-label=\"Article reference 7\" data-doi=\"10.1111/j.1469-0691.2011.03672.x.\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21951385\" aria-label=\"PubMed reference 7\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 7\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Joint%20taskforce%20of%20the%20European%20Respiratory%20Society%20and%20European%20Society%20for%20Clinical%20Microbiology%20and%20Infectious%20Diseases.%20Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections--full%20version&amp;journal=Clin%20Microbiol%20Infect&amp;doi=10.1111%2Fj.1469-0691.2011.03672.x.&amp;volume=17&amp;issue=Suppl%206&amp;pages=E1-59&amp;publication_year=2011&amp;author=Woodhead%2CM&amp;author=Blasi%2CF&amp;author=Ewig%2CS&amp;author=Garau%2CJ&amp;author=Huchon%2CG&amp;author=Ieven%2CM&amp;author=Ortqvist%2CA&amp;author=Schaberg%2CT&amp;author=Torres%2CA&amp;author=Heijden%2CG&amp;author=Read%2CR&amp;author=Verheij%2CTJ\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"8.\"><p class=\"c-article-references__text\" id=\"ref-CR8\">Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. <a href=\"https://doi.org/10.1016/S1473-3099(16)30267-5\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1016/S1473-3099(16)30267-5\">https://doi.org/10.1016/S1473-3099(16)30267-5</a>.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1016/S1473-3099(16)30267-5\" data-track-item_id=\"10.1016/S1473-3099(16)30267-5\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1016%2FS1473-3099%2816%2930267-5\" aria-label=\"Article reference 8\" data-doi=\"10.1016/S1473-3099(16)30267-5\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27593581\" aria-label=\"PubMed reference 8\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 8\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Global%20initiative%20for%20meticillin-resistant%20Staphylococcus%20aureus%20pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;journal=Lancet%20Infect%20Dis&amp;doi=10.1016%2FS1473-3099%2816%2930267-5&amp;volume=16&amp;issue=12&amp;pages=1364-1376&amp;publication_year=2016&amp;author=Aliberti%2CS&amp;author=Reyes%2CLF&amp;author=Faverio%2CP&amp;author=Sotgiu%2CG&amp;author=Dore%2CS&amp;author=Rodriguez%2CAH&amp;author=Soni%2CNJ&amp;author=Restrepo%2CMI&amp;author=investigators%2CGLIMP\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"9.\"><p class=\"c-article-references__text\" id=\"ref-CR9\">Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1099/jmm.0.2008/003814-0\" data-track-item_id=\"10.1099/jmm.0.2008/003814-0\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1099%2Fjmm.0.2008%2F003814-0\" aria-label=\"Article reference 9\" data-doi=\"10.1099/jmm.0.2008/003814-0\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 9\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Detection%20of%20mycoplasma%20pneumoniae%20in%20adult%20community-acquired%20pneumonia%20by%20PCR%20and%20serology&amp;journal=J%20Med%20Microbiol&amp;doi=10.1099%2Fjmm.0.2008%2F003814-0&amp;volume=57&amp;issue=Pt%2012&amp;pages=1491-1495&amp;publication_year=2008&amp;author=Martinez%2CMA&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Luchsinger%2CV&amp;author=Avendano%2CLF\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"10.\"><p class=\"c-article-references__text\" id=\"ref-CR10\">von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/1471-2334-9-62\" data-track-item_id=\"10.1186/1471-2334-9-62\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/1471-2334-9-62\" aria-label=\"Article reference 10\" data-doi=\"10.1186/1471-2334-9-62\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 10\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Mycoplasma%20pneumoniae%20pneumonia%20revisited%20within%20the%20German%20competence%20network%20for%20community-acquired%20pneumonia%20%28CAPNETZ%29&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-9-62&amp;volume=9&amp;publication_year=2009&amp;author=von%2CBH&amp;author=Welte%2CT&amp;author=Marre%2CR&amp;author=Suttorp%2CN&amp;author=Luck%2CC&amp;author=Ewig%2CS\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"11.\"><p class=\"c-article-references__text\" id=\"ref-CR11\">Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1086/597775\" data-track-item_id=\"10.1086/597775\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1086%2F597775\" aria-label=\"Article reference 11\" data-doi=\"10.1086/597775\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 11\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20laboratory%20diagnostic%20procedures%20for%20detection%20of%20mycoplasma%20pneumoniae%20in%20community%20outbreaks&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F597775&amp;volume=48&amp;pages=1244-1249&amp;publication_year=2009&amp;author=Thurman%2CKA&amp;author=Walter%2CND&amp;author=Schwartz%2CSB\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"12.\"><p class=\"c-article-references__text\" id=\"ref-CR12\">Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1007/s15010-004-3107-z\" data-track-item_id=\"10.1007/s15010-004-3107-z\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1007/s15010-004-3107-z\" aria-label=\"Article reference 12\" data-doi=\"10.1007/s15010-004-3107-z\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\" aria-label=\"CAS reference 12\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 12\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=CAPNETZ%3A%20community-acquired%20pneumonia%20competence%20network&amp;journal=Infection&amp;doi=10.1007%2Fs15010-004-3107-z&amp;volume=32&amp;pages=234-238&amp;publication_year=2004&amp;author=Welte%2CT&amp;author=Suttorp%2CN&amp;author=Marre%2CR\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"13.\"><p class=\"c-article-references__text\" id=\"ref-CR13\">Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. <a href=\"https://doi.org/10.1186/s12879-016-1641-9.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1186/s12879-016-1641-9.\">https://doi.org/10.1186/s12879-016-1641-9.</a>\n                        </p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/s12879-016-1641-9.\" data-track-item_id=\"10.1186/s12879-016-1641-9.\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/s12879-016-1641-9.\" aria-label=\"Article reference 13\" data-doi=\"10.1186/s12879-016-1641-9.\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27317257\" aria-label=\"PubMed reference 13\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed central reference\" data-track-action=\"pubmed central reference\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912822\" aria-label=\"PubMed Central reference 13\">PubMed Central</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 13\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Atypical%20aetiology%20in%20patients%20hospitalised%20with%20community-acquired%20pneumonia%20is%20associated%20with%20age%2C%20gender%20and%20season%3B%20a%20data-analysis%20on%20four%20Dutch%20cohorts&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2Fs12879-016-1641-9.&amp;volume=16&amp;publication_year=2016&amp;author=Raeven%2CVM&amp;author=Spoorenberg%2CSM&amp;author=Boersma%2CWG&amp;author=Garde%2CEM&amp;author=Cannegieter%2CSC&amp;author=Voorn%2CGP&amp;author=Bos%2CWJ&amp;author=Steenbergen%2CJE\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"14.\"><p class=\"c-article-references__text\" id=\"ref-CR14\">Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"15.\"><p class=\"c-article-references__text\" id=\"ref-CR15\">Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1016/S0924-8579(01)00402-2\" data-track-item_id=\"10.1016/S0924-8579(01)00402-2\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1016%2FS0924-8579%2801%2900402-2\" aria-label=\"Article reference 15\" data-doi=\"10.1016/S0924-8579(01)00402-2\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\" aria-label=\"CAS reference 15\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 15\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Japanese%20guidelines%20for%20the%20management%20of%20community-acquired%20pneumonia&amp;journal=Int%20J%20Antimicrob%20Agents&amp;doi=10.1016%2FS0924-8579%2801%2900402-2&amp;volume=18&amp;issue=Suppl.%201&amp;pages=S45-S48&amp;publication_year=2001&amp;author=Yanagihara%2CK&amp;author=Kohno%2CS&amp;author=Matsusima%2CT\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"16.\"><p class=\"c-article-references__text\" id=\"ref-CR16\">Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 16\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=S%20Afr%20Med%20J&amp;volume=97&amp;pages=1296-1306&amp;publication_year=2007\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"17.\"><p class=\"c-article-references__text\" id=\"ref-CR17\">Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1183/13993003.02306-2016\" data-track-item_id=\"10.1183/13993003.02306-2016\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1183%2F13993003.02306-2016\" aria-label=\"Article reference 17\" data-doi=\"10.1183/13993003.02306-2016\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 17\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Evaluation%20of%20severity%20score-guided%20approaches%20to%20macrolide%20use%20in%20community-acquired%20pneumonia&amp;journal=Eur%20Respir%20J&amp;doi=10.1183%2F13993003.02306-2016&amp;volume=50&amp;publication_year=2017&amp;author=Singanayagam%2CA&amp;author=Aliberti%2CS&amp;author=Cill%C3%B3niz%2CC\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"18.\"><p class=\"c-article-references__text\" id=\"ref-CR18\">Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1097/MD.0b013e31827f6104\" data-track-item_id=\"10.1097/MD.0b013e31827f6104\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1097%2FMD.0b013e31827f6104\" aria-label=\"Article reference 18\" data-doi=\"10.1097/MD.0b013e31827f6104\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 18\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20legionella%20pneumophila%20pneumonia%3Aa%20single-%20center%20experience%20with%20214%20hospitalized%20sporadic%20cases%20over%2015%20years&amp;journal=Medicine&amp;doi=10.1097%2FMD.0b013e31827f6104&amp;volume=92&amp;pages=51-60&amp;publication_year=2012&amp;author=Viasus%2CD&amp;author=Yacovo%2CS&amp;author=Garcia-Vidal%2CC&amp;author=Verdaguer%2CR&amp;author=Manresa%2CF&amp;author=Dorca%2CJ&amp;author=Gudiol%2CF&amp;author=Carratal%C3%A0%2CJ\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"19.\"><p class=\"c-article-references__text\" id=\"ref-CR19\">Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1001/archinte.160.9.1294\" data-track-item_id=\"10.1001/archinte.160.9.1294\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1001%2Farchinte.160.9.1294\" aria-label=\"Article reference 19\" data-doi=\"10.1001/archinte.160.9.1294\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\" aria-label=\"CAS reference 19\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 19\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Azithromycin%20vs%20cefuroxime%20plus%20erythromycin%20for%20empirical%20treatment%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%3A%20a%20prospective%2C%20randomized%2C%20multicenter%20trial&amp;journal=Arch%20Intern%20Med&amp;doi=10.1001%2Farchinte.160.9.1294&amp;volume=160&amp;issue=9&amp;pages=1294-1300&amp;publication_year=2000&amp;author=Vergis%2CEN&amp;author=Indorf%2CA&amp;author=File%2CTM&amp;author=Phillips%2CJ&amp;author=Bates%2CJ&amp;author=Tan%2CJ&amp;author=Sarosi%2CGA&amp;author=Grayston%2CJT&amp;author=Summersgill%2CJ&amp;author=Yu%2CVL\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"20.\"><p class=\"c-article-references__text\" id=\"ref-CR20\">Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1136/thoraxjnl-2013-203551\" data-track-item_id=\"10.1136/thoraxjnl-2013-203551\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1136%2Fthoraxjnl-2013-203551\" aria-label=\"Article reference 20\" data-doi=\"10.1136/thoraxjnl-2013-203551\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 20\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20pneumonia%20in%20Chile%3A%20the%20clinical%20relevance%20in%20the%20detection%20of%20viruses%20and%20atypical%20bacteria&amp;journal=Thorax&amp;doi=10.1136%2Fthoraxjnl-2013-203551&amp;volume=68&amp;pages=1000-1006&amp;publication_year=2013&amp;author=Luchsinger%2CV&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Mart%C3%ADnez%2CMA&amp;author=Machado%2CC&amp;author=Piedra%2CPA&amp;author=Fasce%2CR&amp;author=Ulloa%2CMT&amp;author=Fink%2CMC&amp;author=Lara%2CP&amp;author=Gebauer%2CM&amp;author=Ch%C3%A1vez%2CF&amp;author=Avenda%C3%B1o%2CLF\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"21.\"><p class=\"c-article-references__text\" id=\"ref-CR21\">Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/1471-2334-14-335\" data-track-item_id=\"10.1186/1471-2334-14-335\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/1471-2334-14-335\" aria-label=\"Article reference 21\" data-doi=\"10.1186/1471-2334-14-335\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 21\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Microbial%20aetiology%2C%20outcomes%2C%20and%20costs%20of%20hospitalisation%20for%20community-acquired%20pneumonia%3B%20an%20observational%20analysis&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-14-335&amp;volume=14&amp;pages=335-343&amp;publication_year=2014&amp;author=Spoorenberg%2CSM&amp;author=Bos%2CWJ&amp;author=Heijligenberg%2CR&amp;author=Voorn%2CPG&amp;author=Grutters%2CJC&amp;author=Rijkers%2CGT&amp;author=Garde%2CEM\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"22.\"><p class=\"c-article-references__text\" id=\"ref-CR22\">Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21337816\" aria-label=\"PubMed reference 22\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 22\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%20in%20northern%20Israel&amp;journal=Isr%20Med%20Assoc%20J&amp;volume=12&amp;pages=477-482&amp;publication_year=2010&amp;author=Shibli%2CF&amp;author=Chazan%2CB&amp;author=Nitzan%2CO&amp;author=Flatau%2CE&amp;author=Edelstein%2CH&amp;author=Blondheim%2CO&amp;author=Raz%2CR&amp;author=Colodner%2CR\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"23.\"><p class=\"c-article-references__text\" id=\"ref-CR23\">Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/s12889-015-1422-1\" data-track-item_id=\"10.1186/s12889-015-1422-1\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/s12889-015-1422-1\" aria-label=\"Article reference 23\" data-doi=\"10.1186/s12889-015-1422-1\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 23\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20aetiology%20of%20community%20associated%20pneumonia%20in%20children%20in%20Nanjing%2C%20China%20and%20aetiological%20patternsassociated%20with%20age%20and%20season&amp;journal=BMC%20Public%20Health&amp;doi=10.1186%2Fs12889-015-1422-1&amp;volume=15&amp;pages=113-118&amp;publication_year=2015&amp;author=Chen%2CK&amp;author=Jia%2CR&amp;author=Li%2CL&amp;author=Yang%2CC&amp;author=Shi%2CY\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"24.\"><p class=\"c-article-references__text\" id=\"ref-CR24\">Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1378/chest.13-0162\" data-track-item_id=\"10.1378/chest.13-0162\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1378%2Fchest.13-0162\" aria-label=\"Article reference 24\" data-doi=\"10.1378/chest.13-0162\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 24\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Importance%20of%20legionella%20pneumophila%20in%20the%20etiology%20of%20severe%20community-acquired%20pneumonia%20in%20Santiago&amp;journal=Chile%20Chest&amp;doi=10.1378%2Fchest.13-0162&amp;volume=145&amp;pages=290-296&amp;publication_year=2014&amp;author=Arancibia%2CF&amp;author=Cortes%2CCP&amp;author=Vald%C3%A9s%2CM&amp;author=Cerda%2CJ&amp;author=Hern%C3%A1ndez%2CA&amp;author=Soto%2CL&amp;author=Torres%2CA\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"25.\"><p class=\"c-article-references__text\" id=\"ref-CR25\">Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1086/431588\" data-track-item_id=\"10.1086/431588\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1086%2F431588\" aria-label=\"Article reference 25\" data-doi=\"10.1086/431588\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 25\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Improved%20diagnosis%20of%20the%20etiology%20of%20community-%20acquired%20pneumonia%20with%20real-time%20polymerase%20chain%20reaction&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F431588&amp;volume=41&amp;pages=345-351&amp;publication_year=2005&amp;author=Templeton%2CKE&amp;author=Scheltinga%2CSA&amp;author=Eeden%2CWC&amp;author=Graffelman%2CAW&amp;author=Broek%2CPJ&amp;author=Claas%2CEC\">\n                    Google Scholar</a>&nbsp;\n                </p></li></ol><p class=\"c-article-references__download u-hide-print\"><a data-track=\"click\" data-track-action=\"download citation references\" data-track-label=\"link\" rel=\"nofollow\" href=\"https://citation-needed.springer.com/v2/references/10.1186/s12879-018-3565-z?format=refman&amp;flavour=references\">Download references<svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-download-medium\"></use></svg></a></p></div></div></div></section></div><section data-title=\"Acknowledgments\"><div class=\"c-article-section\" id=\"Ack1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Ack1\">Acknowledgments</h2><div class=\"c-article-section__content\" id=\"Ack1-content\"><p>GLIMP investigators</p><p>Argentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases &amp; ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal &amp; Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology &amp; Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine &amp; Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott &amp; White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care &amp; Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine &amp; Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia).</p>\n                <h3 class=\"c-article__sub-heading\" id=\"FPar1\">Ethics approval and consent to partecipate</h3>\n                <p>The coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations.</p>\n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar2\">Avaibility of data and materials</h3>\n                <p>The database used for the study is not public but it is available from the corresponding author on reasonable request.</p>\n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar3\">Funding</h3>\n                <p>The authors did not receive any funding for this study.</p>\n              </div></div></section><section aria-labelledby=\"author-information\" data-title=\"Author information\"><div class=\"c-article-section\" id=\"author-information-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"author-information\">Author information</h2><div class=\"c-article-section__content\" id=\"author-information-content\"><h3 class=\"c-article__sub-heading\" id=\"affiliations\">Authors and Affiliations</h3><ol class=\"c-article-author-affiliation__list\"><li id=\"Aff1\"><p class=\"c-article-author-affiliation__address\">Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Andrea Gramegna,&nbsp;Marta Di Pasquale,&nbsp;Francesco Blasi&nbsp;&amp;&nbsp;Stefano Aliberti</p></li><li id=\"Aff2\"><p class=\"c-article-author-affiliation__address\">Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Giovanni Sotgiu</p></li><li id=\"Aff3\"><p class=\"c-article-author-affiliation__address\">Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Dejan Radovanovic</p></li><li id=\"Aff4\"><p class=\"c-article-author-affiliation__address\">Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Silvia Terraneo</p></li><li id=\"Aff5\"><p class=\"c-article-author-affiliation__address\">Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA</p><p class=\"c-article-author-affiliation__authors-list\">Luis F. Reyes&nbsp;&amp;&nbsp;Marcos I. Restrepo</p></li><li id=\"Aff6\"><p class=\"c-article-author-affiliation__address\">Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain</p><p class=\"c-article-author-affiliation__authors-list\">Ester Vendrell</p></li><li id=\"Aff7\"><p class=\"c-article-author-affiliation__address\">Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal</p><p class=\"c-article-author-affiliation__authors-list\">Joao Neves</p></li><li id=\"Aff8\"><p class=\"c-article-author-affiliation__address\">Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Francesco Menzella</p></li></ol><div class=\"u-js-hide u-hide-print\" data-test=\"author-info\"><span class=\"c-article__sub-heading\">Authors</span><ol class=\"c-article-authors-search u-list-reset\"><li id=\"auth-Andrea-Gramegna-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Andrea Gramegna</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Andrea%20Gramegna\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Andrea%20Gramegna%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Giovanni-Sotgiu-Aff2\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Giovanni Sotgiu</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Giovanni%20Sotgiu\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Giovanni%20Sotgiu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Marta-Pasquale-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Marta Di Pasquale</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marta%20Di%20Pasquale\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marta%20Di%20Pasquale%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Dejan-Radovanovic-Aff3\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Dejan Radovanovic</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Dejan%20Radovanovic\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Dejan%20Radovanovic%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Silvia-Terraneo-Aff4\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Silvia Terraneo</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Silvia%20Terraneo\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Silvia%20Terraneo%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Luis_F_-Reyes-Aff5\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Luis F. Reyes</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Luis%20F.%20Reyes\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Luis%20F.%20Reyes%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Ester-Vendrell-Aff6\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Ester Vendrell</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ester%20Vendrell\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ester%20Vendrell%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Joao-Neves-Aff7\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Joao Neves</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Joao%20Neves\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Joao%20Neves\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Joao%20Neves%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Francesco-Menzella-Aff8\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Francesco Menzella</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Francesco%20Menzella\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Francesco%20Menzella%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Francesco-Blasi-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Francesco Blasi</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Francesco%20Blasi\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Francesco%20Blasi%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Stefano-Aliberti-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Stefano Aliberti</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Stefano%20Aliberti\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Stefano%20Aliberti%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Marcos_I_-Restrepo-Aff5\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Marcos I. Restrepo</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marcos%20I.%20Restrepo\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marcos%20I.%20Restrepo%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li></ol></div><h3 class=\"c-article__sub-heading\" id=\"groups\">Consortia</h3><div class=\"c-article-author-institutional-author\" id=\"group-1\"><h3 class=\"c-article-author-institutional-author__name u-h3\">on behalf of the GLIMP Study Group</h3></div><h3 class=\"c-article__sub-heading\" id=\"contributions\">Contributions</h3><p>AG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript.</p><h3 class=\"c-article__sub-heading\" id=\"corresponding-author\">Corresponding author</h3><p id=\"corresponding-author-list\">Correspondence to\n                <a id=\"corresp-c1\" href=\"mailto:stefano.aliberti@unimi.it\">Stefano Aliberti</a>.</p></div></div></section><section data-title=\"Ethics declarations\"><div class=\"c-article-section\" id=\"ethics-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"ethics\">Ethics declarations</h2><div class=\"c-article-section__content\" id=\"ethics-content\">\n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar4\">Consent for publication</h3>\n                <p>Not applicable.</p>\n              \n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar5\">Competing interests</h3>\n                <p>The authors declare that they have no competing interests for this study.</p>\n              \n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar6\">Publisher’s Note</h3>\n                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>\n              \n            </div></div></section><section data-title=\"Additional file\"><div class=\"c-article-section\" id=\"Sec13-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec13\">Additional file</h2><div class=\"c-article-section__content\" id=\"Sec13-content\"><div data-test=\"supplementary-info\"><div id=\"figshareContainer\" class=\"c-article-figshare-container\" data-test=\"figshare-container\"></div><div class=\"c-article-supplementary__item\" data-test=\"supp-item\" id=\"MOESM1\"><h3 class=\"c-article-supplementary__title u-h3\"><a class=\"print-link\" data-track=\"click\" data-track-action=\"view supplementary info\" data-test=\"supp-info-link\" data-track-label=\"additional file 1:\" href=\"https://static-content.springer.com/esm/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_MOESM1_ESM.doc\" data-supp-info-image=\"\">Additional file 1:</a></h3><div class=\"c-article-supplementary__description\" data-component=\"thumbnail-container\"><p>Table A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for <i>C. pneumoniae</i> across continents; A2: Testing frequencies for <i>M. pneumoniae</i> across continents; A3: Testing frequencies for <i>L. pneumophila</i> across continents).- <i>Brief description of the data</i>: a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb)</p></div></div></div></div></div></section><section data-title=\"Rights and permissions\"><div class=\"c-article-section\" id=\"rightslink-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"rightslink\">Rights and permissions</h2><div class=\"c-article-section__content\" id=\"rightslink-content\">\n                <p><b>Open Access</b> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href=\"http://creativecommons.org/licenses/by/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href=\"http://creativecommons.org/publicdomain/zero/1.0/\" rel=\"license\">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</p>\n              <p class=\"c-article-rights\"><a data-track=\"click\" data-track-action=\"view rights and permissions\" data-track-label=\"link\" href=\"https://s100.copyright.com/AppDispatchServlet?title=Atypical%20pathogens%20in%20hospitalized%20patients%20with%20community-acquired%20pneumonia%3A%20a%20worldwide%20perspective&amp;author=Andrea%20Gramegna%20et%20al&amp;contentID=10.1186%2Fs12879-018-3565-z&amp;copyright=The%20Author%28s%29.&amp;publication=1471-2334&amp;publicationDate=2018-12-18&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY%20%2B%20CC0\">Reprints and permissions</a></p></div></div></section><section aria-labelledby=\"article-info\" data-title=\"About this article\"><div class=\"c-article-section\" id=\"article-info-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"article-info\">About this article</h2><div class=\"c-article-section__content\" id=\"article-info-content\"><div class=\"c-bibliographic-information\"><div class=\"u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border\"><a data-crossmark=\"10.1186/s12879-018-3565-z\" target=\"_blank\" rel=\"noopener\" href=\"https://crossmark.crossref.org/dialog/?doi=10.1186/s12879-018-3565-z\" data-track=\"click\" data-track-action=\"Click Crossmark\" data-track-label=\"link\" data-test=\"crossmark\"><img loading=\"lazy\" width=\"57\" height=\"81\" alt=\"Check for updates. Verify currency and authenticity via CrossMark\" src=\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\"></a></div><div class=\"c-bibliographic-information__column\"><h3 class=\"c-article__sub-heading\" id=\"citeas\">Cite this article</h3><p class=\"c-bibliographic-information__citation\">Gramegna, A., Sotgiu, G., Di Pasquale, M. <i>et al.</i> Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.\n                    <i>BMC Infect Dis</i> <b>18</b>, 677 (2018). https://doi.org/10.1186/s12879-018-3565-z</p><p class=\"c-bibliographic-information__download-citation u-hide-print\"><a data-test=\"citation-link\" data-track=\"click\" data-track-action=\"download article citation\" data-track-label=\"link\" data-track-external=\"\" rel=\"nofollow\" href=\"https://citation-needed.springer.com/v2/references/10.1186/s12879-018-3565-z?format=refman&amp;flavour=citation\">Download citation<svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-download-medium\"></use></svg></a></p><ul class=\"c-bibliographic-information__list\" data-test=\"publication-history\"><li class=\"c-bibliographic-information__list-item\"><p>Received<span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\"><time datetime=\"2018-05-28\">28 May 2018</time></span></p></li><li class=\"c-bibliographic-information__list-item\"><p>Accepted<span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\"><time datetime=\"2018-11-28\">28 November 2018</time></span></p></li><li class=\"c-bibliographic-information__list-item\"><p>Published<span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\"><time datetime=\"2018-12-18\">18 December 2018</time></span></p></li><li class=\"c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width\"><p><abbr title=\"Digital Object Identifier\">DOI</abbr><span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\">https://doi.org/10.1186/s12879-018-3565-z</span></p></li></ul><div data-component=\"share-box\"><div class=\"c-article-share-box u-display-block\"><h3 class=\"c-article__sub-heading\">Share this article</h3><p class=\"c-article-share-box__description\">Anyone you share the following link with will be able to read this content:</p><button class=\"js-get-share-url c-article-share-box__button\" type=\"button\" id=\"get-share-url\" data-track=\"click\" data-track-label=\"button\" data-track-external=\"\" data-track-action=\"get shareable link\">Get shareable link</button><div class=\"js-no-share-url-container u-display-none\" hidden=\"\"><p class=\"js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info\">Sorry, a shareable link is not currently available for this article.</p></div><div class=\"js-share-url-container u-display-none\" hidden=\"\"><p class=\"js-share-url c-article-share-box__only-read-input\" id=\"share-url\" data-track=\"click\" data-track-label=\"button\" data-track-action=\"select share url\"></p><button class=\"js-copy-share-url c-article-share-box__button--link-like\" type=\"button\" id=\"copy-share-url\" data-track=\"click\" data-track-label=\"button\" data-track-action=\"copy share url\" data-track-external=\"\">Copy to clipboard</button></div><p class=\"js-c-article-share-box__additional-info c-article-share-box__additional-info\">\n                            Provided by the Springer Nature SharedIt content-sharing initiative\n                        </p></div></div><h3 class=\"c-article__sub-heading\">Keywords</h3><ul class=\"c-article-subject-list\"><li class=\"c-article-subject-list__subject\"><span><a href=\"/search?query=CAP&amp;facet-discipline=&quot;Medicine%20%26%20Public%20Health&quot;\" data-track=\"click\" data-track-action=\"view keyword\" data-track-label=\"link\">CAP</a></span></li><li class=\"c-article-subject-list__subject\"><span><a href=\"/search?query=Atypical%20pathogens&amp;facet-discipline=&quot;Medicine%20%26%20Public%20Health&quot;\" data-track=\"click\" data-track-action=\"view keyword\" data-track-label=\"link\">Atypical pathogens</a></span></li><li class=\"c-article-subject-list__subject\"><span><a href=\"/search?query=Epidemiology&amp;facet-discipline=&quot;Medicine%20%26%20Public%20Health&quot;\" data-track=\"click\" data-track-action=\"view keyword\" data-track-label=\"link\">Epidemiology</a></span></li></ul><div data-component=\"article-info-list\"></div></div></div></div></div></section>\n\n                    \n\n\n                </article>\n            </main>\n\n            <div class=\"c-article-extras u-text-sm u-hide-print\" data-container-type=\"reading-companion\" data-track-component=\"reading companion\">\n                <aside>\n                    <div data-test=\"download-article-link-wrapper\" class=\"js-context-bar-sticky-point-desktop\" data-track-context=\"reading companion\">\n                        \n    <div class=\"c-pdf-download u-clear-both\">\n        <a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\" class=\"u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link\" data-article-pdf=\"true\" data-readcube-pdf-url=\"true\" data-test=\"pdf-link\" data-draft-ignore=\"true\" data-track=\"content_download\" data-track-type=\"article pdf download\" data-track-action=\"download pdf\" data-track-label=\"link\" data-track-external=\"\" download=\"\">\n            <span class=\"c-pdf-download__text\">Download PDF</span>\n            <svg aria-hidden=\"true\" focusable=\"false\" width=\"16\" height=\"16\" class=\"u-icon\"><use xlink:href=\"#icon-download\"></use></svg>\n        </a>\n    </div>\n\n                        \n                    </div>\n\n                    \n    \n\n\n                    <div class=\"c-reading-companion\">\n                        <div class=\"c-reading-companion__sticky\" data-component=\"reading-companion-sticky\" data-test=\"reading-companion-sticky\" style=\"top: 40px;\">\n                            <ul class=\"c-reading-companion__tabs\" role=\"tablist\"><li role=\"presentation\"><button data-tab-target=\"sections\" role=\"tab\" id=\"tab-sections\" aria-controls=\"tabpanel-sections\" aria-selected=\"true\" class=\"c-reading-companion__tab c-reading-companion__tab--active\" data-track=\"click\" data-track-action=\"sections tab\" data-track-label=\"tab\">Sections</button></li><li role=\"presentation\"><button data-tab-target=\"figures\" role=\"tab\" id=\"tab-figures\" aria-controls=\"tabpanel-figures\" aria-selected=\"false\" tabindex=\"-1\" class=\"c-reading-companion__tab\" data-track=\"click\" data-track-action=\"figures tab\" data-track-label=\"tab\">Figures</button></li><li role=\"presentation\"><button data-tab-target=\"references\" role=\"tab\" id=\"tab-references\" aria-controls=\"tabpanel-references\" aria-selected=\"false\" tabindex=\"-1\" class=\"c-reading-companion__tab\" data-track=\"click\" data-track-action=\"references tab\" data-track-label=\"tab\">References</button></li></ul><div class=\"c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active\" id=\"tabpanel-sections\" aria-labelledby=\"tab-sections\" role=\"tabpanel\"><div class=\"c-reading-companion__scroll-pane\" style=\"max-height: none;\"><ul class=\"c-reading-companion__sections-list\"><li id=\"rc-sec-Abs1\" class=\"c-reading-companion__section-item\"><a href=\"#Abs1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Abstract\">Abstract</a></li><li id=\"rc-sec-Sec1\" class=\"c-reading-companion__section-item\"><a href=\"#Sec1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Background\">Background</a></li><li id=\"rc-sec-Sec2\" class=\"c-reading-companion__section-item\"><a href=\"#Sec2\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Methods\">Methods</a></li><li id=\"rc-sec-Sec8\" class=\"c-reading-companion__section-item\"><a href=\"#Sec8\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Results\">Results</a></li><li id=\"rc-sec-Sec11\" class=\"c-reading-companion__section-item\"><a href=\"#Sec11\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Discussion\">Discussion</a></li><li id=\"rc-sec-Sec12\" class=\"c-reading-companion__section-item\"><a href=\"#Sec12\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Conclusions\">Conclusions</a></li><li id=\"rc-sec-change-history\" class=\"c-reading-companion__section-item\"><a href=\"#change-history\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Change history\">Change history</a></li><li id=\"rc-sec-abbreviations\" class=\"c-reading-companion__section-item\"><a href=\"#abbreviations\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Abbreviations\">Abbreviations</a></li><li id=\"rc-sec-Bib1\" class=\"c-reading-companion__section-item\"><a href=\"#Bib1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:References\">References</a></li><li id=\"rc-sec-Ack1\" class=\"c-reading-companion__section-item\"><a href=\"#Ack1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Acknowledgments\">Acknowledgments</a></li><li id=\"rc-sec-author-information\" class=\"c-reading-companion__section-item\"><a href=\"#author-information\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Author information\">Author information</a></li><li id=\"rc-sec-ethics\" class=\"c-reading-companion__section-item\"><a href=\"#ethics\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Ethics declarations\">Ethics declarations</a></li><li id=\"rc-sec-Sec13\" class=\"c-reading-companion__section-item\"><a href=\"#Sec13\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Additional file\">Additional file</a></li><li id=\"rc-sec-rightslink\" class=\"c-reading-companion__section-item\"><a href=\"#rightslink\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Rights and permissions\">Rights and permissions</a></li><li id=\"rc-sec-article-info\" class=\"c-reading-companion__section-item\"><a href=\"#article-info\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:About this article\">About this article</a></li></ul></div>\n                                <div class=\"js-ad u-lazy-ad-wrapper u-mt-16 u-show\" data-component-mpu=\"\">\n                                    \n    \n    <aside class=\"adsbox c-ad c-ad--300x250 u-mt-16\" data-component-mpu=\"\">\n        <div class=\"c-ad__inner\">\n            <p class=\"c-ad__label\">Advertisement</p>\n            <div id=\"div-gpt-ad-MPU1\" data-ad-type=\"MPU1\" data-test=\"MPU1-ad\" data-pa11y-ignore=\"\" data-gpt=\"\" data-gpt-unitpath=\"/270604982/bmc/bmcinfectdis/articles\" data-gpt-sizes=\"300x250\" data-gpt-targeting=\"pos=MPU1;doi=10.1186/s12879-018-3565-z;type=article;kwrd=CAP,Atypical pathogens,Epidemiology;pmc=H33096,B19002,B16003,H61006,H33002;\">\n                <noscript>\n                    <a href=\"//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\">\n                        <img data-test=\"gpt-advert-fallback-img\"\n                            src=\"//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\"\n                            alt=\"Advertisement\"\n                            width=\"300\"\n                            height=\"250\">\n                    </a>\n                </noscript>\n            </div>\n        </div>\n    </aside>\n\n                                </div>\n                            </div>\n                            <div class=\"c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width\" id=\"tabpanel-figures\" aria-labelledby=\"tab-figures\" role=\"tabpanel\"><div class=\"c-reading-companion__scroll-pane\"><ul class=\"c-reading-companion__figures-list\"><li class=\"c-reading-companion__figure-item\"><figure><figcaption><b class=\"c-reading-companion__figure-title u-h4\" id=\"rc-Fig1\">Fig. 1</b></figcaption><picture><source data-srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png?\"><img data-src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\" alt=\"figure 1\" aria-describedby=\"rc-Fig1\"></picture><p class=\"c-reading-companion__figure-links\"><a href=\"#Fig1\" data-track=\"click\" data-track-action=\"figure anchor\" data-track-label=\"link\">View in article</a><a href=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1\" class=\"c-reading-companion__figure-full-link\" data-track=\"click\" data-track-action=\"view figure\" data-track-label=\"link\" rel=\"nofollow\">Full size image<svg width=\"16\" height=\"16\" class=\"u-icon\"><use href=\"#icon-chevron-right\"></use></svg></a></p></figure></li></ul></div></div>\n                            <div class=\"c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width\" id=\"tabpanel-references\" aria-labelledby=\"tab-references\" role=\"tabpanel\"><div class=\"c-reading-companion__scroll-pane\"><ol class=\"c-reading-companion__references-list c-reading-companion__references-list--numeric\" data-track-context=\"article references sidebar\"><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR1\">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1086%2F511159\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1086/511159\" data-track-item_id=\"10.1086/511159\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Infectious%20Diseases%20Society%20of%20America%3B%20American%20Thoracic%20Society.%20Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F511159&amp;volume=44&amp;issue=suppl%202&amp;pages=S27-S72&amp;publication_year=2007&amp;author=Mandell%2CLA&amp;author=Wunderink%2CRG&amp;author=Anzueto%2CA\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR2\">Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1093%2Fcid%2Fcix647\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1093/cid/cix647\" data-track-item_id=\"10.1093/cid/cix647\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=University%20of%20Louisville%20Pneumonia%20Study%20Group.%20Adults%20hospitalized%20with%20pneumonia%20in%20the%20United%20States%3A%20incidence%2C%20epidemiology%2C%20and%20mortality&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1093%2Fcid%2Fcix647&amp;volume=65&amp;issue=11&amp;pages=1806-1812&amp;publication_year=2017&amp;author=Ramirez%2CJA&amp;author=Wiemken%2CTL&amp;author=Peyrani%2CP&amp;author=Arnold%2CFW&amp;author=Kelley%2CR&amp;author=Mattingly%2CWA&amp;author=Nakamatsu%2CR&amp;author=Pena%2CS&amp;author=Guinn%2CBE&amp;author=Furmanek%2CSP&amp;author=Persaud%2CAK&amp;author=Raghuram%2CA&amp;author=Fernandez%2CF&amp;author=Beavin%2CL&amp;author=Bosson%2CR&amp;author=Fernandez-Botran%2CR&amp;author=Cavallazzi%2CR&amp;author=Bordon%2CJ&amp;author=Valdivieso%2CC&amp;author=Schulte%2CJ&amp;author=Carrico%2CRM\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR3\">Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR4\">Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR5\">Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p><p class=\"c-reading-companion__reference-links\"><a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22932165\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20and%20antimicrobial%20resistance%20of%20community-acquired%20pneumonia%20in%20adult%20patients%20in%20China&amp;journal=Chin%20Med%20J&amp;volume=125&amp;issue=17&amp;pages=2967-2972&amp;publication_year=2012&amp;author=Tao%2CLL&amp;author=Hu%2CBJ&amp;author=He%2CLX&amp;author=Wei%2CL&amp;author=Xie%2CHM&amp;author=Wang%2CBQ&amp;author=Li%2CHY&amp;author=Chen%2CXH&amp;author=Zhou%2CCM&amp;author=Deng%2CWW\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR6\">Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1164%2Frccm.200603-350OC\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1164/rccm.200603-350OC\" data-track-item_id=\"10.1164/rccm.200603-350OC\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-acquired%20pneumonia%20organization%20%28CAPO%29%20investigators.%20A%20worldwide%20perspective%20of%20atypical%20pathogens%20in%20community-acquired%20pneumonia&amp;journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;doi=10.1164%2Frccm.200603-350OC&amp;volume=175&amp;issue=10&amp;pages=1086-1093&amp;publication_year=2007&amp;author=Arnold%2CFW&amp;author=Summersgill%2CJT&amp;author=Lajoie%2CAS&amp;author=Peyrani%2CP&amp;author=Marrie%2CTJ&amp;author=Rossi%2CP&amp;author=Blasi%2CF&amp;author=Fernandez%2CP&amp;author=File%2CTM&amp;author=Rello%2CJ&amp;author=Menendez%2CR&amp;author=Marzoratti%2CL&amp;author=Luna%2CCM&amp;author=Ramirez%2CJA\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR7\">Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. <a href=\"https://doi.org/10.1111/j.1469-0691.2011.03672.x.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\">https://doi.org/10.1111/j.1469-0691.2011.03672.x.</a>\n                        </p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1111%2Fj.1469-0691.2011.03672.x.\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\" data-track-item_id=\"10.1111/j.1469-0691.2011.03672.x.\">Article</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21951385\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Joint%20taskforce%20of%20the%20European%20Respiratory%20Society%20and%20European%20Society%20for%20Clinical%20Microbiology%20and%20Infectious%20Diseases.%20Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections--full%20version&amp;journal=Clin%20Microbiol%20Infect&amp;doi=10.1111%2Fj.1469-0691.2011.03672.x.&amp;volume=17&amp;issue=Suppl%206&amp;pages=E1-59&amp;publication_year=2011&amp;author=Woodhead%2CM&amp;author=Blasi%2CF&amp;author=Ewig%2CS&amp;author=Garau%2CJ&amp;author=Huchon%2CG&amp;author=Ieven%2CM&amp;author=Ortqvist%2CA&amp;author=Schaberg%2CT&amp;author=Torres%2CA&amp;author=Heijden%2CG&amp;author=Read%2CR&amp;author=Verheij%2CTJ\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR8\">Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. <a href=\"https://doi.org/10.1016/S1473-3099(16)30267-5\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1016/S1473-3099(16)30267-5\">https://doi.org/10.1016/S1473-3099(16)30267-5</a>.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1016%2FS1473-3099%2816%2930267-5\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1016/S1473-3099(16)30267-5\" data-track-item_id=\"10.1016/S1473-3099(16)30267-5\">Article</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27593581\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Global%20initiative%20for%20meticillin-resistant%20Staphylococcus%20aureus%20pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;journal=Lancet%20Infect%20Dis&amp;doi=10.1016%2FS1473-3099%2816%2930267-5&amp;volume=16&amp;issue=12&amp;pages=1364-1376&amp;publication_year=2016&amp;author=Aliberti%2CS&amp;author=Reyes%2CLF&amp;author=Faverio%2CP&amp;author=Sotgiu%2CG&amp;author=Dore%2CS&amp;author=Rodriguez%2CAH&amp;author=Soni%2CNJ&amp;author=Restrepo%2CMI&amp;author=investigators%2CGLIMP\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR9\">Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1099%2Fjmm.0.2008%2F003814-0\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1099/jmm.0.2008/003814-0\" data-track-item_id=\"10.1099/jmm.0.2008/003814-0\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Detection%20of%20mycoplasma%20pneumoniae%20in%20adult%20community-acquired%20pneumonia%20by%20PCR%20and%20serology&amp;journal=J%20Med%20Microbiol&amp;doi=10.1099%2Fjmm.0.2008%2F003814-0&amp;volume=57&amp;issue=Pt%2012&amp;pages=1491-1495&amp;publication_year=2008&amp;author=Martinez%2CMA&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Luchsinger%2CV&amp;author=Avendano%2CLF\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR10\">von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/1471-2334-9-62\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/1471-2334-9-62\" data-track-item_id=\"10.1186/1471-2334-9-62\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Mycoplasma%20pneumoniae%20pneumonia%20revisited%20within%20the%20German%20competence%20network%20for%20community-acquired%20pneumonia%20%28CAPNETZ%29&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-9-62&amp;volume=9&amp;publication_year=2009&amp;author=von%2CBH&amp;author=Welte%2CT&amp;author=Marre%2CR&amp;author=Suttorp%2CN&amp;author=Luck%2CC&amp;author=Ewig%2CS\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR11\">Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1086%2F597775\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1086/597775\" data-track-item_id=\"10.1086/597775\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20laboratory%20diagnostic%20procedures%20for%20detection%20of%20mycoplasma%20pneumoniae%20in%20community%20outbreaks&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F597775&amp;volume=48&amp;pages=1244-1249&amp;publication_year=2009&amp;author=Thurman%2CKA&amp;author=Walter%2CND&amp;author=Schwartz%2CSB\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR12\">Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1007/s15010-004-3107-z\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1007/s15010-004-3107-z\" data-track-item_id=\"10.1007/s15010-004-3107-z\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=CAPNETZ%3A%20community-acquired%20pneumonia%20competence%20network&amp;journal=Infection&amp;doi=10.1007%2Fs15010-004-3107-z&amp;volume=32&amp;pages=234-238&amp;publication_year=2004&amp;author=Welte%2CT&amp;author=Suttorp%2CN&amp;author=Marre%2CR\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR13\">Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. <a href=\"https://doi.org/10.1186/s12879-016-1641-9.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1186/s12879-016-1641-9.\">https://doi.org/10.1186/s12879-016-1641-9.</a>\n                        </p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/s12879-016-1641-9.\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/s12879-016-1641-9.\" data-track-item_id=\"10.1186/s12879-016-1641-9.\">Article</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27317257\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912822\" data-track=\"click_references\" data-track-action=\"pubmed central reference\" data-track-value=\"pubmed central reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed Central</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Atypical%20aetiology%20in%20patients%20hospitalised%20with%20community-acquired%20pneumonia%20is%20associated%20with%20age%2C%20gender%20and%20season%3B%20a%20data-analysis%20on%20four%20Dutch%20cohorts&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2Fs12879-016-1641-9.&amp;volume=16&amp;publication_year=2016&amp;author=Raeven%2CVM&amp;author=Spoorenberg%2CSM&amp;author=Boersma%2CWG&amp;author=Garde%2CEM&amp;author=Cannegieter%2CSC&amp;author=Voorn%2CGP&amp;author=Bos%2CWJ&amp;author=Steenbergen%2CJE\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR14\">Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR15\">Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1016%2FS0924-8579%2801%2900402-2\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1016/S0924-8579(01)00402-2\" data-track-item_id=\"10.1016/S0924-8579(01)00402-2\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Japanese%20guidelines%20for%20the%20management%20of%20community-acquired%20pneumonia&amp;journal=Int%20J%20Antimicrob%20Agents&amp;doi=10.1016%2FS0924-8579%2801%2900402-2&amp;volume=18&amp;issue=Suppl.%201&amp;pages=S45-S48&amp;publication_year=2001&amp;author=Yanagihara%2CK&amp;author=Kohno%2CS&amp;author=Matsusima%2CT\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR16\">Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p><p class=\"c-reading-companion__reference-links\"><a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=S%20Afr%20Med%20J&amp;volume=97&amp;pages=1296-1306&amp;publication_year=2007\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR17\">Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1183%2F13993003.02306-2016\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1183/13993003.02306-2016\" data-track-item_id=\"10.1183/13993003.02306-2016\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Evaluation%20of%20severity%20score-guided%20approaches%20to%20macrolide%20use%20in%20community-acquired%20pneumonia&amp;journal=Eur%20Respir%20J&amp;doi=10.1183%2F13993003.02306-2016&amp;volume=50&amp;publication_year=2017&amp;author=Singanayagam%2CA&amp;author=Aliberti%2CS&amp;author=Cill%C3%B3niz%2CC\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR18\">Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1097%2FMD.0b013e31827f6104\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1097/MD.0b013e31827f6104\" data-track-item_id=\"10.1097/MD.0b013e31827f6104\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20legionella%20pneumophila%20pneumonia%3Aa%20single-%20center%20experience%20with%20214%20hospitalized%20sporadic%20cases%20over%2015%20years&amp;journal=Medicine&amp;doi=10.1097%2FMD.0b013e31827f6104&amp;volume=92&amp;pages=51-60&amp;publication_year=2012&amp;author=Viasus%2CD&amp;author=Yacovo%2CS&amp;author=Garcia-Vidal%2CC&amp;author=Verdaguer%2CR&amp;author=Manresa%2CF&amp;author=Dorca%2CJ&amp;author=Gudiol%2CF&amp;author=Carratal%C3%A0%2CJ\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR19\">Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1001%2Farchinte.160.9.1294\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1001/archinte.160.9.1294\" data-track-item_id=\"10.1001/archinte.160.9.1294\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Azithromycin%20vs%20cefuroxime%20plus%20erythromycin%20for%20empirical%20treatment%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%3A%20a%20prospective%2C%20randomized%2C%20multicenter%20trial&amp;journal=Arch%20Intern%20Med&amp;doi=10.1001%2Farchinte.160.9.1294&amp;volume=160&amp;issue=9&amp;pages=1294-1300&amp;publication_year=2000&amp;author=Vergis%2CEN&amp;author=Indorf%2CA&amp;author=File%2CTM&amp;author=Phillips%2CJ&amp;author=Bates%2CJ&amp;author=Tan%2CJ&amp;author=Sarosi%2CGA&amp;author=Grayston%2CJT&amp;author=Summersgill%2CJ&amp;author=Yu%2CVL\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR20\">Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1136%2Fthoraxjnl-2013-203551\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1136/thoraxjnl-2013-203551\" data-track-item_id=\"10.1136/thoraxjnl-2013-203551\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20pneumonia%20in%20Chile%3A%20the%20clinical%20relevance%20in%20the%20detection%20of%20viruses%20and%20atypical%20bacteria&amp;journal=Thorax&amp;doi=10.1136%2Fthoraxjnl-2013-203551&amp;volume=68&amp;pages=1000-1006&amp;publication_year=2013&amp;author=Luchsinger%2CV&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Mart%C3%ADnez%2CMA&amp;author=Machado%2CC&amp;author=Piedra%2CPA&amp;author=Fasce%2CR&amp;author=Ulloa%2CMT&amp;author=Fink%2CMC&amp;author=Lara%2CP&amp;author=Gebauer%2CM&amp;author=Ch%C3%A1vez%2CF&amp;author=Avenda%C3%B1o%2CLF\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR21\">Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/1471-2334-14-335\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/1471-2334-14-335\" data-track-item_id=\"10.1186/1471-2334-14-335\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Microbial%20aetiology%2C%20outcomes%2C%20and%20costs%20of%20hospitalisation%20for%20community-acquired%20pneumonia%3B%20an%20observational%20analysis&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-14-335&amp;volume=14&amp;pages=335-343&amp;publication_year=2014&amp;author=Spoorenberg%2CSM&amp;author=Bos%2CWJ&amp;author=Heijligenberg%2CR&amp;author=Voorn%2CPG&amp;author=Grutters%2CJC&amp;author=Rijkers%2CGT&amp;author=Garde%2CEM\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR22\">Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p><p class=\"c-reading-companion__reference-links\"><a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21337816\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%20in%20northern%20Israel&amp;journal=Isr%20Med%20Assoc%20J&amp;volume=12&amp;pages=477-482&amp;publication_year=2010&amp;author=Shibli%2CF&amp;author=Chazan%2CB&amp;author=Nitzan%2CO&amp;author=Flatau%2CE&amp;author=Edelstein%2CH&amp;author=Blondheim%2CO&amp;author=Raz%2CR&amp;author=Colodner%2CR\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR23\">Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/s12889-015-1422-1\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/s12889-015-1422-1\" data-track-item_id=\"10.1186/s12889-015-1422-1\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20aetiology%20of%20community%20associated%20pneumonia%20in%20children%20in%20Nanjing%2C%20China%20and%20aetiological%20patternsassociated%20with%20age%20and%20season&amp;journal=BMC%20Public%20Health&amp;doi=10.1186%2Fs12889-015-1422-1&amp;volume=15&amp;pages=113-118&amp;publication_year=2015&amp;author=Chen%2CK&amp;author=Jia%2CR&amp;author=Li%2CL&amp;author=Yang%2CC&amp;author=Shi%2CY\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR24\">Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1378%2Fchest.13-0162\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1378/chest.13-0162\" data-track-item_id=\"10.1378/chest.13-0162\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Importance%20of%20legionella%20pneumophila%20in%20the%20etiology%20of%20severe%20community-acquired%20pneumonia%20in%20Santiago&amp;journal=Chile%20Chest&amp;doi=10.1378%2Fchest.13-0162&amp;volume=145&amp;pages=290-296&amp;publication_year=2014&amp;author=Arancibia%2CF&amp;author=Cortes%2CCP&amp;author=Vald%C3%A9s%2CM&amp;author=Cerda%2CJ&amp;author=Hern%C3%A1ndez%2CA&amp;author=Soto%2CL&amp;author=Torres%2CA\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR25\">Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1086%2F431588\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1086/431588\" data-track-item_id=\"10.1086/431588\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Improved%20diagnosis%20of%20the%20etiology%20of%20community-%20acquired%20pneumonia%20with%20real-time%20polymerase%20chain%20reaction&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F431588&amp;volume=41&amp;pages=345-351&amp;publication_year=2005&amp;author=Templeton%2CKE&amp;author=Scheltinga%2CSA&amp;author=Eeden%2CWC&amp;author=Graffelman%2CAW&amp;author=Broek%2CPJ&amp;author=Claas%2CEC\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li></ol></div></div>\n                        </div>\n                    </div>\n                </aside>\n            </div>\n        </div>\n\n        \n            <div class=\"c-journal-footer\">\n                <div class=\"c-journal-footer__inner\">\n                    <div class=\"c-journal-footer__summary\">\n                        <h4 class=\"c-journal-title c-journal-title--footer\">\n                            \n                            <span class=\"c-journal-title__text\">BMC Infectious Diseases</span>\n                        </h4>\n                         <p class=\"c-journal-footer__issn\">ISSN: 1471-2334</p>\n                    </div>\n                    \n                        <div class=\"c-journal-footer__contact\">\n                            <h4 class=\"c-journal-footer__contact-title \">Contact us</h4>\n                            <ul class=\"c-journal-footer__contact-list\">\n                                \n                                \n                                    <li class=\"c-journal-footer__contact-item\">General enquiries: <a href=\"mailto:journalsubmissions@springernature.com\">journalsubmissions@springernature.com</a></li>\n                                \n                            </ul>\n                        </div>\n                    \n                </div>\n            </div>\n        \n        \n    <img rel=\"nofollow\" class=\"tracker\" style=\"display:none\" src=\"/track/article/10.1186/s12879-018-3565-z\" alt=\"\">\n\n         \n    <footer>\n        \n            <div class=\"c-publisher-footer u-color-inherit\" data-test=\"publisher-footer\">\n    <div class=\"u-container\">\n        <div class=\"u-display-flex u-flex-wrap u-justify-content-space-between\" data-test=\"publisher-footer-menu\">\n            <div class=\"u-display-flex\">\n                \n                    \n                        <ul class=\"c-list-group c-list-group--sm u-mr-24 u-mb-16\">\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://blogs.biomedcentral.com/\">Read more on our blogs</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/login\">Receive BMC newsletters</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/account\">Manage article alerts</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022\">Language editing for authors</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022\">Scientific editing for authors</a>\n                                </li>\n                            \n                        </ul>\n                    \n                        <ul class=\"c-list-group c-list-group--sm u-mr-24 u-mb-16\">\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/about/policies\">Policies</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/accessibility\">Accessibility</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/about/press-centre\">Press center</a>\n                                </li>\n                            \n                        </ul>\n                    \n                        <ul class=\"c-list-group c-list-group--sm u-mr-24 u-mb-16\">\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://support.biomedcentral.com/support/home\">Support and Contact</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://biomedcentral.typeform.com/to/VLXboo\">Leave feedback</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/about/jobs\">Careers</a>\n                                </li>\n                            \n                        </ul>\n                    \n                \n            </div>\n            <div class=\"u-mb-24\">\n                <h3 id=\"social-menu\" class=\"u-text-sm u-reset-margin u-text-normal\">Follow BMC</h3>\n                <ul class=\"u-display-flex u-list-reset\" data-test=\"footer-social-links\">\n                    \n                        <li class=\"u-mt-8 u-mr-8\">\n                            <a href=\"https://twitter.com/biomedcentral\" data-track=\"click\" data-track-category=\"Social\" data-track-action=\"Clicked BMC Twitter\" class=\"u-gray-link\">\n                                <span class=\"u-visually-hidden\">BMC Twitter page</span>\n                                <svg class=\"u-icon u-text-lg\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\">\n                                    <use xlink:href=\"#icon-twitter-bordered\"></use>\n                                </svg>\n                            </a>\n                        </li>\n                    \n                        <li class=\"u-mt-8 u-mr-8\">\n                            <a href=\"https://www.facebook.com/BioMedCentral\" data-track=\"click\" data-track-category=\"Social\" data-track-action=\"Clicked BMC Facebook\" class=\"u-gray-link\">\n                                <span class=\"u-visually-hidden\">BMC Facebook page</span>\n                                <svg class=\"u-icon u-text-lg\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\">\n                                    <use xlink:href=\"#icon-facebook-bordered\"></use>\n                                </svg>\n                            </a>\n                        </li>\n                    \n                        <li class=\"u-mt-8 u-mr-8\">\n                            <a href=\"http://www.weibo.com/biomedcentral\" data-track=\"click\" data-track-category=\"Social\" data-track-action=\"Clicked BMC Weibo\" class=\"u-gray-link\">\n                                <span class=\"u-visually-hidden\">BMC Weibo page</span>\n                                <svg class=\"u-icon u-text-lg\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\">\n                                    <use xlink:href=\"#icon-weibo-bordered\"></use>\n                                </svg>\n                            </a>\n                        </li>\n                    \n                </ul>\n            </div>\n        </div>\n        <p class=\"u-reset-margin\">\n            By using this website, you agree to our\n            <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/terms-and-conditions\">Terms and Conditions</a>,\n            <a class=\"u-gray-link\" href=\"https://www.springernature.com/ccpa\">Your US state privacy rights</a>,\n            <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/privacy-statement\">Privacy\n                statement</a> and\n            <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/cookies\" data-test=\"cookie-link\">Cookies</a> policy.\n                <a class=\"u-gray-link\" data-cc-action=\"preferences\" href=\"javascript:void(0);\">Your privacy choices/Manage cookies</a> we use in the preference centre.\n        </p>\n    </div>\n</div>\n\n        \n        <div class=\"c-corporate-footer\">\n    <div class=\"u-container\">\n        <img src=\"/static/images/logo-springernature-acb40b85fb.svg\" class=\"c-corporate-footer__logo\" alt=\"Springer Nature\" itemprop=\"logo\" role=\"img\" width=\"135\" height=\"13\">\n        <p class=\"c-corporate-footer__legal\" data-test=\"copyright\"> © 2025 BioMed Central Ltd unless otherwise stated. Part of\n            <a class=\"c-corporate-footer__link\" href=\"https://www.springernature.com\" itemscope=\"\" itemtype=\"http://schema.org/Organization\" itemid=\"#parentOrganization\">Springer Nature</a>.\n        </p>\n    </div>\n</div>\n\n    </footer>\n\n    </div>\n\n\n\n        <div class=\"u-visually-hidden\" aria-hidden=\"true\">\n    \n    <!--?xml version=\"1.0\" encoding=\"UTF-8\"?--><svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><defs><path id=\"a\" d=\"M0 .74h56.72v55.24H0z\"></path></defs><symbol id=\"icon-access\" viewBox=\"0 0 18 18\"><path d=\"m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-account\" viewBox=\"0 0 18 18\"><path d=\"m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-alert\" viewBox=\"0 0 18 18\"><path d=\"m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-broad\" viewBox=\"0 0 16 16\"><path d=\"m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 14 15)\"></path></symbol><symbol id=\"icon-arrow-down\" viewBox=\"0 0 16 16\"><path d=\"m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-left\" viewBox=\"0 0 16 16\"><path d=\"m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-right\" viewBox=\"0 0 16 16\"><path d=\"m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-sub\" viewBox=\"0 0 16 16\"><path d=\"m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-up\" viewBox=\"0 0 16 16\"><path d=\"m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-article\" viewBox=\"0 0 18 18\"><path d=\"m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-audio\" viewBox=\"0 0 18 18\"><path d=\"m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-block\" viewBox=\"0 0 24 24\"><path d=\"m0 0h24v24h-24z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-book\" viewBox=\"0 0 18 18\"><path d=\"m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-broad\" viewBox=\"0 0 24 24\"><path d=\"m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 20.182742 24.805206)\"></path></symbol><symbol id=\"icon-calendar\" viewBox=\"0 0 18 18\"><path d=\"m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-cart\" viewBox=\"0 0 18 18\"><path d=\"m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z\"></path></symbol><symbol id=\"icon-chevron-less\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 -1 0 9 9)\"></path></symbol><symbol id=\"icon-chevron-more\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 1)\"></path></symbol><symbol id=\"icon-chevron-right\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-circle-fill\" viewBox=\"0 0 16 16\"><path d=\"m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-circle\" viewBox=\"0 0 16 16\"><path d=\"m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-citation\" viewBox=\"0 0 18 18\"><path d=\"m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-close\" viewBox=\"0 0 16 16\"><path d=\"m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-collections\" viewBox=\"0 0 18 18\"><path d=\"m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-compare\" viewBox=\"0 0 18 18\"><path d=\"m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download-file\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download\" viewBox=\"0 0 16 16\"><path d=\"m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-editors\" viewBox=\"0 0 18 18\"><path d=\"m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-email\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-error\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-ethics\" viewBox=\"0 0 18 18\"><path d=\"m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-expand\"><path d=\"M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-explore\" viewBox=\"0 0 18 18\"><path d=\"m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-filter\" viewBox=\"0 0 16 16\"><path d=\"m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z\"></path></symbol><symbol id=\"icon-home\" viewBox=\"0 0 18 18\"><path d=\"m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-image\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-info\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-institution\" viewBox=\"0 0 18 18\"><path d=\"m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-location\" viewBox=\"0 0 18 18\"><path d=\"m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-minus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-newsletter\" viewBox=\"0 0 18 18\"><path d=\"m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-orcid\" viewBox=\"0 0 18 18\"><path d=\"m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-plus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-print\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-search\" viewBox=\"0 0 22 22\"><path d=\"M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-facebook\" viewBox=\"0 0 24 24\"><path d=\"m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-twitter\" viewBox=\"0 0 24 24\"><path d=\"m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-youtube\" viewBox=\"0 0 24 24\"><path d=\"m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-subject-medicine\" viewBox=\"0 0 18 18\"><path d=\"m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-success\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-table\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick-circle\" viewBox=\"0 0 24 24\"><path d=\"m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick\" viewBox=\"0 0 16 16\"><path d=\"m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-update\" viewBox=\"0 0 18 18\"><path d=\"m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-upload\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-video\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-warning\" viewBox=\"0 0 18 18\"><path d=\"m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-checklist-banner\" viewBox=\"0 0 56.69 56.69\"><path style=\"fill:none\" d=\"M0 0h56.69v56.69H0z\"></path><clipPath id=\"b\"><use xlink:href=\"#a\" style=\"overflow:visible\"></use></clipPath><path d=\"M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round\"></path><path d=\"M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round\"></path></symbol><symbol id=\"icon-chevron-down\" viewBox=\"0 0 16 16\"><path d=\"m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 1)\"></path></symbol><symbol id=\"icon-eds-i-arrow-right-medium\" viewBox=\"0 0 24 24\"><path d=\"m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z\"></path></symbol><symbol id=\"icon-eds-i-check-circle-medium\" viewBox=\"0 0 24 24\"><path d=\"M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z\"></path></symbol><symbol id=\"icon-eds-i-chevron-down-medium\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-chevron-down-small\" viewBox=\"0 0 16 16\"><path d=\"M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z\"></path></symbol><symbol id=\"icon-eds-i-chevron-right-medium\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-eds-i-chevron-right-small\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-eds-i-chevron-up-medium\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-close-medium\" viewBox=\"0 0 16 16\"><path d=\"m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-copy-link\" viewBox=\"0 0 24 24\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z\"></path><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z\"></path><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z\"></path><path d=\"M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z\"></path><path d=\"M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z\"></path><path d=\"M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z\"></path></symbol><symbol id=\"icon-eds-i-download-medium\" viewBox=\"0 0 16 16\"><path d=\"m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-info-filled-medium\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-institution-medium\" viewBox=\"0 0 24 24\"><g><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z\"></path></g></symbol><symbol id=\"icon-eds-i-mail-medium\" viewBox=\"0 0 24 24\"><path d=\"m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z\"></path></symbol><symbol id=\"icon-eds-i-menu-medium\" viewBox=\"0 0 24 24\"><path d=\"M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z\"></path></symbol><symbol id=\"icon-eds-i-search-medium\" viewBox=\"0 0 24 24\"><path d=\"M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z\"></path></symbol><symbol id=\"icon-eds-i-user-single-medium\" viewBox=\"0 0 24 24\"><path d=\"M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z\"></path></symbol><symbol id=\"icon-eds-i-warning-filled-medium\" viewBox=\"0 0 18 18\"><path d=\"m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-expand-image\" viewBox=\"0 0 18 18\"><path d=\"m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-github\" viewBox=\"0 0 100 100\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z\"></path></symbol><symbol id=\"icon-springer-arrow-left\"><path d=\"M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z\"></path></symbol><symbol id=\"icon-springer-arrow-right\"><path d=\"M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z\"></path></symbol><symbol id=\"icon-submit-open\" viewBox=\"0 0 16 17\"><path d=\"M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z\" fill-rule=\"nonzero\"></path></symbol></svg>\n</div>\n    \n\n\n<script src=\"/static/js/app-es5-bundle-fe9cce56e1.js\" nomodule=\"true\"></script><script src=\"/static/js/app-es6-bundle-fed4944a50.js\" type=\"module\"></script><script src=\"/static/js/global-article-es5-bundle-d1124b54a9.js\" nomodule=\"true\"></script><script src=\"/static/js/global-article-es6-bundle-798832bcce.js\" type=\"module\"></script><div data-cc-ghost=\"\" style=\"height: 392px;\"></div><script type=\"text/javascript\" id=\"fetch-contextual-ads-campaign-data\" charset=\"\">(function(){var g=function(a){a=new CustomEvent(\"campaignDataLoaded\",{detail:a});document.dispatchEvent(a)},b=google_tag_manager[\"rm\"][\"50443292\"](49);if(b){var k=1500;b=google_tag_manager[\"rm\"][\"50443292\"](50);b=\"link\"===b?google_tag_manager[\"rm\"][\"50443292\"](51):google_tag_manager[\"rm\"][\"50443292\"](52);var m=function(a,c){var h=!1,l=setTimeout(function(){h=!0;c(null)},k),d=new XMLHttpRequest;d.onload=function(){var e=null,f=[];if(200===d.status){try{e=JSON.parse(d.responseText)}catch(p){e={}}f=e.campaigns||[]}h||(clearTimeout(l),c(f.length?f.join(\",\"):null))};d.open(\"GET\",\n\"/platform/contextual?doi\\x3d\"+a);d.send()},n=function(a,c){a&&-1===a.indexOf(\"not set\")?m(a,c):setTimeout(c,1)};n(b,function(a){window.campaignsForContextualAds=a;g(a);window.dataLayer.push({content:{article:{campaignID:a}}})})}else window.campaignsForContextualAds=\"\",g(null)})();</script>\n<script id=\"crossmark-script\" text=\"\" charset=\"\" type=\"text/javascript\" src=\"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js\"></script><script type=\"text/javascript\" id=\"polyfill-matches\" charset=\"\">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script></body></html>",
    "cleaned_content": "<dialog>\n<div>\n<div>\n<div>\n<h2>Your privacy, your choice</h2>\n</div>\n<div>\n<div>\n<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href=\"https://www.biomedcentral.com/privacy-statement\">privacy policy</a> for more information on the use of your personal data.</p><p><button>Manage preferences</button> for further information and to change your choices.</p>\n</div>\n</div>\n<div>\n<button>Accept all cookies</button>\n</div>\n</div>\n</div>\n</dialog>\n\n\n<div>\n<a href=\"#main-content\">Skip to main content</a>\n<aside>\n<div>\n<p>Advertisement</p>\n</div>\n</aside>\n<div>\n<header>\n<div>\n<div>\n<div>\n<a href=\"https://www.biomedcentral.com\">\n<img alt=\"BMC\" height=\"18\" itemprop=\"logo\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-series-d1f4e4f0a7.svg\" width=\"76\"/>\n<div>\n<img alt=\"Part of Springer Nature\" height=\"16\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg\" width=\"173\"/>\n</div>\n</a>\n</div>\n</div>\n<div>\n<button>\n<span>\n<span>Search</span>\n</span>\n</button>\n<nav>\n<ul>\n<li>\n<a href=\"//www.biomedcentral.com/journals\">\n                    Explore journals\n                  </a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/getpublished\">\n                    Get published\n                  </a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/about\">\n                    About BMC\n                  </a>\n</li>\n<li>\n<a href=\"/login\">Login</a>\n</li>\n</ul><div><button>Menu</button><ul><li><a href=\"https://www.biomedcentral.com/journals\">\n                    Explore journals\n                  </a></li><li><a href=\"https://www.biomedcentral.com/getpublished\">\n                    Get published\n                  </a></li><li><a href=\"https://www.biomedcentral.com/about\">\n                    About BMC\n                  </a></li><li><a href=\"https://bmcinfectdis.biomedcentral.com/login\">Login</a></li></ul></div>\n</nav>\n</div>\n</div>\n</header>\n<div>\n<div>\n<div>\n<div>\n<form>\n<label>Search all BMC articles</label>\n<div>\n<div>\n<button>\n<span>Search</span>\n</button>\n</div>\n</div>\n</form>\n</div>\n</div>\n</div>\n</div>\n</div>\n<header>\n<div>\n<div>\n<div>\n<a href=\"/\">\n<span>BMC Infectious Diseases</span>\n</a>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<nav>\n<ul>\n<li>\n<a href=\"/\">Home</a>\n</li>\n<li>\n<a href=\"/about\">About</a>\n</li>\n<li>\n<a href=\"/articles\">Articles</a>\n</li>\n<li>\n<a href=\"/submission-guidelines\">Submission Guidelines</a>\n</li>\n<li>\n<a href=\"/join-our-editorial-board\">Join the board</a>\n</li>\n<li>\n<a href=\"/articles/collections\">Collections</a>\n</li>\n</ul>\n</nav>\n</div>\n</div>\n</div>\n</header>\n<div>\n<main>\n<div>\n<div>\n<div>\n              Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\n            </div>\n<div>\n<div>\n<a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\">\n<span>Download PDF</span>\n</a>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\">\n<span>Download PDF</span>\n</a>\n</div>\n</div>\n</div>\n<article>\n<div>\n<ul>\n<li>Research article</li>\n<li>Published: <time>18 December 2018</time></li>\n</ul>\n<h1>Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective</h1>\n<ul><li><a href=\"#auth-Andrea-Gramegna-Aff1\">Andrea Gramegna</a><sup><a href=\"#Aff1\">1</a></sup>, </li><li><a href=\"#auth-Giovanni-Sotgiu-Aff2\">Giovanni Sotgiu</a><sup><a href=\"#Aff2\">2</a></sup>, </li><li><a href=\"#auth-Marta-Pasquale-Aff1\">Marta Di Pasquale</a><sup><a href=\"#Aff1\">1</a></sup>, </li><li><a href=\"#auth-Dejan-Radovanovic-Aff3\">Dejan Radovanovic</a><sup><a href=\"#Aff3\">3</a></sup>, </li><li><a href=\"#auth-Silvia-Terraneo-Aff4\">Silvia Terraneo</a><sup><a href=\"#Aff4\">4</a></sup>, </li><li><a href=\"#auth-Luis_F_-Reyes-Aff5\">Luis F. Reyes</a><sup><a href=\"#Aff5\">5</a></sup>, </li><li><a href=\"#auth-Ester-Vendrell-Aff6\">Ester Vendrell</a><sup><a href=\"#Aff6\">6</a></sup>, </li><li><a href=\"#auth-Joao-Neves-Aff7\">Joao Neves</a><sup><a href=\"#Aff7\">7</a></sup>, </li><li><a href=\"#auth-Francesco-Menzella-Aff8\">Francesco Menzella</a><sup><a href=\"#Aff8\">8</a></sup>, </li><li><a href=\"#auth-Francesco-Blasi-Aff1\">Francesco Blasi</a><sup><a href=\"#Aff1\">1</a></sup>, </li><li><a href=\"#auth-Stefano-Aliberti-Aff1\">Stefano Aliberti</a><sup><a href=\"#Aff1\">1</a></sup> &amp; </li><li><a href=\"#auth-Marcos_I_-Restrepo-Aff5\">Marcos I. Restrepo</a><sup><a href=\"#Aff5\">5</a></sup> </li><li><a href=\"#group-1\">on behalf of the GLIMP Study Group</a></li></ul><button><span>Show authors</span></button>\n<p>\n<a href=\"/\"><i>BMC Infectious Diseases</i></a>\n<b><span>volume</span> 18</b>, Article number: <span>677</span> (<span>2018</span>)\n      <a href=\"#citeas\">Cite this article</a>\n</p>\n<div>\n<ul>\n<li>\n<p>8117 <span>Accesses</span></p>\n</li>\n<li>\n<p>37 <span>Citations</span></p>\n</li>\n<li>\n<p>4 <span>Altmetric</span></p>\n</li>\n<li>\n<p><a href=\"/articles/10.1186/s12879-018-3565-z/metrics\">Metrics <span>details</span></a></p>\n</li>\n</ul>\n</div>\n<div>\n<p>A <a href=\"/articles/10.1186/s12879-020-05472-y\">Correction</a> to this article was published on 13 October 2020</p>\n</div>\n<div>\n<p>This article has been <a href=\"#change-history\">updated</a></p>\n</div>\n</div>\n<section><div><h2>Abstract</h2><div><h3>Background</h3><p>Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity.</p><h3>Methods</h3><p>A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including <i>L. pneumophila</i>, <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis.</p><h3>Results</h3><p>Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, <i>p</i> &lt; 0.0001). Detection of <i>L. pneumophila</i> urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, <i>p</i> = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, <i>p</i> = 0.003) than the rest of the population. Similarly, <i>L. pneumophila</i> testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including <i>M. pneumoniae</i> (26/251 patients, 10.3%), <i>L. pneumophila</i> (30/1186 patients, 2.5%), and <i>C. pneumoniae</i> (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP.</p><h3>Conclusions</h3><p>Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.</p></div></div></section>\n<p>\n<a href=\"/articles/10.1186/s12879-018-3565-z/peer-review\">Peer Review reports</a>\n</p>\n<section><div><h2>Background</h2><div><p>Community-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR2\" title=\"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\">2</a>]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including <i>Mycoplasma pneumoniae</i>, <i>Chlamydia pneumoniae</i>, and <i>Legionella pneumophila</i>, is still a matter of debate [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR3\" title=\"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\">3</a>].</p><p>Several Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR4\" title=\"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\">4</a>]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding <i>Streptococcus pneumoniae</i> [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR5\" title=\"Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\">5</a>]. Other studies described similar prevalences of atypical pathogens [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>].</p><p>Epidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \">7</a>]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>].</p><p>The aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens.</p></div></div></section><section><div><h2>Methods</h2><div><h3>Study design and population</h3><p>The present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n          https://doi.org/10.1016/S1473-3099(16)30267-5\n          \n         .\">8</a>]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n          https://doi.org/10.1016/S1473-3099(16)30267-5\n          \n         .\">8</a>]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015.</p><p>All adults (&gt; 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature &lt; 36 °C); 3) systemic inflammation (e.g., white blood cell count &gt; 10,000/cm<sup>3</sup> or &lt; 4000/cm<sup>3</sup>, C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded.</p><h3>Data collection and microbiology for atypical pathogens</h3><p>Data were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results.</p><p>Physicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for <i>L. pneumophila</i> were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and <i>L. pneumophila</i>.</p><h3>Study groups</h3><p>Definition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for <i>L. pneumophila,</i> serology for <i>L. Pneumophila</i>, <i>C. pneumoniae,</i> and <i>M. pneumoniae</i>.</p><h3>Study definitions</h3><p>CAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission.</p><p>Definition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions.</p><h3>Statistical analysis</h3><p>Testing frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for <i>L. pneumophila</i> performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was &lt; 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software.</p></div></div></section><section><div><h2>Results</h2><div><h3>Testing for atypical pathogens</h3><p>A total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for <i>L. pneumophila</i> (either urinary antigen or serology), 251 (6.8%) for <i>M. pneumoniae</i> (serology), and 228 (6.1%) for <i>C. pneumoniae</i> (serology). Distribution of testing frequencies across countries is showed in Fig. <a href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1a</a>.</p><div><figure><figcaption><b>Fig. 1</b></figcaption><div><div><a href=\"/articles/10.1186/s12879-018-3565-z/figures/1\"><picture><source><img alt=\"figure 1\" aria-describedby=\"Fig1\" height=\"815\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\" width=\"685\"/></source></picture></a></div><div><p><b>a</b>) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. <b>b</b>) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure <a href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1</a> is original and it was created using Stat Planet software with the information created from the study</p></div></div><div><a href=\"/articles/10.1186/s12879-018-3565-z/figures/1\"><span>Full size image</span></a></div></figure></div><p>The frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, <i>P</i> &lt; 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling &gt; 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab1\">1</a>). Data on testing for <i>L. pneumophila</i>, <i>M. pneumoniae</i>, and <i>C. pneumoniae</i> are reported in the additional files (Additional file <a href=\"/articles/10.1186/s12879-018-3565-z#MOESM1\">1</a>: Table A). Detection of <i>L. pneumophila</i> urinary antigen was the most prevalent test performed worldwide (32.0%).</p><div><figure><figcaption><b>Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/1\"><span>Full size table</span></a></div></figure></div><p>The frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than <i>L. pneumophila</i>, <i>P</i> = 0.009; 28.3% VS. 33.5% for <i>L. pneumophila</i>, <i>P</i> = 0.003). <i>L. pneumophila</i> testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column A.</p><h3>Prevalence of atypical pathogens</h3><p>At least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. <i>L. pneumophila</i> was detected in 30 (2.5%), <i>M. pneumoniae</i> in 26 (10.3%), and <i>C. pneumoniae</i> in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. <a href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1b</a>. Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, <i>P</i> = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, <i>P</i> = 0.001) (Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab2\">2</a>).</p><div><figure><figcaption><b>Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/2\"><span>Full size table</span></a></div></figure></div><p>Patients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column B and Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab4\">4</a>).</p><div><figure><figcaption><b>Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B)</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/3\"><span>Full size table</span></a></div></figure></div><div><figure><figcaption><b>Table 4 \n             <span>Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia</span>\n</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/4\"><span>Full size table</span></a></div></figure></div></div></div></section><section><div><h2>Discussion</h2><div><p>This secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, <i>L. pneumophila</i> testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals.</p><p>The most frequent test for atypical pathogens performed in hospitalized patients with CAP was the <i>Legionella</i> urinary antigen (32.0%), followed by <i>Legionella</i> serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for <i>M. pneumoniae</i> and <i>C. pneumoniae</i>, respectively).</p><p>However, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \">7</a>]. Although molecular techniques was found helpful in the diagnosis of CAP caused by <i>L. pneumophila</i>, findings from different studies showed that single available tests were not reliable for the detection of <i>M. pneumoniae</i> and <i>C. pneumoniae</i> in CAP patients [<a href=\"#ref-CR9\" title=\"Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\">9</a>,<a href=\"#ref-CR10\" title=\"von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\">10</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR11\" title=\"Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\">11</a>]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR12\" title=\"Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\">12</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR13\" title=\"Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n          https://doi.org/10.1186/s12879-016-1641-9.\n          \n         \n            \">13</a>]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for <i>Legionella</i>, is not routinely prescribed.</p><p>One of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain.</p><p>Furthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"#ref-CR14\" title=\"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\">14</a>,<a href=\"#ref-CR15\" title=\"Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\">15</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR16\" title=\"Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\">16</a>]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, <i>L. pneumophila</i> testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\">17</a>].</p><p>The present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. <i>L. pneumophila</i> and <i>M. pneumoniae</i> seem to be the most frequent pathogens worldwide. The prevalence of <i>M. pneumoniae</i> is highest in South America, whereas <i>L. pneumophila</i> did show a homogeneous geographical distribution. <i>L. pneumophila</i> prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR18\" title=\"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\">18</a>]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR19\" title=\"Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\">19</a>].</p><p>The CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [<a href=\"#ref-CR20\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\">20</a>,<a href=\"#ref-CR21\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\">21</a>,<a href=\"#ref-CR22\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\">22</a>,<a href=\"#ref-CR23\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\">23</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\">24</a>]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\">17</a>]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\">17</a>, <a href=\"#ref-CR20\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\">20</a>,<a href=\"#ref-CR21\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\">21</a>,<a href=\"#ref-CR22\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\">22</a>,<a href=\"#ref-CR23\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\">23</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\">24</a>].</p><p>The prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for <i>Legionella</i> [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR25\" title=\"Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\">25</a>]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up.</p><p>Second, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology.</p><p>However, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians.</p><p>Potential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others.</p></div></div></section><section><div><h2>Conclusions</h2><div><p>In conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide.</p><p>Testing for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations.</p></div></div></section>\n<section><div><h2>Change history</h2><div><ul><li><ins><h3>13 October 2020</h3><div><p>An amendment to this paper has been published and can be accessed via the original article.</p></div></ins></li></ul></div></div></section><section><div><h2>Abbreviations</h2><div><dl><dt><dfn>CAP:</dfn></dt><dd>\n<p>Community-acquired pneumonia</p>\n</dd><dt><dfn>GLIMP:</dfn></dt><dd>\n<p>Global Initiative for MRSA Pneumonia</p>\n</dd><dt><dfn>ICU:</dfn></dt><dd>\n<p>Intensive care unit</p>\n</dd></dl></div></div></section><div><section><div><h2>References</h2><div><div><ol><li><p>Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p> \n  <a href=\"/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\">CAS</a> \n   \n        </p></li><li><p>Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p></li><li><p>Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li><p>Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li><p>Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p></li><li><p>Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p></li><li><p>Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n</p></li><li><p>Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .</p></li><li><p>Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p></li><li><p>von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p></li><li><p>Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p></li><li><p>Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p> \n  <a href=\"/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\">CAS</a> \n   \n        </p></li><li><p>Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n</p></li><li><p>Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li><p>Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p> \n  <a href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\">CAS</a> \n   \n        </p></li><li><p>Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p></li><li><p>Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p></li><li><p>Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p></li><li><p>Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p> \n  <a href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\">CAS</a> \n   \n        </p></li><li><p>Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p></li><li><p>Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p></li><li><p>Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p></li><li><p>Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p></li><li><p>Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p></li><li><p>Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p></li></ol></div></div></div></section></div><section><div><h2>Acknowledgments</h2><div><p>GLIMP investigators</p><p>Argentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases &amp; ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal &amp; Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology &amp; Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine &amp; Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott &amp; White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care &amp; Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine &amp; Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia).</p>\n<h3>Ethics approval and consent to partecipate</h3>\n<p>The coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations.</p>\n<h3>Avaibility of data and materials</h3>\n<p>The database used for the study is not public but it is available from the corresponding author on reasonable request.</p>\n<h3>Funding</h3>\n<p>The authors did not receive any funding for this study.</p>\n</div></div></section><section><div><h2>Author information</h2><div><h3>Authors and Affiliations</h3><ol><li><p>Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy</p><p>Andrea Gramegna, Marta Di Pasquale, Francesco Blasi &amp; Stefano Aliberti</p></li><li><p>Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</p><p>Giovanni Sotgiu</p></li><li><p>Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy</p><p>Dejan Radovanovic</p></li><li><p>Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy</p><p>Silvia Terraneo</p></li><li><p>Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA</p><p>Luis F. Reyes &amp; Marcos I. Restrepo</p></li><li><p>Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain</p><p>Ester Vendrell</p></li><li><p>Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal</p><p>Joao Neves</p></li><li><p>Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy</p><p>Francesco Menzella</p></li></ol><div><span>Authors</span><ol><li><span>Andrea Gramegna</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Giovanni Sotgiu</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Marta Di Pasquale</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Dejan Radovanovic</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Silvia Terraneo</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Luis F. Reyes</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Ester Vendrell</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Joao Neves</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Joao%20Neves\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Francesco Menzella</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Francesco Blasi</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Stefano Aliberti</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Marcos I. Restrepo</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li></ol></div><h3>Consortia</h3><div><h3>on behalf of the GLIMP Study Group</h3></div><h3>Contributions</h3><p>AG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript.</p><h3>Corresponding author</h3><p>Correspondence to\n        .</p></div></div></section><section><div><h2>Ethics declarations</h2><div>\n<h3>Consent for publication</h3>\n<p>Not applicable.</p>\n<h3>Competing interests</h3>\n<p>The authors declare that they have no competing interests for this study.</p>\n<h3>Publisher’s Note</h3>\n<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>\n</div></div></section><section><div><h2>Additional file</h2><div><div><div><div><p>Table A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for <i>C. pneumoniae</i> across continents; A2: Testing frequencies for <i>M. pneumoniae</i> across continents; A3: Testing frequencies for <i>L. pneumophila</i> across continents).- <i>Brief description of the data</i>: a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb)</p></div></div></div></div></div></section><section><div><h2>Rights and permissions</h2><div>\n<p><b>Open Access</b> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver () applies to the data made available in this article, unless otherwise stated.</p>\n</div></div></section><section><div><h2>About this article</h2><div><div><div><h3>Cite this article</h3><p>Gramegna, A., Sotgiu, G., Di Pasquale, M. <i>et al.</i> Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.\n          <i>BMC Infect Dis</i> <b>18</b>, 677 (2018). https://doi.org/10.1186/s12879-018-3565-z</p><ul><li><p>Received<span>: </span><span><time>28 May 2018</time></span></p></li><li><p>Accepted<span>: </span><span><time>28 November 2018</time></span></p></li><li><p>Published<span>: </span><span><time>18 December 2018</time></span></p></li><li><p><abbr title=\"Digital Object Identifier\">DOI</abbr><span>: </span><span>https://doi.org/10.1186/s12879-018-3565-z</span></p></li></ul><div><div><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button>Get shareable link</button><div><p>Sorry, a shareable link is not currently available for this article.</p></div><div><button>Copy to clipboard</button></div><p>\n              Provided by the Springer Nature SharedIt content-sharing initiative\n            </p></div></div><h3>Keywords</h3><ul><li><span><a href='/search?query=CAP&amp;facet-discipline=\"Medicine%20%26%20Public%20Health\"'>CAP</a></span></li><li><span><a href='/search?query=Atypical%20pathogens&amp;facet-discipline=\"Medicine%20%26%20Public%20Health\"'>Atypical pathogens</a></span></li><li><span><a href='/search?query=Epidemiology&amp;facet-discipline=\"Medicine%20%26%20Public%20Health\"'>Epidemiology</a></span></li></ul></div></div></div></div></section>\n</article>\n</main>\n<div>\n<aside>\n<div>\n<div>\n<a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\">\n<span>Download PDF</span>\n</a>\n</div>\n</div>\n<div>\n<div>\n<ul><li><button>Sections</button></li><li><button>Figures</button></li><li><button>References</button></li></ul><div><div><ul><li><a href=\"#Abs1\">Abstract</a></li><li><a href=\"#Sec1\">Background</a></li><li><a href=\"#Sec2\">Methods</a></li><li><a href=\"#Sec8\">Results</a></li><li><a href=\"#Sec11\">Discussion</a></li><li><a href=\"#Sec12\">Conclusions</a></li><li><a href=\"#change-history\">Change history</a></li><li><a href=\"#abbreviations\">Abbreviations</a></li><li><a href=\"#Bib1\">References</a></li><li><a href=\"#Ack1\">Acknowledgments</a></li><li><a href=\"#author-information\">Author information</a></li><li><a href=\"#ethics\">Ethics declarations</a></li><li><a href=\"#Sec13\">Additional file</a></li><li><a href=\"#rightslink\">Rights and permissions</a></li><li><a href=\"#article-info\">About this article</a></li></ul></div>\n<div>\n<aside>\n<div>\n<p>Advertisement</p>\n</div>\n</aside>\n</div>\n</div>\n<div><div><ul><li><figure><figcaption><b>Fig. 1</b></figcaption><picture><source><img alt=\"figure 1\" aria-describedby=\"rc-Fig1\" data-src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\"/></source></picture><p><a href=\"#Fig1\">View in article</a><a href=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1\">Full size image</a></p></figure></li></ul></div></div>\n<div><div><ol><li><p>Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\">CAS</a>  </p></li><li><p>Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p></li><li><p>Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li><p>Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li><p>Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p></li><li><p>Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p></li><li><p>Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n</p></li><li><p>Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .</p></li><li><p>Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p></li><li><p>von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p></li><li><p>Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p></li><li><p>Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\">CAS</a>  </p></li><li><p>Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n</p></li><li><p>Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li><p>Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\">CAS</a>  </p></li><li><p>Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p></li><li><p>Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p></li><li><p>Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p></li><li><p>Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\">CAS</a>  </p></li><li><p>Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p></li><li><p>Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p></li><li><p>Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p></li><li><p>Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p></li><li><p>Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p></li><li><p>Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p></li></ol></div></div>\n</div>\n</div>\n</aside>\n</div>\n</div>\n<div>\n<div>\n<div>\n<h4>\n<span>BMC Infectious Diseases</span>\n</h4>\n<p>ISSN: 1471-2334</p>\n</div>\n<div>\n<h4>Contact us</h4>\n<ul>\n<li>General enquiries: </li>\n</ul>\n</div>\n</div>\n</div>\n<img alt=\"\" class=\"tracker\" rel=\"nofollow\" src=\"/track/article/10.1186/s12879-018-3565-z\" style=\"display:none\"/>\n<footer>\n<div>\n<div>\n<div>\n<div>\n<ul>\n<li>\n<a href=\"https://blogs.biomedcentral.com/\">Read more on our blogs</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/login\">Receive BMC newsletters</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/account\">Manage article alerts</a>\n</li>\n\n</ul>\n<ul>\n<li>\n<a href=\"//www.biomedcentral.com/about/policies\">Policies</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/accessibility\">Accessibility</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/about/press-centre\">Press center</a>\n</li>\n</ul>\n<ul>\n<li>\n<a href=\"https://support.biomedcentral.com/support/home\">Support and Contact</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/about/jobs\">Careers</a>\n</li>\n</ul>\n</div>\n<div>\n<h3>Follow BMC</h3>\n</div>\n</div>\n<p>\n      By using this website, you agree to our\n      <a href=\"//www.biomedcentral.com/terms-and-conditions\">Terms and Conditions</a>,\n      ,\n      <a href=\"//www.biomedcentral.com/privacy-statement\">Privacy\n        statement</a> and\n      <a href=\"//www.biomedcentral.com/cookies\">Cookies</a> policy.\n         we use in the preference centre.\n    </p>\n</div>\n</div>\n<div>\n<div>\n<img alt=\"Springer Nature\" class=\"c-corporate-footer__logo\" height=\"13\" itemprop=\"logo\" role=\"img\" src=\"/static/images/logo-springernature-acb40b85fb.svg\" width=\"135\"/>\n<p> © 2025 BioMed Central Ltd unless otherwise stated. Part of\n      .\n    </p>\n</div>\n</div>\n</footer>\n</div>\n\n",
    "markdown_content": "## Your privacy, your choice\nWe use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.\nBy accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.\nSee our [privacy policy](https://www.biomedcentral.com/privacy-statement) for more information on the use of your personal data.\nManage preferences for further information and to change your choices.\nAccept all cookies\n[Skip to main content](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#main-content)\nAdvertisement\n[ ![BMC](https://bmcinfectdis.biomedcentral.com/static/images/bmc/logos/logo-bmc-white-series-d1f4e4f0a7.svg) ![Part of Springer Nature](https://bmcinfectdis.biomedcentral.com/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg) ](https://www.biomedcentral.com)\nSearch\n  * [ Explore journals ](https://www.biomedcentral.com/journals)\n  * [ Get published ](https://www.biomedcentral.com/getpublished)\n  * [ About BMC ](https://www.biomedcentral.com/about)\n  * [Login](https://bmcinfectdis.biomedcentral.com/login)\n\n\nMenu\n  * [ Explore journals ](https://www.biomedcentral.com/journals)\n  * [ Get published ](https://www.biomedcentral.com/getpublished)\n  * [ About BMC ](https://www.biomedcentral.com/about)\n  * [Login](https://bmcinfectdis.biomedcentral.com/login)\n\n\nSearch all BMC articles\nSearch\n[ BMC Infectious Diseases ](https://bmcinfectdis.biomedcentral.com/)\n  * [Home](https://bmcinfectdis.biomedcentral.com/)\n  * [About](https://bmcinfectdis.biomedcentral.com/about)\n  * [Articles](https://bmcinfectdis.biomedcentral.com/articles)\n  * [Submission Guidelines](https://bmcinfectdis.biomedcentral.com/submission-guidelines)\n  * [Join the board](https://bmcinfectdis.biomedcentral.com/join-our-editorial-board)\n  * [Collections](https://bmcinfectdis.biomedcentral.com/articles/collections)\n\n\nAtypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective \n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n  * Research article\n  * Published: 18 December 2018\n\n\n# Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\n  * [Andrea Gramegna](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Andrea-Gramegna-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Giovanni Sotgiu](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Giovanni-Sotgiu-Aff2)[2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff2), \n  * [Marta Di Pasquale](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Marta-Pasquale-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Dejan Radovanovic](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Dejan-Radovanovic-Aff3)[3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff3), \n  * [Silvia Terraneo](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Silvia-Terraneo-Aff4)[4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff4), \n  * [Luis F. Reyes](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Luis_F_-Reyes-Aff5)[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff5), \n  * [Ester Vendrell](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Ester-Vendrell-Aff6)[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff6), \n  * [Joao Neves](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Joao-Neves-Aff7)[7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff7), \n  * [Francesco Menzella](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Francesco-Menzella-Aff8)[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff8), \n  * [Francesco Blasi](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Francesco-Blasi-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Stefano Aliberti](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Stefano-Aliberti-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1) &\n  * [Marcos I. Restrepo](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Marcos_I_-Restrepo-Aff5)[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff5)\n  * [on behalf of the GLIMP Study Group](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#group-1)\n\nShow authors\n[_BMC Infectious Diseases_](https://bmcinfectdis.biomedcentral.com/) **volume 18**, Article number: 677 (2018) [Cite this article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#citeas)\n  * 8117 Accesses\n  * 37 Citations\n  * 4 Altmetric\n  * [Metrics details](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/metrics)\n\n\nA [Correction](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05472-y) to this article was published on 13 October 2020\nThis article has been [updated](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#change-history)\n## Abstract\n### Background\nEmpirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity.\n### Methods\nA secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including _L. pneumophila_ , _M. pneumoniae_ , _C. pneumoniae_ , and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis.\n### Results\nAmong 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, _p_ < 0.0001). Detection of _L. pneumophila_ urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, _p_ = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, _p_ = 0.003) than the rest of the population. Similarly, _L. pneumophila_ testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including _M. pneumoniae_ (26/251 patients, 10.3%), _L. pneumophila_ (30/1186 patients, 2.5%), and _C. pneumoniae_ (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP.\n### Conclusions\nTesting for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\n[Peer Review reports](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/peer-review)\n## Background\nCommunity-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\")]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [[2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR2 \"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65\\(11\\):1806–12.\")]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including _Mycoplasma pneumoniae_ , _Chlamydia pneumoniae_ , and _Legionella pneumophila_ , is still a matter of debate [[3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR3 \"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\")].\nSeveral Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [[4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR4 \"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37\\(6\\):819–28 Epub 2016 Dec 13.\")]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding _Streptococcus pneumoniae_ [[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR5 \"Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125\\(17\\):2967–72.\")]. Other studies described similar prevalences of atypical pathogens [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")].\nEpidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7 \"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17\\(Suppl 6\\):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \")]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")].\nThe aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens.\n## Methods\n### Study design and population\nThe present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8 \"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia \\(GLIMP\\): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16\\(12\\):1364–76. \n          https://doi.org/10.1016/S1473-3099\\(16\\)30267-5\n          \n         .\")]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8 \"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia \\(GLIMP\\): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16\\(12\\):1364–76. \n          https://doi.org/10.1016/S1473-3099\\(16\\)30267-5\n          \n         .\")]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015.\nAll adults (> 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature < 36 °C); 3) systemic inflammation (e.g., white blood cell count > 10,000/cm3 or < 4000/cm3, C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded.\n### Data collection and microbiology for atypical pathogens\nData were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results.\nPhysicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for _L. pneumophila_ were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: _M. pneumoniae_ , _C. pneumoniae_ , and _L. pneumophila_.\n### Study groups\nDefinition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for _L. pneumophila,_ serology for _L. Pneumophila_ , _C. pneumoniae,_ and _M. pneumoniae_.\n### Study definitions\nCAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission.\nDefinition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions.\n### Statistical analysis\nTesting frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for _L. pneumophila_ performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was < 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software.\n## Results\n### Testing for atypical pathogens\nA total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for _L. pneumophila_ (either urinary antigen or serology), 251 (6.8%) for _M. pneumoniae_ (serology), and 228 (6.1%) for _C. pneumoniae_ (serology). Distribution of testing frequencies across countries is showed in Fig. [1a](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1).\n**Fig. 1**\n[![figure 1](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png)](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\n**a**) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. **b**) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1) is original and it was created using Stat Planet software with the information created from the study\n[Full size image](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\nThe frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, _P_ < 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling > 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab1)). Data on testing for _L. pneumophila_ , _M. pneumoniae_ , and _C. pneumoniae_ are reported in the additional files (Additional file [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#MOESM1): Table A). Detection of _L. pneumophila_ urinary antigen was the most prevalent test performed worldwide (32.0%).\n**Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/1)\nThe frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than _L. pneumophila_ , _P_ = 0.009; 28.3% VS. 33.5% for _L. pneumophila_ , _P_ = 0.003). _L. pneumophila_ testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table [3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3), column A.\n### Prevalence of atypical pathogens\nAt least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. _L. pneumophila_ was detected in 30 (2.5%), _M. pneumoniae_ in 26 (10.3%), and _C. pneumoniae_ in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. [1b](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1). Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, _P_ = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, _P_ = 0.001) (Table [2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab2)).\n**Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/2)\nPatients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table [3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3), column B and Table [4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab4)).\n**Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B)**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/3)\n**Table 4 Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia **\n[Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/4)\n## Discussion\nThis secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, _L. pneumophila_ testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals.\nThe most frequent test for atypical pathogens performed in hospitalized patients with CAP was the _Legionella_ urinary antigen (32.0%), followed by _Legionella_ serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for _M. pneumoniae_ and _C. pneumoniae_ , respectively).\nHowever, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7 \"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17\\(Suppl 6\\):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \")]. Although molecular techniques was found helpful in the diagnosis of CAP caused by _L. pneumophila_ , findings from different studies showed that single available tests were not reliable for the detection of _M. pneumoniae_ and _C. pneumoniae_ in CAP patients [[9](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR9 \"Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57\\(Pt 12\\):1491–5.\"),[10](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR10 \"von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia \\(CAPNETZ\\). BMC Infect Dis. 2009;9:62.\"),[11](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR11 \"Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\")]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\"), [12](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR12 \"Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\"), [13](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR13 \"Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n          https://doi.org/10.1186/s12879-016-1641-9.\n          \n         \n            \")]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for _Legionella_ , is not routinely prescribed.\nOne of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain.\nFurthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\")]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [14](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR14 \"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\"),[15](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR15 \"Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18\\(Suppl. 1\\):S45–8.\"),[16](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR16 \"Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\")]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, _L. pneumophila_ testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\")].\nThe present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. _L. pneumophila_ and _M. pneumoniae_ seem to be the most frequent pathogens worldwide. The prevalence of _M. pneumoniae_ is highest in South America, whereas _L. pneumophila_ did show a homogeneous geographical distribution. _L. pneumophila_ prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [[18](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR18 \"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\")]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [[19](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR19 \"Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160\\(9\\):1294–300.\")].\nThe CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [[20](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR20 \"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\"),[21](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR21 \"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\"),[22](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR22 \"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\"),[23](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR23 \"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\"),[24](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24 \"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\")]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\")]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\"), [20](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR20 \"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\"),[21](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR21 \"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\"),[22](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR22 \"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\"),[23](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR23 \"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\"),[24](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24 \"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\")].\nThe prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for _Legionella_ [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [25](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR25 \"Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\")]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up.\nSecond, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology.\nHowever, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians.\nPotential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others.\n## Conclusions\nIn conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide.\nTesting for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations.\n## Change history\n  * ### 13 October 2020\nAn amendment to this paper has been published and can be accessed via the original article.\n\n\n## Abbreviations\n\nCAP:\n    \nCommunity-acquired pneumonia \n\nGLIMP:\n    \nGlobal Initiative for MRSA Pneumonia \n\nICU:\n    \nIntensive care unit\n## References\n  1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D)\n  2. Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\n  3. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\n  4. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\n  5. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\n  6. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\n  7. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n  8. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .\n  9. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\n  10. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\n  11. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\n  12. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D)\n  13. Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n  14. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\n  15. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D)\n  16. Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\n  17. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\n  18. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\n  19. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D)\n  20. Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\n  21. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\n  22. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\n  23. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\n  24. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\n  25. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\n\n\n## Acknowledgments\nGLIMP investigators\nArgentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases & ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal & Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology & Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine & Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology & Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology & Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott & White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care & Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine & Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia).\n### Ethics approval and consent to partecipate\nThe coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations.\n### Avaibility of data and materials\nThe database used for the study is not public but it is available from the corresponding author on reasonable request.\n### Funding\nThe authors did not receive any funding for this study.\n## Author information\n### Authors and Affiliations\n  1. Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy\nAndrea Gramegna, Marta Di Pasquale, Francesco Blasi & Stefano Aliberti\n  2. Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy\nGiovanni Sotgiu\n  3. Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy\nDejan Radovanovic\n  4. Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy\nSilvia Terraneo\n  5. Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA\nLuis F. Reyes & Marcos I. Restrepo\n  6. Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain\nEster Vendrell\n  7. Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal\nJoao Neves\n  8. Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy\nFrancesco Menzella\n\n\nAuthors\n  1. Andrea Gramegna\n[View author publications](https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna)\nYou can also search for this author in\n  2. Giovanni Sotgiu\n[View author publications](https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu)\nYou can also search for this author in\n  3. Marta Di Pasquale\n[View author publications](https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale)\nYou can also search for this author in\n  4. Dejan Radovanovic\n[View author publications](https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic)\nYou can also search for this author in\n  5. Silvia Terraneo\n[View author publications](https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo)\nYou can also search for this author in\n  6. Luis F. Reyes\n[View author publications](https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes)\nYou can also search for this author in\n  7. Ester Vendrell\n[View author publications](https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell)\nYou can also search for this author in\n  8. Joao Neves\n[View author publications](https://www.biomedcentral.com/search?query=author%23Joao%20Neves)\nYou can also search for this author in\n  9. Francesco Menzella\n[View author publications](https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella)\nYou can also search for this author in\n  10. Francesco Blasi\n[View author publications](https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi)\nYou can also search for this author in\n  11. Stefano Aliberti\n[View author publications](https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti)\nYou can also search for this author in\n  12. Marcos I. Restrepo\n[View author publications](https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo)\nYou can also search for this author in\n\n\n### Consortia\n### on behalf of the GLIMP Study Group\n### Contributions\nAG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript.\n### Corresponding author\nCorrespondence to .\n## Ethics declarations\n### Consent for publication\nNot applicable.\n### Competing interests\nThe authors declare that they have no competing interests for this study.\n### Publisher’s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n## Additional file\nTable A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for _C. pneumoniae_ across continents; A2: Testing frequencies for _M. pneumoniae_ across continents; A3: Testing frequencies for _L. pneumophila_ across continents).- _Brief description of the data_ : a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb)\n## Rights and permissions\n**Open Access** This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver () applies to the data made available in this article, unless otherwise stated.\n## About this article\n### Cite this article\nGramegna, A., Sotgiu, G., Di Pasquale, M. _et al._ Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. _BMC Infect Dis_ **18** , 677 (2018). https://doi.org/10.1186/s12879-018-3565-z\n  * Received: 28 May 2018\n  * Accepted: 28 November 2018\n  * Published: 18 December 2018\n  * DOI: https://doi.org/10.1186/s12879-018-3565-z\n\n\n### Share this article\nAnyone you share the following link with will be able to read this content:\nGet shareable link\nSorry, a shareable link is not currently available for this article.\nCopy to clipboard\nProvided by the Springer Nature SharedIt content-sharing initiative \n### Keywords\n  * [CAP](https://bmcinfectdis.biomedcentral.com/search?query=CAP&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n  * [Atypical pathogens](https://bmcinfectdis.biomedcentral.com/search?query=Atypical%20pathogens&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n  * [Epidemiology](https://bmcinfectdis.biomedcentral.com/search?query=Epidemiology&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n\n\n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n  * Sections\n  * Figures\n  * References\n\n\n  * [Abstract](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Abs1)\n  * [Background](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec1)\n  * [Methods](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec2)\n  * [Results](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec8)\n  * [Discussion](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec11)\n  * [Conclusions](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec12)\n  * [Change history](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#change-history)\n  * [Abbreviations](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#abbreviations)\n  * [References](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Bib1)\n  * [Acknowledgments](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Ack1)\n  * [Author information](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#author-information)\n  * [Ethics declarations](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ethics)\n  * [Additional file](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec13)\n  * [Rights and permissions](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#rightslink)\n  * [About this article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#article-info)\n\n\nAdvertisement\n  * **Fig. 1**\n[View in article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1)[Full size image](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\n\n\n  1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D)\n  2. Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\n  3. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\n  4. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\n  5. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\n  6. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\n  7. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n  8. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .\n  9. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\n  10. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\n  11. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\n  12. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D)\n  13. Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n  14. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\n  15. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D)\n  16. Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\n  17. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\n  18. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\n  19. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D)\n  20. Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\n  21. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\n  22. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\n  23. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\n  24. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\n  25. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\n\n\n####  BMC Infectious Diseases\nISSN: 1471-2334\n#### Contact us\n  * General enquiries: \n\n\n![](https://bmcinfectdis.biomedcentral.com/track/article/10.1186/s12879-018-3565-z)\n  * [Read more on our blogs](https://blogs.biomedcentral.com/)\n  * [Receive BMC newsletters](https://www.biomedcentral.com/login)\n  * [Manage article alerts](https://www.biomedcentral.com/account)\n\n\n  * [Policies](https://www.biomedcentral.com/about/policies)\n  * [Accessibility](https://www.biomedcentral.com/accessibility)\n  * [Press center](https://www.biomedcentral.com/about/press-centre)\n\n\n  * [Support and Contact](https://support.biomedcentral.com/support/home)\n  * [Careers](https://www.biomedcentral.com/about/jobs)\n\n\n### Follow BMC\nBy using this website, you agree to our [Terms and Conditions](https://www.biomedcentral.com/terms-and-conditions), , [Privacy statement](https://www.biomedcentral.com/privacy-statement) and [Cookies](https://www.biomedcentral.com/cookies) policy. we use in the preference centre. \n![Springer Nature](https://bmcinfectdis.biomedcentral.com/static/images/logo-springernature-acb40b85fb.svg)\n© 2025 BioMed Central Ltd unless otherwise stated. Part of . \n  *[DOI]: Digital Object Identifier\n",
    "extracted_content": null,
    "links": [
      {
        "href": "https://www.biomedcentral.com/privacy-statement",
        "text": "privacy policy",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#main-content",
        "text": "Skip to main content",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://www.biomedcentral.com",
        "text": "",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://www.biomedcentral.com/journals",
        "text": "Explore journals",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://www.biomedcentral.com/getpublished",
        "text": "Get published",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://www.biomedcentral.com/about",
        "text": "About BMC",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/login",
        "text": "Login",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/",
        "text": "BMC Infectious Diseases",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/about",
        "text": "About",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles",
        "text": "Articles",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/submission-guidelines",
        "text": "Submission Guidelines",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/join-our-editorial-board",
        "text": "Join the board",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/collections",
        "text": "Collections",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf",
        "text": "Download PDF",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Andrea-Gramegna-Aff1",
        "text": "Andrea Gramegna",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff1",
        "text": "1",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Giovanni-Sotgiu-Aff2",
        "text": "Giovanni Sotgiu",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff2",
        "text": "2",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Marta-Pasquale-Aff1",
        "text": "Marta Di Pasquale",
        "title": "",
        "base_domain": "biomedcentral.com"
      },
      {
        "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Dejan-Radovanovic-Aff3",
        "text": "Dejan Radovanovic",
        "title": "",
        "base_domain": "biomedcentral.com"
      }
    ],
    "images": [
      {
        "src": "//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png",
        "data": "",
        "alt": "figure 1",
        "desc": "a ) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. b ) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure 1 is original and it was created using Stat Planet software with the information created from the study",
        "score": 6,
        "type": "image",
        "group_id": 2,
        "format": "png",
        "width": null
      },
      {
        "src": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png",
        "data": "",
        "alt": "figure 1",
        "desc": "Fig. 1 View in article Full size image",
        "score": 3,
        "type": "image",
        "group_id": 3,
        "format": "png",
        "width": null
      }
    ],
    "processed_content": {
      "success": true,
      "status_code": 200,
      "error_message": "",
      "timestamp": "2025-06-11T05:12:01.311802",
      "url": "https://dx.doi.org/10.1186/s12879-018-3565-z?utm_medium=email&utm_source=transaction",
      "institution_type": "hospital",
      "metadata": {
        "title": "Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective | BMC Infectious Diseases | Full Text",
        "description": "Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.",
        "keywords": null,
        "author": null,
        "og:url": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z",
        "og:type": "article",
        "og:site_name": "BioMed Central",
        "og:title": "Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective - BMC Infectious Diseases",
        "og:description": "Background Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Results Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Conclusions Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.",
        "og:image": "https://static-content.springer.com/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png"
      },
      "title": "Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective | BMC Infectious Diseases | Full Text",
      "description": "Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.",
      "language": "unknown",
      "keywords": null,
      "author": null,
      "charset": "",
      "viewport": "",
      "content_formats": {
        "raw_html": "<!DOCTYPE html><html lang=\"en\" class=\"js webfonts-loaded\"><head>\n        <meta charset=\"UTF-8\">\n        <meta http-equiv=\"X-UA-Compatible\" content=\"IE=edge\">\n        <meta name=\"applicable-device\" content=\"pc,mobile\">\n        <meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n\n        <title>Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective | BMC Infectious Diseases | Full Text</title>\n\n        \n    \n    <meta name=\"citation_abstract\" content=\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta name=\"journal_id\" content=\"12879\">\n    <meta name=\"dc.title\" content=\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\">\n    <meta name=\"dc.source\" content=\"BMC Infectious Diseases 2018 18:1\">\n    <meta name=\"dc.format\" content=\"text/html\">\n    <meta name=\"dc.publisher\" content=\"BioMed Central\">\n    <meta name=\"dc.date\" content=\"2018-12-18\">\n    <meta name=\"dc.type\" content=\"OriginalPaper\">\n    <meta name=\"dc.language\" content=\"En\">\n    <meta name=\"dc.copyright\" content=\"2018 The Author(s).\">\n    <meta name=\"dc.rights\" content=\"2018 The Author(s).\">\n    <meta name=\"dc.rightsAgent\" content=\"reprints@biomedcentral.com\">\n    <meta name=\"dc.description\" content=\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &amp;lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta name=\"prism.issn\" content=\"1471-2334\">\n    <meta name=\"prism.publicationName\" content=\"BMC Infectious Diseases\">\n    <meta name=\"prism.publicationDate\" content=\"2018-12-18\">\n    <meta name=\"prism.volume\" content=\"18\">\n    <meta name=\"prism.number\" content=\"1\">\n    <meta name=\"prism.section\" content=\"OriginalPaper\">\n    <meta name=\"prism.startingPage\" content=\"1\">\n    <meta name=\"prism.endingPage\" content=\"11\">\n    <meta name=\"prism.copyright\" content=\"2018 The Author(s).\">\n    <meta name=\"prism.rightsAgent\" content=\"reprints@biomedcentral.com\">\n    <meta name=\"prism.url\" content=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    <meta name=\"prism.doi\" content=\"doi:10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_pdf_url\" content=\"https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_fulltext_html_url\" content=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_journal_title\" content=\"BMC Infectious Diseases\">\n    <meta name=\"citation_journal_abbrev\" content=\"BMC Infect Dis\">\n    <meta name=\"citation_publisher\" content=\"BioMed Central\">\n    <meta name=\"citation_issn\" content=\"1471-2334\">\n    <meta name=\"citation_title\" content=\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\">\n    <meta name=\"citation_volume\" content=\"18\">\n    <meta name=\"citation_issue\" content=\"1\">\n    <meta name=\"citation_publication_date\" content=\"2018/12\">\n    <meta name=\"citation_online_date\" content=\"2018/12/18\">\n    <meta name=\"citation_firstpage\" content=\"1\">\n    <meta name=\"citation_lastpage\" content=\"11\">\n    <meta name=\"citation_article_type\" content=\"Research article\">\n    <meta name=\"citation_fulltext_world_readable\" content=\"\">\n    <meta name=\"citation_language\" content=\"en\">\n    <meta name=\"dc.identifier\" content=\"doi:10.1186/s12879-018-3565-z\">\n    <meta name=\"DOI\" content=\"10.1186/s12879-018-3565-z\">\n    <meta name=\"size\" content=\"226948\">\n    <meta name=\"citation_doi\" content=\"10.1186/s12879-018-3565-z\">\n    <meta name=\"citation_springer_api_url\" content=\"http://api.springer.com/xmldata/jats?q=doi:10.1186/s12879-018-3565-z&amp;api_key=\">\n    <meta name=\"description\" content=\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &amp;lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta name=\"dc.creator\" content=\"Gramegna, Andrea\">\n    <meta name=\"dc.creator\" content=\"Sotgiu, Giovanni\">\n    <meta name=\"dc.creator\" content=\"Di Pasquale, Marta\">\n    <meta name=\"dc.creator\" content=\"Radovanovic, Dejan\">\n    <meta name=\"dc.creator\" content=\"Terraneo, Silvia\">\n    <meta name=\"dc.creator\" content=\"Reyes, Luis F.\">\n    <meta name=\"dc.creator\" content=\"Vendrell, Ester\">\n    <meta name=\"dc.creator\" content=\"Neves, Joao\">\n    <meta name=\"dc.creator\" content=\"Menzella, Francesco\">\n    <meta name=\"dc.creator\" content=\"Blasi, Francesco\">\n    <meta name=\"dc.creator\" content=\"Aliberti, Stefano\">\n    <meta name=\"dc.creator\" content=\"Restrepo, Marcos I.\">\n    <meta name=\"dc.subject\" content=\"Infectious Diseases\">\n    <meta name=\"dc.subject\" content=\"Parasitology\">\n    <meta name=\"dc.subject\" content=\"Medical Microbiology\">\n    <meta name=\"dc.subject\" content=\"Tropical Medicine\">\n    <meta name=\"dc.subject\" content=\"Internal Medicine\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults; citation_author=LA Mandell, RG Wunderink, A Anzueto; citation_volume=44; citation_issue=suppl 2; citation_publication_date=2007; citation_pages=S27-S72; citation_doi=10.1086/511159; citation_id=CR1\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality; citation_author=JA Ramirez, TL Wiemken, P Peyrani, FW Arnold, R Kelley, WA Mattingly, R Nakamatsu, S Pena, BE Guinn, SP Furmanek, AK Persaud, A Raghuram, F Fernandez, L Beavin, R Bosson, R Fernandez-Botran, R Cavallazzi, J Bordon, C Valdivieso, J Schulte, RM Carrico; citation_volume=65; citation_issue=11; citation_publication_date=2017; citation_pages=1806-1812; citation_doi=10.1093/cid/cix647; citation_id=CR2\">\n    <meta name=\"citation_reference\" content=\"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\">\n    <meta name=\"citation_reference\" content=\"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Chin Med J; citation_title=Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China; citation_author=LL Tao, BJ Hu, LX He, L Wei, HM Xie, BQ Wang, HY Li, XH Chen, CM Zhou, WW Deng; citation_volume=125; citation_issue=17; citation_publication_date=2012; citation_pages=2967-2972; citation_id=CR5\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Am J Respir Crit Care Med; citation_title=Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia; citation_author=FW Arnold, JT Summersgill, AS Lajoie, P Peyrani, TJ Marrie, P Rossi, F Blasi, P Fernandez, TM File, J Rello, R Menendez, L Marzoratti, CM Luna, JA Ramirez; citation_volume=175; citation_issue=10; citation_publication_date=2007; citation_pages=1086-1093; citation_doi=10.1164/rccm.200603-350OC; citation_id=CR6\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Microbiol Infect; citation_title=Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version; citation_author=M Woodhead, F Blasi, S Ewig, J Garau, G Huchon, M Ieven, A Ortqvist, T Schaberg, A Torres, G Heijden, R Read, TJ Verheij; citation_volume=17; citation_issue=Suppl 6; citation_publication_date=2011; citation_pages=E1-59; citation_doi=10.1111/j.1469-0691.2011.03672.x.; citation_id=CR7\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Lancet Infect Dis; citation_title=Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study; citation_author=S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, MI Restrepo, GLIMP investigators; citation_volume=16; citation_issue=12; citation_publication_date=2016; citation_pages=1364-1376; citation_doi=10.1016/S1473-3099(16)30267-5; citation_id=CR8\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=J Med Microbiol; citation_title=Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology; citation_author=MA Martinez, M Ruiz, E Zunino, V Luchsinger, LF Avendano; citation_volume=57; citation_issue=Pt 12; citation_publication_date=2008; citation_pages=1491-1495; citation_doi=10.1099/jmm.0.2008/003814-0; citation_id=CR9\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Infect Dis; citation_title=Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ); citation_author=BH von, T Welte, R Marre, N Suttorp, C Luck, S Ewig; citation_volume=9; citation_publication_date=2009; citation_pages=62; citation_doi=10.1186/1471-2334-9-62; citation_id=CR10\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks; citation_author=KA Thurman, ND Walter, SB Schwartz; citation_volume=48; citation_publication_date=2009; citation_pages=1244-1249; citation_doi=10.1086/597775; citation_id=CR11\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Infection; citation_title=CAPNETZ: community-acquired pneumonia competence network; citation_author=T Welte, N Suttorp, R Marre; citation_volume=32; citation_publication_date=2004; citation_pages=234-238; citation_doi=10.1007/s15010-004-3107-z; citation_id=CR12\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Infect Dis; citation_title=Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts; citation_author=VM Raeven, SM Spoorenberg, WG Boersma, EM Garde, SC Cannegieter, GP Voorn, WJ Bos, JE Steenbergen; citation_volume=16; citation_publication_date=2016; citation_pages=299; citation_doi=10.1186/s12879-016-1641-9.; citation_id=CR13\">\n    <meta name=\"citation_reference\" content=\"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Int J Antimicrob Agents; citation_title=Japanese guidelines for the management of community-acquired pneumonia; citation_author=K Yanagihara, S Kohno, T Matsusima; citation_volume=18; citation_issue=Suppl. 1; citation_publication_date=2001; citation_pages=S45-S48; citation_doi=10.1016/S0924-8579(01)00402-2; citation_id=CR15\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=S Afr Med J; citation_title=Management of community-acquired pneumonia in adults; citation_author=; citation_volume=97; citation_publication_date=2007; citation_pages=1296-1306; citation_id=CR16\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Eur Respir J; citation_title=Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia; citation_author=A Singanayagam, S Aliberti, C Cillóniz; citation_volume=50; citation_publication_date=2017; citation_pages=1602306; citation_doi=10.1183/13993003.02306-2016; citation_id=CR17\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Medicine; citation_title=Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years; citation_author=D Viasus, S Yacovo, C Garcia-Vidal, R Verdaguer, F Manresa, J Dorca, F Gudiol, J Carratalà; citation_volume=92; citation_publication_date=2012; citation_pages=51-60; citation_doi=10.1097/MD.0b013e31827f6104; citation_id=CR18\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Arch Intern Med; citation_title=Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial; citation_author=EN Vergis, A Indorf, TM File, J Phillips, J Bates, J Tan, GA Sarosi, JT Grayston, J Summersgill, VL Yu; citation_volume=160; citation_issue=9; citation_publication_date=2000; citation_pages=1294-1300; citation_doi=10.1001/archinte.160.9.1294; citation_id=CR19\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Thorax; citation_title=Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria; citation_author=V Luchsinger, M Ruiz, E Zunino, MA Martínez, C Machado, PA Piedra, R Fasce, MT Ulloa, MC Fink, P Lara, M Gebauer, F Chávez, LF Avendaño; citation_volume=68; citation_publication_date=2013; citation_pages=1000-1006; citation_doi=10.1136/thoraxjnl-2013-203551; citation_id=CR20\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Infect Dis; citation_title=Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis; citation_author=SM Spoorenberg, WJ Bos, R Heijligenberg, PG Voorn, JC Grutters, GT Rijkers, EM Garde; citation_volume=14; citation_publication_date=2014; citation_pages=335-343; citation_doi=10.1186/1471-2334-14-335; citation_id=CR21\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Isr Med Assoc J; citation_title=Etiology of community-acquired pneumonia in hospitalized patients in northern Israel; citation_author=F Shibli, B Chazan, O Nitzan, E Flatau, H Edelstein, O Blondheim, R Raz, R Colodner; citation_volume=12; citation_publication_date=2010; citation_pages=477-482; citation_id=CR22\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=BMC Public Health; citation_title=The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season; citation_author=K Chen, R Jia, L Li, C Yang, Y Shi; citation_volume=15; citation_publication_date=2015; citation_pages=113-118; citation_doi=10.1186/s12889-015-1422-1; citation_id=CR23\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Chile Chest; citation_title=Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago; citation_author=F Arancibia, CP Cortes, M Valdés, J Cerda, A Hernández, L Soto, A Torres; citation_volume=145; citation_publication_date=2014; citation_pages=290-296; citation_doi=10.1378/chest.13-0162; citation_id=CR24\">\n    <meta name=\"citation_reference\" content=\"citation_journal_title=Clin Infect Dis; citation_title=Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction; citation_author=KE Templeton, SA Scheltinga, WC Eeden, AW Graffelman, PJ Broek, EC Claas; citation_volume=41; citation_publication_date=2005; citation_pages=345-351; citation_doi=10.1086/431588; citation_id=CR25\">\n    <meta name=\"citation_author\" content=\"Gramegna, Andrea\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Sotgiu, Giovanni\">\n    <meta name=\"citation_author_institution\" content=\"Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy\">\n    <meta name=\"citation_author\" content=\"Di Pasquale, Marta\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Radovanovic, Dejan\">\n    <meta name=\"citation_author_institution\" content=\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Terraneo, Silvia\">\n    <meta name=\"citation_author_institution\" content=\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Reyes, Luis F.\">\n    <meta name=\"citation_author_institution\" content=\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\">\n    <meta name=\"citation_author\" content=\"Vendrell, Ester\">\n    <meta name=\"citation_author_institution\" content=\"Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Barcelona, Spain\">\n    <meta name=\"citation_author\" content=\"Neves, Joao\">\n    <meta name=\"citation_author_institution\" content=\"Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal\">\n    <meta name=\"citation_author\" content=\"Menzella, Francesco\">\n    <meta name=\"citation_author_institution\" content=\"Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy\">\n    <meta name=\"citation_author\" content=\"Blasi, Francesco\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Aliberti, Stefano\">\n    <meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\">\n    <meta name=\"citation_author\" content=\"Restrepo, Marcos I.\">\n    <meta name=\"citation_author_institution\" content=\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\">\n    \n\n\n        <meta name=\"format-detection\" content=\"telephone=no\">\n\n        \n        \n\n        \n\n        <link rel=\"apple-touch-icon\" sizes=\"180x180\" href=\"/static/img/favicons/bmc/apple-touch-icon-582ef1d0f5.png\">\n<link rel=\"icon\" type=\"image/png\" sizes=\"192x192\" href=\"/static/img/favicons/bmc/android-chrome-192x192-9625b7cdba.png\">\n<link rel=\"icon\" type=\"image/png\" sizes=\"32x32\" href=\"/static/img/favicons/bmc/favicon-32x32-5d7879efe1.png\">\n<link rel=\"icon\" type=\"image/png\" sizes=\"16x16\" href=\"/static/img/favicons/bmc/favicon-16x16-c241ac1a2f.png\">\n<link rel=\"shortcut icon\" data-test=\"shortcut-icon\" href=\"/static/img/favicons/bmc/favicon-1886637b78.ico\">\n\n    <link rel=\"manifest\" href=\"/static/app-bmc/manifest-3bb9ad383b.json\">\n    <meta name=\"msapplication-config\" content=\"/static/app-bmc/browserconfig-ecd9aa8205.xml\">\n    <meta name=\"msapplication-TileColor\" content=\"#1b3051\">\n    <meta name=\"msapplication-TileImage\" content=\"/static/img/favicons/bmc/app-icon-144x144.png\">\n\n<meta name=\"theme-color\" content=\"#1b3051\">\n\n        \n        <script type=\"text/javascript\" async=\"\" src=\"https://pagead2.googlesyndication.com/tag/js/gpt.js\"></script><script async=\"\" src=\"//cdn.jsdelivr.net/npm/mathjax@2.7.5/MathJax.js?config=TeX-AMS-MML_SVG.js\"></script><script async=\"\" src=\"https://sgtm.biomedcentral.com/gtm.js?id=GTM-MRVXSHQ\"></script><script>(function(H){H.className=H.className.replace(/\\bno-js\\b/,'js')})(document.documentElement)</script><script src=\"https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-42.js\" onload=\"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\"></script>\n\n        \n\n\n    <link rel=\"stylesheet\" media=\"screen\" href=\"/static/app-bmc/css/core-article-f3872e738d.css\">\n\n\n<link rel=\"stylesheet\" media=\"screen\" href=\"/static/app-bmc/css/core-eac3097aa4.css\">\n<link rel=\"stylesheet\" media=\"print\" href=\"/static/app-bmc/css/print-b8af42253b.css\">\n\n\n\n\n    <!-- This template is only used by BMC for now -->\n\n\n    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,form,input,p{margin:0;padding:0}body{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.61803;padding:16px 0}.c-navbar--with-submit-button{padding-bottom:24px}@media only screen and (min-width:540px){.c-navbar--with-submit-button{padding-bottom:16px}}.c-navbar__container{display:flex;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__content{display:flex;flex:0 1 auto}.c-navbar__nav{align-items:center;display:flex;flex-wrap:wrap;gap:16px 16px;list-style:none;margin:0;padding:0}.c-navbar__item{flex:0 0 auto}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad--728x90 iframe{height:90px;max-width:970px}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad iframe{border:0;overflow:auto;vertical-align:top}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}.c-dropdown__button:after{border-color:transparent transparent transparent #fff;border-style:solid;border-width:4px 0 4px 14px;content:\"\";display:block;height:0;margin-left:3px;width:0}.c-dropdown{display:inline-block;position:relative}.c-dropdown__button{background-color:transparent;border:0;display:inline-block;padding:0;white-space:nowrap}.c-dropdown__button:after{border-color:currentcolor transparent transparent;border-width:5px 4px 0 5px;display:inline-block;margin-left:8px;vertical-align:middle}.c-dropdown__menu{background-color:#fff;border:1px solid #d9d9d9;border-radius:3px;box-shadow:0 2px 6px rgba(0,0,0,.1);font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.4;list-style:none;margin:0;padding:8px 0;position:absolute;top:100%;transform:translateY(8px);width:180px;z-index:100}.c-dropdown__menu:after,.c-dropdown__menu:before{border-style:solid;bottom:100%;content:\"\";display:block;height:0;left:16px;position:absolute;width:0}.c-dropdown__menu:before{border-color:transparent transparent #d9d9d9;border-width:0 9px 9px;transform:translateX(-1px)}.c-dropdown__menu:after{border-color:transparent transparent #fff;border-width:0 8px 8px}.c-dropdown__menu--right{left:auto;right:0}.c-dropdown__menu--right:after,.c-dropdown__menu--right:before{left:auto;right:16px}.c-dropdown__menu--right:before{transform:translateX(1px)}.c-dropdown__link{background-color:transparent;color:#004b83;display:block;padding:4px 16px}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container,.c-header__menu{align-items:center;display:flex;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu{gap:2em 2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}@supports not (gap:2em){.c-header__item{margin-left:24px}}.c-header__container{justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}@supports not (gap:2em){.c-header__brand{margin-right:48px}}.c-header__brand a{display:block;text-decoration:none}.c-header__link{color:#fff}.c-journal-title a{text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-form-field{margin-bottom:1em}.c-form-field__label{color:#666;display:block;font-size:14px;margin-bottom:.4em}.c-form-field__input{border:1px solid #a6a6a6;border-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);font-size:14px;line-height:1.28571;padding:.75em 1em;vertical-align:middle;width:100%}.c-popup-search{background-color:#25426f;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.c-logo img{display:block}.ctx-search .c-form-field{margin-bottom:0}.ctx-search .c-form-field__label{color:#fff}.ctx-search .c-form-field__input{border-bottom-right-radius:0;border-top-right-radius:0;margin-right:0}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-header__identity--default{background:url(/static/images/bmc/identities/patterns/default-7e3a6b1388.svg) 0 0 no-repeat #04caa8}.c-journal-title{color:#1b3051;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#0061a9;color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-logo{display:block}html.webfonts-loaded .u-h3,html.webfonts-loaded .u-h4{font-family:Europa,Trebuchet MS}.u-button{align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button svg,.u-button--primary svg,.u-button--tertiary svg{fill:currentcolor}.u-button{color:#004b83}.u-button--primary,.u-button--tertiary{background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);color:#fff}.u-button--tertiary{font-weight:400}.u-button--full-width{display:flex;width:100%}.u-clearfix:after,.u-clearfix:before{content:\"\";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-display-none{display:none}.js .u-js-hide{display:none;visibility:hidden}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3,.u-h4{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}.u-h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}.u-h4{color:#1b3051;font-size:18px;font-style:italic;font-weight:700;margin-bottom:.7em}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none;visibility:hidden}.u-hide-at-lt-lg:first-child+*{margin-block-start:0}}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.u-button--tertiary{font-size:.875rem;padding:8px 16px}@media only screen and (max-width:539px){.u-button--alt-colour-on-mobile{background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;color:#004b83}}body{font-size:1.125rem}.c-header__navigation{display:flex;gap:.5rem .5rem} }</style>\n    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,form,input,p{margin:0;padding:0}body{padding:0}a{color:#004b83;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}a>img{vertical-align:middle}h1,h2{color:#1b3051;font-style:normal;font-weight:700}h1{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:28px;line-height:1.4}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h2{font-size:26px;margin-bottom:.5em}h2,h3{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;line-height:1.4}h3{color:#1b3051;font-size:18px;font-style:normal;margin-bottom:.7em}p{overflow-wrap:break-word;word-break:break-word}.u-h3{font-size:1.5rem}.u-h3,.u-h4{font-weight:700}.u-h4{font-size:1.25rem}.c-reading-companion__figure-title{font-size:1.25rem;font-weight:700}body{font-size:1.125rem}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin-bottom:16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#173962;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:0 0 16px}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:Georgia,Palatino,serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;margin-top:0;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article__sub-heading{color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;font-style:normal;font-weight:400;line-height:1.3;margin:24px 0 8px}@media only screen and (min-width:768px){.c-article__sub-heading{font-size:1.5rem;line-height:1.24}}.c-article__sub-heading:first-child{margin-top:0}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#0067c5;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#0067c5;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-reading-companion__panel--active{display:block}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%;padding:13px 24px!important}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-article-associated-content__container a,.c-card__summary a{text-decoration:underline}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{clip:rect(0,0,0,0);border:0;height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.hide{display:none;visibility:hidden}.c-article-associated-content__container .c-article-associated-content__collection.collection~.c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.section .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__title{display:none}.c-article-associated-content__container .c-article-associated-content__collection.collection .c-article-associated-content__collection-label,.c-article-associated-content__container .c-article-associated-content__collection.section .c-article-associated-content__collection-label{display:block}.c-article-associated-content__container .c-article-associated-content__collection.collection,.c-article-associated-content__container .c-article-associated-content__collection.section{margin-bottom:5px}.c-article-associated-content__container .c-article-associated-content__collection.section~.c-article-associated-content__collection.collection{margin-top:28px}.c-article-associated-content__container .c-article-associated-content__collection:first-child{margin-top:0}.c-article-associated-content__container .c-article-associated-content__collection:last-child{margin-bottom:2.4rem}.c-article-associated-content__container .c-article-associated-content__collection-label{color:#1b3051}.c-article-associated-content__container .c-article-associated-content__collection-title{font-size:1.063rem;font-weight:400}.webfonts-loaded .c-article__sub-heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif} }</style>\n\n    <link rel=\"stylesheet\" data-test=\"critical-css-handler\" data-inline-css-source=\"critical-css\" href=\"/static/app-bmc/css/enhanced-9894e8f787.css\" media=\"only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)\" onload=\"this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null\">\n\n    <link rel=\"stylesheet\" data-test=\"critical-css-handler\" data-inline-css-source=\"critical-css\" href=\"/static/app-bmc/css/enhanced-article-568f59de28.css\" media=\"only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)\" onload=\"this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null\">\n\n\n\n        \n\n        \n    <script type=\"text/javascript\">\n        config = {\n            env: 'live',\n            site: 'bmcinfectdis.biomedcentral.com',\n            siteWithPath: 'bmcinfectdis.biomedcentral.com' + window.location.pathname,\n            twitterHashtag: '',\n            cmsPrefix: 'https://studio-cms.springernature.com/studio/',\n            \n            doi: '10.1186/s12879-018-3565-z',\n            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',\n            hasFigshareInvoked: false,\n            publisherBrand: 'BioMed Central',\n            mustardcut: false\n        };\n    </script>\n\n        \n    <script type=\"text/javascript\" data-test=\"dataLayer\">\n        window.dataLayer = [{\"content\":{\"article\":{\"doi\":\"10.1186/s12879-018-3565-z\",\"articleType\":\"Research article\",\"peerReviewType\":\"Open\",\"supplement\":null,\"keywords\":\"CAP;Atypical pathogens;Epidemiology\"},\"contentInfo\":{\"imprint\":\"BioMed Central\",\"title\":\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\",\"publishedAt\":1545091200000,\"publishedAtDate\":\"2018-12-18\",\"author\":[\"Andrea Gramegna\",\"Giovanni Sotgiu\",\"Marta Pasquale\",\"Dejan Radovanovic\",\"Silvia Terraneo\",\"Luis F. Reyes\",\"Ester Vendrell\",\"Joao Neves\",\"Francesco Menzella\",\"Francesco Blasi\",\"Stefano Aliberti\",\"Marcos I. Restrepo\"],\"collection\":[]},\"attributes\":{\"deliveryPlatform\":\"oscar\",\"template\":\"rebrand\",\"cms\":null,\"copyright\":{\"creativeCommonsType\":\"CC BY + CC0\",\"openAccess\":true},\"environment\":\"live\"},\"journal\":{\"siteKey\":\"bmcinfectdis.biomedcentral.com\",\"volume\":\"18\",\"issue\":\"1\",\"title\":\"BMC Infectious Diseases\",\"type\":\"SERIES\",\"journalID\":12879,\"section\":[{\"sectionId\":\"AC_57613ed1ce2f7fd9e438c2e3f22a5de7\",\"sectionName\":\"Bacterial and fungal diseases\"}]},\"category\":{\"pmc\":{\"primarySubject\":\"Medicine & Public Health\"},\"contentType\":\"Research article\",\"publishingSegment\":\"BMC Series 2\",\"snt\":[\"Diseases\",\"Parasitology\",\"Medical Microbiology\",\"Tropical Medicine\",\"Internal Medicine\"]}},\"session\":{\"authentication\":{\"authenticationID\":[]}},\"version\":\"1.0.0\",\"page\":{\"category\":{\"pageType\":\"article\"},\"attributes\":{\"featureFlags\":[],\"environment\":\"live\",\"darwin\":false}},\"japan\":false,\"event\":\"dataLayerCreated\",\"collection\":null,\"publisherBrand\":\"BioMed Central\"}];\n    </script>\n\n        \n        \n        \n            <script>\n                window.dataLayer = window.dataLayer || [];\n                window.dataLayer.push({\n                    ga4MeasurementId: 'G-PJCTJWPV25',\n                    ga360TrackingId: 'UA-54492316-9',\n                    twitterId: 'o47a2',\n                    baiduId: 'd1b4bc3b5ada4eb7290535e72899bac1',\n                    ga4ServerUrl: 'https://collect.biomedcentral.com',\n                    imprint: 'biomedcentral'\n                });\n            </script>\n        \n        \n\n        \n\n        <script>\n    (function(w, d) {\n        w.config = w.config || {};\n        w.config.mustardcut = false;\n\n        \n        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {\n            w.config.mustardcut = true;\n            d.classList.add('js');\n            d.classList.remove('grade-c');\n            d.classList.remove('no-js');\n        }\n    })(window, document.documentElement);\n</script>\n\n\n        \n<script>\n    (function () {\n        if ( typeof window.CustomEvent === \"function\" ) return false;\n        function CustomEvent ( event, params ) {\n            params = params || { bubbles: false, cancelable: false, detail: null };\n            var evt = document.createEvent( 'CustomEvent' );\n            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );\n            return evt;\n        }\n\n        CustomEvent.prototype = window.Event.prototype;\n\n        window.CustomEvent = CustomEvent;\n    })();\n</script>\n\n        <script class=\"js-entry\">\n    if (window.config.mustardcut) {\n        (function(w, d) {\n            \n            \n            \n                window.Component = {};\n                window.suppressShareButton = true;\n                window.onArticlePage = true;\n            \n\n            var currentScript = d.currentScript || d.head.querySelector('script.js-entry');\n\n            \n            function catchNoModuleSupport() {\n                var scriptEl = d.createElement('script');\n                return (!('noModule' in scriptEl) && 'onbeforeload' in scriptEl)\n            }\n\n            var headScripts = [\n                {'src': '/static/js/polyfill-es5-bundle-b4356fa7f5.js', 'async': false}\n            ];\n\n            var bodyScripts = [\n                \n                    {'src': '/static/js/app-es5-bundle-fe9cce56e1.js', 'async': false, 'module': false},\n                    {'src': '/static/js/app-es6-bundle-fed4944a50.js', 'async': false, 'module': true}\n                \n                \n                    \n                        , {'src': '/static/js/global-article-es5-bundle-d1124b54a9.js', 'async': false, 'module': false},\n                        {'src': '/static/js/global-article-es6-bundle-798832bcce.js', 'async': false, 'module': true}\n                    \n                \n                \n                \n            ];\n\n            function createScript(script) {\n                var scriptEl = d.createElement('script');\n                scriptEl.src = script.src;\n                scriptEl.async = script.async;\n                if (script.module === true) {\n                    scriptEl.type = \"module\";\n                    if (catchNoModuleSupport()) {\n                        scriptEl.src = '';\n                    }\n                } else if (script.module === false) {\n                    scriptEl.setAttribute('nomodule', true)\n                }\n                if (script.charset) {\n                    scriptEl.setAttribute('charset', script.charset);\n                }\n\n                return scriptEl;\n            }\n\n            for (var i = 0; i < headScripts.length; ++i) {\n                var scriptEl = createScript(headScripts[i]);\n                currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);\n            }\n\n            d.addEventListener('DOMContentLoaded', function() {\n                for (var i = 0; i < bodyScripts.length; ++i) {\n                    var scriptEl = createScript(bodyScripts[i]);\n                    d.body.appendChild(scriptEl);\n                }\n            });\n\n            // Webfont repeat view\n            var config = w.config;\n            if (config && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {\n                d.documentElement.className += ' webfonts-loaded';\n            }\n        })(window, document);\n    }\n</script><script src=\"/static/js/polyfill-es5-bundle-b4356fa7f5.js\"></script>\n\n\n        \n            \n            \n                \n<script data-test=\"gtm-head\">\n    window.initGTM = function() {\n        (function (w, d, s, l, i) {\n            w[l] = w[l] || [];\n            w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});\n            var f = d.getElementsByTagName(s)[0],\n                j = d.createElement(s),\n                dl = l != 'dataLayer' ? '&l=' + l : '';\n            j.async = true;\n            j.src = 'https://sgtm.biomedcentral.com/gtm.js?id=' + i + dl;\n            f.parentNode.insertBefore(j, f);\n        })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');\n    }\n</script>\n\n            \n            \n        \n\n        \n            <meta name=\"360-site-verification\" content=\"2e1d87196f82c9ac5454a21aede69eda\">\n        \n\n        <script>\n(function (w, d, t) {\n    function cc() {\n        var h = w.location.hostname;\n        var e = d.createElement(t),\n        s = d.getElementsByTagName(t)[0];\n\n        \n        if (h.indexOf('springer.com') > -1 && h.indexOf('biomedcentral.com') === -1 && h.indexOf('springeropen.com') === -1) {\n            if (h.indexOf('link-qa.springer.com') > -1 || h.indexOf('test-www.springer.com') > -1) {\n                e.src = 'https://cmp.springer.com/production_live/en/consent-bundle-17-57.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            } else {\n                e.src = 'https://cmp.springer.com/production_live/en/consent-bundle-17-57.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            }\n        } else if (h.indexOf('biomedcentral.com') > -1) {\n            if (h.indexOf('biomedcentral.com.qa') > -1) {\n                e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-42.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            } else {\n                e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-42.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            }\n        } else if (h.indexOf('springeropen.com') > -1) {\n            if (h.indexOf('springeropen.com.qa') > -1) {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-38.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            } else {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-38.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')\");\n            }\n        } else if (h.indexOf('springernature.com') > -1) {\n            if (h.indexOf('beta-qa.springernature.com') > -1) {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-43.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-NK22KLS')\");\n            } else {\n                e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-43.js';\n                e.setAttribute('onload', \"initGTM(window,document,'script','dataLayer','GTM-NK22KLS')\");\n            }\n        } else {\n            e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';\n            e.setAttribute('data-consent', h);\n        }\n        s.insertAdjacentElement('afterend', e);\n    }\n\n    cc();\n})(window, document, 'script');\n</script>\n\n\n        \n    \n        \n    \n\n\n        \n    \n    <link rel=\"canonical\" href=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    \n\n        \n        \n        \n    \n    <meta property=\"og:url\" content=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z\">\n    <meta property=\"og:type\" content=\"article\">\n    <meta property=\"og:site_name\" content=\"BioMed Central\">\n    <meta property=\"og:title\" content=\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective - BMC Infectious Diseases\">\n    <meta property=\"og:description\" content=\"Background Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Results Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Conclusions Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\">\n    <meta property=\"og:image\" content=\"https://static-content.springer.com/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\">\n    \n\n        \n\n        \n    <script type=\"application/ld+json\">{\"mainEntity\":{\"headline\":\"Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\",\"description\":\"Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\",\"datePublished\":\"2018-12-18T00:00:00Z\",\"dateModified\":\"2020-10-13T00:00:00Z\",\"pageStart\":\"1\",\"pageEnd\":\"11\",\"license\":\"http://creativecommons.org/publicdomain/zero/1.0/\",\"sameAs\":\"https://doi.org/10.1186/s12879-018-3565-z\",\"keywords\":[\"CAP\",\"Atypical pathogens\",\"Epidemiology\",\"Infectious Diseases\",\"Parasitology\",\"Medical Microbiology\",\"Tropical Medicine\",\"Internal Medicine\"],\"image\":[\"https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\"],\"isPartOf\":{\"name\":\"BMC Infectious Diseases\",\"issn\":[\"1471-2334\"],\"volumeNumber\":\"18\",\"@type\":[\"Periodical\",\"PublicationVolume\"]},\"publisher\":{\"name\":\"BioMed Central\",\"logo\":{\"url\":\"https://www.springernature.com/app-sn/public/images/logo-springernature.png\",\"@type\":\"ImageObject\"},\"@type\":\"Organization\"},\"author\":[{\"name\":\"Andrea Gramegna\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Giovanni Sotgiu\",\"affiliation\":[{\"name\":\"Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari\",\"address\":{\"name\":\"Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Marta Di Pasquale\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Dejan Radovanovic\",\"affiliation\":[{\"name\":\"University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco\",\"address\":{\"name\":\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Silvia Terraneo\",\"affiliation\":[{\"name\":\"University of Milan\",\"address\":{\"name\":\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Luis F. Reyes\",\"affiliation\":[{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\",\"address\":{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Ester Vendrell\",\"affiliation\":[{\"name\":\"Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme\",\"address\":{\"name\":\"Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Barcelona, Spain\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Joao Neves\",\"affiliation\":[{\"name\":\"Internal Medicine Department, Centro Hospitalar do Porto\",\"address\":{\"name\":\"Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Francesco Menzella\",\"affiliation\":[{\"name\":\"Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova\",\"address\":{\"name\":\"Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Francesco Blasi\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"},{\"name\":\"Stefano Aliberti\",\"affiliation\":[{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico\",\"address\":{\"name\":\"Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"email\":\"stefano.aliberti@unimi.it\",\"@type\":\"Person\"},{\"name\":\"Marcos I. Restrepo\",\"affiliation\":[{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\",\"address\":{\"name\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, USA\",\"@type\":\"PostalAddress\"},\"@type\":\"Organization\"}],\"@type\":\"Person\"}],\"isAccessibleForFree\":true,\"@type\":\"ScholarlyArticle\"},\"@context\":\"https://schema.org\",\"@type\":\"WebPage\"}</script>\n\n        \n\n    <style type=\"text/css\">.cc-banner{background-color:#01324b;border:none!important;bottom:0;box-sizing:border-box;color:#fff!important;left:0;line-height:1.3;margin:auto 0 0;max-width:100%;outline:0;overflow:visible;padding:0;position:fixed;right:0;width:100%;z-index:99999}.cc-banner::backdrop{background-color:#0000004d}.cc-banner *{color:inherit!important}.cc-banner:focus{box-shadow:none;outline:0}.cc-banner a{color:#fff!important;text-decoration:underline}.cc-banner a:active,.cc-banner a:focus,.cc-banner a:hover{color:inherit;text-decoration:none}.cc-banner a:focus{outline:3px solid #08c!important}.cc-banner h2,.cc-banner h3,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-banner .cc-h2,.cc-banner h2{font-size:18px}.cc-banner .cc-h3,.cc-banner h3{font-size:16px}.cc-banner .cc-h4,.cc-banner .cc-h5,.cc-banner .cc-h6,.cc-banner h4,.cc-banner h5,.cc-banner h6{font-size:14px}.cc-banner .cc-button{font-size:16px}.cc-banner__content{background-color:#01324b;display:flex;flex-direction:column;margin:0 auto;max-height:90vh;max-width:100%;padding:16px;position:relative}.cc-banner__content:focus{outline:0}@media (min-width:680px){.cc-banner__content{padding:12px}}@media (min-width:980px){.cc-banner__content{max-height:60vh;padding-bottom:20px;padding-top:20px}}@media (min-width:1320px){.cc-banner__content{padding-bottom:40px;padding-top:40px}}.cc-banner__container{display:flex;flex-direction:column;margin:auto;max-width:1320px;overflow:auto}.cc-banner__title{background:none!important;border:0;flex-shrink:0;font-size:18px!important;font-size:22px!important;font-weight:700!important;letter-spacing:normal;margin:0 0 12px!important;padding:0}@media (min-width:680px){.cc-banner__title{font-size:24px!important;margin:0 0 16px!important}}@media (min-width:1320px){.cc-banner__title{font-size:26px!important;margin:0 0 24px!important}}.cc-banner__body{display:flex;flex-direction:column;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif!important;overflow-x:hidden;overflow-y:auto;padding:3px 3px 16px}@media (min-width:980px){.cc-banner__body{flex-direction:row}}.cc-banner__policy p{font-size:16px!important;margin:0;max-width:none;padding:0}.cc-banner__policy p:not(:last-child){margin:0 0 16px}@media (min-width:980px){.cc-banner__policy p:not(:last-child){margin:0 0 24px}}.cc-banner__policy p a{font-size:16px!important;font-weight:700}.cc-banner__footer{box-shadow:none;flex-shrink:0;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif !important!important;margin:0;padding:12px 0 3px 3px;position:relative}@media (min-width:380px){.cc-banner__footer{align-items:stretch;display:flex;flex-wrap:wrap}}@media (min-width:680px){.cc-banner__footer{box-shadow:none;flex-wrap:nowrap;width:40%}}.cc-banner__footer .cc-banner__button{flex:1 1 auto;font-weight:700;overflow:hidden;padding:.5em 1em;width:100%}@media (min-width:680px){.cc-banner__footer .cc-banner__button{max-width:275px}}.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:12px}@media (min-width:680px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-bottom:0;margin-right:16px}}@media (min-width:980px){.cc-banner__footer .cc-banner__button:not(:last-child){margin-right:24px}}.cc-banner__button-preferences{padding-left:0;padding-right:0}@media (min-width:380px){.cc-banner__button-preferences{flex:0 0 auto;margin:auto}}@media (min-width:680px){.cc-banner__button-preferences{margin:0}}@media (min-width:380px) and (max-width:680px){.cc-banner__button-break{display:block}}@media (min-width:680px){.cc-banner--is-tcf .cc-banner__footer{width:auto}}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__footer{padding-right:48px;width:66%}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px!important}.cc-banner--is-tcf .cc-banner__stacks{margin:16px 0 0}@media (min-width:980px){.cc-banner--is-tcf .cc-banner__stacks{display:flex;flex:0 0 33%;flex-direction:column;margin:0 0 0 48px;overflow:auto}}.cc-banner--is-tcf .cc-banner__stacks-intro{font-size:16px;margin:0 0 12px}.cc-banner--is-tcf .cc-banner__stacks-details{padding:0 3px}.cc-banner--is-tcf .cc-banner .cc-details{border-color:#fff3!important}.cc-box{border-radius:10px;padding:12px}.cc-box--info{background-color:#eff6fb}.cc-box--light{background-color:#faf9f6}.cc-button{border:2px solid #0000;border-radius:32px!important;color:inherit;cursor:pointer;font-size:14px;font-weight:700!important;left:auto;line-height:1.2;margin:0;padding:.5em 1em;right:auto;text-transform:none!important;transition:all .2s}@media (min-width:680px){.cc-button{font-size:14px;padding:.75em 1em}}.cc-button--sm{font-size:12px;padding:2px 8px!important}.cc-button--primary{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--primary:focus{outline:3px solid #08c}.cc-button--primary:focus,.cc-button--primary:hover,.cc-button--secondary{background-color:#fff!important;border-color:#025e8d!important;color:#025e8d!important}.cc-button--secondary:focus{background-color:#025e8d!important;border-color:#fff!important;color:#fff!important;outline:3px solid #08c!important}.cc-button--secondary:hover{background-color:#025e8d!important;border-color:#025e8d!important;color:#fff!important}.cc-button--secondary:active{border:2px solid #01324b!important}.cc-button--secondary.cc-button--contrast{border-color:#fff!important}.cc-button--secondary.cc-button--contrast:hover{background-color:initial!important;color:#fff!important}.cc-button--tertiary{background-color:#f0f7fc!important;background-image:none;border:2px solid #f0f7fc;color:#025e8d!important;text-decoration:underline!important;text-underline-offset:.25em}.cc-button--tertiary:focus{outline:3px solid #08c!important}.cc-button--tertiary:hover{text-decoration-thickness:.25em}.cc-button--tertiary:active{color:#013c5b}.cc-button--link{background-color:initial!important;border-color:#0000!important;border-radius:0!important;color:inherit!important;padding:0!important;text-decoration:underline!important;width:inherit!important}.cc-button--link:focus{outline:3px solid #08c}.cc-button--link:hover{background-color:initial!important;box-shadow:none;text-decoration:none}.cc-button--text{border-radius:0;padding:0}.cc-button--details{padding-right:24px!important;position:relative;width:auto}.cc-button--details:after,.cc-button--details:before{background-color:currentColor;content:\"\";position:absolute;transition:transform .25s ease-out}.cc-button--details:before{height:10px;margin-top:-5px;right:12px;top:50%;width:2px}.cc-button--details:after{height:2px;margin-top:-1px;right:8px;top:50%;width:10px}.cc-button--details.cc-active:before{transform:rotate(90deg);transform-origin:center}.cc-button--details.cc-active:after{display:none}.cc-details{border-bottom:1px solid #0000001a;padding:12px 0;position:relative;width:100%}.cc-details__summary{align-items:center;display:flex;font-size:14px;font-weight:700;list-style-type:none}.cc-details__summary:focus,.cc-details__summary:focus-visible{outline:3px solid #08c!important;will-change:auto}.cc-details__title{align-items:baseline;display:flex}.cc-details__title h2,.cc-details__title h3,.cc-details__title h4,.cc-details__title h5{line-height:1.4;margin:0!important;padding:0!important}.cc-details__title svg{flex-shrink:0;height:auto;margin-right:8px;position:relative;top:-1px;transition:all .2s;width:auto}.cc-details[open] .cc-details__title svg{top:2px;transform:rotate(90deg)}.cc-details__switch{margin-left:auto}.cc-details__section{padding:16px 0 0 18px}.cc-details__section p{margin:0}.cc-details__section p:not(:last-child){margin-bottom:12px}details summary::-webkit-details-marker{display:none}.cc-radio{align-items:center;display:flex;position:relative}.cc-radio *{cursor:pointer}.cc-radio__input{height:22px;left:0;position:absolute;top:0;width:22px}.cc-radio__input:focus{outline:none}.cc-radio__label{color:inherit;font-size:14px;font-weight:700;line-height:23px;margin:0;padding-left:28px}.cc-radio__label:after,.cc-radio__label:before{background-color:#fff;content:\"\";display:block;position:absolute;transition:transform .25s ease-out}.cc-radio__label:before{border:1px solid #777;border-radius:50%;height:22px;left:0;top:0;width:22px}.cc-radio__label:after{border:7px solid #025e8d;border-radius:50%;height:0;left:4px;opacity:0;top:4px;width:0}.cc-radio__input:focus+.cc-radio__label:before{box-shadow:0 0 0 2px #08c;outline:none}.cc-radio__label--hidden{display:none}.cc-radio__input:checked+.cc-radio__label:after{opacity:1}.cc-radio__input:disabled{cursor:default}.cc-radio__input:disabled+.cc-radio__label{cursor:default;opacity:.5}.cc-switch *{cursor:pointer}.cc-switch{align-items:center;display:flex;line-height:1}.cc-switch__label{cursor:pointer;display:inline-block;font-size:14px;font-weight:700;margin:0;-webkit-user-select:none;user-select:none}.cc-switch__input[type=checkbox]{-webkit-appearance:none;appearance:none;background-color:#fff!important;background-image:url(\"data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='rgba(0, 0, 0, 0.25)'/%3E%3C/svg%3E\")!important;background-position:0!important;background-repeat:no-repeat!important;border:1px solid #777!important;border-radius:16px!important;height:18px!important;margin:0 8px 0 0!important;transition:background-position .2s ease-in-out!important;width:32px!important}.cc-switch__input[type=checkbox]:focus{background-image:url(\"data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%2380b3cc'/%3E%3C/svg%3E\")!important}.cc-switch__input[type=checkbox]:checked{background-color:#025e8d!important;background-image:url(\"data:image/svg+xml;charset=utf-8,%3Csvg xmlns='http://www.w3.org/2000/svg' viewBox='-4 -4 8 8'%3E%3Ccircle r='3' fill='%23fff'/%3E%3C/svg%3E\")!important;background-position:100%!important}.cc-switch__input[type=checkbox]:checked~.cc-switch__label>.cc-switch__text-off,.cc-switch__input[type=checkbox]:not(:checked)~.cc-switch__label>.cc-switch__text-on{display:none}.cc-switch__input[type=checkbox]:hover{cursor:pointer;outline:none}.cc-switch__input[type=checkbox]:focus-visible{cursor:pointer;outline:3px solid #fc0}.cc-switch__input[type=checkbox]:checked:before{background-color:none!important;color:#0000!important}.cc-list>ul,ul.cc-list{list-style-type:disc;margin-left:0;padding-left:0}.cc-list>ul>li,ul.cc-list>li{margin-left:1em}.cc-list>ul>li:not(:last-child),ul.cc-list>li:not(:last-child){margin-bottom:4px}.cc-list__title{margin-bottom:8px!important}.cc-list--inline>ul,ul.cc-list--inline{display:flex;flex-wrap:wrap;list-style-type:none}.cc-list--inline>ul>li,ul.cc-list--inline>li{margin:0 .5em .5em 0}.cc-overlay{background-color:#0000004d;z-index:99998}.cc-overlay,.cc-preferences{bottom:0;left:0;position:fixed;right:0;top:0}.cc-preferences{background-color:#050a14f2!important;border:0;box-sizing:border-box;color:#111;font-family:sans-serif!important;line-height:1.4;margin:auto;max-height:100vh;overflow:auto;padding:0;z-index:100000}.cc-preferences:focus{outline:none}.cc-preferences *,.cc-preferences :after,.cc-preferences :before{box-sizing:inherit!important}.cc-preferences h2,.cc-preferences h3,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-family:sans-serif;font-style:normal;font-weight:700;margin:0 0 .5em}.cc-preferences .cc-h2,.cc-preferences h2{font-size:18px}.cc-preferences .cc-h3,.cc-preferences h3{font-size:16px}.cc-preferences .cc-h4,.cc-preferences .cc-h5,.cc-preferences .cc-h6,.cc-preferences h4,.cc-preferences h5,.cc-preferences h6{font-size:14px}.cc-preferences a{color:#025e8d;text-decoration:underline}.cc-preferences a:hover{color:inherit;text-decoration:none}.cc-preferences h3{background:none;color:#111;padding:0;text-transform:none}dialog.cc-preferences{background-color:initial}dialog.cc-preferences::backdrop{background-color:#000000e6}.cc-preferences__dialog{display:flex;flex-direction:column;margin:auto;max-height:100vh;max-width:860px;padding:12px;position:relative}.cc-preferences__dialog>:last-child{border-bottom-left-radius:10px;border-bottom-right-radius:10px}@media (min-width:980px){.cc-preferences__dialog{padding:16px}}.cc-preferences__close{background:#0000!important;border:1px solid #ececec;border-radius:50%;color:#111!important;cursor:pointer;font-family:Times New Roman,serif;font-size:40px;height:40px;left:auto;line-height:1;margin-top:-20px;padding:0!important;position:absolute;right:20px;top:50%;width:40px}.cc-preferences__close:focus{outline:3px solid #08c}.cc-preferences__close-label{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__header{background:#fff!important;border-bottom:1px solid #0000001a;border-top-left-radius:10px;border-top-right-radius:10px;padding:16px;position:relative;text-align:center}.cc-preferences__title{background:none!important;color:#111!important;font-family:sans-serif!important;font-size:18px!important;font-weight:700!important;margin:0!important;padding:0 16px 0 0!important}@media (min-width:480px){.cc-preferences__title{padding-right:0!important}}@media (min-width:980px){.cc-preferences__title{font-size:22px!important}}.cc-preferences__body{background:#fff!important;flex:1 1 auto;min-height:200px;overflow-x:hidden;overflow-y:auto;padding:16px}.cc-preferences__footer{background:#fff!important;border-top:1px solid #d0d0d0;box-shadow:0 0 5px 0 #0003;margin-bottom:0;padding:12px;position:relative}@media (min-width:480px){.cc-preferences__footer{align-items:stretch;display:flex}}.cc-preferences__footer>.cc-button{display:block;width:100%}@media (min-width:480px){.cc-preferences__footer>.cc-button{flex:1 1 auto}}@media (min-width:980px){.cc-preferences__footer>.cc-button{flex-basis:auto}}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:first-child){margin-left:12px}}.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:8px}@media (min-width:480px){.cc-preferences__footer>.cc-button:not(:last-child){margin-bottom:0}}.cc-preferences__categories{list-style:none;margin:0;padding:0}.cc-preferences__category:not(:last-child){border-bottom:1px solid #0000001a;margin-bottom:12px;padding-bottom:12px}.cc-preferences__category-description{font-size:14px;margin:0 0 8px;padding:0}.cc-preferences__category-footer{align-items:center;display:flex;justify-content:space-between}.cc-preferences__status{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.cc-preferences__controls{display:flex;margin:0}.cc-preferences__controls>:not(:last-child){margin-right:12px}.cc-preferences__always-on{font-size:14px;font-weight:700;padding-left:26px;position:relative}.cc-preferences__always-on:before{background:#0000!important;border:solid;border-top-color:#0000;border-width:0 0 4px 4px;content:\"\";display:block;height:10px;left:0;position:absolute;top:2px;transform:rotate(-45deg);width:18px}.cc-preferences__details{background-color:#eff6fb!important;border-radius:10px;font-size:14px;margin:12px 0 0;padding:12px}.cc-preferences__cookie-list,.cc-preferences__provider-list{list-style:none;margin:0;padding:0}.cc-preferences__provider-list{columns:170px}.cc-preferences__cookie-title{font-size:1em;margin:0}.cc-preferences__cookie-description{font-size:1em;margin:0 0 8px}.cc-preferences__cookie-domain,.cc-preferences__cookie-lifespan{border-left:1px solid #999;color:#666;margin-left:8px;padding-left:4px}body.cc-has-preferences-open{overflow:hidden;position:relative}.cc-table{border-collapse:collapse;width:100%}.cc-table tbody tr{border-top:1px solid #0000001a}.cc-table td,.cc-table th{font-size:14px;padding:4px 8px;vertical-align:top}.cc-table+.cc-table{margin-top:8px}.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:70%}@media (min-width:680px){.cc-table--purposes td:first-child,.cc-table--purposes th:first-child{width:80%}}.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{padding-left:8px;width:40%}@media (min-width:680px){.cc-table--purposes td:last-child,.cc-table--purposes th:last-child{width:30%}}.cc-tabs,.cc-tabs>ul{background-color:#faf9f6;display:flex;list-style:none;margin:0;padding:0}.cc-tabs__panel{border-top:1px solid #ececec;margin-top:-1px}.cc-tabs__button{background-color:initial;border:0;border-left:1px solid #0000;border-right:1px solid #0000;color:#111;font-size:16px;font-weight:700;margin:0;padding:15px 16px 12px;position:relative}.cc-tabs__button:before{background-color:initial;content:\"\";display:block;height:3px;left:0;position:absolute;top:0;width:100%}.cc-tabs__button.cc-active{background-color:#fff;border-color:#025e8d #ececec #ececec;color:#111}.cc-tabs__button.cc-active:before{background-color:#025e8d}.cc-tabs__content{background-color:#fff;display:none;font-size:14px;padding:16px}.cc-tabs__section:not(:first-child){padding-top:24px}.cc-tcf{font-size:14px;margin-top:16px}.cc-tcf__list{list-style:none;margin:0;padding:0}.cc-vendor-count{color:#666;font-size:16px;margin:0 0 8px}.cc-hide{display:none!important}.cc-show{display:block!important}.cc-external-link{background-color:#ececec;background-image:url(\"data:image/svg+xml;base64,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\");background-position:right 8px center;background-repeat:no-repeat;background-size:10px auto;border-radius:3px;box-shadow:0 1px 0 #0003;color:#111!important;display:inline-block;font-size:12px;padding:4px 26px 4px 8px;text-decoration:none!important}.cc-external-link:hover{text-decoration:underline!important}.cc-m-0{margin:0!important}.cc-grey{color:#666}</style><style type=\"text/css\">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}\n.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}\n.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}\n.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}\n.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}\n</style><style type=\"text/css\">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}\n#MathJax_About.MathJax_MousePost {outline: none}\n.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 2px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}\n.MathJax_MenuItem {padding: 2px 2em; background: transparent}\n.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}\n.MathJax_MenuActive .MathJax_MenuArrow {color: white}\n.MathJax_MenuArrow.RTL {left: .5em; right: auto}\n.MathJax_MenuCheck {position: absolute; left: .7em}\n.MathJax_MenuCheck.RTL {right: .7em; left: auto}\n.MathJax_MenuRadioCheck {position: absolute; left: 1em}\n.MathJax_MenuRadioCheck.RTL {right: 1em; left: auto}\n.MathJax_MenuLabel {padding: 2px 2em 4px 1.33em; font-style: italic}\n.MathJax_MenuRule {border-top: 1px solid #CCCCCC; margin: 4px 1px 0px}\n.MathJax_MenuDisabled {color: GrayText}\n.MathJax_MenuActive {background-color: Highlight; color: HighlightText}\n.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}\n.MathJax_ContextMenu:focus {outline: none}\n.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}\n#MathJax_AboutClose {top: .2em; right: .2em}\n.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}\n.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}\n.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}\n.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}\n.MathJax_MenuClose:hover span {background-color: #CCC!important}\n.MathJax_MenuClose:hover:focus {outline: none}\n</style><style type=\"text/css\">.MJX_Assistive_MathML {position: absolute!important; top: 0; left: 0; clip: rect(1px, 1px, 1px, 1px); padding: 1px 0 0 0!important; border: 0!important; height: 1px!important; width: 1px!important; overflow: hidden!important; display: block!important; -webkit-touch-callout: none; -webkit-user-select: none; -khtml-user-select: none; -moz-user-select: none; -ms-user-select: none; user-select: none}\n.MJX_Assistive_MathML.MJX_Assistive_MathML_Block {width: 100%!important}\n</style><style type=\"text/css\">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}\n#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}\n#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}\n#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}\n</style><style type=\"text/css\">.MathJax_Preview {color: #888}\n#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}\n#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}\n.MathJax_Error {color: #CC0000; font-style: italic}\n</style><style type=\"text/css\">.MJXp-script {font-size: .8em}\n.MJXp-right {-webkit-transform-origin: right; -moz-transform-origin: right; -ms-transform-origin: right; -o-transform-origin: right; transform-origin: right}\n.MJXp-bold {font-weight: bold}\n.MJXp-italic {font-style: italic}\n.MJXp-scr {font-family: MathJax_Script,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-frak {font-family: MathJax_Fraktur,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-sf {font-family: MathJax_SansSerif,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-cal {font-family: MathJax_Caligraphic,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-mono {font-family: MathJax_Typewriter,'Times New Roman',Times,STIXGeneral,serif}\n.MJXp-largeop {font-size: 150%}\n.MJXp-largeop.MJXp-int {vertical-align: -.2em}\n.MJXp-math {display: inline-block; line-height: 1.2; text-indent: 0; font-family: 'Times New Roman',Times,STIXGeneral,serif; white-space: nowrap; border-collapse: collapse}\n.MJXp-display {display: block; text-align: center; margin: 1em 0}\n.MJXp-math span {display: inline-block}\n.MJXp-box {display: block!important; text-align: center}\n.MJXp-box:after {content: \" \"}\n.MJXp-rule {display: block!important; margin-top: .1em}\n.MJXp-char {display: block!important}\n.MJXp-mo {margin: 0 .15em}\n.MJXp-mfrac {margin: 0 .125em; vertical-align: .25em}\n.MJXp-denom {display: inline-table!important; width: 100%}\n.MJXp-denom > * {display: table-row!important}\n.MJXp-surd {vertical-align: top}\n.MJXp-surd > * {display: block!important}\n.MJXp-script-box > *  {display: table!important; height: 50%}\n.MJXp-script-box > * > * {display: table-cell!important; vertical-align: top}\n.MJXp-script-box > *:last-child > * {vertical-align: bottom}\n.MJXp-script-box > * > * > * {display: block!important}\n.MJXp-mphantom {visibility: hidden}\n.MJXp-munderover, .MJXp-munder {display: inline-table!important}\n.MJXp-over {display: inline-block!important; text-align: center}\n.MJXp-over > * {display: block!important}\n.MJXp-munderover > *, .MJXp-munder > * {display: table-row!important}\n.MJXp-mtable {vertical-align: .25em; margin: 0 .125em}\n.MJXp-mtable > * {display: inline-table!important; vertical-align: middle}\n.MJXp-mtr {display: table-row!important}\n.MJXp-mtd {display: table-cell!important; text-align: center; padding: .5em 0 0 .5em}\n.MJXp-mtr > .MJXp-mtd:first-child {padding-left: 0}\n.MJXp-mtr:first-child > .MJXp-mtd {padding-top: 0}\n.MJXp-mlabeledtr {display: table-row!important}\n.MJXp-mlabeledtr > .MJXp-mtd:first-child {padding-left: 0}\n.MJXp-mlabeledtr:first-child > .MJXp-mtd {padding-top: 0}\n.MJXp-merror {background-color: #FFFF88; color: #CC0000; border: 1px solid #CC0000; padding: 1px 3px; font-style: normal; font-size: 90%}\n.MJXp-scale0 {-webkit-transform: scaleX(.0); -moz-transform: scaleX(.0); -ms-transform: scaleX(.0); -o-transform: scaleX(.0); transform: scaleX(.0)}\n.MJXp-scale1 {-webkit-transform: scaleX(.1); -moz-transform: scaleX(.1); -ms-transform: scaleX(.1); -o-transform: scaleX(.1); transform: scaleX(.1)}\n.MJXp-scale2 {-webkit-transform: scaleX(.2); -moz-transform: scaleX(.2); -ms-transform: scaleX(.2); -o-transform: scaleX(.2); transform: scaleX(.2)}\n.MJXp-scale3 {-webkit-transform: scaleX(.3); -moz-transform: scaleX(.3); -ms-transform: scaleX(.3); -o-transform: scaleX(.3); transform: scaleX(.3)}\n.MJXp-scale4 {-webkit-transform: scaleX(.4); -moz-transform: scaleX(.4); -ms-transform: scaleX(.4); -o-transform: scaleX(.4); transform: scaleX(.4)}\n.MJXp-scale5 {-webkit-transform: scaleX(.5); -moz-transform: scaleX(.5); -ms-transform: scaleX(.5); -o-transform: scaleX(.5); transform: scaleX(.5)}\n.MJXp-scale6 {-webkit-transform: scaleX(.6); -moz-transform: scaleX(.6); -ms-transform: scaleX(.6); -o-transform: scaleX(.6); transform: scaleX(.6)}\n.MJXp-scale7 {-webkit-transform: scaleX(.7); -moz-transform: scaleX(.7); -ms-transform: scaleX(.7); -o-transform: scaleX(.7); transform: scaleX(.7)}\n.MJXp-scale8 {-webkit-transform: scaleX(.8); -moz-transform: scaleX(.8); -ms-transform: scaleX(.8); -o-transform: scaleX(.8); transform: scaleX(.8)}\n.MJXp-scale9 {-webkit-transform: scaleX(.9); -moz-transform: scaleX(.9); -ms-transform: scaleX(.9); -o-transform: scaleX(.9); transform: scaleX(.9)}\n.MathJax_PHTML .noError {vertical-align: ; font-size: 90%; text-align: left; color: black; padding: 1px 3px; border: 1px solid}\n</style></head>\n\n    <body class=\"journal journal-fulltext\"><div id=\"MathJax_Message\" style=\"display: none;\"></div><dialog class=\"cc-banner\" data-cc-banner=\"\" data-nosnippet=\"\" aria-labelledby=\"cc-banner-label\" open=\"\">\n\t\t<div class=\"cc-banner__content\" autofocus=\"\" tabindex=\"-1\">\n\t\t\t<div class=\"cc-banner__container\">\n\t\t\t\t<div class=\"cc-banner__header\">\n\t\t\t\t\t<h2 class=\"cc-banner__title\" id=\"cc-banner-label\">Your privacy, your choice</h2>\n\t\t\t\t</div>\n\t\t\t\t<div class=\"cc-banner__body\">\n\t\t\t\t\t<div class=\"cc-banner__policy\">\n\t\t\t\t\t\t<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href=\"https://www.biomedcentral.com/privacy-statement\" data-cc-action=\"privacy\">privacy policy</a> for more information on the use of your personal data.</p><p><button type=\"button\" data-cc-action=\"preferences\" class=\"cc-button cc-button--link cc-button--text\">Manage preferences</button> for further information and to change your choices.</p>\n\t\t\t\t\t</div>\n\t\t\t\t\t\n\t\t\t\t</div>\n\t\t\t\t<div class=\"cc-banner__footer\">\n\t\t\t\t\t\n\t\t\t<button data-cc-action=\"accept\" class=\"cc-button cc-button--secondary cc-button--contrast cc-banner__button cc-banner__button-accept\">Accept all cookies</button>\n\t\t\t\n\t\t\n\t\t\t\t</div>\n\t\t\t</div>\n\t\t</div>\n\t</dialog>\n        <div class=\"ctm\"></div> \n        \n    \n        \n            <!-- Google Tag Manager (noscript) -->\n            <noscript>\n                <iframe src=\"https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ\"\n                        height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"></iframe>\n            </noscript>\n            <!-- End Google Tag Manager (noscript) -->\n        \n    \n\n        <div class=\"u-visually-hidden\" aria-hidden=\"true\">\n    \n    <!--?xml version=\"1.0\" encoding=\"UTF-8\"?--><svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><defs><path id=\"a\" d=\"M0 .74h56.72v55.24H0z\"></path></defs><symbol id=\"icon-access\" viewBox=\"0 0 18 18\"><path d=\"m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-account\" viewBox=\"0 0 18 18\"><path d=\"m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-alert\" viewBox=\"0 0 18 18\"><path d=\"m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-broad\" viewBox=\"0 0 16 16\"><path d=\"m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 14 15)\"></path></symbol><symbol id=\"icon-arrow-down\" viewBox=\"0 0 16 16\"><path d=\"m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-left\" viewBox=\"0 0 16 16\"><path d=\"m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-right\" viewBox=\"0 0 16 16\"><path d=\"m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-sub\" viewBox=\"0 0 16 16\"><path d=\"m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-up\" viewBox=\"0 0 16 16\"><path d=\"m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-article\" viewBox=\"0 0 18 18\"><path d=\"m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-audio\" viewBox=\"0 0 18 18\"><path d=\"m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-block\" viewBox=\"0 0 24 24\"><path d=\"m0 0h24v24h-24z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-book\" viewBox=\"0 0 18 18\"><path d=\"m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-broad\" viewBox=\"0 0 24 24\"><path d=\"m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 20.182742 24.805206)\"></path></symbol><symbol id=\"icon-calendar\" viewBox=\"0 0 18 18\"><path d=\"m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-cart\" viewBox=\"0 0 18 18\"><path d=\"m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z\"></path></symbol><symbol id=\"icon-chevron-less\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 -1 0 9 9)\"></path></symbol><symbol id=\"icon-chevron-more\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 1)\"></path></symbol><symbol id=\"icon-chevron-right\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-circle-fill\" viewBox=\"0 0 16 16\"><path d=\"m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-circle\" viewBox=\"0 0 16 16\"><path d=\"m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-citation\" viewBox=\"0 0 18 18\"><path d=\"m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-close\" viewBox=\"0 0 16 16\"><path d=\"m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-collections\" viewBox=\"0 0 18 18\"><path d=\"m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-compare\" viewBox=\"0 0 18 18\"><path d=\"m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download-file\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download\" viewBox=\"0 0 16 16\"><path d=\"m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-editors\" viewBox=\"0 0 18 18\"><path d=\"m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-email\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-error\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-ethics\" viewBox=\"0 0 18 18\"><path d=\"m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-expand\"><path d=\"M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-explore\" viewBox=\"0 0 18 18\"><path d=\"m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-filter\" viewBox=\"0 0 16 16\"><path d=\"m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z\"></path></symbol><symbol id=\"icon-home\" viewBox=\"0 0 18 18\"><path d=\"m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-image\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-info\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-institution\" viewBox=\"0 0 18 18\"><path d=\"m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-location\" viewBox=\"0 0 18 18\"><path d=\"m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-minus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-newsletter\" viewBox=\"0 0 18 18\"><path d=\"m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-orcid\" viewBox=\"0 0 18 18\"><path d=\"m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-plus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-print\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-search\" viewBox=\"0 0 22 22\"><path d=\"M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-facebook\" viewBox=\"0 0 24 24\"><path d=\"m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-twitter\" viewBox=\"0 0 24 24\"><path d=\"m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-youtube\" viewBox=\"0 0 24 24\"><path d=\"m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-subject-medicine\" viewBox=\"0 0 18 18\"><path d=\"m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-success\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-table\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick-circle\" viewBox=\"0 0 24 24\"><path d=\"m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick\" viewBox=\"0 0 16 16\"><path d=\"m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-update\" viewBox=\"0 0 18 18\"><path d=\"m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-upload\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-video\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-warning\" viewBox=\"0 0 18 18\"><path d=\"m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-left-bullet\" viewBox=\"0 0 8 16\"><path d=\"M3 8l5 5v3L0 8l8-8v3L3 8z\"></path></symbol><symbol id=\"icon-chevron-down\" viewBox=\"0 0 16 16\"><path d=\"m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 3)\"></path></symbol><symbol id=\"icon-download-rounded\"><path d=\"M0 13c0-.556.449-1 1.002-1h9.996a.999.999 0 110 2H1.002A1.006 1.006 0 010 13zM7 1v6.8l2.482-2.482c.392-.392 1.022-.4 1.403-.02a1.001 1.001 0 010 1.417l-4.177 4.177a1.001 1.001 0 01-1.416 0L1.115 6.715a.991.991 0 01-.016-1.4 1 1 0 011.42.003L5 7.8V1c0-.55.444-.996 1-.996.552 0 1 .445 1 .996z\"></path></symbol><symbol id=\"icon-ext-link\" viewBox=\"0 0 16 16\"><path d=\"M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z\"></path><path d=\"M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z\"></path><path d=\"M9.7 0L16 6.2V0z\"></path></symbol><symbol id=\"icon-remove\" viewBox=\"-296 388 18 18\"><path d=\"M-291.7 396.1h9v2h-9z\"></path><path d=\"M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z\"></path></symbol><symbol id=\"icon-rss\" viewBox=\"0 0 18 18\"><path d=\"m.97480857 6.01583891.11675372.00378391c5.75903295.51984988 10.34261021 5.10537458 10.85988231 10.86480098.0494035.5500707-.3564674 1.0360406-.906538 1.0854441-.5500707.0494036-1.0360406-.3564673-1.08544412-.906538-.43079083-4.7965248-4.25151132-8.61886853-9.04770289-9.05180573-.55004837-.04965115-.95570047-.53580366-.90604933-1.08585203.04610464-.5107592.46858035-.89701345.96909831-.90983323zm1.52519143 6.95474179c1.38071187 0 2.5 1.1192881 2.5 2.5s-1.11928813 2.5-2.5 2.5-2.5-1.1192881-2.5-2.5 1.11928813-2.5 2.5-2.5zm-1.43253846-12.96884168c9.09581416.53242539 16.37540296 7.8163886 16.90205336 16.91294558.0319214.5513615-.389168 1.0242056-.9405294 1.056127-.5513615.0319214-1.0242057-.389168-1.0561271-.9405294-.4679958-8.08344784-6.93949306-14.55883389-15.02226722-15.03196077-.55134101-.03227286-.97212889-.50538538-.93985602-1.05672639.03227286-.551341.50538538-.97212888 1.05672638-.93985602z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-springer-arrow-left\"><path d=\"M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z\"></path></symbol><symbol id=\"icon-springer-arrow-right\"><path d=\"M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z\"></path></symbol><symbol id=\"icon-springer-collections\" viewBox=\"3 3 32 32\"><path fill-rule=\"evenodd\" d=\"M25.583333,30.1249997 L25.583333,7.1207574 C25.583333,7.10772495 25.579812,7.10416665 25.5859851,7.10416665 L6.10400517,7.10571021 L6.10400517,30.1355179 C6.10400517,31.1064087 6.89406744,31.8958329 7.86448169,31.8958329 L26.057145,31.8958329 C25.7558021,31.374901 25.583333,30.7700915 25.583333,30.1249997 Z M4.33333333,30.1355179 L4.33333333,7.10571021 C4.33333333,6.12070047 5.12497502,5.33333333 6.10151452,5.33333333 L25.5859851,5.33333333 C26.5617372,5.33333333 27.3541664,6.13359035 27.3541664,7.1207574 L27.3541664,12.4166666 L32.6666663,12.4166666 L32.6666663,30.1098941 C32.6666663,32.0694626 31.0857174,33.6666663 29.1355179,33.6666663 L7.86448169,33.6666663 C5.91736809,33.6666663 4.33333333,32.0857174 4.33333333,30.1355179 Z M27.3541664,14.1874999 L27.3541664,30.1249997 C27.3541664,31.1030039 28.1469954,31.8958329 29.1249997,31.8958329 C30.1030039,31.8958329 30.8958329,31.1030039 30.8958329,30.1249997 L30.8958329,14.1874999 L27.3541664,14.1874999 Z M9.64583326,10.6458333 L22.0416665,10.6458333 L22.0416665,17.7291665 L9.64583326,17.7291665 L9.64583326,10.6458333 Z M11.4166666,12.4166666 L11.4166666,15.9583331 L20.2708331,15.9583331 L20.2708331,12.4166666 L11.4166666,12.4166666 Z M9.64583326,19.4999998 L22.0416665,19.4999998 L22.0416665,21.2708331 L9.64583326,21.2708331 L9.64583326,19.4999998 Z M9.64583326,23.0416665 L22.0416665,23.0416665 L22.0416665,24.8124997 L9.64583326,24.8124997 L9.64583326,23.0416665 Z M9.64583326,26.583333 L22.0416665,26.583333 L22.0416665,28.3541664 L9.64583326,28.3541664 L9.64583326,26.583333 Z\"></path></symbol><symbol id=\"icon-springer-download\" viewBox=\"-301 390 9 14\"><path d=\"M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z\"></path></symbol><symbol id=\"icon-springer-info\" viewBox=\"0 0 24 24\"><!--Generator: Sketch 63.1 (92452) - https://sketch.com--><g id=\"V&amp;I\" stroke=\"none\" stroke-width=\"1\" fill-rule=\"evenodd\"><g id=\"info\" fill-rule=\"nonzero\"><path d=\"M12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 Z M12.5540543,9.1 L11.5540543,9.1 C11.0017696,9.1 10.5540543,9.54771525 10.5540543,10.1 L10.5540543,10.1 L10.5540543,18.1 C10.5540543,18.6522847 11.0017696,19.1 11.5540543,19.1 L11.5540543,19.1 L12.5540543,19.1 C13.1063391,19.1 13.5540543,18.6522847 13.5540543,18.1 L13.5540543,18.1 L13.5540543,10.1 C13.5540543,9.54771525 13.1063391,9.1 12.5540543,9.1 L12.5540543,9.1 Z M12,5 C11.5356863,5 11.1529412,5.14640523 10.8517647,5.43921569 C10.5505882,5.73202614 10.4,6.11546841 10.4,6.58954248 C10.4,7.06361656 10.5505882,7.45054466 10.8517647,7.7503268 C11.1529412,8.05010893 11.5356863,8.2 12,8.2 C12.4768627,8.2 12.8627451,8.05010893 13.1576471,7.7503268 C13.452549,7.45054466 13.6,7.06361656 13.6,6.58954248 C13.6,6.11546841 13.452549,5.73202614 13.1576471,5.43921569 C12.8627451,5.14640523 12.4768627,5 12,5 Z\" id=\"Combined-Shape\"></path></g></g></symbol><symbol id=\"icon-springer-tick-circle\" viewBox=\"0 0 24 24\"><g id=\"Page-1\" stroke=\"none\" stroke-width=\"1\" fill-rule=\"evenodd\"><g id=\"springer-tick-circle\" fill-rule=\"nonzero\"><path d=\"M12,24 C5.372583,24 0,18.627417 0,12 C0,5.372583 5.372583,0 12,0 C18.627417,0 24,5.372583 24,12 C24,18.627417 18.627417,24 12,24 Z M7.657,10.79 C7.45285634,10.6137568 7.18569967,10.5283283 6.91717333,10.5534259 C6.648647,10.5785236 6.40194824,10.7119794 6.234,10.923 C5.87705269,11.3666969 5.93445559,12.0131419 6.364,12.387 L10.261,15.754 C10.6765468,16.112859 11.3037113,16.0695601 11.666,15.657 L17.759,8.713 C18.120307,8.27302248 18.0695334,7.62621189 17.644,7.248 C17.4414817,7.06995024 17.1751516,6.9821166 16.9064461,7.00476032 C16.6377406,7.02740404 16.3898655,7.15856958 16.22,7.368 L10.768,13.489 L7.657,10.79 Z\" id=\"path-1\"></path></g></g></symbol><symbol id=\"icon-updates\" viewBox=\"0 0 18 18\"><g fill-rule=\"nonzero\"><path d=\"M16.98 3.484h-.48c-2.52-.058-5.04 1.161-7.44 2.903-2.46-1.8-4.74-2.903-8.04-2.903-.3 0-.54.29-.54.58v9.813c0 .29.24.523.54.581 2.76.348 4.86 1.045 7.62 2.903.24.116.54.116.72 0 2.76-1.858 4.86-2.555 7.62-2.903.3-.058.54-.29.54-.58V4.064c0-.29-.24-.523-.54-.581zm-15.3 1.22c2.34 0 4.86 1.509 6.72 2.786v8.478c-2.34-1.394-4.38-2.09-6.72-2.439V4.703zm14.58 8.767c-2.34.348-4.38 1.045-6.72 2.439V7.374C12 5.632 14.1 4.645 16.26 4.645v8.826z\"></path><path d=\"M9 .058c-1.56 0-2.76 1.22-2.76 2.671C6.24 4.181 7.5 5.4 9 5.4c1.5 0 2.76-1.22 2.76-2.671 0-1.452-1.2-2.67-2.76-2.67zm0 4.413c-.96 0-1.8-.755-1.8-1.742C7.2 1.8 7.98.987 9 .987s1.8.755 1.8 1.742c0 .93-.84 1.742-1.8 1.742z\"></path></g></symbol><symbol id=\"icon-checklist-banner\" viewBox=\"0 0 56.69 56.69\"><path style=\"fill:none\" d=\"M0 0h56.69v56.69H0z\"></path><clipPath id=\"b\"><use xlink:href=\"#a\" style=\"overflow:visible\"></use></clipPath><path d=\"M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round\"></path><path d=\"M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round\"></path></symbol><symbol id=\"icon-submit-closed\" viewBox=\"0 0 18 18\"><path d=\"m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-3.03756612 2.46243388-5.5 5.5-5.5zm0 1c-2.4852814 0-4.5 2.0147186-4.5 4.5s2.0147186 4.5 4.5 4.5 4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5zm2.3087379 2.1912621c.2550161.2550162.2550161.668479 0 .9234952l-1.3859024 1.3845831 1.3859024 1.3859023c.2550161.2550162.2550161.668479 0 .9234952-.2550162.2550161-.668479.2550161-.9234952 0l-1.3859023-1.3859024-1.3845831 1.3859024c-.2550162.2550161-.668479.2550161-.9234952 0-.25501614-.2550162-.25501614-.668479 0-.9234952l1.3845831-1.3859023-1.3845831-1.3845831c-.25501614-.2550162-.25501614-.668479 0-.9234952.2550162-.25501614.668479-.25501614.9234952 0l1.3845831 1.3845831 1.3859023-1.3845831c.2550162-.25501614.668479-.25501614.9234952 0zm-9.8087379-8.7782621-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z\"></path></symbol><symbol id=\"icon-submit-open\" viewBox=\"0 0 18 18\"><path d=\"m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\"></path></symbol><symbol id=\"icon-submit-upcoming\" viewBox=\"0 0 18 18\"><path d=\"m15 0c1.1045695 0 2 .8954305 2 2v4.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-4.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h4.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-4.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-2.5 7c3.0375661 0 5.5 2.46243388 5.5 5.5 0 3.0375661-2.4624339 5.5-5.5 5.5-3.03756612 0-5.5-2.4624339-5.5-5.5 0-1.6607442.73606908-3.14957021 1.89976608-4.15803695l-1.51549374.02214397c-.27613212.00263356-.49998143-.22483432-.49998143-.49020681 0-.24299316.17766103-.44509007.40961587-.48700057l.08928713-.00797472h2.66407569c.2449213 0 .4486219.17766776.490865.40963137l.008038.08929051v2.6642143c0 .275547-.2296028.4989219-.4949753.4989219-.24299317 0-.44342617-.1744719-.4830969-.4093269l-.00710993-.0906783.01983146-1.46576707c-.96740882.82538117-1.58082193 2.05345007-1.58082193 3.42478927 0 2.4852814 2.0147186 4.5 4.5 4.5s4.5-2.0147186 4.5-4.5-2.0147186-4.5-4.5-4.5c-.7684937 0-.7684937-1 0-1zm0 2.85c.3263501 0 .5965265.2405082.6429523.5539478l.0070477.0960522v1.731l.8096194.8093806c.2284567.2284567.2513024.5846637.068537.8386705l-.068537.0805683c-.2284567.2284567-.5846637.2513024-.8386705.068537l-.0805683-.068537-.9707107-.9707107c-.1125218-.1125218-.1855975-.257116-.2103268-.412296l-.0093431-.1180341v-1.9585786c0-.3589851.2910149-.65.65-.65zm-7.5-8.437-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1z\"></path></symbol><symbol id=\"icon-facebook-bordered\" viewBox=\"463.812 263.868 32 32\"><path d=\"M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z\n\t M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z\"></path><path d=\"M483.025,280.48l0.32-2.477h-2.453v-1.582c0-0.715,0.199-1.207,1.227-1.207h1.311v-2.213\n\tc-0.227-0.029-1.003-0.098-1.907-0.098c-1.894,0-3.186,1.154-3.186,3.271v1.826h-2.142v2.477h2.142v6.354h2.557v-6.354\n\tL483.025,280.48L483.025,280.48z\"></path></symbol><symbol id=\"icon-twitter-bordered\" viewBox=\"463.812 263.868 32 32\"><g><path d=\"M486.416,276.191c-0.483,0.215-1.007,0.357-1.554,0.429c0.558-0.338,0.991-0.868,1.19-1.502\n\t\tc-0.521,0.308-1.104,0.536-1.72,0.657c-0.494-0.526-1.2-0.854-1.979-0.854c-1.496,0-2.711,1.213-2.711,2.71\n\t\tc0,0.212,0.023,0.419,0.069,0.616c-2.252-0.111-4.25-1.19-5.586-2.831c-0.231,0.398-0.365,0.866-0.365,1.361\n\t\tc0,0.94,0.479,1.772,1.204,2.257c-0.441-0.015-0.861-0.138-1.227-0.339v0.031c0,1.314,0.937,2.41,2.174,2.656\n\t\tc-0.227,0.062-0.47,0.098-0.718,0.098c-0.171,0-0.343-0.018-0.511-0.049c0.35,1.074,1.347,1.859,2.531,1.883\n\t\tc-0.928,0.726-2.095,1.16-3.366,1.16c-0.22,0-0.433-0.014-0.644-0.037c1.2,0.768,2.621,1.215,4.155,1.215\n\t\tc4.983,0,7.71-4.129,7.71-7.711c0-0.115-0.004-0.232-0.006-0.351C485.592,277.212,486.054,276.734,486.416,276.191z\"></path></g><path d=\"M479.812,263.868c-8.837,0-16,7.163-16,16s7.163,16,16,16s16-7.163,16-16S488.649,263.868,479.812,263.868z\n\t M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14s14,6.269,14,14S487.545,293.868,479.812,293.868z\"></path></symbol><symbol id=\"icon-weibo-bordered\" viewBox=\"463.812 263.868 32 32\"><path d=\"M479.812,263.868c-8.838,0-16,7.163-16,16s7.162,16,16,16c8.837,0,16-7.163,16-16S488.649,263.868,479.812,263.868z\n\t M479.812,293.868c-7.732,0-14-6.269-14-14s6.268-14,14-14c7.731,0,14,6.269,14,14S487.545,293.868,479.812,293.868z\"></path><g><path d=\"M478.552,285.348c-2.616,0.261-4.876-0.926-5.044-2.649c-0.167-1.722,1.814-3.33,4.433-3.588\n\t\tc2.609-0.263,4.871,0.926,5.041,2.647C483.147,283.479,481.164,285.089,478.552,285.348 M483.782,279.63\n\t\tc-0.226-0.065-0.374-0.109-0.259-0.403c0.25-0.639,0.276-1.188,0.005-1.581c-0.515-0.734-1.915-0.693-3.521-0.021\n\t\tc0,0-0.508,0.224-0.378-0.181c0.247-0.798,0.209-1.468-0.178-1.852c-0.87-0.878-3.194,0.032-5.183,2.027\n\t\tc-1.489,1.494-2.357,3.082-2.357,4.453c0,2.619,3.354,4.213,6.631,4.213c4.297,0,7.154-2.504,7.154-4.493\n\t\tC485.697,280.594,484.689,279.911,483.782,279.63\"></path><path d=\"M486.637,274.833c-1.039-1.154-2.57-1.592-3.982-1.291l0,0c-0.325,0.068-0.532,0.391-0.465,0.72\n\t\tc0.068,0.328,0.391,0.537,0.72,0.466c1.005-0.215,2.092,0.104,2.827,0.92c0.736,0.818,0.938,1.939,0.625,2.918l0,0\n\t\tc-0.102,0.318,0.068,0.661,0.39,0.762c0.32,0.104,0.658-0.069,0.763-0.391v-0.001C487.953,277.558,487.674,275.985,486.637,274.833\n\t\t\"></path><path d=\"M485.041,276.276c-0.504-0.562-1.25-0.774-1.938-0.63c-0.279,0.06-0.461,0.339-0.396,0.621\n\t\tc0.062,0.281,0.335,0.461,0.617,0.398l0,0c0.336-0.071,0.702,0.03,0.947,0.307s0.312,0.649,0.207,0.979l0,0\n\t\tc-0.089,0.271,0.062,0.565,0.336,0.654c0.274,0.09,0.564-0.062,0.657-0.336C485.686,277.604,485.549,276.837,485.041,276.276\"></path><path d=\"M478.694,282.227c-0.09,0.156-0.293,0.233-0.451,0.166c-0.151-0.062-0.204-0.235-0.115-0.389\n\t\tc0.093-0.155,0.284-0.229,0.44-0.168C478.725,281.892,478.782,282.071,478.694,282.227 M477.862,283.301\n\t\tc-0.253,0.405-0.795,0.58-1.202,0.396c-0.403-0.186-0.521-0.655-0.27-1.051c0.248-0.39,0.771-0.566,1.176-0.393\n\t\tC477.979,282.423,478.109,282.889,477.862,283.301 M478.812,280.437c-1.244-0.326-2.65,0.294-3.19,1.396\n\t\tc-0.553,1.119-0.021,2.369,1.236,2.775c1.303,0.42,2.84-0.225,3.374-1.436C480.758,281.989,480.1,280.77,478.812,280.437\"></path></g></symbol></svg>\n</div>\n\n\n        \n\n        \n\n    <div class=\"u-vh-full\">\n        <a class=\"c-skip-link\" href=\"#main-content\">Skip to main content</a>\n        \n            \n    \n        <div class=\"u-hide u-show-following-ad\"></div>\n    \n    <aside class=\"adsbox c-ad c-ad--728x90\" data-component-mpu=\"\">\n        <div class=\"c-ad__inner\">\n            <p class=\"c-ad__label\">Advertisement</p>\n            <div id=\"div-gpt-ad-LB1\" data-ad-type=\"LB1\" data-test=\"LB1-ad\" data-pa11y-ignore=\"\" data-gpt=\"\" data-gpt-unitpath=\"/270604982/bmc/bmcinfectdis/articles\" data-gpt-sizes=\"728x90,970x90\" data-gpt-targeting=\"pos=LB1;doi=10.1186/s12879-018-3565-z;type=article;kwrd=CAP,Atypical pathogens,Epidemiology;pmc=H33096,B19002,B16003,H61006,H33002;\">\n                <noscript>\n                    <a href=\"//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\">\n                        <img data-test=\"gpt-advert-fallback-img\"\n                            src=\"//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\"\n                            alt=\"Advertisement\"\n                            width=\"728\"\n                            height=\"90\">\n                    </a>\n                </noscript>\n            </div>\n        </div>\n    </aside>\n\n        \n        \n\n         \n    \n        <div id=\"membership-message-loader-desktop\" class=\"placeholder\" data-placeholder=\"/placeholder/v1/membership/message\"></div>\n    \n    \n        <div id=\"top\" class=\"u-position-relative\">\n    <header class=\"c-header\" data-test=\"publisher-header\">\n        <div class=\"c-header__container\">\n            <div class=\"c-header__brand u-mr-48\" itemscope=\"\" itemtype=\"http://schema.org/Organization\" data-test=\"navbar-logo-header\">\n                <div class=\"c-logo\">\n    <a href=\"https://www.biomedcentral.com\" itemprop=\"url\">\n        <img alt=\"BMC\" itemprop=\"logo\" width=\"76\" height=\"18\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-series-d1f4e4f0a7.svg\">\n        <div class=\"c-logo__strapline\">\n            <img alt=\"Part of Springer Nature\" width=\"173\" height=\"16\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg\">\n        </div>\n    </a>\n</div>\n\n            </div>\n            <div class=\"c-header__navigation\">\n                <button type=\"button\" class=\"c-header__link u-button-reset u-mr-24\" data-expander=\"\" data-expander-target=\"#publisher-header-search\" data-expander-autofocus=\"firstTabbable\" data-test=\"header-search-button\" aria-controls=\"publisher-header-search\" aria-expanded=\"false\" aria-haspopup=\"true\">\n                    <span class=\"u-display-flex u-align-items-center\">\n                        <span>Search</span>\n                        <svg class=\"u-icon u-flex-static u-ml-8\" aria-hidden=\"true\" focusable=\"false\">\n                            <use xlink:href=\"#icon-search\"></use>\n                        </svg>\n                    </span>\n                </button>\n                <nav>\n                    <ul class=\"c-header__menu u-hide-at-lt-lg\" data-enhanced-menu=\"\" data-test=\"publisher-navigation\">\n                        \n                            \n                                <li class=\"c-header__item u-hide-at-lt-lg\">\n                                    <a class=\"c-header__link\" href=\"//www.biomedcentral.com/journals\">\n                                        Explore journals\n                                    </a>\n                                </li>\n                            \n                                <li class=\"c-header__item u-hide-at-lt-lg\">\n                                    <a class=\"c-header__link\" href=\"//www.biomedcentral.com/getpublished\">\n                                        Get published\n                                    </a>\n                                </li>\n                            \n                                <li class=\"c-header__item u-hide-at-lt-lg\">\n                                    <a class=\"c-header__link\" href=\"//www.biomedcentral.com/about\">\n                                        About BMC\n                                    </a>\n                                </li>\n                            \n                        \n                        <li class=\"c-header__item\">\n                            <a href=\"/login\" class=\"c-header__link\">Login</a>\n                        </li>\n                    </ul><div class=\"c-dropdown u-hide-at-lg\"><button class=\"c-dropdown__button c-header__item\" aria-expanded=\"false\" aria-haspopup=\"true\">Menu</button><ul class=\"c-dropdown__menu u-hide c-dropdown__menu--right\"><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://www.biomedcentral.com/journals\">\n                                        Explore journals\n                                    </a></li><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://www.biomedcentral.com/getpublished\">\n                                        Get published\n                                    </a></li><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://www.biomedcentral.com/about\">\n                                        About BMC\n                                    </a></li><li class=\"c-dropdown__item\"><a class=\"c-dropdown__link\" href=\"https://bmcinfectdis.biomedcentral.com/login\">Login</a></li></ul></div>\n                </nav>\n            </div>\n        </div>\n    </header>\n    <div class=\"c-popup-search u-js-hide\" id=\"publisher-header-search\" hidden=\"\">\n        <div class=\"u-container\">\n            <div class=\"c-popup-search__container\">\n                <div class=\"ctx-search\">\n    <form role=\"search\" class=\"c-form-field js-skip-validation\" method=\"GET\" action=\"//www.biomedcentral.com/search\" data-track=\"search\" data-track-context=\"pop out website-wide search in bmc website header\" data-track-category=\"Search and Results\" data-track-action=\"Submit search\" data-dynamic-track-label=\"\" data-track-label=\"\" data-test=\"global-search\">\n        <label for=\"publisherSearch\" class=\"c-form-field__label\">Search all BMC articles</label>\n        <div class=\"u-display-flex\">\n            <input id=\"publisherSearch\" class=\"c-form-field__input\" data-search-input=\"\" autocomplete=\"off\" role=\"textbox\" data-test=\"search-input\" name=\"query\" type=\"text\" value=\"\">\n            <div>\n                <button class=\"u-button\" type=\"submit\" data-test=\"search-submit-button\">\n    <span class=\"u-visually-hidden\">Search</span>\n    <svg class=\"u-icon u-flex-static\" width=\"16\" height=\"16\" aria-hidden=\"true\" focusable=\"false\">\n        <use xlink:href=\"#icon-search\"></use>\n    </svg>\n</button>\n\n\n            </div>\n        </div>\n        <input type=\"hidden\" name=\"searchType\" value=\"publisherSearch\">\n    </form>\n</div>\n\n            </div>\n        </div>\n    </div>\n</div>\n\n    \n\n        \n            <header class=\"c-journal-header c-journal-header--bmc-infectious-diseases ctx-journal-header\">\n                <div class=\"u-container\">\n                    <div class=\"c-journal-header__inner \">\n                        \n                        <div class=\"c-journal-title\" id=\"journalTitle\">\n                            <a href=\"/\">\n    \n        \n    \n    <span class=\"c-journal-title__text \">BMC Infectious Diseases</span>\n    \n</a>\n                        </div>\n                        \n                    </div>\n                </div>\n                <div class=\"c-navbar c-navbar--with-submit-button\">\n                    <div class=\"c-navbar__container\">\n                        \n                            <div class=\"c-navbar__content\">\n                                <nav class=\"c-navbar__nav\">\n                                    <ul class=\"c-navbar__nav c-navbar__nav--journal\" role=\"menu\" data-test=\"site-navigation\">\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Home\" data-track-action=\"Clicked journal navigation link\" href=\"/\">Home</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"About\" data-track-action=\"Clicked journal navigation link\" href=\"/about\">About</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link c-navbar__link--is-shown\" data-track=\"click\" data-track-category=\"Articles\" data-track-action=\"Clicked journal navigation link\" href=\"/articles\">Articles</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Submission Guidelines\" data-track-action=\"Clicked journal navigation link\" href=\"/submission-guidelines\">Submission Guidelines</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Join the board\" data-track-action=\"Clicked journal navigation link\" href=\"/join-our-editorial-board\">Join the board</a>\n                                            </li>\n                                        \n                                            <li class=\"c-navbar__item\" role=\"menuitem\">\n                                                <a class=\"c-navbar__link\" data-track=\"click\" data-track-category=\"Collections\" data-track-action=\"Clicked journal navigation link\" href=\"/articles/collections\">Collections</a>\n                                            </li>\n                                        \n                                        \n                                            \n                                                <li class=\"c-navbar__item\" role=\"menuitem\" data-test=\"journal-header-submit-button\">\n                                                    \n    \n\n    \n        <div class=\"\">\n            \n        <a class=\"u-button u-button--tertiary u-button--alt-colour-on-mobile\" href=\"https://submission.nature.com/new-submission/12879/3\" data-track=\"click_submit_manuscript\" data-track-action=\"manuscript submission\" data-track-category=\"article\" data-track-label=\"button in journal nav\" data-track-context=\"journal header on article page\" data-track-external=\"\" data-gtm-criteo=\"submit-manuscript\" data-test=\"submit-manuscript-button\">Submit manuscript<svg class=\"u-ml-8\" width=\"15\" height=\"16\" aria-hidden=\"true\" focusable=\"false\"><use xlink:href=\"#icon-submit-open\"></use></svg></a>\n    \n        </div>\n    \n\n\n                                                </li>\n                                            \n                                        \n                                    </ul>\n                                </nav>\n                            </div>\n                        \n                    </div>\n                </div>\n                <div class=\"c-journal-header__identity c-journal-header__identity--default\">\n                    \n                </div>\n            </header>\n            \n        \n\n        <div class=\"u-container u-mt-32 u-mb-32 u-clearfix\" id=\"main-content\" data-component=\"article-container\">\n            <main class=\"c-article-main-column u-float-left js-main-column\" data-track-component=\"article body\">\n                <div class=\"c-context-bar u-hide\" data-test=\"context-bar\" data-context-bar=\"\" aria-hidden=\"true\">\n                    <div class=\"c-context-bar__container u-container\" data-track-context=\"sticky banner\">\n                        <div class=\"c-context-bar__title\">\n                            Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\n                        </div>\n                        <div class=\"c-pdf-container\">\n                            \n    <div class=\"c-pdf-download u-clear-both\">\n        <a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\" class=\"u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link\" data-article-pdf=\"true\" data-readcube-pdf-url=\"true\" data-test=\"pdf-link\" data-draft-ignore=\"true\" data-track=\"content_download\" data-track-type=\"article pdf download\" data-track-action=\"download pdf\" data-track-label=\"link\" data-track-external=\"\" download=\"\">\n            <span class=\"c-pdf-download__text\">Download PDF</span>\n            <svg aria-hidden=\"true\" focusable=\"false\" width=\"16\" height=\"16\" class=\"u-icon\"><use xlink:href=\"#icon-download\"></use></svg>\n        </a>\n    </div>\n\n                            \n                        </div>\n                    </div>\n                </div>\n\n                <div class=\"c-pdf-button__container u-hide-at-lg js-context-bar-sticky-point-mobile\">\n                    <div class=\"c-pdf-container\" data-track-context=\"article body\">\n                        \n    <div class=\"c-pdf-download u-clear-both\">\n        <a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\" class=\"u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link\" data-article-pdf=\"true\" data-readcube-pdf-url=\"true\" data-test=\"pdf-link\" data-draft-ignore=\"true\" data-track=\"content_download\" data-track-type=\"article pdf download\" data-track-action=\"download pdf\" data-track-label=\"link\" data-track-external=\"\" download=\"\">\n            <span class=\"c-pdf-download__text\">Download PDF</span>\n            <svg aria-hidden=\"true\" focusable=\"false\" width=\"16\" height=\"16\" class=\"u-icon\"><use xlink:href=\"#icon-download\"></use></svg>\n        </a>\n    </div>\n\n                        \n                    </div>\n                </div>\n                <article lang=\"en\">\n                    <div class=\"c-article-header\">\n                        \n    \n\n\n                        <ul class=\"c-article-identifiers\" data-test=\"article-identifier\">\n                            \n        <li class=\"c-article-identifiers__item\" data-test=\"article-category\">Research article</li>\n    \n        <li class=\"c-article-identifiers__item\">\n            <a href=\"https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research\" data-track=\"click\" data-track-action=\"open access\" data-track-label=\"link\" class=\"u-color-open-access\" data-test=\"open-access\">Open access</a>\n        </li>\n    \n    \n\n                            <li class=\"c-article-identifiers__item\">Published: <time datetime=\"2018-12-18\">18 December 2018</time></li>\n                        </ul>\n\n                        <h1 class=\"c-article-title\" data-test=\"article-title\" data-article-title=\"\">Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective</h1>\n                        <ul class=\"c-article-author-list c-article-author-list--short js-no-scroll\" data-test=\"authors-list\" data-component-authors-activator=\"authors-list\"><li class=\"c-article-author-list__item\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Andrea-Gramegna-Aff1\" data-author-popup=\"auth-Andrea-Gramegna-Aff1\" data-author-search=\"Gramegna, Andrea\" data-track-context=\"researcher popup with no profile\" data-track-index=\"1_13\">Andrea Gramegna</a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup>, </li><li class=\"c-article-author-list__item\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Giovanni-Sotgiu-Aff2\" data-author-popup=\"auth-Giovanni-Sotgiu-Aff2\" data-author-search=\"Sotgiu, Giovanni\" data-track-context=\"researcher popup with no profile\" data-track-index=\"2_13\">Giovanni Sotgiu</a><sup class=\"u-js-hide\"><a href=\"#Aff2\" tabindex=\"-1\">2</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Marta-Pasquale-Aff1\" data-author-popup=\"auth-Marta-Pasquale-Aff1\" data-author-search=\"Di Pasquale, Marta\" data-track-context=\"researcher popup with no profile\" data-track-index=\"3_13\">Marta Di Pasquale</a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Dejan-Radovanovic-Aff3\" data-author-popup=\"auth-Dejan-Radovanovic-Aff3\" data-author-search=\"Radovanovic, Dejan\" data-track-context=\"researcher popup with no profile\" data-track-index=\"4_13\">Dejan Radovanovic</a><sup class=\"u-js-hide\"><a href=\"#Aff3\" tabindex=\"-1\">3</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Silvia-Terraneo-Aff4\" data-author-popup=\"auth-Silvia-Terraneo-Aff4\" data-author-search=\"Terraneo, Silvia\" data-track-context=\"researcher popup with no profile\" data-track-index=\"5_13\">Silvia Terraneo</a><sup class=\"u-js-hide\"><a href=\"#Aff4\" tabindex=\"-1\">4</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Luis_F_-Reyes-Aff5\" data-author-popup=\"auth-Luis_F_-Reyes-Aff5\" data-author-search=\"Reyes, Luis F.\" data-track-context=\"researcher popup with no profile\" data-track-index=\"6_13\">Luis F. Reyes</a><sup class=\"u-js-hide\"><a href=\"#Aff5\" tabindex=\"-1\">5</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Ester-Vendrell-Aff6\" data-author-popup=\"auth-Ester-Vendrell-Aff6\" data-author-search=\"Vendrell, Ester\" data-track-context=\"researcher popup with no profile\" data-track-index=\"7_13\">Ester Vendrell</a><sup class=\"u-js-hide\"><a href=\"#Aff6\" tabindex=\"-1\">6</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Joao-Neves-Aff7\" data-author-popup=\"auth-Joao-Neves-Aff7\" data-author-search=\"Neves, Joao\" data-track-context=\"researcher popup with no profile\" data-track-index=\"8_13\">Joao Neves</a><sup class=\"u-js-hide\"><a href=\"#Aff7\" tabindex=\"-1\">7</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Francesco-Menzella-Aff8\" data-author-popup=\"auth-Francesco-Menzella-Aff8\" data-author-search=\"Menzella, Francesco\" data-track-context=\"researcher popup with no profile\" data-track-index=\"9_13\">Francesco Menzella</a><sup class=\"u-js-hide\"><a href=\"#Aff8\" tabindex=\"-1\">8</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Francesco-Blasi-Aff1\" data-author-popup=\"auth-Francesco-Blasi-Aff1\" data-author-search=\"Blasi, Francesco\" data-track-context=\"researcher popup with no profile\" data-track-index=\"10_13\">Francesco Blasi</a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup>, </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Stefano-Aliberti-Aff1\" data-author-popup=\"auth-Stefano-Aliberti-Aff1\" data-author-search=\"Aliberti, Stefano\" data-corresp-id=\"c1\" data-track-context=\"researcher popup with no profile\" data-track-index=\"11_13\">Stefano Aliberti<svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-mail-medium\"></use></svg></a><sup class=\"u-js-hide\"><a href=\"#Aff1\" tabindex=\"-1\">1</a></sup> &amp; </li><li class=\"c-article-author-list__item c-article-author-list__item--hide-small-screen\"><a data-test=\"author-name\" data-track=\"click\" data-track-action=\"open author\" data-track-label=\"link\" href=\"#auth-Marcos_I_-Restrepo-Aff5\" data-author-popup=\"auth-Marcos_I_-Restrepo-Aff5\" data-author-search=\"Restrepo, Marcos I.\" data-track-context=\"researcher popup with no profile\" data-track-index=\"12_13\">Marcos I. Restrepo</a><sup class=\"u-js-hide\"><a href=\"#Aff5\" tabindex=\"-1\">5</a></sup> </li><li class=\"c-article-author-list__item\"><a data-test=\"author-name\" data-author-popup=\"group-1\" href=\"#group-1\" data-track-context=\"researcher popup with no profile\" data-track-index=\"13_13\">on behalf of the GLIMP Study Group</a></li></ul><button aria-expanded=\"false\" class=\"c-article-author-list__button\"><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-down-medium\"></use></svg><span>Show authors</span></button>\n                        <p class=\"c-article-info-details\" data-container-section=\"info\">\n                            \n    <a data-test=\"journal-link\" href=\"/\" data-track=\"click\" data-track-action=\"journal homepage\" data-track-category=\"article body\" data-track-label=\"link\"><i data-test=\"journal-title\">BMC Infectious Diseases</i></a>\n\n                            <b data-test=\"journal-volume\"><span class=\"u-visually-hidden\">volume</span>&nbsp;18</b>, Article&nbsp;number:&nbsp;<span data-test=\"article-number\">677</span> (<span data-test=\"article-publication-year\">2018</span>)\n            <a href=\"#citeas\" class=\"c-article-info-details__cite-as u-hide-print\" data-track=\"click\" data-track-action=\"cite this article\" data-track-label=\"link\">Cite this article</a>\n                        </p>\n                        \n        <div class=\"c-article-metrics-bar__wrapper u-clear-both\">\n            <ul class=\"c-article-metrics-bar u-list-reset\">\n                \n                    <li class=\" c-article-metrics-bar__item\" data-test=\"access-count\">\n                        <p class=\"c-article-metrics-bar__count\">8117 <span class=\"c-article-metrics-bar__label\">Accesses</span></p>\n                    </li>\n                \n                \n                    <li class=\"c-article-metrics-bar__item\" data-test=\"citation-count\">\n                        <p class=\"c-article-metrics-bar__count\">37 <span class=\"c-article-metrics-bar__label\">Citations</span></p>\n                    </li>\n                \n                \n                    \n                        <li class=\"c-article-metrics-bar__item\" data-test=\"altmetric-score\">\n                            <p class=\"c-article-metrics-bar__count\">4 <span class=\"c-article-metrics-bar__label\">Altmetric</span></p>\n                        </li>\n                    \n                \n                <li class=\"c-article-metrics-bar__item\">\n                    <p class=\"c-article-metrics-bar__details\"><a href=\"/articles/10.1186/s12879-018-3565-z/metrics\" data-track=\"click\" data-track-action=\"view metrics\" data-track-label=\"link\" rel=\"nofollow\">Metrics <span class=\"u-visually-hidden\">details</span></a></p>\n                </li>\n            </ul>\n        </div>\n    \n                        \n                        \n    \n    \n        <div class=\"u-mb-8 c-status-message c-status-message--boxed c-status-message--info\">\n            \n                <span class=\"c-status-message__icon\">\n                    <svg class=\"u-icon\" width=\"18\" height=\"18\" aria-hidden=\"true\" focusable=\"false\">\n                        <use xlink:href=\"#icon-eds-i-info-filled-medium\"></use>\n                    </svg>\n                </span>\n            \n            \n                \n                    <p class=\"u-mt-0\">A <a href=\"/articles/10.1186/s12879-020-05472-y\" class=\"relation-link\" data-track=\"click\" data-track-action=\"view linked article\" data-track-label=\"link\">Correction</a> to this article was published on 13 October 2020</p>\n                \n            \n        </div>\n    \n\n    \n        <div class=\"u-mb-8 c-status-message c-status-message--boxed c-status-message--info\">\n            \n                <span class=\"c-status-message__icon\">\n                    <svg class=\"u-icon\" width=\"18\" height=\"18\" aria-hidden=\"true\" focusable=\"false\">\n                        <use xlink:href=\"#icon-eds-i-info-filled-medium\"></use>\n                    </svg>\n                </span>\n            \n            <p class=\"u-mt-0\">This article has been <a href=\"#change-history\">updated</a></p>\n        </div>\n    \n    \n\n                        \n                    </div>\n\n                    <section aria-labelledby=\"Abs1\" data-title=\"Abstract\" lang=\"en\"><div class=\"c-article-section\" id=\"Abs1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Abs1\">Abstract</h2><div class=\"c-article-section__content\" id=\"Abs1-content\"><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Background</h3><p>Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity.</p><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Methods</h3><p>A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including <i>L. pneumophila</i>, <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis.</p><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Results</h3><p>Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, <i>p</i> &lt; 0.0001). Detection of <i>L. pneumophila</i> urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, <i>p</i> = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, <i>p</i> = 0.003) than the rest of the population. Similarly, <i>L. pneumophila</i> testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including <i>M. pneumoniae</i> (26/251 patients, 10.3%), <i>L. pneumophila</i> (30/1186 patients, 2.5%), and <i>C. pneumoniae</i> (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP.</p><h3 class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Conclusions</h3><p>Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.</p></div></div></section>\n                    \n    \n        <p class=\"c-status-message c-status-message--info c-status-message--boxed u-mb-32\">\n            <svg class=\"c-status-message__icon\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\"><use xlink:href=\"#icon-eds-i-info-filled-medium\"></use></svg>\n            <a href=\"/articles/10.1186/s12879-018-3565-z/peer-review\" data-track=\"click\" data-track-category=\"article body\" data-track-action=\"open peer review reports\" data-track-label=\"10.1186/s12879-018-3565-z\">Peer Review reports</a>\n        </p>\n    \n\n\n                    <section data-title=\"Background\"><div class=\"c-article-section\" id=\"Sec1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec1\">Background</h2><div class=\"c-article-section__content\" id=\"Sec1-content\"><p>Community-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e799\">1</a>]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 2\" title=\"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR2\" id=\"ref-link-section-d56842855e802\">2</a>]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including <i>Mycoplasma pneumoniae</i>, <i>Chlamydia pneumoniae</i>, and <i>Legionella pneumophila</i>, is still a matter of debate [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 3\" title=\"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR3\" id=\"ref-link-section-d56842855e815\">3</a>].</p><p>Several Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 4\" title=\"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR4\" id=\"ref-link-section-d56842855e821\">4</a>]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding <i>Streptococcus pneumoniae</i> [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 5\" title=\"Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR5\" id=\"ref-link-section-d56842855e827\">5</a>]. Other studies described similar prevalences of atypical pathogens [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e830\">6</a>].</p><p>Epidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e836\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n                    https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n                    \n                  \n                        \" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" id=\"ref-link-section-d56842855e839\">7</a>]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e842\">6</a>].</p><p>The aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens.</p></div></div></section><section data-title=\"Methods\"><div class=\"c-article-section\" id=\"Sec2-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec2\">Methods</h2><div class=\"c-article-section__content\" id=\"Sec2-content\"><h3 class=\"c-article__sub-heading\" id=\"Sec3\">Study design and population</h3><p>The present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n                    https://doi.org/10.1016/S1473-3099(16)30267-5\n                    \n                  .\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" id=\"ref-link-section-d56842855e860\">8</a>]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n                    https://doi.org/10.1016/S1473-3099(16)30267-5\n                    \n                  .\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" id=\"ref-link-section-d56842855e863\">8</a>]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015.</p><p>All adults (&gt; 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature &lt; 36 °C); 3) systemic inflammation (e.g., white blood cell count &gt; 10,000/cm<sup>3</sup> or &lt; 4000/cm<sup>3</sup>, C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded.</p><h3 class=\"c-article__sub-heading\" id=\"Sec4\">Data collection and microbiology for atypical pathogens</h3><p>Data were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results.</p><p>Physicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for <i>L. pneumophila</i> were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and <i>L. pneumophila</i>.</p><h3 class=\"c-article__sub-heading\" id=\"Sec5\">Study groups</h3><p>Definition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for <i>L. pneumophila,</i> serology for <i>L. Pneumophila</i>, <i>C. pneumoniae,</i> and <i>M. pneumoniae</i>.</p><h3 class=\"c-article__sub-heading\" id=\"Sec6\">Study definitions</h3><p>CAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission.</p><p>Definition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions.</p><h3 class=\"c-article__sub-heading\" id=\"Sec7\">Statistical analysis</h3><p>Testing frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for <i>L. pneumophila</i> performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was &lt; 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software.</p></div></div></section><section data-title=\"Results\"><div class=\"c-article-section\" id=\"Sec8-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec8\">Results</h2><div class=\"c-article-section__content\" id=\"Sec8-content\"><h3 class=\"c-article__sub-heading\" id=\"Sec9\">Testing for atypical pathogens</h3><p>A total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for <i>L. pneumophila</i> (either urinary antigen or serology), 251 (6.8%) for <i>M. pneumoniae</i> (serology), and 228 (6.1%) for <i>C. pneumoniae</i> (serology). Distribution of testing frequencies across countries is showed in Fig.&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"figure anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1a</a>.</p><div class=\"c-article-section__figure js-c-reading-companion-figures-item\" data-test=\"figure\" data-container-section=\"figure\" id=\"figure-1\" data-title=\"Fig. 1\"><figure><figcaption><b id=\"Fig1\" class=\"c-article-section__figure-caption\" data-test=\"figure-caption-text\">Fig. 1</b></figcaption><div class=\"c-article-section__figure-content\"><div class=\"c-article-section__figure-item\"><a class=\"c-article-section__figure-link\" data-test=\"img-link\" data-track=\"click\" data-track-label=\"image\" data-track-action=\"view figure\" href=\"/articles/10.1186/s12879-018-3565-z/figures/1\" rel=\"nofollow\"><picture><source type=\"image/webp\" srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png?as=webp\"><img aria-describedby=\"Fig1\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\" alt=\"figure 1\" loading=\"lazy\" width=\"685\" height=\"815\"></picture></a></div><div class=\"c-article-section__figure-description\" data-test=\"bottom-caption\" id=\"figure-1-desc\"><p><b>a</b>) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. <b>b</b>) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"figure anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1</a> is original and it was created using Stat Planet software with the information created from the study</p></div></div><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"article-link\" data-track=\"click\" data-track-label=\"button\" data-track-action=\"view figure\" href=\"/articles/10.1186/s12879-018-3565-z/figures/1\" data-track-dest=\"link:Figure1 Full size image\" aria-label=\"Full size image figure 1\" rel=\"nofollow\"><span>Full size image</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><p>The frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, <i>P</i> &lt; 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling &gt; 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab1\">1</a>). Data on testing for <i>L. pneumophila</i>, <i>M. pneumoniae</i>, and <i>C. pneumoniae</i> are reported in the additional files (Additional&nbsp;file&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"supplementary material anchor\" href=\"/articles/10.1186/s12879-018-3565-z#MOESM1\">1</a>: Table A). Detection of <i>L. pneumophila</i> urinary antigen was the most prevalent test performed worldwide (32.0%).</p><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-1\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab1\" data-test=\"table-caption\">Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries</b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/1\" aria-label=\"Full size table 1\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><p>The frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than <i>L. pneumophila</i>, <i>P</i> = 0.009; 28.3% VS. 33.5% for <i>L. pneumophila</i>, <i>P</i> = 0.003). <i>L. pneumophila</i> testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column A.</p><h3 class=\"c-article__sub-heading\" id=\"Sec10\">Prevalence of atypical pathogens</h3><p>At least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. <i>L. pneumophila</i> was detected in 30 (2.5%), <i>M. pneumoniae</i> in 26 (10.3%), and <i>C. pneumoniae</i> in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"figure anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1b</a>. Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, <i>P</i> = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, <i>P</i> = 0.001)&nbsp;(Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab2\">2</a>).</p><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-2\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab2\" data-test=\"table-caption\">Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents</b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/2\" aria-label=\"Full size table 2\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><p>Patients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table <a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column B and Table&nbsp;<a data-track=\"click\" data-track-label=\"link\" data-track-action=\"table anchor\" href=\"/articles/10.1186/s12879-018-3565-z#Tab4\">4</a>).</p><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-3\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab3\" data-test=\"table-caption\">Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B)</b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/3\" aria-label=\"Full size table 3\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div><div class=\"c-article-table\" data-test=\"inline-table\" data-container-section=\"table\" id=\"table-4\"><figure><figcaption class=\"c-article-table__figcaption\"><b id=\"Tab4\" data-test=\"table-caption\">Table 4 \n                          <span class=\"u-sans-serif\">Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia</span>\n                        </b></figcaption><div class=\"u-text-right u-hide-print\"><a class=\"c-article__pill-button\" data-test=\"table-link\" data-track=\"click\" data-track-action=\"view table\" data-track-label=\"button\" rel=\"nofollow\" href=\"/articles/10.1186/s12879-018-3565-z/tables/4\" aria-label=\"Full size table 4\"><span>Full size table</span><svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-chevron-right-small\"></use></svg></a></div></figure></div></div></div></section><section data-title=\"Discussion\"><div class=\"c-article-section\" id=\"Sec11-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec11\">Discussion</h2><div class=\"c-article-section__content\" id=\"Sec11-content\"><p>This secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, <i>L. pneumophila</i> testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals.</p><p>The most frequent test for atypical pathogens performed in hospitalized patients with CAP was the <i>Legionella</i> urinary antigen (32.0%), followed by <i>Legionella</i> serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for <i>M. pneumoniae</i> and <i>C. pneumoniae</i>, respectively).</p><p>However, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4850\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n                    https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n                    \n                  \n                        \" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" id=\"ref-link-section-d56842855e4853\">7</a>]. Although molecular techniques was found helpful in the diagnosis of CAP caused by <i>L. pneumophila</i>, findings from different studies showed that single available tests were not reliable for the detection of <i>M. pneumoniae</i> and <i>C. pneumoniae</i> in CAP patients [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\" href=\"#ref-CR9\" id=\"ref-link-section-d56842855e4866\">9</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\" href=\"#ref-CR10\" id=\"ref-link-section-d56842855e4866_1\">10</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 11\" title=\"Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR11\" id=\"ref-link-section-d56842855e4869\">11</a>]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e4872\">6</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 12\" title=\"Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR12\" id=\"ref-link-section-d56842855e4875\">12</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 13\" title=\"Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n                    https://doi.org/10.1186/s12879-016-1641-9.\n                    \n                  \n                        \" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR13\" id=\"ref-link-section-d56842855e4878\">13</a>]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for <i>Legionella</i>, is not routinely prescribed.</p><p>One of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain.</p><p>Furthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4891\">1</a>]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4894\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\" href=\"#ref-CR14\" id=\"ref-link-section-d56842855e4897\">14</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\" href=\"#ref-CR15\" id=\"ref-link-section-d56842855e4897_1\">15</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 16\" title=\"Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR16\" id=\"ref-link-section-d56842855e4900\">16</a>]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, <i>L. pneumophila</i> testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" id=\"ref-link-section-d56842855e4907\">17</a>].</p><p>The present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. <i>L. pneumophila</i> and <i>M. pneumoniae</i> seem to be the most frequent pathogens worldwide. The prevalence of <i>M. pneumoniae</i> is highest in South America, whereas <i>L. pneumophila</i> did show a homogeneous geographical distribution. <i>L. pneumophila</i> prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 18\" title=\"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR18\" id=\"ref-link-section-d56842855e4929\">18</a>]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 19\" title=\"Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR19\" id=\"ref-link-section-d56842855e4932\">19</a>].</p><p>The CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" id=\"ref-link-section-d56842855e4938\">6</a>]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\" href=\"#ref-CR20\" id=\"ref-link-section-d56842855e4941\">20</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\" href=\"#ref-CR21\" id=\"ref-link-section-d56842855e4941_1\">21</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\" href=\"#ref-CR22\" id=\"ref-link-section-d56842855e4941_2\">22</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\" href=\"#ref-CR23\" id=\"ref-link-section-d56842855e4941_3\">23</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" id=\"ref-link-section-d56842855e4944\">24</a>]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" id=\"ref-link-section-d56842855e4947\">17</a>]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" id=\"ref-link-section-d56842855e4950\">17</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\" href=\"#ref-CR20\" id=\"ref-link-section-d56842855e4954\">20</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\" href=\"#ref-CR21\" id=\"ref-link-section-d56842855e4954_1\">21</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\" href=\"#ref-CR22\" id=\"ref-link-section-d56842855e4954_2\">22</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\" href=\"#ref-CR23\" id=\"ref-link-section-d56842855e4954_3\">23</a>,<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" id=\"ref-link-section-d56842855e4957\">24</a>].</p><p>The prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for <i>Legionella</i> [<a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" id=\"ref-link-section-d56842855e4966\">1</a>, <a data-track=\"click\" data-track-action=\"reference anchor\" data-track-label=\"link\" data-test=\"citation-ref\" aria-label=\"Reference 25\" title=\"Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\" href=\"/articles/10.1186/s12879-018-3565-z#ref-CR25\" id=\"ref-link-section-d56842855e4969\">25</a>]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up.</p><p>Second, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology.</p><p>However, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians.</p><p>Potential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others.</p></div></div></section><section data-title=\"Conclusions\"><div class=\"c-article-section\" id=\"Sec12-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec12\">Conclusions</h2><div class=\"c-article-section__content\" id=\"Sec12-content\"><p>In conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide.</p><p>Testing for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations.</p></div></div></section>\n                    <section data-title=\"Change history\"><div class=\"c-article-section\" id=\"change-history-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"change-history\">Change history</h2><div class=\"c-article-section__content\" id=\"change-history-content\"><ul class=\"c-article-change-list\"><li class=\"c-article-change-list__item u-mb-24\" id=\"chg1\"><ins datetime=\"2020-10-13\"><h3 class=\"c-article-change-list__heading u-h3 u-pr-8 u-display-inline\">13 October 2020</h3><div class=\"c-article-change-list__details\"><p>An amendment to this paper has been published and can be accessed via the original article.</p></div></ins></li></ul></div></div></section><section data-title=\"Abbreviations\"><div class=\"c-article-section\" id=\"abbreviations-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"abbreviations\">Abbreviations</h2><div class=\"c-article-section__content\" id=\"abbreviations-content\"><dl class=\"c-abbreviation_list\"><dt class=\"c-abbreviation_list__term u-text-bold u-float-left u-pr-16\" style=\"min-width:50px;\"><dfn>CAP:</dfn></dt><dd class=\"c-abbreviation_list__description u-mb-24\">\n                    <p>Community-acquired pneumonia</p>\n                  </dd><dt class=\"c-abbreviation_list__term u-text-bold u-float-left u-pr-16\" style=\"min-width:50px;\"><dfn>GLIMP:</dfn></dt><dd class=\"c-abbreviation_list__description u-mb-24\">\n                    <p>Global Initiative for MRSA Pneumonia</p>\n                  </dd><dt class=\"c-abbreviation_list__term u-text-bold u-float-left u-pr-16\" style=\"min-width:50px;\"><dfn>ICU:</dfn></dt><dd class=\"c-abbreviation_list__description u-mb-24\">\n                    <p>Intensive care unit</p>\n                  </dd></dl></div></div></section><div id=\"MagazineFulltextArticleBodySuffix\"><section aria-labelledby=\"Bib1\" data-title=\"References\"><div class=\"c-article-section\" id=\"Bib1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Bib1\">References</h2><div class=\"c-article-section__content\" id=\"Bib1-content\"><div data-container-section=\"references\"><ol class=\"c-article-references\" data-track-component=\"outbound reference\" data-track-context=\"references section\"><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"1.\"><p class=\"c-article-references__text\" id=\"ref-CR1\">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1086/511159\" data-track-item_id=\"10.1086/511159\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1086%2F511159\" aria-label=\"Article reference 1\" data-doi=\"10.1086/511159\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\" aria-label=\"CAS reference 1\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 1\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Infectious%20Diseases%20Society%20of%20America%3B%20American%20Thoracic%20Society.%20Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F511159&amp;volume=44&amp;issue=suppl%202&amp;pages=S27-S72&amp;publication_year=2007&amp;author=Mandell%2CLA&amp;author=Wunderink%2CRG&amp;author=Anzueto%2CA\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"2.\"><p class=\"c-article-references__text\" id=\"ref-CR2\">Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1093/cid/cix647\" data-track-item_id=\"10.1093/cid/cix647\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1093%2Fcid%2Fcix647\" aria-label=\"Article reference 2\" data-doi=\"10.1093/cid/cix647\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 2\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=University%20of%20Louisville%20Pneumonia%20Study%20Group.%20Adults%20hospitalized%20with%20pneumonia%20in%20the%20United%20States%3A%20incidence%2C%20epidemiology%2C%20and%20mortality&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1093%2Fcid%2Fcix647&amp;volume=65&amp;issue=11&amp;pages=1806-1812&amp;publication_year=2017&amp;author=Ramirez%2CJA&amp;author=Wiemken%2CTL&amp;author=Peyrani%2CP&amp;author=Arnold%2CFW&amp;author=Kelley%2CR&amp;author=Mattingly%2CWA&amp;author=Nakamatsu%2CR&amp;author=Pena%2CS&amp;author=Guinn%2CBE&amp;author=Furmanek%2CSP&amp;author=Persaud%2CAK&amp;author=Raghuram%2CA&amp;author=Fernandez%2CF&amp;author=Beavin%2CL&amp;author=Bosson%2CR&amp;author=Fernandez-Botran%2CR&amp;author=Cavallazzi%2CR&amp;author=Bordon%2CJ&amp;author=Valdivieso%2CC&amp;author=Schulte%2CJ&amp;author=Carrico%2CRM\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"3.\"><p class=\"c-article-references__text\" id=\"ref-CR3\">Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"4.\"><p class=\"c-article-references__text\" id=\"ref-CR4\">Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"5.\"><p class=\"c-article-references__text\" id=\"ref-CR5\">Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22932165\" aria-label=\"PubMed reference 5\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 5\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20and%20antimicrobial%20resistance%20of%20community-acquired%20pneumonia%20in%20adult%20patients%20in%20China&amp;journal=Chin%20Med%20J&amp;volume=125&amp;issue=17&amp;pages=2967-2972&amp;publication_year=2012&amp;author=Tao%2CLL&amp;author=Hu%2CBJ&amp;author=He%2CLX&amp;author=Wei%2CL&amp;author=Xie%2CHM&amp;author=Wang%2CBQ&amp;author=Li%2CHY&amp;author=Chen%2CXH&amp;author=Zhou%2CCM&amp;author=Deng%2CWW\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"6.\"><p class=\"c-article-references__text\" id=\"ref-CR6\">Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1164/rccm.200603-350OC\" data-track-item_id=\"10.1164/rccm.200603-350OC\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1164%2Frccm.200603-350OC\" aria-label=\"Article reference 6\" data-doi=\"10.1164/rccm.200603-350OC\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 6\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-acquired%20pneumonia%20organization%20%28CAPO%29%20investigators.%20A%20worldwide%20perspective%20of%20atypical%20pathogens%20in%20community-acquired%20pneumonia&amp;journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;doi=10.1164%2Frccm.200603-350OC&amp;volume=175&amp;issue=10&amp;pages=1086-1093&amp;publication_year=2007&amp;author=Arnold%2CFW&amp;author=Summersgill%2CJT&amp;author=Lajoie%2CAS&amp;author=Peyrani%2CP&amp;author=Marrie%2CTJ&amp;author=Rossi%2CP&amp;author=Blasi%2CF&amp;author=Fernandez%2CP&amp;author=File%2CTM&amp;author=Rello%2CJ&amp;author=Menendez%2CR&amp;author=Marzoratti%2CL&amp;author=Luna%2CCM&amp;author=Ramirez%2CJA\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"7.\"><p class=\"c-article-references__text\" id=\"ref-CR7\">Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. <a href=\"https://doi.org/10.1111/j.1469-0691.2011.03672.x.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\">https://doi.org/10.1111/j.1469-0691.2011.03672.x.</a>\n                        </p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\" data-track-item_id=\"10.1111/j.1469-0691.2011.03672.x.\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1111%2Fj.1469-0691.2011.03672.x.\" aria-label=\"Article reference 7\" data-doi=\"10.1111/j.1469-0691.2011.03672.x.\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21951385\" aria-label=\"PubMed reference 7\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 7\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Joint%20taskforce%20of%20the%20European%20Respiratory%20Society%20and%20European%20Society%20for%20Clinical%20Microbiology%20and%20Infectious%20Diseases.%20Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections--full%20version&amp;journal=Clin%20Microbiol%20Infect&amp;doi=10.1111%2Fj.1469-0691.2011.03672.x.&amp;volume=17&amp;issue=Suppl%206&amp;pages=E1-59&amp;publication_year=2011&amp;author=Woodhead%2CM&amp;author=Blasi%2CF&amp;author=Ewig%2CS&amp;author=Garau%2CJ&amp;author=Huchon%2CG&amp;author=Ieven%2CM&amp;author=Ortqvist%2CA&amp;author=Schaberg%2CT&amp;author=Torres%2CA&amp;author=Heijden%2CG&amp;author=Read%2CR&amp;author=Verheij%2CTJ\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"8.\"><p class=\"c-article-references__text\" id=\"ref-CR8\">Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. <a href=\"https://doi.org/10.1016/S1473-3099(16)30267-5\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1016/S1473-3099(16)30267-5\">https://doi.org/10.1016/S1473-3099(16)30267-5</a>.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1016/S1473-3099(16)30267-5\" data-track-item_id=\"10.1016/S1473-3099(16)30267-5\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1016%2FS1473-3099%2816%2930267-5\" aria-label=\"Article reference 8\" data-doi=\"10.1016/S1473-3099(16)30267-5\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27593581\" aria-label=\"PubMed reference 8\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 8\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Global%20initiative%20for%20meticillin-resistant%20Staphylococcus%20aureus%20pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;journal=Lancet%20Infect%20Dis&amp;doi=10.1016%2FS1473-3099%2816%2930267-5&amp;volume=16&amp;issue=12&amp;pages=1364-1376&amp;publication_year=2016&amp;author=Aliberti%2CS&amp;author=Reyes%2CLF&amp;author=Faverio%2CP&amp;author=Sotgiu%2CG&amp;author=Dore%2CS&amp;author=Rodriguez%2CAH&amp;author=Soni%2CNJ&amp;author=Restrepo%2CMI&amp;author=investigators%2CGLIMP\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"9.\"><p class=\"c-article-references__text\" id=\"ref-CR9\">Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1099/jmm.0.2008/003814-0\" data-track-item_id=\"10.1099/jmm.0.2008/003814-0\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1099%2Fjmm.0.2008%2F003814-0\" aria-label=\"Article reference 9\" data-doi=\"10.1099/jmm.0.2008/003814-0\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 9\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Detection%20of%20mycoplasma%20pneumoniae%20in%20adult%20community-acquired%20pneumonia%20by%20PCR%20and%20serology&amp;journal=J%20Med%20Microbiol&amp;doi=10.1099%2Fjmm.0.2008%2F003814-0&amp;volume=57&amp;issue=Pt%2012&amp;pages=1491-1495&amp;publication_year=2008&amp;author=Martinez%2CMA&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Luchsinger%2CV&amp;author=Avendano%2CLF\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"10.\"><p class=\"c-article-references__text\" id=\"ref-CR10\">von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/1471-2334-9-62\" data-track-item_id=\"10.1186/1471-2334-9-62\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/1471-2334-9-62\" aria-label=\"Article reference 10\" data-doi=\"10.1186/1471-2334-9-62\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 10\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Mycoplasma%20pneumoniae%20pneumonia%20revisited%20within%20the%20German%20competence%20network%20for%20community-acquired%20pneumonia%20%28CAPNETZ%29&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-9-62&amp;volume=9&amp;publication_year=2009&amp;author=von%2CBH&amp;author=Welte%2CT&amp;author=Marre%2CR&amp;author=Suttorp%2CN&amp;author=Luck%2CC&amp;author=Ewig%2CS\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"11.\"><p class=\"c-article-references__text\" id=\"ref-CR11\">Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1086/597775\" data-track-item_id=\"10.1086/597775\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1086%2F597775\" aria-label=\"Article reference 11\" data-doi=\"10.1086/597775\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 11\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20laboratory%20diagnostic%20procedures%20for%20detection%20of%20mycoplasma%20pneumoniae%20in%20community%20outbreaks&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F597775&amp;volume=48&amp;pages=1244-1249&amp;publication_year=2009&amp;author=Thurman%2CKA&amp;author=Walter%2CND&amp;author=Schwartz%2CSB\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"12.\"><p class=\"c-article-references__text\" id=\"ref-CR12\">Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1007/s15010-004-3107-z\" data-track-item_id=\"10.1007/s15010-004-3107-z\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1007/s15010-004-3107-z\" aria-label=\"Article reference 12\" data-doi=\"10.1007/s15010-004-3107-z\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\" aria-label=\"CAS reference 12\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 12\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=CAPNETZ%3A%20community-acquired%20pneumonia%20competence%20network&amp;journal=Infection&amp;doi=10.1007%2Fs15010-004-3107-z&amp;volume=32&amp;pages=234-238&amp;publication_year=2004&amp;author=Welte%2CT&amp;author=Suttorp%2CN&amp;author=Marre%2CR\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"13.\"><p class=\"c-article-references__text\" id=\"ref-CR13\">Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. <a href=\"https://doi.org/10.1186/s12879-016-1641-9.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1186/s12879-016-1641-9.\">https://doi.org/10.1186/s12879-016-1641-9.</a>\n                        </p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/s12879-016-1641-9.\" data-track-item_id=\"10.1186/s12879-016-1641-9.\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/s12879-016-1641-9.\" aria-label=\"Article reference 13\" data-doi=\"10.1186/s12879-016-1641-9.\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27317257\" aria-label=\"PubMed reference 13\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed central reference\" data-track-action=\"pubmed central reference\" href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912822\" aria-label=\"PubMed Central reference 13\">PubMed Central</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 13\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Atypical%20aetiology%20in%20patients%20hospitalised%20with%20community-acquired%20pneumonia%20is%20associated%20with%20age%2C%20gender%20and%20season%3B%20a%20data-analysis%20on%20four%20Dutch%20cohorts&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2Fs12879-016-1641-9.&amp;volume=16&amp;publication_year=2016&amp;author=Raeven%2CVM&amp;author=Spoorenberg%2CSM&amp;author=Boersma%2CWG&amp;author=Garde%2CEM&amp;author=Cannegieter%2CSC&amp;author=Voorn%2CGP&amp;author=Bos%2CWJ&amp;author=Steenbergen%2CJE\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"14.\"><p class=\"c-article-references__text\" id=\"ref-CR14\">Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"15.\"><p class=\"c-article-references__text\" id=\"ref-CR15\">Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1016/S0924-8579(01)00402-2\" data-track-item_id=\"10.1016/S0924-8579(01)00402-2\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1016%2FS0924-8579%2801%2900402-2\" aria-label=\"Article reference 15\" data-doi=\"10.1016/S0924-8579(01)00402-2\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\" aria-label=\"CAS reference 15\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 15\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Japanese%20guidelines%20for%20the%20management%20of%20community-acquired%20pneumonia&amp;journal=Int%20J%20Antimicrob%20Agents&amp;doi=10.1016%2FS0924-8579%2801%2900402-2&amp;volume=18&amp;issue=Suppl.%201&amp;pages=S45-S48&amp;publication_year=2001&amp;author=Yanagihara%2CK&amp;author=Kohno%2CS&amp;author=Matsusima%2CT\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"16.\"><p class=\"c-article-references__text\" id=\"ref-CR16\">Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 16\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=S%20Afr%20Med%20J&amp;volume=97&amp;pages=1296-1306&amp;publication_year=2007\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"17.\"><p class=\"c-article-references__text\" id=\"ref-CR17\">Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1183/13993003.02306-2016\" data-track-item_id=\"10.1183/13993003.02306-2016\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1183%2F13993003.02306-2016\" aria-label=\"Article reference 17\" data-doi=\"10.1183/13993003.02306-2016\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 17\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Evaluation%20of%20severity%20score-guided%20approaches%20to%20macrolide%20use%20in%20community-acquired%20pneumonia&amp;journal=Eur%20Respir%20J&amp;doi=10.1183%2F13993003.02306-2016&amp;volume=50&amp;publication_year=2017&amp;author=Singanayagam%2CA&amp;author=Aliberti%2CS&amp;author=Cill%C3%B3niz%2CC\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"18.\"><p class=\"c-article-references__text\" id=\"ref-CR18\">Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1097/MD.0b013e31827f6104\" data-track-item_id=\"10.1097/MD.0b013e31827f6104\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1097%2FMD.0b013e31827f6104\" aria-label=\"Article reference 18\" data-doi=\"10.1097/MD.0b013e31827f6104\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 18\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20legionella%20pneumophila%20pneumonia%3Aa%20single-%20center%20experience%20with%20214%20hospitalized%20sporadic%20cases%20over%2015%20years&amp;journal=Medicine&amp;doi=10.1097%2FMD.0b013e31827f6104&amp;volume=92&amp;pages=51-60&amp;publication_year=2012&amp;author=Viasus%2CD&amp;author=Yacovo%2CS&amp;author=Garcia-Vidal%2CC&amp;author=Verdaguer%2CR&amp;author=Manresa%2CF&amp;author=Dorca%2CJ&amp;author=Gudiol%2CF&amp;author=Carratal%C3%A0%2CJ\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"19.\"><p class=\"c-article-references__text\" id=\"ref-CR19\">Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1001/archinte.160.9.1294\" data-track-item_id=\"10.1001/archinte.160.9.1294\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1001%2Farchinte.160.9.1294\" aria-label=\"Article reference 19\" data-doi=\"10.1001/archinte.160.9.1294\">Article</a>&nbsp;\n    <a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"cas reference\" data-track-action=\"cas reference\" href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\" aria-label=\"CAS reference 19\">CAS</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 19\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Azithromycin%20vs%20cefuroxime%20plus%20erythromycin%20for%20empirical%20treatment%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%3A%20a%20prospective%2C%20randomized%2C%20multicenter%20trial&amp;journal=Arch%20Intern%20Med&amp;doi=10.1001%2Farchinte.160.9.1294&amp;volume=160&amp;issue=9&amp;pages=1294-1300&amp;publication_year=2000&amp;author=Vergis%2CEN&amp;author=Indorf%2CA&amp;author=File%2CTM&amp;author=Phillips%2CJ&amp;author=Bates%2CJ&amp;author=Tan%2CJ&amp;author=Sarosi%2CGA&amp;author=Grayston%2CJT&amp;author=Summersgill%2CJ&amp;author=Yu%2CVL\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"20.\"><p class=\"c-article-references__text\" id=\"ref-CR20\">Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1136/thoraxjnl-2013-203551\" data-track-item_id=\"10.1136/thoraxjnl-2013-203551\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1136%2Fthoraxjnl-2013-203551\" aria-label=\"Article reference 20\" data-doi=\"10.1136/thoraxjnl-2013-203551\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 20\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20pneumonia%20in%20Chile%3A%20the%20clinical%20relevance%20in%20the%20detection%20of%20viruses%20and%20atypical%20bacteria&amp;journal=Thorax&amp;doi=10.1136%2Fthoraxjnl-2013-203551&amp;volume=68&amp;pages=1000-1006&amp;publication_year=2013&amp;author=Luchsinger%2CV&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Mart%C3%ADnez%2CMA&amp;author=Machado%2CC&amp;author=Piedra%2CPA&amp;author=Fasce%2CR&amp;author=Ulloa%2CMT&amp;author=Fink%2CMC&amp;author=Lara%2CP&amp;author=Gebauer%2CM&amp;author=Ch%C3%A1vez%2CF&amp;author=Avenda%C3%B1o%2CLF\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"21.\"><p class=\"c-article-references__text\" id=\"ref-CR21\">Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/1471-2334-14-335\" data-track-item_id=\"10.1186/1471-2334-14-335\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/1471-2334-14-335\" aria-label=\"Article reference 21\" data-doi=\"10.1186/1471-2334-14-335\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 21\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Microbial%20aetiology%2C%20outcomes%2C%20and%20costs%20of%20hospitalisation%20for%20community-acquired%20pneumonia%3B%20an%20observational%20analysis&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-14-335&amp;volume=14&amp;pages=335-343&amp;publication_year=2014&amp;author=Spoorenberg%2CSM&amp;author=Bos%2CWJ&amp;author=Heijligenberg%2CR&amp;author=Voorn%2CPG&amp;author=Grutters%2CJC&amp;author=Rijkers%2CGT&amp;author=Garde%2CEM\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"22.\"><p class=\"c-article-references__text\" id=\"ref-CR22\">Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"link\" data-track-item_id=\"link\" data-track-value=\"pubmed reference\" data-track-action=\"pubmed reference\" href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21337816\" aria-label=\"PubMed reference 22\">PubMed</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 22\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%20in%20northern%20Israel&amp;journal=Isr%20Med%20Assoc%20J&amp;volume=12&amp;pages=477-482&amp;publication_year=2010&amp;author=Shibli%2CF&amp;author=Chazan%2CB&amp;author=Nitzan%2CO&amp;author=Flatau%2CE&amp;author=Edelstein%2CH&amp;author=Blondheim%2CO&amp;author=Raz%2CR&amp;author=Colodner%2CR\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"23.\"><p class=\"c-article-references__text\" id=\"ref-CR23\">Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"noopener\" data-track-label=\"10.1186/s12889-015-1422-1\" data-track-item_id=\"10.1186/s12889-015-1422-1\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://link.springer.com/doi/10.1186/s12889-015-1422-1\" aria-label=\"Article reference 23\" data-doi=\"10.1186/s12889-015-1422-1\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 23\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20aetiology%20of%20community%20associated%20pneumonia%20in%20children%20in%20Nanjing%2C%20China%20and%20aetiological%20patternsassociated%20with%20age%20and%20season&amp;journal=BMC%20Public%20Health&amp;doi=10.1186%2Fs12889-015-1422-1&amp;volume=15&amp;pages=113-118&amp;publication_year=2015&amp;author=Chen%2CK&amp;author=Jia%2CR&amp;author=Li%2CL&amp;author=Yang%2CC&amp;author=Shi%2CY\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"24.\"><p class=\"c-article-references__text\" id=\"ref-CR24\">Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1378/chest.13-0162\" data-track-item_id=\"10.1378/chest.13-0162\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1378%2Fchest.13-0162\" aria-label=\"Article reference 24\" data-doi=\"10.1378/chest.13-0162\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 24\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Importance%20of%20legionella%20pneumophila%20in%20the%20etiology%20of%20severe%20community-acquired%20pneumonia%20in%20Santiago&amp;journal=Chile%20Chest&amp;doi=10.1378%2Fchest.13-0162&amp;volume=145&amp;pages=290-296&amp;publication_year=2014&amp;author=Arancibia%2CF&amp;author=Cortes%2CCP&amp;author=Vald%C3%A9s%2CM&amp;author=Cerda%2CJ&amp;author=Hern%C3%A1ndez%2CA&amp;author=Soto%2CL&amp;author=Torres%2CA\">\n                    Google Scholar</a>&nbsp;\n                </p></li><li class=\"c-article-references__item js-c-reading-companion-references-item\" data-counter=\"25.\"><p class=\"c-article-references__text\" id=\"ref-CR25\">Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p><p class=\"c-article-references__links u-hide-print\"><a data-track=\"click_references\" rel=\"nofollow noopener\" data-track-label=\"10.1086/431588\" data-track-item_id=\"10.1086/431588\" data-track-value=\"article reference\" data-track-action=\"article reference\" href=\"https://doi.org/10.1086%2F431588\" aria-label=\"Article reference 25\" data-doi=\"10.1086/431588\">Article</a>&nbsp;\n    <a data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\" rel=\"nofollow noopener\" aria-label=\"Google Scholar reference 25\" href=\"http://scholar.google.com/scholar_lookup?&amp;title=Improved%20diagnosis%20of%20the%20etiology%20of%20community-%20acquired%20pneumonia%20with%20real-time%20polymerase%20chain%20reaction&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F431588&amp;volume=41&amp;pages=345-351&amp;publication_year=2005&amp;author=Templeton%2CKE&amp;author=Scheltinga%2CSA&amp;author=Eeden%2CWC&amp;author=Graffelman%2CAW&amp;author=Broek%2CPJ&amp;author=Claas%2CEC\">\n                    Google Scholar</a>&nbsp;\n                </p></li></ol><p class=\"c-article-references__download u-hide-print\"><a data-track=\"click\" data-track-action=\"download citation references\" data-track-label=\"link\" rel=\"nofollow\" href=\"https://citation-needed.springer.com/v2/references/10.1186/s12879-018-3565-z?format=refman&amp;flavour=references\">Download references<svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-download-medium\"></use></svg></a></p></div></div></div></section></div><section data-title=\"Acknowledgments\"><div class=\"c-article-section\" id=\"Ack1-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Ack1\">Acknowledgments</h2><div class=\"c-article-section__content\" id=\"Ack1-content\"><p>GLIMP investigators</p><p>Argentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases &amp; ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal &amp; Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology &amp; Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine &amp; Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott &amp; White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care &amp; Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine &amp; Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia).</p>\n                <h3 class=\"c-article__sub-heading\" id=\"FPar1\">Ethics approval and consent to partecipate</h3>\n                <p>The coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations.</p>\n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar2\">Avaibility of data and materials</h3>\n                <p>The database used for the study is not public but it is available from the corresponding author on reasonable request.</p>\n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar3\">Funding</h3>\n                <p>The authors did not receive any funding for this study.</p>\n              </div></div></section><section aria-labelledby=\"author-information\" data-title=\"Author information\"><div class=\"c-article-section\" id=\"author-information-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"author-information\">Author information</h2><div class=\"c-article-section__content\" id=\"author-information-content\"><h3 class=\"c-article__sub-heading\" id=\"affiliations\">Authors and Affiliations</h3><ol class=\"c-article-author-affiliation__list\"><li id=\"Aff1\"><p class=\"c-article-author-affiliation__address\">Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Andrea Gramegna,&nbsp;Marta Di Pasquale,&nbsp;Francesco Blasi&nbsp;&amp;&nbsp;Stefano Aliberti</p></li><li id=\"Aff2\"><p class=\"c-article-author-affiliation__address\">Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Giovanni Sotgiu</p></li><li id=\"Aff3\"><p class=\"c-article-author-affiliation__address\">Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Dejan Radovanovic</p></li><li id=\"Aff4\"><p class=\"c-article-author-affiliation__address\">Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Silvia Terraneo</p></li><li id=\"Aff5\"><p class=\"c-article-author-affiliation__address\">Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA</p><p class=\"c-article-author-affiliation__authors-list\">Luis F. Reyes&nbsp;&amp;&nbsp;Marcos I. Restrepo</p></li><li id=\"Aff6\"><p class=\"c-article-author-affiliation__address\">Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain</p><p class=\"c-article-author-affiliation__authors-list\">Ester Vendrell</p></li><li id=\"Aff7\"><p class=\"c-article-author-affiliation__address\">Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal</p><p class=\"c-article-author-affiliation__authors-list\">Joao Neves</p></li><li id=\"Aff8\"><p class=\"c-article-author-affiliation__address\">Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy</p><p class=\"c-article-author-affiliation__authors-list\">Francesco Menzella</p></li></ol><div class=\"u-js-hide u-hide-print\" data-test=\"author-info\"><span class=\"c-article__sub-heading\">Authors</span><ol class=\"c-article-authors-search u-list-reset\"><li id=\"auth-Andrea-Gramegna-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Andrea Gramegna</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Andrea%20Gramegna\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Andrea%20Gramegna%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Giovanni-Sotgiu-Aff2\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Giovanni Sotgiu</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Giovanni%20Sotgiu\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Giovanni%20Sotgiu%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Marta-Pasquale-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Marta Di Pasquale</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marta%20Di%20Pasquale\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marta%20Di%20Pasquale%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Dejan-Radovanovic-Aff3\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Dejan Radovanovic</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Dejan%20Radovanovic\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Dejan%20Radovanovic%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Silvia-Terraneo-Aff4\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Silvia Terraneo</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Silvia%20Terraneo\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Silvia%20Terraneo%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Luis_F_-Reyes-Aff5\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Luis F. Reyes</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Luis%20F.%20Reyes\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Luis%20F.%20Reyes%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Ester-Vendrell-Aff6\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Ester Vendrell</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ester%20Vendrell\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ester%20Vendrell%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Joao-Neves-Aff7\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Joao Neves</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Joao%20Neves\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Joao%20Neves\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Joao%20Neves%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Francesco-Menzella-Aff8\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Francesco Menzella</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Francesco%20Menzella\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Francesco%20Menzella%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Francesco-Blasi-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Francesco Blasi</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Francesco%20Blasi\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Francesco%20Blasi%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Stefano-Aliberti-Aff1\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Stefano Aliberti</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Stefano%20Aliberti\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Stefano%20Aliberti%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li><li id=\"auth-Marcos_I_-Restrepo-Aff5\"><span class=\"c-article-authors-search__title u-h3 js-search-name\">Marcos I. Restrepo</span><div class=\"c-article-authors-search__list\"><div class=\"c-article-authors-search__item c-article-authors-search__list-item--left\"><a href=\"https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo\" class=\"c-article-button\" data-track=\"click\" data-track-action=\"author link - publication\" data-track-label=\"link\" rel=\"nofollow\">View author publications</a></div><div class=\"c-article-authors-search__item c-article-authors-search__list-item--right\"><p class=\"search-in-title-js c-article-authors-search__text\"><span class=\"c-article-authors-search__links-text\">You can also search for this author in</span><span class=\"c-article-identifiers\"><a class=\"c-article-identifiers__item\" href=\"https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Marcos%20I.%20Restrepo\" data-track=\"click\" data-track-action=\"author link - pubmed\" data-track-label=\"link\" rel=\"nofollow\">PubMed</a><span class=\"u-hide\">&nbsp;</span><a class=\"c-article-identifiers__item\" href=\"https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Marcos%20I.%20Restrepo%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en\" data-track=\"click\" data-track-action=\"author link - scholar\" data-track-label=\"link\" rel=\"nofollow\">Google Scholar</a></span></p></div></div></li></ol></div><h3 class=\"c-article__sub-heading\" id=\"groups\">Consortia</h3><div class=\"c-article-author-institutional-author\" id=\"group-1\"><h3 class=\"c-article-author-institutional-author__name u-h3\">on behalf of the GLIMP Study Group</h3></div><h3 class=\"c-article__sub-heading\" id=\"contributions\">Contributions</h3><p>AG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript.</p><h3 class=\"c-article__sub-heading\" id=\"corresponding-author\">Corresponding author</h3><p id=\"corresponding-author-list\">Correspondence to\n                <a id=\"corresp-c1\" href=\"mailto:stefano.aliberti@unimi.it\">Stefano Aliberti</a>.</p></div></div></section><section data-title=\"Ethics declarations\"><div class=\"c-article-section\" id=\"ethics-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"ethics\">Ethics declarations</h2><div class=\"c-article-section__content\" id=\"ethics-content\">\n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar4\">Consent for publication</h3>\n                <p>Not applicable.</p>\n              \n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar5\">Competing interests</h3>\n                <p>The authors declare that they have no competing interests for this study.</p>\n              \n              \n                <h3 class=\"c-article__sub-heading\" id=\"FPar6\">Publisher’s Note</h3>\n                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>\n              \n            </div></div></section><section data-title=\"Additional file\"><div class=\"c-article-section\" id=\"Sec13-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"Sec13\">Additional file</h2><div class=\"c-article-section__content\" id=\"Sec13-content\"><div data-test=\"supplementary-info\"><div id=\"figshareContainer\" class=\"c-article-figshare-container\" data-test=\"figshare-container\"></div><div class=\"c-article-supplementary__item\" data-test=\"supp-item\" id=\"MOESM1\"><h3 class=\"c-article-supplementary__title u-h3\"><a class=\"print-link\" data-track=\"click\" data-track-action=\"view supplementary info\" data-test=\"supp-info-link\" data-track-label=\"additional file 1:\" href=\"https://static-content.springer.com/esm/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_MOESM1_ESM.doc\" data-supp-info-image=\"\">Additional file 1:</a></h3><div class=\"c-article-supplementary__description\" data-component=\"thumbnail-container\"><p>Table A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for <i>C. pneumoniae</i> across continents; A2: Testing frequencies for <i>M. pneumoniae</i> across continents; A3: Testing frequencies for <i>L. pneumophila</i> across continents).- <i>Brief description of the data</i>: a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb)</p></div></div></div></div></div></section><section data-title=\"Rights and permissions\"><div class=\"c-article-section\" id=\"rightslink-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"rightslink\">Rights and permissions</h2><div class=\"c-article-section__content\" id=\"rightslink-content\">\n                <p><b>Open Access</b> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href=\"http://creativecommons.org/licenses/by/4.0/\" rel=\"license\">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href=\"http://creativecommons.org/publicdomain/zero/1.0/\" rel=\"license\">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</p>\n              <p class=\"c-article-rights\"><a data-track=\"click\" data-track-action=\"view rights and permissions\" data-track-label=\"link\" href=\"https://s100.copyright.com/AppDispatchServlet?title=Atypical%20pathogens%20in%20hospitalized%20patients%20with%20community-acquired%20pneumonia%3A%20a%20worldwide%20perspective&amp;author=Andrea%20Gramegna%20et%20al&amp;contentID=10.1186%2Fs12879-018-3565-z&amp;copyright=The%20Author%28s%29.&amp;publication=1471-2334&amp;publicationDate=2018-12-18&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY%20%2B%20CC0\">Reprints and permissions</a></p></div></div></section><section aria-labelledby=\"article-info\" data-title=\"About this article\"><div class=\"c-article-section\" id=\"article-info-section\"><h2 class=\"c-article-section__title js-section-title js-c-reading-companion-sections-item\" id=\"article-info\">About this article</h2><div class=\"c-article-section__content\" id=\"article-info-content\"><div class=\"c-bibliographic-information\"><div class=\"u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border\"><a data-crossmark=\"10.1186/s12879-018-3565-z\" target=\"_blank\" rel=\"noopener\" href=\"https://crossmark.crossref.org/dialog/?doi=10.1186/s12879-018-3565-z\" data-track=\"click\" data-track-action=\"Click Crossmark\" data-track-label=\"link\" data-test=\"crossmark\"><img loading=\"lazy\" width=\"57\" height=\"81\" alt=\"Check for updates. Verify currency and authenticity via CrossMark\" src=\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\"></a></div><div class=\"c-bibliographic-information__column\"><h3 class=\"c-article__sub-heading\" id=\"citeas\">Cite this article</h3><p class=\"c-bibliographic-information__citation\">Gramegna, A., Sotgiu, G., Di Pasquale, M. <i>et al.</i> Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.\n                    <i>BMC Infect Dis</i> <b>18</b>, 677 (2018). https://doi.org/10.1186/s12879-018-3565-z</p><p class=\"c-bibliographic-information__download-citation u-hide-print\"><a data-test=\"citation-link\" data-track=\"click\" data-track-action=\"download article citation\" data-track-label=\"link\" data-track-external=\"\" rel=\"nofollow\" href=\"https://citation-needed.springer.com/v2/references/10.1186/s12879-018-3565-z?format=refman&amp;flavour=citation\">Download citation<svg width=\"16\" height=\"16\" focusable=\"false\" role=\"img\" aria-hidden=\"true\" class=\"u-icon\"><use xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"#icon-eds-i-download-medium\"></use></svg></a></p><ul class=\"c-bibliographic-information__list\" data-test=\"publication-history\"><li class=\"c-bibliographic-information__list-item\"><p>Received<span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\"><time datetime=\"2018-05-28\">28 May 2018</time></span></p></li><li class=\"c-bibliographic-information__list-item\"><p>Accepted<span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\"><time datetime=\"2018-11-28\">28 November 2018</time></span></p></li><li class=\"c-bibliographic-information__list-item\"><p>Published<span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\"><time datetime=\"2018-12-18\">18 December 2018</time></span></p></li><li class=\"c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width\"><p><abbr title=\"Digital Object Identifier\">DOI</abbr><span class=\"u-hide\">: </span><span class=\"c-bibliographic-information__value\">https://doi.org/10.1186/s12879-018-3565-z</span></p></li></ul><div data-component=\"share-box\"><div class=\"c-article-share-box u-display-block\"><h3 class=\"c-article__sub-heading\">Share this article</h3><p class=\"c-article-share-box__description\">Anyone you share the following link with will be able to read this content:</p><button class=\"js-get-share-url c-article-share-box__button\" type=\"button\" id=\"get-share-url\" data-track=\"click\" data-track-label=\"button\" data-track-external=\"\" data-track-action=\"get shareable link\">Get shareable link</button><div class=\"js-no-share-url-container u-display-none\" hidden=\"\"><p class=\"js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info\">Sorry, a shareable link is not currently available for this article.</p></div><div class=\"js-share-url-container u-display-none\" hidden=\"\"><p class=\"js-share-url c-article-share-box__only-read-input\" id=\"share-url\" data-track=\"click\" data-track-label=\"button\" data-track-action=\"select share url\"></p><button class=\"js-copy-share-url c-article-share-box__button--link-like\" type=\"button\" id=\"copy-share-url\" data-track=\"click\" data-track-label=\"button\" data-track-action=\"copy share url\" data-track-external=\"\">Copy to clipboard</button></div><p class=\"js-c-article-share-box__additional-info c-article-share-box__additional-info\">\n                            Provided by the Springer Nature SharedIt content-sharing initiative\n                        </p></div></div><h3 class=\"c-article__sub-heading\">Keywords</h3><ul class=\"c-article-subject-list\"><li class=\"c-article-subject-list__subject\"><span><a href=\"/search?query=CAP&amp;facet-discipline=&quot;Medicine%20%26%20Public%20Health&quot;\" data-track=\"click\" data-track-action=\"view keyword\" data-track-label=\"link\">CAP</a></span></li><li class=\"c-article-subject-list__subject\"><span><a href=\"/search?query=Atypical%20pathogens&amp;facet-discipline=&quot;Medicine%20%26%20Public%20Health&quot;\" data-track=\"click\" data-track-action=\"view keyword\" data-track-label=\"link\">Atypical pathogens</a></span></li><li class=\"c-article-subject-list__subject\"><span><a href=\"/search?query=Epidemiology&amp;facet-discipline=&quot;Medicine%20%26%20Public%20Health&quot;\" data-track=\"click\" data-track-action=\"view keyword\" data-track-label=\"link\">Epidemiology</a></span></li></ul><div data-component=\"article-info-list\"></div></div></div></div></div></section>\n\n                    \n\n\n                </article>\n            </main>\n\n            <div class=\"c-article-extras u-text-sm u-hide-print\" data-container-type=\"reading-companion\" data-track-component=\"reading companion\">\n                <aside>\n                    <div data-test=\"download-article-link-wrapper\" class=\"js-context-bar-sticky-point-desktop\" data-track-context=\"reading companion\">\n                        \n    <div class=\"c-pdf-download u-clear-both\">\n        <a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\" class=\"u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link\" data-article-pdf=\"true\" data-readcube-pdf-url=\"true\" data-test=\"pdf-link\" data-draft-ignore=\"true\" data-track=\"content_download\" data-track-type=\"article pdf download\" data-track-action=\"download pdf\" data-track-label=\"link\" data-track-external=\"\" download=\"\">\n            <span class=\"c-pdf-download__text\">Download PDF</span>\n            <svg aria-hidden=\"true\" focusable=\"false\" width=\"16\" height=\"16\" class=\"u-icon\"><use xlink:href=\"#icon-download\"></use></svg>\n        </a>\n    </div>\n\n                        \n                    </div>\n\n                    \n    \n\n\n                    <div class=\"c-reading-companion\">\n                        <div class=\"c-reading-companion__sticky\" data-component=\"reading-companion-sticky\" data-test=\"reading-companion-sticky\" style=\"top: 40px;\">\n                            <ul class=\"c-reading-companion__tabs\" role=\"tablist\"><li role=\"presentation\"><button data-tab-target=\"sections\" role=\"tab\" id=\"tab-sections\" aria-controls=\"tabpanel-sections\" aria-selected=\"true\" class=\"c-reading-companion__tab c-reading-companion__tab--active\" data-track=\"click\" data-track-action=\"sections tab\" data-track-label=\"tab\">Sections</button></li><li role=\"presentation\"><button data-tab-target=\"figures\" role=\"tab\" id=\"tab-figures\" aria-controls=\"tabpanel-figures\" aria-selected=\"false\" tabindex=\"-1\" class=\"c-reading-companion__tab\" data-track=\"click\" data-track-action=\"figures tab\" data-track-label=\"tab\">Figures</button></li><li role=\"presentation\"><button data-tab-target=\"references\" role=\"tab\" id=\"tab-references\" aria-controls=\"tabpanel-references\" aria-selected=\"false\" tabindex=\"-1\" class=\"c-reading-companion__tab\" data-track=\"click\" data-track-action=\"references tab\" data-track-label=\"tab\">References</button></li></ul><div class=\"c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active\" id=\"tabpanel-sections\" aria-labelledby=\"tab-sections\" role=\"tabpanel\"><div class=\"c-reading-companion__scroll-pane\" style=\"max-height: none;\"><ul class=\"c-reading-companion__sections-list\"><li id=\"rc-sec-Abs1\" class=\"c-reading-companion__section-item\"><a href=\"#Abs1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Abstract\">Abstract</a></li><li id=\"rc-sec-Sec1\" class=\"c-reading-companion__section-item\"><a href=\"#Sec1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Background\">Background</a></li><li id=\"rc-sec-Sec2\" class=\"c-reading-companion__section-item\"><a href=\"#Sec2\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Methods\">Methods</a></li><li id=\"rc-sec-Sec8\" class=\"c-reading-companion__section-item\"><a href=\"#Sec8\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Results\">Results</a></li><li id=\"rc-sec-Sec11\" class=\"c-reading-companion__section-item\"><a href=\"#Sec11\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Discussion\">Discussion</a></li><li id=\"rc-sec-Sec12\" class=\"c-reading-companion__section-item\"><a href=\"#Sec12\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Conclusions\">Conclusions</a></li><li id=\"rc-sec-change-history\" class=\"c-reading-companion__section-item\"><a href=\"#change-history\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Change history\">Change history</a></li><li id=\"rc-sec-abbreviations\" class=\"c-reading-companion__section-item\"><a href=\"#abbreviations\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Abbreviations\">Abbreviations</a></li><li id=\"rc-sec-Bib1\" class=\"c-reading-companion__section-item\"><a href=\"#Bib1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:References\">References</a></li><li id=\"rc-sec-Ack1\" class=\"c-reading-companion__section-item\"><a href=\"#Ack1\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Acknowledgments\">Acknowledgments</a></li><li id=\"rc-sec-author-information\" class=\"c-reading-companion__section-item\"><a href=\"#author-information\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Author information\">Author information</a></li><li id=\"rc-sec-ethics\" class=\"c-reading-companion__section-item\"><a href=\"#ethics\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Ethics declarations\">Ethics declarations</a></li><li id=\"rc-sec-Sec13\" class=\"c-reading-companion__section-item\"><a href=\"#Sec13\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Additional file\">Additional file</a></li><li id=\"rc-sec-rightslink\" class=\"c-reading-companion__section-item\"><a href=\"#rightslink\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:Rights and permissions\">Rights and permissions</a></li><li id=\"rc-sec-article-info\" class=\"c-reading-companion__section-item\"><a href=\"#article-info\" data-track=\"click\" data-track-action=\"section anchor\" data-track-label=\"link:About this article\">About this article</a></li></ul></div>\n                                <div class=\"js-ad u-lazy-ad-wrapper u-mt-16 u-show\" data-component-mpu=\"\">\n                                    \n    \n    <aside class=\"adsbox c-ad c-ad--300x250 u-mt-16\" data-component-mpu=\"\">\n        <div class=\"c-ad__inner\">\n            <p class=\"c-ad__label\">Advertisement</p>\n            <div id=\"div-gpt-ad-MPU1\" data-ad-type=\"MPU1\" data-test=\"MPU1-ad\" data-pa11y-ignore=\"\" data-gpt=\"\" data-gpt-unitpath=\"/270604982/bmc/bmcinfectdis/articles\" data-gpt-sizes=\"300x250\" data-gpt-targeting=\"pos=MPU1;doi=10.1186/s12879-018-3565-z;type=article;kwrd=CAP,Atypical pathogens,Epidemiology;pmc=H33096,B19002,B16003,H61006,H33002;\">\n                <noscript>\n                    <a href=\"//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\">\n                        <img data-test=\"gpt-advert-fallback-img\"\n                            src=\"//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/bmcinfectdis/articles&amp;sz=300x250&amp;pos=MPU1&amp;doi=10.1186/s12879-018-3565-z&amp;type=article&amp;kwrd=CAP,Atypical pathogens,Epidemiology&amp;pmc=H33096,B19002,B16003,H61006,H33002&amp;\"\n                            alt=\"Advertisement\"\n                            width=\"300\"\n                            height=\"250\">\n                    </a>\n                </noscript>\n            </div>\n        </div>\n    </aside>\n\n                                </div>\n                            </div>\n                            <div class=\"c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width\" id=\"tabpanel-figures\" aria-labelledby=\"tab-figures\" role=\"tabpanel\"><div class=\"c-reading-companion__scroll-pane\"><ul class=\"c-reading-companion__figures-list\"><li class=\"c-reading-companion__figure-item\"><figure><figcaption><b class=\"c-reading-companion__figure-title u-h4\" id=\"rc-Fig1\">Fig. 1</b></figcaption><picture><source data-srcset=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png?\"><img data-src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\" alt=\"figure 1\" aria-describedby=\"rc-Fig1\"></picture><p class=\"c-reading-companion__figure-links\"><a href=\"#Fig1\" data-track=\"click\" data-track-action=\"figure anchor\" data-track-label=\"link\">View in article</a><a href=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1\" class=\"c-reading-companion__figure-full-link\" data-track=\"click\" data-track-action=\"view figure\" data-track-label=\"link\" rel=\"nofollow\">Full size image<svg width=\"16\" height=\"16\" class=\"u-icon\"><use href=\"#icon-chevron-right\"></use></svg></a></p></figure></li></ul></div></div>\n                            <div class=\"c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width\" id=\"tabpanel-references\" aria-labelledby=\"tab-references\" role=\"tabpanel\"><div class=\"c-reading-companion__scroll-pane\"><ol class=\"c-reading-companion__references-list c-reading-companion__references-list--numeric\" data-track-context=\"article references sidebar\"><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR1\">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1086%2F511159\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1086/511159\" data-track-item_id=\"10.1086/511159\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Infectious%20Diseases%20Society%20of%20America%3B%20American%20Thoracic%20Society.%20Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F511159&amp;volume=44&amp;issue=suppl%202&amp;pages=S27-S72&amp;publication_year=2007&amp;author=Mandell%2CLA&amp;author=Wunderink%2CRG&amp;author=Anzueto%2CA\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR2\">Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1093%2Fcid%2Fcix647\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1093/cid/cix647\" data-track-item_id=\"10.1093/cid/cix647\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=University%20of%20Louisville%20Pneumonia%20Study%20Group.%20Adults%20hospitalized%20with%20pneumonia%20in%20the%20United%20States%3A%20incidence%2C%20epidemiology%2C%20and%20mortality&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1093%2Fcid%2Fcix647&amp;volume=65&amp;issue=11&amp;pages=1806-1812&amp;publication_year=2017&amp;author=Ramirez%2CJA&amp;author=Wiemken%2CTL&amp;author=Peyrani%2CP&amp;author=Arnold%2CFW&amp;author=Kelley%2CR&amp;author=Mattingly%2CWA&amp;author=Nakamatsu%2CR&amp;author=Pena%2CS&amp;author=Guinn%2CBE&amp;author=Furmanek%2CSP&amp;author=Persaud%2CAK&amp;author=Raghuram%2CA&amp;author=Fernandez%2CF&amp;author=Beavin%2CL&amp;author=Bosson%2CR&amp;author=Fernandez-Botran%2CR&amp;author=Cavallazzi%2CR&amp;author=Bordon%2CJ&amp;author=Valdivieso%2CC&amp;author=Schulte%2CJ&amp;author=Carrico%2CRM\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR3\">Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR4\">Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR5\">Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p><p class=\"c-reading-companion__reference-links\"><a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22932165\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20and%20antimicrobial%20resistance%20of%20community-acquired%20pneumonia%20in%20adult%20patients%20in%20China&amp;journal=Chin%20Med%20J&amp;volume=125&amp;issue=17&amp;pages=2967-2972&amp;publication_year=2012&amp;author=Tao%2CLL&amp;author=Hu%2CBJ&amp;author=He%2CLX&amp;author=Wei%2CL&amp;author=Xie%2CHM&amp;author=Wang%2CBQ&amp;author=Li%2CHY&amp;author=Chen%2CXH&amp;author=Zhou%2CCM&amp;author=Deng%2CWW\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR6\">Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1164%2Frccm.200603-350OC\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1164/rccm.200603-350OC\" data-track-item_id=\"10.1164/rccm.200603-350OC\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-acquired%20pneumonia%20organization%20%28CAPO%29%20investigators.%20A%20worldwide%20perspective%20of%20atypical%20pathogens%20in%20community-acquired%20pneumonia&amp;journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;doi=10.1164%2Frccm.200603-350OC&amp;volume=175&amp;issue=10&amp;pages=1086-1093&amp;publication_year=2007&amp;author=Arnold%2CFW&amp;author=Summersgill%2CJT&amp;author=Lajoie%2CAS&amp;author=Peyrani%2CP&amp;author=Marrie%2CTJ&amp;author=Rossi%2CP&amp;author=Blasi%2CF&amp;author=Fernandez%2CP&amp;author=File%2CTM&amp;author=Rello%2CJ&amp;author=Menendez%2CR&amp;author=Marzoratti%2CL&amp;author=Luna%2CCM&amp;author=Ramirez%2CJA\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR7\">Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. <a href=\"https://doi.org/10.1111/j.1469-0691.2011.03672.x.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\">https://doi.org/10.1111/j.1469-0691.2011.03672.x.</a>\n                        </p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1111%2Fj.1469-0691.2011.03672.x.\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1111/j.1469-0691.2011.03672.x.\" data-track-item_id=\"10.1111/j.1469-0691.2011.03672.x.\">Article</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21951385\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Joint%20taskforce%20of%20the%20European%20Respiratory%20Society%20and%20European%20Society%20for%20Clinical%20Microbiology%20and%20Infectious%20Diseases.%20Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections--full%20version&amp;journal=Clin%20Microbiol%20Infect&amp;doi=10.1111%2Fj.1469-0691.2011.03672.x.&amp;volume=17&amp;issue=Suppl%206&amp;pages=E1-59&amp;publication_year=2011&amp;author=Woodhead%2CM&amp;author=Blasi%2CF&amp;author=Ewig%2CS&amp;author=Garau%2CJ&amp;author=Huchon%2CG&amp;author=Ieven%2CM&amp;author=Ortqvist%2CA&amp;author=Schaberg%2CT&amp;author=Torres%2CA&amp;author=Heijden%2CG&amp;author=Read%2CR&amp;author=Verheij%2CTJ\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR8\">Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. <a href=\"https://doi.org/10.1016/S1473-3099(16)30267-5\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1016/S1473-3099(16)30267-5\">https://doi.org/10.1016/S1473-3099(16)30267-5</a>.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1016%2FS1473-3099%2816%2930267-5\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1016/S1473-3099(16)30267-5\" data-track-item_id=\"10.1016/S1473-3099(16)30267-5\">Article</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27593581\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Global%20initiative%20for%20meticillin-resistant%20Staphylococcus%20aureus%20pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;journal=Lancet%20Infect%20Dis&amp;doi=10.1016%2FS1473-3099%2816%2930267-5&amp;volume=16&amp;issue=12&amp;pages=1364-1376&amp;publication_year=2016&amp;author=Aliberti%2CS&amp;author=Reyes%2CLF&amp;author=Faverio%2CP&amp;author=Sotgiu%2CG&amp;author=Dore%2CS&amp;author=Rodriguez%2CAH&amp;author=Soni%2CNJ&amp;author=Restrepo%2CMI&amp;author=investigators%2CGLIMP\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR9\">Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1099%2Fjmm.0.2008%2F003814-0\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1099/jmm.0.2008/003814-0\" data-track-item_id=\"10.1099/jmm.0.2008/003814-0\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Detection%20of%20mycoplasma%20pneumoniae%20in%20adult%20community-acquired%20pneumonia%20by%20PCR%20and%20serology&amp;journal=J%20Med%20Microbiol&amp;doi=10.1099%2Fjmm.0.2008%2F003814-0&amp;volume=57&amp;issue=Pt%2012&amp;pages=1491-1495&amp;publication_year=2008&amp;author=Martinez%2CMA&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Luchsinger%2CV&amp;author=Avendano%2CLF\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR10\">von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/1471-2334-9-62\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/1471-2334-9-62\" data-track-item_id=\"10.1186/1471-2334-9-62\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Mycoplasma%20pneumoniae%20pneumonia%20revisited%20within%20the%20German%20competence%20network%20for%20community-acquired%20pneumonia%20%28CAPNETZ%29&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-9-62&amp;volume=9&amp;publication_year=2009&amp;author=von%2CBH&amp;author=Welte%2CT&amp;author=Marre%2CR&amp;author=Suttorp%2CN&amp;author=Luck%2CC&amp;author=Ewig%2CS\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR11\">Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1086%2F597775\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1086/597775\" data-track-item_id=\"10.1086/597775\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Comparison%20of%20laboratory%20diagnostic%20procedures%20for%20detection%20of%20mycoplasma%20pneumoniae%20in%20community%20outbreaks&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F597775&amp;volume=48&amp;pages=1244-1249&amp;publication_year=2009&amp;author=Thurman%2CKA&amp;author=Walter%2CND&amp;author=Schwartz%2CSB\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR12\">Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1007/s15010-004-3107-z\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1007/s15010-004-3107-z\" data-track-item_id=\"10.1007/s15010-004-3107-z\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=CAPNETZ%3A%20community-acquired%20pneumonia%20competence%20network&amp;journal=Infection&amp;doi=10.1007%2Fs15010-004-3107-z&amp;volume=32&amp;pages=234-238&amp;publication_year=2004&amp;author=Welte%2CT&amp;author=Suttorp%2CN&amp;author=Marre%2CR\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR13\">Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. <a href=\"https://doi.org/10.1186/s12879-016-1641-9.\" data-track=\"click_references\" data-track-action=\"external reference\" data-track-value=\"external reference\" data-track-label=\"10.1186/s12879-016-1641-9.\">https://doi.org/10.1186/s12879-016-1641-9.</a>\n                        </p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/s12879-016-1641-9.\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/s12879-016-1641-9.\" data-track-item_id=\"10.1186/s12879-016-1641-9.\">Article</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27317257\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912822\" data-track=\"click_references\" data-track-action=\"pubmed central reference\" data-track-value=\"pubmed central reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed Central</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Atypical%20aetiology%20in%20patients%20hospitalised%20with%20community-acquired%20pneumonia%20is%20associated%20with%20age%2C%20gender%20and%20season%3B%20a%20data-analysis%20on%20four%20Dutch%20cohorts&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2Fs12879-016-1641-9.&amp;volume=16&amp;publication_year=2016&amp;author=Raeven%2CVM&amp;author=Spoorenberg%2CSM&amp;author=Boersma%2CWG&amp;author=Garde%2CEM&amp;author=Cannegieter%2CSC&amp;author=Voorn%2CGP&amp;author=Bos%2CWJ&amp;author=Steenbergen%2CJE\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR14\">Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR15\">Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1016%2FS0924-8579%2801%2900402-2\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1016/S0924-8579(01)00402-2\" data-track-item_id=\"10.1016/S0924-8579(01)00402-2\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Japanese%20guidelines%20for%20the%20management%20of%20community-acquired%20pneumonia&amp;journal=Int%20J%20Antimicrob%20Agents&amp;doi=10.1016%2FS0924-8579%2801%2900402-2&amp;volume=18&amp;issue=Suppl.%201&amp;pages=S45-S48&amp;publication_year=2001&amp;author=Yanagihara%2CK&amp;author=Kohno%2CS&amp;author=Matsusima%2CT\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR16\">Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p><p class=\"c-reading-companion__reference-links\"><a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Management%20of%20community-acquired%20pneumonia%20in%20adults&amp;journal=S%20Afr%20Med%20J&amp;volume=97&amp;pages=1296-1306&amp;publication_year=2007\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR17\">Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1183%2F13993003.02306-2016\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1183/13993003.02306-2016\" data-track-item_id=\"10.1183/13993003.02306-2016\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Evaluation%20of%20severity%20score-guided%20approaches%20to%20macrolide%20use%20in%20community-acquired%20pneumonia&amp;journal=Eur%20Respir%20J&amp;doi=10.1183%2F13993003.02306-2016&amp;volume=50&amp;publication_year=2017&amp;author=Singanayagam%2CA&amp;author=Aliberti%2CS&amp;author=Cill%C3%B3niz%2CC\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR18\">Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1097%2FMD.0b013e31827f6104\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1097/MD.0b013e31827f6104\" data-track-item_id=\"10.1097/MD.0b013e31827f6104\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20legionella%20pneumophila%20pneumonia%3Aa%20single-%20center%20experience%20with%20214%20hospitalized%20sporadic%20cases%20over%2015%20years&amp;journal=Medicine&amp;doi=10.1097%2FMD.0b013e31827f6104&amp;volume=92&amp;pages=51-60&amp;publication_year=2012&amp;author=Viasus%2CD&amp;author=Yacovo%2CS&amp;author=Garcia-Vidal%2CC&amp;author=Verdaguer%2CR&amp;author=Manresa%2CF&amp;author=Dorca%2CJ&amp;author=Gudiol%2CF&amp;author=Carratal%C3%A0%2CJ\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR19\">Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1001%2Farchinte.160.9.1294\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1001/archinte.160.9.1294\" data-track-item_id=\"10.1001/archinte.160.9.1294\">Article</a>&nbsp;<a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\" data-track=\"click_references\" data-track-action=\"cas reference\" data-track-value=\"cas reference\" data-track-label=\"link\" data-track-item_id=\"link\">CAS</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Azithromycin%20vs%20cefuroxime%20plus%20erythromycin%20for%20empirical%20treatment%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%3A%20a%20prospective%2C%20randomized%2C%20multicenter%20trial&amp;journal=Arch%20Intern%20Med&amp;doi=10.1001%2Farchinte.160.9.1294&amp;volume=160&amp;issue=9&amp;pages=1294-1300&amp;publication_year=2000&amp;author=Vergis%2CEN&amp;author=Indorf%2CA&amp;author=File%2CTM&amp;author=Phillips%2CJ&amp;author=Bates%2CJ&amp;author=Tan%2CJ&amp;author=Sarosi%2CGA&amp;author=Grayston%2CJT&amp;author=Summersgill%2CJ&amp;author=Yu%2CVL\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR20\">Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1136%2Fthoraxjnl-2013-203551\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1136/thoraxjnl-2013-203551\" data-track-item_id=\"10.1136/thoraxjnl-2013-203551\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Community-%20acquired%20pneumonia%20in%20Chile%3A%20the%20clinical%20relevance%20in%20the%20detection%20of%20viruses%20and%20atypical%20bacteria&amp;journal=Thorax&amp;doi=10.1136%2Fthoraxjnl-2013-203551&amp;volume=68&amp;pages=1000-1006&amp;publication_year=2013&amp;author=Luchsinger%2CV&amp;author=Ruiz%2CM&amp;author=Zunino%2CE&amp;author=Mart%C3%ADnez%2CMA&amp;author=Machado%2CC&amp;author=Piedra%2CPA&amp;author=Fasce%2CR&amp;author=Ulloa%2CMT&amp;author=Fink%2CMC&amp;author=Lara%2CP&amp;author=Gebauer%2CM&amp;author=Ch%C3%A1vez%2CF&amp;author=Avenda%C3%B1o%2CLF\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR21\">Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/1471-2334-14-335\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/1471-2334-14-335\" data-track-item_id=\"10.1186/1471-2334-14-335\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Microbial%20aetiology%2C%20outcomes%2C%20and%20costs%20of%20hospitalisation%20for%20community-acquired%20pneumonia%3B%20an%20observational%20analysis&amp;journal=BMC%20Infect%20Dis&amp;doi=10.1186%2F1471-2334-14-335&amp;volume=14&amp;pages=335-343&amp;publication_year=2014&amp;author=Spoorenberg%2CSM&amp;author=Bos%2CWJ&amp;author=Heijligenberg%2CR&amp;author=Voorn%2CPG&amp;author=Grutters%2CJC&amp;author=Rijkers%2CGT&amp;author=Garde%2CEM\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR22\">Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p><p class=\"c-reading-companion__reference-links\"><a href=\"http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21337816\" data-track=\"click_references\" data-track-action=\"pubmed reference\" data-track-value=\"pubmed reference\" data-track-label=\"link\" data-track-item_id=\"link\">PubMed</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Etiology%20of%20community-acquired%20pneumonia%20in%20hospitalized%20patients%20in%20northern%20Israel&amp;journal=Isr%20Med%20Assoc%20J&amp;volume=12&amp;pages=477-482&amp;publication_year=2010&amp;author=Shibli%2CF&amp;author=Chazan%2CB&amp;author=Nitzan%2CO&amp;author=Flatau%2CE&amp;author=Edelstein%2CH&amp;author=Blondheim%2CO&amp;author=Raz%2CR&amp;author=Colodner%2CR\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR23\">Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://link.springer.com/doi/10.1186/s12889-015-1422-1\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1186/s12889-015-1422-1\" data-track-item_id=\"10.1186/s12889-015-1422-1\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=The%20aetiology%20of%20community%20associated%20pneumonia%20in%20children%20in%20Nanjing%2C%20China%20and%20aetiological%20patternsassociated%20with%20age%20and%20season&amp;journal=BMC%20Public%20Health&amp;doi=10.1186%2Fs12889-015-1422-1&amp;volume=15&amp;pages=113-118&amp;publication_year=2015&amp;author=Chen%2CK&amp;author=Jia%2CR&amp;author=Li%2CL&amp;author=Yang%2CC&amp;author=Shi%2CY\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR24\">Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1378%2Fchest.13-0162\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1378/chest.13-0162\" data-track-item_id=\"10.1378/chest.13-0162\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Importance%20of%20legionella%20pneumophila%20in%20the%20etiology%20of%20severe%20community-acquired%20pneumonia%20in%20Santiago&amp;journal=Chile%20Chest&amp;doi=10.1378%2Fchest.13-0162&amp;volume=145&amp;pages=290-296&amp;publication_year=2014&amp;author=Arancibia%2CF&amp;author=Cortes%2CCP&amp;author=Vald%C3%A9s%2CM&amp;author=Cerda%2CJ&amp;author=Hern%C3%A1ndez%2CA&amp;author=Soto%2CL&amp;author=Torres%2CA\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li><li class=\"c-reading-companion__reference-item\"><p class=\"c-reading-companion__reference-citation u-font-family-serif\" id=\"rc-ref-CR25\">Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p><p class=\"c-reading-companion__reference-links\"><a href=\"https://doi.org/10.1086%2F431588\" data-track=\"click_references\" data-track-action=\"article reference\" data-track-value=\"article reference\" data-track-label=\"10.1086/431588\" data-track-item_id=\"10.1086/431588\">Article</a>&nbsp;<a href=\"http://scholar.google.com/scholar_lookup?&amp;title=Improved%20diagnosis%20of%20the%20etiology%20of%20community-%20acquired%20pneumonia%20with%20real-time%20polymerase%20chain%20reaction&amp;journal=Clin%20Infect%20Dis&amp;doi=10.1086%2F431588&amp;volume=41&amp;pages=345-351&amp;publication_year=2005&amp;author=Templeton%2CKE&amp;author=Scheltinga%2CSA&amp;author=Eeden%2CWC&amp;author=Graffelman%2CAW&amp;author=Broek%2CPJ&amp;author=Claas%2CEC\" data-track=\"click_references\" data-track-action=\"google scholar reference\" data-track-value=\"google scholar reference\" data-track-label=\"link\" data-track-item_id=\"link\">\n                    Google Scholar</a>&nbsp;</p></li></ol></div></div>\n                        </div>\n                    </div>\n                </aside>\n            </div>\n        </div>\n\n        \n            <div class=\"c-journal-footer\">\n                <div class=\"c-journal-footer__inner\">\n                    <div class=\"c-journal-footer__summary\">\n                        <h4 class=\"c-journal-title c-journal-title--footer\">\n                            \n                            <span class=\"c-journal-title__text\">BMC Infectious Diseases</span>\n                        </h4>\n                         <p class=\"c-journal-footer__issn\">ISSN: 1471-2334</p>\n                    </div>\n                    \n                        <div class=\"c-journal-footer__contact\">\n                            <h4 class=\"c-journal-footer__contact-title \">Contact us</h4>\n                            <ul class=\"c-journal-footer__contact-list\">\n                                \n                                \n                                    <li class=\"c-journal-footer__contact-item\">General enquiries: <a href=\"mailto:journalsubmissions@springernature.com\">journalsubmissions@springernature.com</a></li>\n                                \n                            </ul>\n                        </div>\n                    \n                </div>\n            </div>\n        \n        \n    <img rel=\"nofollow\" class=\"tracker\" style=\"display:none\" src=\"/track/article/10.1186/s12879-018-3565-z\" alt=\"\">\n\n         \n    <footer>\n        \n            <div class=\"c-publisher-footer u-color-inherit\" data-test=\"publisher-footer\">\n    <div class=\"u-container\">\n        <div class=\"u-display-flex u-flex-wrap u-justify-content-space-between\" data-test=\"publisher-footer-menu\">\n            <div class=\"u-display-flex\">\n                \n                    \n                        <ul class=\"c-list-group c-list-group--sm u-mr-24 u-mb-16\">\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://blogs.biomedcentral.com/\">Read more on our blogs</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/login\">Receive BMC newsletters</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/account\">Manage article alerts</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022\">Language editing for authors</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://authorservices.springernature.com/go/sn/?utm_source=Website&amp;utm_medium=BMC&amp;utm_campaign=SNAS+Referrals+2022&amp;utm_id=ref2022\">Scientific editing for authors</a>\n                                </li>\n                            \n                        </ul>\n                    \n                        <ul class=\"c-list-group c-list-group--sm u-mr-24 u-mb-16\">\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/about/policies\">Policies</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/accessibility\">Accessibility</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/about/press-centre\">Press center</a>\n                                </li>\n                            \n                        </ul>\n                    \n                        <ul class=\"c-list-group c-list-group--sm u-mr-24 u-mb-16\">\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://support.biomedcentral.com/support/home\">Support and Contact</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"https://biomedcentral.typeform.com/to/VLXboo\">Leave feedback</a>\n                                </li>\n                            \n                                <li class=\"c-list-group__item\">\n                                    <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/about/jobs\">Careers</a>\n                                </li>\n                            \n                        </ul>\n                    \n                \n            </div>\n            <div class=\"u-mb-24\">\n                <h3 id=\"social-menu\" class=\"u-text-sm u-reset-margin u-text-normal\">Follow BMC</h3>\n                <ul class=\"u-display-flex u-list-reset\" data-test=\"footer-social-links\">\n                    \n                        <li class=\"u-mt-8 u-mr-8\">\n                            <a href=\"https://twitter.com/biomedcentral\" data-track=\"click\" data-track-category=\"Social\" data-track-action=\"Clicked BMC Twitter\" class=\"u-gray-link\">\n                                <span class=\"u-visually-hidden\">BMC Twitter page</span>\n                                <svg class=\"u-icon u-text-lg\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\">\n                                    <use xlink:href=\"#icon-twitter-bordered\"></use>\n                                </svg>\n                            </a>\n                        </li>\n                    \n                        <li class=\"u-mt-8 u-mr-8\">\n                            <a href=\"https://www.facebook.com/BioMedCentral\" data-track=\"click\" data-track-category=\"Social\" data-track-action=\"Clicked BMC Facebook\" class=\"u-gray-link\">\n                                <span class=\"u-visually-hidden\">BMC Facebook page</span>\n                                <svg class=\"u-icon u-text-lg\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\">\n                                    <use xlink:href=\"#icon-facebook-bordered\"></use>\n                                </svg>\n                            </a>\n                        </li>\n                    \n                        <li class=\"u-mt-8 u-mr-8\">\n                            <a href=\"http://www.weibo.com/biomedcentral\" data-track=\"click\" data-track-category=\"Social\" data-track-action=\"Clicked BMC Weibo\" class=\"u-gray-link\">\n                                <span class=\"u-visually-hidden\">BMC Weibo page</span>\n                                <svg class=\"u-icon u-text-lg\" width=\"24\" height=\"24\" aria-hidden=\"true\" focusable=\"false\">\n                                    <use xlink:href=\"#icon-weibo-bordered\"></use>\n                                </svg>\n                            </a>\n                        </li>\n                    \n                </ul>\n            </div>\n        </div>\n        <p class=\"u-reset-margin\">\n            By using this website, you agree to our\n            <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/terms-and-conditions\">Terms and Conditions</a>,\n            <a class=\"u-gray-link\" href=\"https://www.springernature.com/ccpa\">Your US state privacy rights</a>,\n            <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/privacy-statement\">Privacy\n                statement</a> and\n            <a class=\"u-gray-link\" href=\"//www.biomedcentral.com/cookies\" data-test=\"cookie-link\">Cookies</a> policy.\n                <a class=\"u-gray-link\" data-cc-action=\"preferences\" href=\"javascript:void(0);\">Your privacy choices/Manage cookies</a> we use in the preference centre.\n        </p>\n    </div>\n</div>\n\n        \n        <div class=\"c-corporate-footer\">\n    <div class=\"u-container\">\n        <img src=\"/static/images/logo-springernature-acb40b85fb.svg\" class=\"c-corporate-footer__logo\" alt=\"Springer Nature\" itemprop=\"logo\" role=\"img\" width=\"135\" height=\"13\">\n        <p class=\"c-corporate-footer__legal\" data-test=\"copyright\"> © 2025 BioMed Central Ltd unless otherwise stated. Part of\n            <a class=\"c-corporate-footer__link\" href=\"https://www.springernature.com\" itemscope=\"\" itemtype=\"http://schema.org/Organization\" itemid=\"#parentOrganization\">Springer Nature</a>.\n        </p>\n    </div>\n</div>\n\n    </footer>\n\n    </div>\n\n\n\n        <div class=\"u-visually-hidden\" aria-hidden=\"true\">\n    \n    <!--?xml version=\"1.0\" encoding=\"UTF-8\"?--><svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"><defs><path id=\"a\" d=\"M0 .74h56.72v55.24H0z\"></path></defs><symbol id=\"icon-access\" viewBox=\"0 0 18 18\"><path d=\"m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-account\" viewBox=\"0 0 18 18\"><path d=\"m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-alert\" viewBox=\"0 0 18 18\"><path d=\"m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-broad\" viewBox=\"0 0 16 16\"><path d=\"m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 14 15)\"></path></symbol><symbol id=\"icon-arrow-down\" viewBox=\"0 0 16 16\"><path d=\"m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-left\" viewBox=\"0 0 16 16\"><path d=\"m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-right\" viewBox=\"0 0 16 16\"><path d=\"m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-sub\" viewBox=\"0 0 16 16\"><path d=\"m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-arrow-up\" viewBox=\"0 0 16 16\"><path d=\"m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-article\" viewBox=\"0 0 18 18\"><path d=\"m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-audio\" viewBox=\"0 0 18 18\"><path d=\"m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-block\" viewBox=\"0 0 24 24\"><path d=\"m0 0h24v24h-24z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-book\" viewBox=\"0 0 18 18\"><path d=\"m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-broad\" viewBox=\"0 0 24 24\"><path d=\"m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z\" fill-rule=\"evenodd\" transform=\"matrix(-1 0 0 -1 20.182742 24.805206)\"></path></symbol><symbol id=\"icon-calendar\" viewBox=\"0 0 18 18\"><path d=\"m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-cart\" viewBox=\"0 0 18 18\"><path d=\"m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z\"></path></symbol><symbol id=\"icon-chevron-less\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 -1 0 9 9)\"></path></symbol><symbol id=\"icon-chevron-more\" viewBox=\"0 0 10 10\"><path d=\"m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 1)\"></path></symbol><symbol id=\"icon-chevron-right\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-circle-fill\" viewBox=\"0 0 16 16\"><path d=\"m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-circle\" viewBox=\"0 0 16 16\"><path d=\"m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-citation\" viewBox=\"0 0 18 18\"><path d=\"m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-close\" viewBox=\"0 0 16 16\"><path d=\"m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-collections\" viewBox=\"0 0 18 18\"><path d=\"m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-compare\" viewBox=\"0 0 18 18\"><path d=\"m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download-file\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-download\" viewBox=\"0 0 16 16\"><path d=\"m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-editors\" viewBox=\"0 0 18 18\"><path d=\"m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-email\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-error\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-ethics\" viewBox=\"0 0 18 18\"><path d=\"m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-expand\"><path d=\"M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-explore\" viewBox=\"0 0 18 18\"><path d=\"m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-filter\" viewBox=\"0 0 16 16\"><path d=\"m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z\"></path></symbol><symbol id=\"icon-home\" viewBox=\"0 0 18 18\"><path d=\"m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-image\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-info\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-institution\" viewBox=\"0 0 18 18\"><path d=\"m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-location\" viewBox=\"0 0 18 18\"><path d=\"m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-minus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-newsletter\" viewBox=\"0 0 18 18\"><path d=\"m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-orcid\" viewBox=\"0 0 18 18\"><path d=\"m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-plus\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-print\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-search\" viewBox=\"0 0 22 22\"><path d=\"M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-facebook\" viewBox=\"0 0 24 24\"><path d=\"m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-twitter\" viewBox=\"0 0 24 24\"><path d=\"m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-social-youtube\" viewBox=\"0 0 24 24\"><path d=\"m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-subject-medicine\" viewBox=\"0 0 18 18\"><path d=\"m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-success\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-table\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick-circle\" viewBox=\"0 0 24 24\"><path d=\"m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-tick\" viewBox=\"0 0 16 16\"><path d=\"m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-update\" viewBox=\"0 0 18 18\"><path d=\"m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-upload\" viewBox=\"0 0 18 18\"><path d=\"m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-video\" viewBox=\"0 0 18 18\"><path d=\"m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-warning\" viewBox=\"0 0 18 18\"><path d=\"m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-checklist-banner\" viewBox=\"0 0 56.69 56.69\"><path style=\"fill:none\" d=\"M0 0h56.69v56.69H0z\"></path><clipPath id=\"b\"><use xlink:href=\"#a\" style=\"overflow:visible\"></use></clipPath><path d=\"M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round\"></path><path d=\"M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5\" style=\"clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round\"></path></symbol><symbol id=\"icon-chevron-down\" viewBox=\"0 0 16 16\"><path d=\"m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z\" fill-rule=\"evenodd\" transform=\"matrix(0 1 -1 0 11 1)\"></path></symbol><symbol id=\"icon-eds-i-arrow-right-medium\" viewBox=\"0 0 24 24\"><path d=\"m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z\"></path></symbol><symbol id=\"icon-eds-i-check-circle-medium\" viewBox=\"0 0 24 24\"><path d=\"M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z\"></path></symbol><symbol id=\"icon-eds-i-chevron-down-medium\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-chevron-down-small\" viewBox=\"0 0 16 16\"><path d=\"M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z\"></path></symbol><symbol id=\"icon-eds-i-chevron-right-medium\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-eds-i-chevron-right-small\" viewBox=\"0 0 10 10\"><path d=\"m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z\" fill-rule=\"evenodd\" transform=\"matrix(0 -1 1 0 0 10)\"></path></symbol><symbol id=\"icon-eds-i-chevron-up-medium\" viewBox=\"0 0 16 16\"><path d=\"m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-close-medium\" viewBox=\"0 0 16 16\"><path d=\"m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-copy-link\" viewBox=\"0 0 24 24\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z\"></path><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z\"></path><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z\"></path><path d=\"M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z\"></path><path d=\"M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z\"></path><path d=\"M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z\"></path></symbol><symbol id=\"icon-eds-i-download-medium\" viewBox=\"0 0 16 16\"><path d=\"m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-info-filled-medium\" viewBox=\"0 0 18 18\"><path d=\"m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-eds-i-institution-medium\" viewBox=\"0 0 24 24\"><g><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z\"></path></g></symbol><symbol id=\"icon-eds-i-mail-medium\" viewBox=\"0 0 24 24\"><path d=\"m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z\"></path></symbol><symbol id=\"icon-eds-i-menu-medium\" viewBox=\"0 0 24 24\"><path d=\"M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z\"></path></symbol><symbol id=\"icon-eds-i-search-medium\" viewBox=\"0 0 24 24\"><path d=\"M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z\"></path></symbol><symbol id=\"icon-eds-i-user-single-medium\" viewBox=\"0 0 24 24\"><path d=\"M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z\"></path></symbol><symbol id=\"icon-eds-i-warning-filled-medium\" viewBox=\"0 0 18 18\"><path d=\"m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-expand-image\" viewBox=\"0 0 18 18\"><path d=\"m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z\" fill-rule=\"evenodd\"></path></symbol><symbol id=\"icon-github\" viewBox=\"0 0 100 100\"><path fill-rule=\"evenodd\" clip-rule=\"evenodd\" d=\"M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z\"></path></symbol><symbol id=\"icon-springer-arrow-left\"><path d=\"M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z\"></path></symbol><symbol id=\"icon-springer-arrow-right\"><path d=\"M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z\"></path></symbol><symbol id=\"icon-submit-open\" viewBox=\"0 0 16 17\"><path d=\"M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z\" fill-rule=\"nonzero\"></path></symbol></svg>\n</div>\n    \n\n\n<script src=\"/static/js/app-es5-bundle-fe9cce56e1.js\" nomodule=\"true\"></script><script src=\"/static/js/app-es6-bundle-fed4944a50.js\" type=\"module\"></script><script src=\"/static/js/global-article-es5-bundle-d1124b54a9.js\" nomodule=\"true\"></script><script src=\"/static/js/global-article-es6-bundle-798832bcce.js\" type=\"module\"></script><div data-cc-ghost=\"\" style=\"height: 392px;\"></div><script type=\"text/javascript\" id=\"fetch-contextual-ads-campaign-data\" charset=\"\">(function(){var g=function(a){a=new CustomEvent(\"campaignDataLoaded\",{detail:a});document.dispatchEvent(a)},b=google_tag_manager[\"rm\"][\"50443292\"](49);if(b){var k=1500;b=google_tag_manager[\"rm\"][\"50443292\"](50);b=\"link\"===b?google_tag_manager[\"rm\"][\"50443292\"](51):google_tag_manager[\"rm\"][\"50443292\"](52);var m=function(a,c){var h=!1,l=setTimeout(function(){h=!0;c(null)},k),d=new XMLHttpRequest;d.onload=function(){var e=null,f=[];if(200===d.status){try{e=JSON.parse(d.responseText)}catch(p){e={}}f=e.campaigns||[]}h||(clearTimeout(l),c(f.length?f.join(\",\"):null))};d.open(\"GET\",\n\"/platform/contextual?doi\\x3d\"+a);d.send()},n=function(a,c){a&&-1===a.indexOf(\"not set\")?m(a,c):setTimeout(c,1)};n(b,function(a){window.campaignsForContextualAds=a;g(a);window.dataLayer.push({content:{article:{campaignID:a}}})})}else window.campaignsForContextualAds=\"\",g(null)})();</script>\n<script id=\"crossmark-script\" text=\"\" charset=\"\" type=\"text/javascript\" src=\"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js\"></script><script type=\"text/javascript\" id=\"polyfill-matches\" charset=\"\">Element.prototype.matches||(Element.prototype.matches=Element.prototype.matchesSelector||Element.prototype.mozMatchesSelector||Element.prototype.msMatchesSelector||Element.prototype.oMatchesSelector||Element.prototype.webkitMatchesSelector||function(a){a=(this.document||this.ownerDocument).querySelectorAll(a);for(var b=a.length;0<=--b&&a.item(b)!==this;);return-1<b});</script></body></html>",
        "cleaned_html": "<dialog>\n<div>\n<div>\n<div>\n<h2>Your privacy, your choice</h2>\n</div>\n<div>\n<div>\n<p>We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.</p><p>By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.</p><p>See our <a href=\"https://www.biomedcentral.com/privacy-statement\">privacy policy</a> for more information on the use of your personal data.</p><p><button>Manage preferences</button> for further information and to change your choices.</p>\n</div>\n</div>\n<div>\n<button>Accept all cookies</button>\n</div>\n</div>\n</div>\n</dialog>\n\n\n<div>\n<a href=\"#main-content\">Skip to main content</a>\n<aside>\n<div>\n<p>Advertisement</p>\n</div>\n</aside>\n<div>\n<header>\n<div>\n<div>\n<div>\n<a href=\"https://www.biomedcentral.com\">\n<img alt=\"BMC\" height=\"18\" itemprop=\"logo\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-series-d1f4e4f0a7.svg\" width=\"76\"/>\n<div>\n<img alt=\"Part of Springer Nature\" height=\"16\" role=\"img\" src=\"/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg\" width=\"173\"/>\n</div>\n</a>\n</div>\n</div>\n<div>\n<button>\n<span>\n<span>Search</span>\n</span>\n</button>\n<nav>\n<ul>\n<li>\n<a href=\"//www.biomedcentral.com/journals\">\n                    Explore journals\n                  </a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/getpublished\">\n                    Get published\n                  </a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/about\">\n                    About BMC\n                  </a>\n</li>\n<li>\n<a href=\"/login\">Login</a>\n</li>\n</ul><div><button>Menu</button><ul><li><a href=\"https://www.biomedcentral.com/journals\">\n                    Explore journals\n                  </a></li><li><a href=\"https://www.biomedcentral.com/getpublished\">\n                    Get published\n                  </a></li><li><a href=\"https://www.biomedcentral.com/about\">\n                    About BMC\n                  </a></li><li><a href=\"https://bmcinfectdis.biomedcentral.com/login\">Login</a></li></ul></div>\n</nav>\n</div>\n</div>\n</header>\n<div>\n<div>\n<div>\n<div>\n<form>\n<label>Search all BMC articles</label>\n<div>\n<div>\n<button>\n<span>Search</span>\n</button>\n</div>\n</div>\n</form>\n</div>\n</div>\n</div>\n</div>\n</div>\n<header>\n<div>\n<div>\n<div>\n<a href=\"/\">\n<span>BMC Infectious Diseases</span>\n</a>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<nav>\n<ul>\n<li>\n<a href=\"/\">Home</a>\n</li>\n<li>\n<a href=\"/about\">About</a>\n</li>\n<li>\n<a href=\"/articles\">Articles</a>\n</li>\n<li>\n<a href=\"/submission-guidelines\">Submission Guidelines</a>\n</li>\n<li>\n<a href=\"/join-our-editorial-board\">Join the board</a>\n</li>\n<li>\n<a href=\"/articles/collections\">Collections</a>\n</li>\n</ul>\n</nav>\n</div>\n</div>\n</div>\n</header>\n<div>\n<main>\n<div>\n<div>\n<div>\n              Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\n            </div>\n<div>\n<div>\n<a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\">\n<span>Download PDF</span>\n</a>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\">\n<span>Download PDF</span>\n</a>\n</div>\n</div>\n</div>\n<article>\n<div>\n<ul>\n<li>Research article</li>\n<li>Published: <time>18 December 2018</time></li>\n</ul>\n<h1>Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective</h1>\n<ul><li><a href=\"#auth-Andrea-Gramegna-Aff1\">Andrea Gramegna</a><sup><a href=\"#Aff1\">1</a></sup>, </li><li><a href=\"#auth-Giovanni-Sotgiu-Aff2\">Giovanni Sotgiu</a><sup><a href=\"#Aff2\">2</a></sup>, </li><li><a href=\"#auth-Marta-Pasquale-Aff1\">Marta Di Pasquale</a><sup><a href=\"#Aff1\">1</a></sup>, </li><li><a href=\"#auth-Dejan-Radovanovic-Aff3\">Dejan Radovanovic</a><sup><a href=\"#Aff3\">3</a></sup>, </li><li><a href=\"#auth-Silvia-Terraneo-Aff4\">Silvia Terraneo</a><sup><a href=\"#Aff4\">4</a></sup>, </li><li><a href=\"#auth-Luis_F_-Reyes-Aff5\">Luis F. Reyes</a><sup><a href=\"#Aff5\">5</a></sup>, </li><li><a href=\"#auth-Ester-Vendrell-Aff6\">Ester Vendrell</a><sup><a href=\"#Aff6\">6</a></sup>, </li><li><a href=\"#auth-Joao-Neves-Aff7\">Joao Neves</a><sup><a href=\"#Aff7\">7</a></sup>, </li><li><a href=\"#auth-Francesco-Menzella-Aff8\">Francesco Menzella</a><sup><a href=\"#Aff8\">8</a></sup>, </li><li><a href=\"#auth-Francesco-Blasi-Aff1\">Francesco Blasi</a><sup><a href=\"#Aff1\">1</a></sup>, </li><li><a href=\"#auth-Stefano-Aliberti-Aff1\">Stefano Aliberti</a><sup><a href=\"#Aff1\">1</a></sup> &amp; </li><li><a href=\"#auth-Marcos_I_-Restrepo-Aff5\">Marcos I. Restrepo</a><sup><a href=\"#Aff5\">5</a></sup> </li><li><a href=\"#group-1\">on behalf of the GLIMP Study Group</a></li></ul><button><span>Show authors</span></button>\n<p>\n<a href=\"/\"><i>BMC Infectious Diseases</i></a>\n<b><span>volume</span> 18</b>, Article number: <span>677</span> (<span>2018</span>)\n      <a href=\"#citeas\">Cite this article</a>\n</p>\n<div>\n<ul>\n<li>\n<p>8117 <span>Accesses</span></p>\n</li>\n<li>\n<p>37 <span>Citations</span></p>\n</li>\n<li>\n<p>4 <span>Altmetric</span></p>\n</li>\n<li>\n<p><a href=\"/articles/10.1186/s12879-018-3565-z/metrics\">Metrics <span>details</span></a></p>\n</li>\n</ul>\n</div>\n<div>\n<p>A <a href=\"/articles/10.1186/s12879-020-05472-y\">Correction</a> to this article was published on 13 October 2020</p>\n</div>\n<div>\n<p>This article has been <a href=\"#change-history\">updated</a></p>\n</div>\n</div>\n<section><div><h2>Abstract</h2><div><h3>Background</h3><p>Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity.</p><h3>Methods</h3><p>A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including <i>L. pneumophila</i>, <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis.</p><h3>Results</h3><p>Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, <i>p</i> &lt; 0.0001). Detection of <i>L. pneumophila</i> urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, <i>p</i> = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, <i>p</i> = 0.003) than the rest of the population. Similarly, <i>L. pneumophila</i> testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including <i>M. pneumoniae</i> (26/251 patients, 10.3%), <i>L. pneumophila</i> (30/1186 patients, 2.5%), and <i>C. pneumoniae</i> (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP.</p><h3>Conclusions</h3><p>Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.</p></div></div></section>\n<p>\n<a href=\"/articles/10.1186/s12879-018-3565-z/peer-review\">Peer Review reports</a>\n</p>\n<section><div><h2>Background</h2><div><p>Community-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR2\" title=\"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\">2</a>]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including <i>Mycoplasma pneumoniae</i>, <i>Chlamydia pneumoniae</i>, and <i>Legionella pneumophila</i>, is still a matter of debate [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR3\" title=\"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\">3</a>].</p><p>Several Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR4\" title=\"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\">4</a>]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding <i>Streptococcus pneumoniae</i> [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR5\" title=\"Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\">5</a>]. Other studies described similar prevalences of atypical pathogens [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>].</p><p>Epidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \">7</a>]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>].</p><p>The aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens.</p></div></div></section><section><div><h2>Methods</h2><div><h3>Study design and population</h3><p>The present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n          https://doi.org/10.1016/S1473-3099(16)30267-5\n          \n         .\">8</a>]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR8\" title=\"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n          https://doi.org/10.1016/S1473-3099(16)30267-5\n          \n         .\">8</a>]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015.</p><p>All adults (&gt; 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature &lt; 36 °C); 3) systemic inflammation (e.g., white blood cell count &gt; 10,000/cm<sup>3</sup> or &lt; 4000/cm<sup>3</sup>, C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded.</p><h3>Data collection and microbiology for atypical pathogens</h3><p>Data were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results.</p><p>Physicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for <i>L. pneumophila</i> were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: <i>M. pneumoniae</i>, <i>C. pneumoniae</i>, and <i>L. pneumophila</i>.</p><h3>Study groups</h3><p>Definition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for <i>L. pneumophila,</i> serology for <i>L. Pneumophila</i>, <i>C. pneumoniae,</i> and <i>M. pneumoniae</i>.</p><h3>Study definitions</h3><p>CAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission.</p><p>Definition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions.</p><h3>Statistical analysis</h3><p>Testing frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for <i>L. pneumophila</i> performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was &lt; 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software.</p></div></div></section><section><div><h2>Results</h2><div><h3>Testing for atypical pathogens</h3><p>A total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for <i>L. pneumophila</i> (either urinary antigen or serology), 251 (6.8%) for <i>M. pneumoniae</i> (serology), and 228 (6.1%) for <i>C. pneumoniae</i> (serology). Distribution of testing frequencies across countries is showed in Fig. <a href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1a</a>.</p><div><figure><figcaption><b>Fig. 1</b></figcaption><div><div><a href=\"/articles/10.1186/s12879-018-3565-z/figures/1\"><picture><source><img alt=\"figure 1\" aria-describedby=\"Fig1\" height=\"815\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\" width=\"685\"/></source></picture></a></div><div><p><b>a</b>) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. <b>b</b>) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure <a href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1</a> is original and it was created using Stat Planet software with the information created from the study</p></div></div><div><a href=\"/articles/10.1186/s12879-018-3565-z/figures/1\"><span>Full size image</span></a></div></figure></div><p>The frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, <i>P</i> &lt; 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling &gt; 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab1\">1</a>). Data on testing for <i>L. pneumophila</i>, <i>M. pneumoniae</i>, and <i>C. pneumoniae</i> are reported in the additional files (Additional file <a href=\"/articles/10.1186/s12879-018-3565-z#MOESM1\">1</a>: Table A). Detection of <i>L. pneumophila</i> urinary antigen was the most prevalent test performed worldwide (32.0%).</p><div><figure><figcaption><b>Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/1\"><span>Full size table</span></a></div></figure></div><p>The frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than <i>L. pneumophila</i>, <i>P</i> = 0.009; 28.3% VS. 33.5% for <i>L. pneumophila</i>, <i>P</i> = 0.003). <i>L. pneumophila</i> testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column A.</p><h3>Prevalence of atypical pathogens</h3><p>At least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. <i>L. pneumophila</i> was detected in 30 (2.5%), <i>M. pneumoniae</i> in 26 (10.3%), and <i>C. pneumoniae</i> in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. <a href=\"/articles/10.1186/s12879-018-3565-z#Fig1\">1b</a>. Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, <i>P</i> = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, <i>P</i> = 0.001) (Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab2\">2</a>).</p><div><figure><figcaption><b>Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/2\"><span>Full size table</span></a></div></figure></div><p>Patients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab3\">3</a>, column B and Table <a href=\"/articles/10.1186/s12879-018-3565-z#Tab4\">4</a>).</p><div><figure><figcaption><b>Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B)</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/3\"><span>Full size table</span></a></div></figure></div><div><figure><figcaption><b>Table 4 \n             <span>Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia</span>\n</b></figcaption><div><a href=\"/articles/10.1186/s12879-018-3565-z/tables/4\"><span>Full size table</span></a></div></figure></div></div></div></section><section><div><h2>Discussion</h2><div><p>This secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, <i>L. pneumophila</i> testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals.</p><p>The most frequent test for atypical pathogens performed in hospitalized patients with CAP was the <i>Legionella</i> urinary antigen (32.0%), followed by <i>Legionella</i> serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for <i>M. pneumoniae</i> and <i>C. pneumoniae</i>, respectively).</p><p>However, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR7\" title=\"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \">7</a>]. Although molecular techniques was found helpful in the diagnosis of CAP caused by <i>L. pneumophila</i>, findings from different studies showed that single available tests were not reliable for the detection of <i>M. pneumoniae</i> and <i>C. pneumoniae</i> in CAP patients [<a href=\"#ref-CR9\" title=\"Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\">9</a>,<a href=\"#ref-CR10\" title=\"von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\">10</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR11\" title=\"Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\">11</a>]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR12\" title=\"Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\">12</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR13\" title=\"Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n          https://doi.org/10.1186/s12879-016-1641-9.\n          \n         \n            \">13</a>]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for <i>Legionella</i>, is not routinely prescribed.</p><p>One of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain.</p><p>Furthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"#ref-CR14\" title=\"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\">14</a>,<a href=\"#ref-CR15\" title=\"Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\">15</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR16\" title=\"Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\">16</a>]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, <i>L. pneumophila</i> testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\">17</a>].</p><p>The present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. <i>L. pneumophila</i> and <i>M. pneumoniae</i> seem to be the most frequent pathogens worldwide. The prevalence of <i>M. pneumoniae</i> is highest in South America, whereas <i>L. pneumophila</i> did show a homogeneous geographical distribution. <i>L. pneumophila</i> prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR18\" title=\"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\">18</a>]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR19\" title=\"Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\">19</a>].</p><p>The CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR6\" title=\"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\">6</a>]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [<a href=\"#ref-CR20\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\">20</a>,<a href=\"#ref-CR21\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\">21</a>,<a href=\"#ref-CR22\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\">22</a>,<a href=\"#ref-CR23\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\">23</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\">24</a>]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\">17</a>]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR17\" title=\"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\">17</a>, <a href=\"#ref-CR20\" title=\"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\">20</a>,<a href=\"#ref-CR21\" title=\"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\">21</a>,<a href=\"#ref-CR22\" title=\"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\">22</a>,<a href=\"#ref-CR23\" title=\"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\">23</a>,<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR24\" title=\"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\">24</a>].</p><p>The prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for <i>Legionella</i> [<a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR1\" title=\"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\">1</a>, <a href=\"/articles/10.1186/s12879-018-3565-z#ref-CR25\" title=\"Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\">25</a>]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up.</p><p>Second, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology.</p><p>However, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians.</p><p>Potential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others.</p></div></div></section><section><div><h2>Conclusions</h2><div><p>In conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide.</p><p>Testing for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations.</p></div></div></section>\n<section><div><h2>Change history</h2><div><ul><li><ins><h3>13 October 2020</h3><div><p>An amendment to this paper has been published and can be accessed via the original article.</p></div></ins></li></ul></div></div></section><section><div><h2>Abbreviations</h2><div><dl><dt><dfn>CAP:</dfn></dt><dd>\n<p>Community-acquired pneumonia</p>\n</dd><dt><dfn>GLIMP:</dfn></dt><dd>\n<p>Global Initiative for MRSA Pneumonia</p>\n</dd><dt><dfn>ICU:</dfn></dt><dd>\n<p>Intensive care unit</p>\n</dd></dl></div></div></section><div><section><div><h2>References</h2><div><div><ol><li><p>Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p> \n  <a href=\"/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\">CAS</a> \n   \n        </p></li><li><p>Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p></li><li><p>Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li><p>Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li><p>Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p></li><li><p>Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p></li><li><p>Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n</p></li><li><p>Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .</p></li><li><p>Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p></li><li><p>von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p></li><li><p>Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p></li><li><p>Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p> \n  <a href=\"/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\">CAS</a> \n   \n        </p></li><li><p>Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n</p></li><li><p>Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li><p>Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p> \n  <a href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\">CAS</a> \n   \n        </p></li><li><p>Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p></li><li><p>Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p></li><li><p>Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p></li><li><p>Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p> \n  <a href=\"/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\">CAS</a> \n   \n        </p></li><li><p>Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p></li><li><p>Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p></li><li><p>Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p></li><li><p>Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p></li><li><p>Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p></li><li><p>Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p></li></ol></div></div></div></section></div><section><div><h2>Acknowledgments</h2><div><p>GLIMP investigators</p><p>Argentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases &amp; ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal &amp; Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology &amp; Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine &amp; Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott &amp; White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care &amp; Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine &amp; Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia).</p>\n<h3>Ethics approval and consent to partecipate</h3>\n<p>The coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations.</p>\n<h3>Avaibility of data and materials</h3>\n<p>The database used for the study is not public but it is available from the corresponding author on reasonable request.</p>\n<h3>Funding</h3>\n<p>The authors did not receive any funding for this study.</p>\n</div></div></section><section><div><h2>Author information</h2><div><h3>Authors and Affiliations</h3><ol><li><p>Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy</p><p>Andrea Gramegna, Marta Di Pasquale, Francesco Blasi &amp; Stefano Aliberti</p></li><li><p>Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy</p><p>Giovanni Sotgiu</p></li><li><p>Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy</p><p>Dejan Radovanovic</p></li><li><p>Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy</p><p>Silvia Terraneo</p></li><li><p>Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA</p><p>Luis F. Reyes &amp; Marcos I. Restrepo</p></li><li><p>Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain</p><p>Ester Vendrell</p></li><li><p>Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal</p><p>Joao Neves</p></li><li><p>Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy</p><p>Francesco Menzella</p></li></ol><div><span>Authors</span><ol><li><span>Andrea Gramegna</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Giovanni Sotgiu</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Marta Di Pasquale</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Dejan Radovanovic</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Silvia Terraneo</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Luis F. Reyes</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Ester Vendrell</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Joao Neves</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Joao%20Neves\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Francesco Menzella</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Francesco Blasi</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Stefano Aliberti</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li><li><span>Marcos I. Restrepo</span><div><div><a href=\"https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo\">View author publications</a></div><div><p><span>You can also search for this author in</span></p></div></div></li></ol></div><h3>Consortia</h3><div><h3>on behalf of the GLIMP Study Group</h3></div><h3>Contributions</h3><p>AG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript.</p><h3>Corresponding author</h3><p>Correspondence to\n        .</p></div></div></section><section><div><h2>Ethics declarations</h2><div>\n<h3>Consent for publication</h3>\n<p>Not applicable.</p>\n<h3>Competing interests</h3>\n<p>The authors declare that they have no competing interests for this study.</p>\n<h3>Publisher’s Note</h3>\n<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>\n</div></div></section><section><div><h2>Additional file</h2><div><div><div><div><p>Table A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for <i>C. pneumoniae</i> across continents; A2: Testing frequencies for <i>M. pneumoniae</i> across continents; A3: Testing frequencies for <i>L. pneumophila</i> across continents).- <i>Brief description of the data</i>: a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb)</p></div></div></div></div></div></section><section><div><h2>Rights and permissions</h2><div>\n<p><b>Open Access</b> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver () applies to the data made available in this article, unless otherwise stated.</p>\n</div></div></section><section><div><h2>About this article</h2><div><div><div><h3>Cite this article</h3><p>Gramegna, A., Sotgiu, G., Di Pasquale, M. <i>et al.</i> Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.\n          <i>BMC Infect Dis</i> <b>18</b>, 677 (2018). https://doi.org/10.1186/s12879-018-3565-z</p><ul><li><p>Received<span>: </span><span><time>28 May 2018</time></span></p></li><li><p>Accepted<span>: </span><span><time>28 November 2018</time></span></p></li><li><p>Published<span>: </span><span><time>18 December 2018</time></span></p></li><li><p><abbr title=\"Digital Object Identifier\">DOI</abbr><span>: </span><span>https://doi.org/10.1186/s12879-018-3565-z</span></p></li></ul><div><div><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button>Get shareable link</button><div><p>Sorry, a shareable link is not currently available for this article.</p></div><div><button>Copy to clipboard</button></div><p>\n              Provided by the Springer Nature SharedIt content-sharing initiative\n            </p></div></div><h3>Keywords</h3><ul><li><span><a href='/search?query=CAP&amp;facet-discipline=\"Medicine%20%26%20Public%20Health\"'>CAP</a></span></li><li><span><a href='/search?query=Atypical%20pathogens&amp;facet-discipline=\"Medicine%20%26%20Public%20Health\"'>Atypical pathogens</a></span></li><li><span><a href='/search?query=Epidemiology&amp;facet-discipline=\"Medicine%20%26%20Public%20Health\"'>Epidemiology</a></span></li></ul></div></div></div></div></section>\n</article>\n</main>\n<div>\n<aside>\n<div>\n<div>\n<a href=\"//bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf\">\n<span>Download PDF</span>\n</a>\n</div>\n</div>\n<div>\n<div>\n<ul><li><button>Sections</button></li><li><button>Figures</button></li><li><button>References</button></li></ul><div><div><ul><li><a href=\"#Abs1\">Abstract</a></li><li><a href=\"#Sec1\">Background</a></li><li><a href=\"#Sec2\">Methods</a></li><li><a href=\"#Sec8\">Results</a></li><li><a href=\"#Sec11\">Discussion</a></li><li><a href=\"#Sec12\">Conclusions</a></li><li><a href=\"#change-history\">Change history</a></li><li><a href=\"#abbreviations\">Abbreviations</a></li><li><a href=\"#Bib1\">References</a></li><li><a href=\"#Ack1\">Acknowledgments</a></li><li><a href=\"#author-information\">Author information</a></li><li><a href=\"#ethics\">Ethics declarations</a></li><li><a href=\"#Sec13\">Additional file</a></li><li><a href=\"#rightslink\">Rights and permissions</a></li><li><a href=\"#article-info\">About this article</a></li></ul></div>\n<div>\n<aside>\n<div>\n<p>Advertisement</p>\n</div>\n</aside>\n</div>\n</div>\n<div><div><ul><li><figure><figcaption><b>Fig. 1</b></figcaption><picture><source><img alt=\"figure 1\" aria-describedby=\"rc-Fig1\" data-src=\"https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png\"/></source></picture><p><a href=\"#Fig1\">View in article</a><a href=\"https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1\">Full size image</a></p></figure></li></ul></div></div>\n<div><div><ol><li><p>Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D\">CAS</a>  </p></li><li><p>Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.</p></li><li><p>Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.</p></li><li><p>Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.</p></li><li><p>Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.</p></li><li><p>Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.</p></li><li><p>Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n</p></li><li><p>Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .</p></li><li><p>Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.</p></li><li><p>von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.</p></li><li><p>Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.</p></li><li><p>Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D\">CAS</a>  </p></li><li><p>Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n</p></li><li><p>Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.</p></li><li><p>Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D\">CAS</a>  </p></li><li><p>Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.</p></li><li><p>Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.</p></li><li><p>Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.</p></li><li><p>Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.</p><p> <a href=\"https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D\">CAS</a>  </p></li><li><p>Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.</p></li><li><p>Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.</p></li><li><p>Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.</p></li><li><p>Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.</p></li><li><p>Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.</p></li><li><p>Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.</p></li></ol></div></div>\n</div>\n</div>\n</aside>\n</div>\n</div>\n<div>\n<div>\n<div>\n<h4>\n<span>BMC Infectious Diseases</span>\n</h4>\n<p>ISSN: 1471-2334</p>\n</div>\n<div>\n<h4>Contact us</h4>\n<ul>\n<li>General enquiries: </li>\n</ul>\n</div>\n</div>\n</div>\n<img alt=\"\" class=\"tracker\" rel=\"nofollow\" src=\"/track/article/10.1186/s12879-018-3565-z\" style=\"display:none\"/>\n<footer>\n<div>\n<div>\n<div>\n<div>\n<ul>\n<li>\n<a href=\"https://blogs.biomedcentral.com/\">Read more on our blogs</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/login\">Receive BMC newsletters</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/account\">Manage article alerts</a>\n</li>\n\n</ul>\n<ul>\n<li>\n<a href=\"//www.biomedcentral.com/about/policies\">Policies</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/accessibility\">Accessibility</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/about/press-centre\">Press center</a>\n</li>\n</ul>\n<ul>\n<li>\n<a href=\"https://support.biomedcentral.com/support/home\">Support and Contact</a>\n</li>\n<li>\n<a href=\"//www.biomedcentral.com/about/jobs\">Careers</a>\n</li>\n</ul>\n</div>\n<div>\n<h3>Follow BMC</h3>\n</div>\n</div>\n<p>\n      By using this website, you agree to our\n      <a href=\"//www.biomedcentral.com/terms-and-conditions\">Terms and Conditions</a>,\n      ,\n      <a href=\"//www.biomedcentral.com/privacy-statement\">Privacy\n        statement</a> and\n      <a href=\"//www.biomedcentral.com/cookies\">Cookies</a> policy.\n         we use in the preference centre.\n    </p>\n</div>\n</div>\n<div>\n<div>\n<img alt=\"Springer Nature\" class=\"c-corporate-footer__logo\" height=\"13\" itemprop=\"logo\" role=\"img\" src=\"/static/images/logo-springernature-acb40b85fb.svg\" width=\"135\"/>\n<p> © 2025 BioMed Central Ltd unless otherwise stated. Part of\n      .\n    </p>\n</div>\n</div>\n</footer>\n</div>\n\n",
        "markdown": {
          "raw_markdown": "## Your privacy, your choice\nWe use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.\nBy accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.\nSee our [privacy policy](https://www.biomedcentral.com/privacy-statement) for more information on the use of your personal data.\nManage preferences for further information and to change your choices.\nAccept all cookies\n[Skip to main content](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#main-content)\nAdvertisement\n[ ![BMC](https://bmcinfectdis.biomedcentral.com/static/images/bmc/logos/logo-bmc-white-series-d1f4e4f0a7.svg) ![Part of Springer Nature](https://bmcinfectdis.biomedcentral.com/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg) ](https://www.biomedcentral.com)\nSearch\n  * [ Explore journals ](https://www.biomedcentral.com/journals)\n  * [ Get published ](https://www.biomedcentral.com/getpublished)\n  * [ About BMC ](https://www.biomedcentral.com/about)\n  * [Login](https://bmcinfectdis.biomedcentral.com/login)\n\n\nMenu\n  * [ Explore journals ](https://www.biomedcentral.com/journals)\n  * [ Get published ](https://www.biomedcentral.com/getpublished)\n  * [ About BMC ](https://www.biomedcentral.com/about)\n  * [Login](https://bmcinfectdis.biomedcentral.com/login)\n\n\nSearch all BMC articles\nSearch\n[ BMC Infectious Diseases ](https://bmcinfectdis.biomedcentral.com/)\n  * [Home](https://bmcinfectdis.biomedcentral.com/)\n  * [About](https://bmcinfectdis.biomedcentral.com/about)\n  * [Articles](https://bmcinfectdis.biomedcentral.com/articles)\n  * [Submission Guidelines](https://bmcinfectdis.biomedcentral.com/submission-guidelines)\n  * [Join the board](https://bmcinfectdis.biomedcentral.com/join-our-editorial-board)\n  * [Collections](https://bmcinfectdis.biomedcentral.com/articles/collections)\n\n\nAtypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective \n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n  * Research article\n  * Published: 18 December 2018\n\n\n# Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\n  * [Andrea Gramegna](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Andrea-Gramegna-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Giovanni Sotgiu](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Giovanni-Sotgiu-Aff2)[2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff2), \n  * [Marta Di Pasquale](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Marta-Pasquale-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Dejan Radovanovic](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Dejan-Radovanovic-Aff3)[3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff3), \n  * [Silvia Terraneo](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Silvia-Terraneo-Aff4)[4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff4), \n  * [Luis F. Reyes](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Luis_F_-Reyes-Aff5)[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff5), \n  * [Ester Vendrell](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Ester-Vendrell-Aff6)[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff6), \n  * [Joao Neves](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Joao-Neves-Aff7)[7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff7), \n  * [Francesco Menzella](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Francesco-Menzella-Aff8)[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff8), \n  * [Francesco Blasi](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Francesco-Blasi-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Stefano Aliberti](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Stefano-Aliberti-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1) &\n  * [Marcos I. Restrepo](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Marcos_I_-Restrepo-Aff5)[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff5)\n  * [on behalf of the GLIMP Study Group](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#group-1)\n\nShow authors\n[_BMC Infectious Diseases_](https://bmcinfectdis.biomedcentral.com/) **volume 18**, Article number: 677 (2018) [Cite this article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#citeas)\n  * 8117 Accesses\n  * 37 Citations\n  * 4 Altmetric\n  * [Metrics details](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/metrics)\n\n\nA [Correction](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05472-y) to this article was published on 13 October 2020\nThis article has been [updated](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#change-history)\n## Abstract\n### Background\nEmpirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity.\n### Methods\nA secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including _L. pneumophila_ , _M. pneumoniae_ , _C. pneumoniae_ , and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis.\n### Results\nAmong 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, _p_ < 0.0001). Detection of _L. pneumophila_ urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, _p_ = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, _p_ = 0.003) than the rest of the population. Similarly, _L. pneumophila_ testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including _M. pneumoniae_ (26/251 patients, 10.3%), _L. pneumophila_ (30/1186 patients, 2.5%), and _C. pneumoniae_ (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP.\n### Conclusions\nTesting for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\n[Peer Review reports](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/peer-review)\n## Background\nCommunity-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\")]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [[2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR2 \"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65\\(11\\):1806–12.\")]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including _Mycoplasma pneumoniae_ , _Chlamydia pneumoniae_ , and _Legionella pneumophila_ , is still a matter of debate [[3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR3 \"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\")].\nSeveral Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [[4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR4 \"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37\\(6\\):819–28 Epub 2016 Dec 13.\")]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding _Streptococcus pneumoniae_ [[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR5 \"Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125\\(17\\):2967–72.\")]. Other studies described similar prevalences of atypical pathogens [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")].\nEpidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7 \"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17\\(Suppl 6\\):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \")]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")].\nThe aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens.\n## Methods\n### Study design and population\nThe present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8 \"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia \\(GLIMP\\): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16\\(12\\):1364–76. \n          https://doi.org/10.1016/S1473-3099\\(16\\)30267-5\n          \n         .\")]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8 \"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia \\(GLIMP\\): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16\\(12\\):1364–76. \n          https://doi.org/10.1016/S1473-3099\\(16\\)30267-5\n          \n         .\")]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015.\nAll adults (> 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature < 36 °C); 3) systemic inflammation (e.g., white blood cell count > 10,000/cm3 or < 4000/cm3, C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded.\n### Data collection and microbiology for atypical pathogens\nData were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results.\nPhysicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for _L. pneumophila_ were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: _M. pneumoniae_ , _C. pneumoniae_ , and _L. pneumophila_.\n### Study groups\nDefinition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for _L. pneumophila,_ serology for _L. Pneumophila_ , _C. pneumoniae,_ and _M. pneumoniae_.\n### Study definitions\nCAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission.\nDefinition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions.\n### Statistical analysis\nTesting frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for _L. pneumophila_ performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was < 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software.\n## Results\n### Testing for atypical pathogens\nA total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for _L. pneumophila_ (either urinary antigen or serology), 251 (6.8%) for _M. pneumoniae_ (serology), and 228 (6.1%) for _C. pneumoniae_ (serology). Distribution of testing frequencies across countries is showed in Fig. [1a](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1).\n**Fig. 1**\n[![figure 1](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png)](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\n**a**) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. **b**) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1) is original and it was created using Stat Planet software with the information created from the study\n[Full size image](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\nThe frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, _P_ < 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling > 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab1)). Data on testing for _L. pneumophila_ , _M. pneumoniae_ , and _C. pneumoniae_ are reported in the additional files (Additional file [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#MOESM1): Table A). Detection of _L. pneumophila_ urinary antigen was the most prevalent test performed worldwide (32.0%).\n**Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/1)\nThe frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than _L. pneumophila_ , _P_ = 0.009; 28.3% VS. 33.5% for _L. pneumophila_ , _P_ = 0.003). _L. pneumophila_ testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table [3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3), column A.\n### Prevalence of atypical pathogens\nAt least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. _L. pneumophila_ was detected in 30 (2.5%), _M. pneumoniae_ in 26 (10.3%), and _C. pneumoniae_ in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. [1b](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1). Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, _P_ = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, _P_ = 0.001) (Table [2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab2)).\n**Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/2)\nPatients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table [3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3), column B and Table [4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab4)).\n**Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B)**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/3)\n**Table 4 Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia **\n[Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/4)\n## Discussion\nThis secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, _L. pneumophila_ testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals.\nThe most frequent test for atypical pathogens performed in hospitalized patients with CAP was the _Legionella_ urinary antigen (32.0%), followed by _Legionella_ serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for _M. pneumoniae_ and _C. pneumoniae_ , respectively).\nHowever, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7 \"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17\\(Suppl 6\\):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \")]. Although molecular techniques was found helpful in the diagnosis of CAP caused by _L. pneumophila_ , findings from different studies showed that single available tests were not reliable for the detection of _M. pneumoniae_ and _C. pneumoniae_ in CAP patients [[9](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR9 \"Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57\\(Pt 12\\):1491–5.\"),[10](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR10 \"von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia \\(CAPNETZ\\). BMC Infect Dis. 2009;9:62.\"),[11](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR11 \"Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\")]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\"), [12](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR12 \"Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\"), [13](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR13 \"Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n          https://doi.org/10.1186/s12879-016-1641-9.\n          \n         \n            \")]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for _Legionella_ , is not routinely prescribed.\nOne of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain.\nFurthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\")]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [14](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR14 \"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\"),[15](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR15 \"Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18\\(Suppl. 1\\):S45–8.\"),[16](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR16 \"Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\")]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, _L. pneumophila_ testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\")].\nThe present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. _L. pneumophila_ and _M. pneumoniae_ seem to be the most frequent pathogens worldwide. The prevalence of _M. pneumoniae_ is highest in South America, whereas _L. pneumophila_ did show a homogeneous geographical distribution. _L. pneumophila_ prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [[18](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR18 \"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\")]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [[19](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR19 \"Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160\\(9\\):1294–300.\")].\nThe CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [[20](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR20 \"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\"),[21](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR21 \"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\"),[22](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR22 \"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\"),[23](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR23 \"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\"),[24](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24 \"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\")]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\")]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\"), [20](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR20 \"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\"),[21](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR21 \"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\"),[22](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR22 \"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\"),[23](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR23 \"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\"),[24](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24 \"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\")].\nThe prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for _Legionella_ [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [25](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR25 \"Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\")]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up.\nSecond, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology.\nHowever, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians.\nPotential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others.\n## Conclusions\nIn conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide.\nTesting for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations.\n## Change history\n  * ### 13 October 2020\nAn amendment to this paper has been published and can be accessed via the original article.\n\n\n## Abbreviations\n\nCAP:\n    \nCommunity-acquired pneumonia \n\nGLIMP:\n    \nGlobal Initiative for MRSA Pneumonia \n\nICU:\n    \nIntensive care unit\n## References\n  1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D)\n  2. Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\n  3. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\n  4. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\n  5. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\n  6. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\n  7. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n  8. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .\n  9. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\n  10. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\n  11. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\n  12. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D)\n  13. Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n  14. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\n  15. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D)\n  16. Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\n  17. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\n  18. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\n  19. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D)\n  20. Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\n  21. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\n  22. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\n  23. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\n  24. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\n  25. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\n\n\n## Acknowledgments\nGLIMP investigators\nArgentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases & ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal & Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology & Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine & Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology & Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology & Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott & White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care & Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine & Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia).\n### Ethics approval and consent to partecipate\nThe coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations.\n### Avaibility of data and materials\nThe database used for the study is not public but it is available from the corresponding author on reasonable request.\n### Funding\nThe authors did not receive any funding for this study.\n## Author information\n### Authors and Affiliations\n  1. Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy\nAndrea Gramegna, Marta Di Pasquale, Francesco Blasi & Stefano Aliberti\n  2. Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy\nGiovanni Sotgiu\n  3. Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy\nDejan Radovanovic\n  4. Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy\nSilvia Terraneo\n  5. Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA\nLuis F. Reyes & Marcos I. Restrepo\n  6. Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain\nEster Vendrell\n  7. Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal\nJoao Neves\n  8. Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy\nFrancesco Menzella\n\n\nAuthors\n  1. Andrea Gramegna\n[View author publications](https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna)\nYou can also search for this author in\n  2. Giovanni Sotgiu\n[View author publications](https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu)\nYou can also search for this author in\n  3. Marta Di Pasquale\n[View author publications](https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale)\nYou can also search for this author in\n  4. Dejan Radovanovic\n[View author publications](https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic)\nYou can also search for this author in\n  5. Silvia Terraneo\n[View author publications](https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo)\nYou can also search for this author in\n  6. Luis F. Reyes\n[View author publications](https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes)\nYou can also search for this author in\n  7. Ester Vendrell\n[View author publications](https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell)\nYou can also search for this author in\n  8. Joao Neves\n[View author publications](https://www.biomedcentral.com/search?query=author%23Joao%20Neves)\nYou can also search for this author in\n  9. Francesco Menzella\n[View author publications](https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella)\nYou can also search for this author in\n  10. Francesco Blasi\n[View author publications](https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi)\nYou can also search for this author in\n  11. Stefano Aliberti\n[View author publications](https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti)\nYou can also search for this author in\n  12. Marcos I. Restrepo\n[View author publications](https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo)\nYou can also search for this author in\n\n\n### Consortia\n### on behalf of the GLIMP Study Group\n### Contributions\nAG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript.\n### Corresponding author\nCorrespondence to .\n## Ethics declarations\n### Consent for publication\nNot applicable.\n### Competing interests\nThe authors declare that they have no competing interests for this study.\n### Publisher’s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n## Additional file\nTable A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for _C. pneumoniae_ across continents; A2: Testing frequencies for _M. pneumoniae_ across continents; A3: Testing frequencies for _L. pneumophila_ across continents).- _Brief description of the data_ : a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb)\n## Rights and permissions\n**Open Access** This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver () applies to the data made available in this article, unless otherwise stated.\n## About this article\n### Cite this article\nGramegna, A., Sotgiu, G., Di Pasquale, M. _et al._ Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. _BMC Infect Dis_ **18** , 677 (2018). https://doi.org/10.1186/s12879-018-3565-z\n  * Received: 28 May 2018\n  * Accepted: 28 November 2018\n  * Published: 18 December 2018\n  * DOI: https://doi.org/10.1186/s12879-018-3565-z\n\n\n### Share this article\nAnyone you share the following link with will be able to read this content:\nGet shareable link\nSorry, a shareable link is not currently available for this article.\nCopy to clipboard\nProvided by the Springer Nature SharedIt content-sharing initiative \n### Keywords\n  * [CAP](https://bmcinfectdis.biomedcentral.com/search?query=CAP&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n  * [Atypical pathogens](https://bmcinfectdis.biomedcentral.com/search?query=Atypical%20pathogens&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n  * [Epidemiology](https://bmcinfectdis.biomedcentral.com/search?query=Epidemiology&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n\n\n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n  * Sections\n  * Figures\n  * References\n\n\n  * [Abstract](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Abs1)\n  * [Background](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec1)\n  * [Methods](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec2)\n  * [Results](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec8)\n  * [Discussion](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec11)\n  * [Conclusions](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec12)\n  * [Change history](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#change-history)\n  * [Abbreviations](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#abbreviations)\n  * [References](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Bib1)\n  * [Acknowledgments](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Ack1)\n  * [Author information](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#author-information)\n  * [Ethics declarations](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ethics)\n  * [Additional file](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec13)\n  * [Rights and permissions](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#rightslink)\n  * [About this article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#article-info)\n\n\nAdvertisement\n  * **Fig. 1**\n[View in article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1)[Full size image](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\n\n\n  1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D)\n  2. Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\n  3. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\n  4. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\n  5. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\n  6. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\n  7. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n  8. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .\n  9. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\n  10. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\n  11. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\n  12. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D)\n  13. Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n  14. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\n  15. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D)\n  16. Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\n  17. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\n  18. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\n  19. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D)\n  20. Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\n  21. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\n  22. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\n  23. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\n  24. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\n  25. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\n\n\n####  BMC Infectious Diseases\nISSN: 1471-2334\n#### Contact us\n  * General enquiries: \n\n\n![](https://bmcinfectdis.biomedcentral.com/track/article/10.1186/s12879-018-3565-z)\n  * [Read more on our blogs](https://blogs.biomedcentral.com/)\n  * [Receive BMC newsletters](https://www.biomedcentral.com/login)\n  * [Manage article alerts](https://www.biomedcentral.com/account)\n\n\n  * [Policies](https://www.biomedcentral.com/about/policies)\n  * [Accessibility](https://www.biomedcentral.com/accessibility)\n  * [Press center](https://www.biomedcentral.com/about/press-centre)\n\n\n  * [Support and Contact](https://support.biomedcentral.com/support/home)\n  * [Careers](https://www.biomedcentral.com/about/jobs)\n\n\n### Follow BMC\nBy using this website, you agree to our [Terms and Conditions](https://www.biomedcentral.com/terms-and-conditions), , [Privacy statement](https://www.biomedcentral.com/privacy-statement) and [Cookies](https://www.biomedcentral.com/cookies) policy. we use in the preference centre. \n![Springer Nature](https://bmcinfectdis.biomedcentral.com/static/images/logo-springernature-acb40b85fb.svg)\n© 2025 BioMed Central Ltd unless otherwise stated. Part of . \n  *[DOI]: Digital Object Identifier\n",
          "fit_markdown": "",
          "fit_html": "",
          "primary_content": "## Your privacy, your choice\nWe use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.\nBy accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.\nSee our [privacy policy](https://www.biomedcentral.com/privacy-statement) for more information on the use of your personal data.\nManage preferences for further information and to change your choices.\nAccept all cookies\n[Skip to main content](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#main-content)\nAdvertisement\n[ ![BMC](https://bmcinfectdis.biomedcentral.com/static/images/bmc/logos/logo-bmc-white-series-d1f4e4f0a7.svg) ![Part of Springer Nature](https://bmcinfectdis.biomedcentral.com/static/images/bmc/logos/logo-bmc-white-strapline-sn-f224388d67.svg) ](https://www.biomedcentral.com)\nSearch\n  * [ Explore journals ](https://www.biomedcentral.com/journals)\n  * [ Get published ](https://www.biomedcentral.com/getpublished)\n  * [ About BMC ](https://www.biomedcentral.com/about)\n  * [Login](https://bmcinfectdis.biomedcentral.com/login)\n\n\nMenu\n  * [ Explore journals ](https://www.biomedcentral.com/journals)\n  * [ Get published ](https://www.biomedcentral.com/getpublished)\n  * [ About BMC ](https://www.biomedcentral.com/about)\n  * [Login](https://bmcinfectdis.biomedcentral.com/login)\n\n\nSearch all BMC articles\nSearch\n[ BMC Infectious Diseases ](https://bmcinfectdis.biomedcentral.com/)\n  * [Home](https://bmcinfectdis.biomedcentral.com/)\n  * [About](https://bmcinfectdis.biomedcentral.com/about)\n  * [Articles](https://bmcinfectdis.biomedcentral.com/articles)\n  * [Submission Guidelines](https://bmcinfectdis.biomedcentral.com/submission-guidelines)\n  * [Join the board](https://bmcinfectdis.biomedcentral.com/join-our-editorial-board)\n  * [Collections](https://bmcinfectdis.biomedcentral.com/articles/collections)\n\n\nAtypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective \n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n  * Research article\n  * Published: 18 December 2018\n\n\n# Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective\n  * [Andrea Gramegna](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Andrea-Gramegna-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Giovanni Sotgiu](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Giovanni-Sotgiu-Aff2)[2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff2), \n  * [Marta Di Pasquale](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Marta-Pasquale-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Dejan Radovanovic](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Dejan-Radovanovic-Aff3)[3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff3), \n  * [Silvia Terraneo](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Silvia-Terraneo-Aff4)[4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff4), \n  * [Luis F. Reyes](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Luis_F_-Reyes-Aff5)[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff5), \n  * [Ester Vendrell](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Ester-Vendrell-Aff6)[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff6), \n  * [Joao Neves](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Joao-Neves-Aff7)[7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff7), \n  * [Francesco Menzella](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Francesco-Menzella-Aff8)[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff8), \n  * [Francesco Blasi](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Francesco-Blasi-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1), \n  * [Stefano Aliberti](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Stefano-Aliberti-Aff1)[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff1) &\n  * [Marcos I. Restrepo](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#auth-Marcos_I_-Restrepo-Aff5)[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Aff5)\n  * [on behalf of the GLIMP Study Group](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#group-1)\n\nShow authors\n[_BMC Infectious Diseases_](https://bmcinfectdis.biomedcentral.com/) **volume 18**, Article number: 677 (2018) [Cite this article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#citeas)\n  * 8117 Accesses\n  * 37 Citations\n  * 4 Altmetric\n  * [Metrics details](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/metrics)\n\n\nA [Correction](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05472-y) to this article was published on 13 October 2020\nThis article has been [updated](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#change-history)\n## Abstract\n### Background\nEmpirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity.\n### Methods\nA secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including _L. pneumophila_ , _M. pneumoniae_ , _C. pneumoniae_ , and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis.\n### Results\nAmong 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, _p_ < 0.0001). Detection of _L. pneumophila_ urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, _p_ = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, _p_ = 0.003) than the rest of the population. Similarly, _L. pneumophila_ testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including _M. pneumoniae_ (26/251 patients, 10.3%), _L. pneumophila_ (30/1186 patients, 2.5%), and _C. pneumoniae_ (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP.\n### Conclusions\nTesting for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.\n[Peer Review reports](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/peer-review)\n## Background\nCommunity-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\")]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [[2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR2 \"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65\\(11\\):1806–12.\")]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including _Mycoplasma pneumoniae_ , _Chlamydia pneumoniae_ , and _Legionella pneumophila_ , is still a matter of debate [[3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR3 \"Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\")].\nSeveral Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [[4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR4 \"Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37\\(6\\):819–28 Epub 2016 Dec 13.\")]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding _Streptococcus pneumoniae_ [[5](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR5 \"Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125\\(17\\):2967–72.\")]. Other studies described similar prevalences of atypical pathogens [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")].\nEpidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7 \"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17\\(Suppl 6\\):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \")]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")].\nThe aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens.\n## Methods\n### Study design and population\nThe present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8 \"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia \\(GLIMP\\): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16\\(12\\):1364–76. \n          https://doi.org/10.1016/S1473-3099\\(16\\)30267-5\n          \n         .\")]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [[8](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8 \"Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia \\(GLIMP\\): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16\\(12\\):1364–76. \n          https://doi.org/10.1016/S1473-3099\\(16\\)30267-5\n          \n         .\")]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015.\nAll adults (> 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature < 36 °C); 3) systemic inflammation (e.g., white blood cell count > 10,000/cm3 or < 4000/cm3, C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded.\n### Data collection and microbiology for atypical pathogens\nData were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results.\nPhysicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for _L. pneumophila_ were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: _M. pneumoniae_ , _C. pneumoniae_ , and _L. pneumophila_.\n### Study groups\nDefinition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for _L. pneumophila,_ serology for _L. Pneumophila_ , _C. pneumoniae,_ and _M. pneumoniae_.\n### Study definitions\nCAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission.\nDefinition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions.\n### Statistical analysis\nTesting frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for _L. pneumophila_ performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was < 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software.\n## Results\n### Testing for atypical pathogens\nA total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for _L. pneumophila_ (either urinary antigen or serology), 251 (6.8%) for _M. pneumoniae_ (serology), and 228 (6.1%) for _C. pneumoniae_ (serology). Distribution of testing frequencies across countries is showed in Fig. [1a](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1).\n**Fig. 1**\n[![figure 1](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png)](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\n**a**) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. **b**) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1) is original and it was created using Stat Planet software with the information created from the study\n[Full size image](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\nThe frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, _P_ < 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling > 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab1)). Data on testing for _L. pneumophila_ , _M. pneumoniae_ , and _C. pneumoniae_ are reported in the additional files (Additional file [1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#MOESM1): Table A). Detection of _L. pneumophila_ urinary antigen was the most prevalent test performed worldwide (32.0%).\n**Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/1)\nThe frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than _L. pneumophila_ , _P_ = 0.009; 28.3% VS. 33.5% for _L. pneumophila_ , _P_ = 0.003). _L. pneumophila_ testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table [3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3), column A.\n### Prevalence of atypical pathogens\nAt least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. _L. pneumophila_ was detected in 30 (2.5%), _M. pneumoniae_ in 26 (10.3%), and _C. pneumoniae_ in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. [1b](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1). Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, _P_ = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, _P_ = 0.001) (Table [2](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab2)).\n**Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/2)\nPatients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table [3](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3), column B and Table [4](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab4)).\n**Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B)**\n[ Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/3)\n**Table 4 Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia **\n[Full size table](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/4)\n## Discussion\nThis secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, _L. pneumophila_ testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals.\nThe most frequent test for atypical pathogens performed in hospitalized patients with CAP was the _Legionella_ urinary antigen (32.0%), followed by _Legionella_ serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for _M. pneumoniae_ and _C. pneumoniae_ , respectively).\nHowever, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [7](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7 \"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17\\(Suppl 6\\):E1–59. \n          https://doi.org/10.1111/j.1469-0691.2011.03672.x.\n          \n         \n            \")]. Although molecular techniques was found helpful in the diagnosis of CAP caused by _L. pneumophila_ , findings from different studies showed that single available tests were not reliable for the detection of _M. pneumoniae_ and _C. pneumoniae_ in CAP patients [[9](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR9 \"Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57\\(Pt 12\\):1491–5.\"),[10](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR10 \"von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia \\(CAPNETZ\\). BMC Infect Dis. 2009;9:62.\"),[11](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR11 \"Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\")]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\"), [12](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR12 \"Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\"), [13](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR13 \"Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n          https://doi.org/10.1186/s12879-016-1641-9.\n          \n         \n            \")]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for _Legionella_ , is not routinely prescribed.\nOne of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain.\nFurthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\")]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [14](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR14 \"Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\"),[15](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR15 \"Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18\\(Suppl. 1\\):S45–8.\"),[16](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR16 \"Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\")]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, _L. pneumophila_ testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\")].\nThe present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. _L. pneumophila_ and _M. pneumoniae_ seem to be the most frequent pathogens worldwide. The prevalence of _M. pneumoniae_ is highest in South America, whereas _L. pneumophila_ did show a homogeneous geographical distribution. _L. pneumophila_ prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [[18](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR18 \"Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\")]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [[19](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR19 \"Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160\\(9\\):1294–300.\")].\nThe CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [[6](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6 \"Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization \\(CAPO\\) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175\\(10\\):1086–93.\")]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [[20](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR20 \"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\"),[21](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR21 \"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\"),[22](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR22 \"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\"),[23](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR23 \"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\"),[24](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24 \"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\")]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\")]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [[17](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17 \"Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\"), [20](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR20 \"Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\"),[21](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR21 \"Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\"),[22](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR22 \"Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\"),[23](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR23 \"Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\"),[24](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24 \"Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\")].\nThe prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for _Legionella_ [[1](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1 \"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44\\(suppl 2\\):S27–72.\"), [25](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR25 \"Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\")]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up.\nSecond, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology.\nHowever, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians.\nPotential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others.\n## Conclusions\nIn conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide.\nTesting for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations.\n## Change history\n  * ### 13 October 2020\nAn amendment to this paper has been published and can be accessed via the original article.\n\n\n## Abbreviations\n\nCAP:\n    \nCommunity-acquired pneumonia \n\nGLIMP:\n    \nGlobal Initiative for MRSA Pneumonia \n\nICU:\n    \nIntensive care unit\n## References\n  1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D)\n  2. Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\n  3. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\n  4. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\n  5. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\n  6. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\n  7. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n  8. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .\n  9. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\n  10. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\n  11. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\n  12. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D)\n  13. Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n  14. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\n  15. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D)\n  16. Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\n  17. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\n  18. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\n  19. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D)\n  20. Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\n  21. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\n  22. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\n  23. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\n  24. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\n  25. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\n\n\n## Acknowledgments\nGLIMP investigators\nArgentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases & ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal & Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology & Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine & Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology & Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology & Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott & White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care & Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine & Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia).\n### Ethics approval and consent to partecipate\nThe coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations.\n### Avaibility of data and materials\nThe database used for the study is not public but it is available from the corresponding author on reasonable request.\n### Funding\nThe authors did not receive any funding for this study.\n## Author information\n### Authors and Affiliations\n  1. Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy\nAndrea Gramegna, Marta Di Pasquale, Francesco Blasi & Stefano Aliberti\n  2. Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy\nGiovanni Sotgiu\n  3. Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy\nDejan Radovanovic\n  4. Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy\nSilvia Terraneo\n  5. Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA\nLuis F. Reyes & Marcos I. Restrepo\n  6. Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain\nEster Vendrell\n  7. Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal\nJoao Neves\n  8. Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy\nFrancesco Menzella\n\n\nAuthors\n  1. Andrea Gramegna\n[View author publications](https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna)\nYou can also search for this author in\n  2. Giovanni Sotgiu\n[View author publications](https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu)\nYou can also search for this author in\n  3. Marta Di Pasquale\n[View author publications](https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale)\nYou can also search for this author in\n  4. Dejan Radovanovic\n[View author publications](https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic)\nYou can also search for this author in\n  5. Silvia Terraneo\n[View author publications](https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo)\nYou can also search for this author in\n  6. Luis F. Reyes\n[View author publications](https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes)\nYou can also search for this author in\n  7. Ester Vendrell\n[View author publications](https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell)\nYou can also search for this author in\n  8. Joao Neves\n[View author publications](https://www.biomedcentral.com/search?query=author%23Joao%20Neves)\nYou can also search for this author in\n  9. Francesco Menzella\n[View author publications](https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella)\nYou can also search for this author in\n  10. Francesco Blasi\n[View author publications](https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi)\nYou can also search for this author in\n  11. Stefano Aliberti\n[View author publications](https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti)\nYou can also search for this author in\n  12. Marcos I. Restrepo\n[View author publications](https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo)\nYou can also search for this author in\n\n\n### Consortia\n### on behalf of the GLIMP Study Group\n### Contributions\nAG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript.\n### Corresponding author\nCorrespondence to .\n## Ethics declarations\n### Consent for publication\nNot applicable.\n### Competing interests\nThe authors declare that they have no competing interests for this study.\n### Publisher’s Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\n## Additional file\nTable A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for _C. pneumoniae_ across continents; A2: Testing frequencies for _M. pneumoniae_ across continents; A3: Testing frequencies for _L. pneumophila_ across continents).- _Brief description of the data_ : a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb)\n## Rights and permissions\n**Open Access** This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver () applies to the data made available in this article, unless otherwise stated.\n## About this article\n### Cite this article\nGramegna, A., Sotgiu, G., Di Pasquale, M. _et al._ Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. _BMC Infect Dis_ **18** , 677 (2018). https://doi.org/10.1186/s12879-018-3565-z\n  * Received: 28 May 2018\n  * Accepted: 28 November 2018\n  * Published: 18 December 2018\n  * DOI: https://doi.org/10.1186/s12879-018-3565-z\n\n\n### Share this article\nAnyone you share the following link with will be able to read this content:\nGet shareable link\nSorry, a shareable link is not currently available for this article.\nCopy to clipboard\nProvided by the Springer Nature SharedIt content-sharing initiative \n### Keywords\n  * [CAP](https://bmcinfectdis.biomedcentral.com/search?query=CAP&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n  * [Atypical pathogens](https://bmcinfectdis.biomedcentral.com/search?query=Atypical%20pathogens&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n  * [Epidemiology](https://bmcinfectdis.biomedcentral.com/search?query=Epidemiology&facet-discipline=\"Medicine%20%26%20Public%20Health\")\n\n\n[ Download PDF ](https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf)\n  * Sections\n  * Figures\n  * References\n\n\n  * [Abstract](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Abs1)\n  * [Background](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec1)\n  * [Methods](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec2)\n  * [Results](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec8)\n  * [Discussion](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec11)\n  * [Conclusions](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec12)\n  * [Change history](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#change-history)\n  * [Abbreviations](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#abbreviations)\n  * [References](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Bib1)\n  * [Acknowledgments](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Ack1)\n  * [Author information](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#author-information)\n  * [Ethics declarations](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ethics)\n  * [Additional file](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Sec13)\n  * [Rights and permissions](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#rightslink)\n  * [About this article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#article-info)\n\n\nAdvertisement\n  * **Fig. 1**\n[View in article](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1)[Full size image](https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1)\n\n\n  1. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D)\n  2. Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.\n  3. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.\n  4. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.\n  5. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.\n  6. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.\n  7. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n  8. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. .\n  9. Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.\n  10. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.\n  11. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.\n  12. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D)\n  13. Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n  14. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.\n  15. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D)\n  16. Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.\n  17. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.\n  18. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.\n  19. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.\n[CAS](https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D)\n  20. Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.\n  21. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.\n  22. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.\n  23. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.\n  24. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.\n  25. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.\n\n\n####  BMC Infectious Diseases\nISSN: 1471-2334\n#### Contact us\n  * General enquiries: \n\n\n![](https://bmcinfectdis.biomedcentral.com/track/article/10.1186/s12879-018-3565-z)\n  * [Read more on our blogs](https://blogs.biomedcentral.com/)\n  * [Receive BMC newsletters](https://www.biomedcentral.com/login)\n  * [Manage article alerts](https://www.biomedcentral.com/account)\n\n\n  * [Policies](https://www.biomedcentral.com/about/policies)\n  * [Accessibility](https://www.biomedcentral.com/accessibility)\n  * [Press center](https://www.biomedcentral.com/about/press-centre)\n\n\n  * [Support and Contact](https://support.biomedcentral.com/support/home)\n  * [Careers](https://www.biomedcentral.com/about/jobs)\n\n\n### Follow BMC\nBy using this website, you agree to our [Terms and Conditions](https://www.biomedcentral.com/terms-and-conditions), , [Privacy statement](https://www.biomedcentral.com/privacy-statement) and [Cookies](https://www.biomedcentral.com/cookies) policy. we use in the preference centre. \n![Springer Nature](https://bmcinfectdis.biomedcentral.com/static/images/logo-springernature-acb40b85fb.svg)\n© 2025 BioMed Central Ltd unless otherwise stated. Part of . \n  *[DOI]: Digital Object Identifier\n"
        },
        "text_content": "Your privacy, your choice We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies Skip to main content Advertisement Search Explore journals Get published About BMC Login Menu Explore journals Get published About BMC Login Search all BMC articles Search BMC Infectious Diseases Home About Articles Submission Guidelines Join the board Collections Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective Download PDF Download PDF Research article Published: 18 December 2018 Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective Andrea Gramegna 1 , Giovanni Sotgiu 2 , Marta Di Pasquale 1 , Dejan Radovanovic 3 , Silvia Terraneo 4 , Luis F. Reyes 5 , Ester Vendrell 6 , Joao Neves 7 , Francesco Menzella 8 , Francesco Blasi 1 , Stefano Aliberti 1 &amp; Marcos I. Restrepo 5 on behalf of the GLIMP Study Group Show authors BMC Infectious Diseases volume 18 , Article number: 677 ( 2018 ) Cite this article 8117 Accesses 37 Citations 4 Altmetric Metrics details A Correction to this article was published on 13 October 2020 This article has been updated Abstract Background Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila , M. pneumoniae , C. pneumoniae , and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Results Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Conclusions Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation. Peer Review reports Background Community-acquired pneumonia (CAP) is a leading cause of hospitalization and death worldwide [ 1 ]. The annual estimated CAP burden in the Unites States of America (USA) accounts for more than 1.5 million adult hospitalizations and one third of hospitalized patients die within 1 year [ 2 ]. The assessment of the epidemiology of CAP-related pathogens is crucial to target appropriate empiric therapy in order to improve patients’ outcomes. The empirical coverage for atypical pathogens, including Mycoplasma pneumoniae , Chlamydia pneumoniae , and Legionella pneumophila , is still a matter of debate [ 3 ]. Several Authors reported on an increased trend of atypical pathogens over the last 15 years, with prevalences ranging from 6 to 40% in both Europe and USA [ 4 ]. One study performed in China showed atypical pathogens as the most frequent cause of CAP with incidence rates far exceeding Streptococcus pneumoniae [ 5 ]. Other studies described similar prevalences of atypical pathogens [ 6 ]. Epidemiological data are mainly based on retrospective studies or secondary analyses of local or national datasets with key design limitations, such as: 1) cultures for atypicals are rarely performed and a standardized diagnostic approach has not been adopted; 2) serology for atypical pathogens could be prescribed for epidemiological studies according to international guidelines and an all-encompassing microbiological work-up should be carried out only for hospitalized patients with severe CAP [ 1 , 7 ]; 3) information on testing frequency of atypical pathogens and which population subgroups are more likely to be investigated are missing. Finally, the only published description on atypical pathogens in CAP is a secondary analysis of a retrospective database [ 6 ]. The aim of this study was to provide a real-life description of both testing frequency and prevalence of atypical pathogens in hospitalized patients with CAP worldwide, along with the evaluation of predisposing conditions for testing and risk factors for CAP caused by atypical pathogens. Methods Study design and population The present study is based on a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) international database [ 8 ]. This project was not funded and relied upon voluntary site and investigator participation. The GLIMP methodology has been already published elsewhere [ 8 ]. The coordinating center (University of Texas Health at San Antonio –UT Health-, Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Study participants were enrolled on a single day in the months of March, April, May, and June in 2015. All adults (&gt; 18 years old) hospitalized with CAP were screened for study selection. CAP was defined by the evidence of new radiological pulmonary infiltrates during the first 48 h of hospitalization and by ≥1 of the following criteria: 1) new or increased cough with/without sputum production and/or purulent respiratory secretions; 2) fever (documented rectal or oral temperature ≥ 37.8 °C) or hypothermia (documented rectal or oral temperature &lt; 36 °C); 3) systemic inflammation (e.g., white blood cell count &gt; 10,000/cm 3 or &lt; 4000/cm 3 , C-reactive protein or procalcitonin values above the local upper limit of normality). Patients hospitalized with a diagnosis of hospital-acquired and/or ventilator-associated pneumonia were excluded. Patients without any bacterial tests for atypical pathogens collected within 24 h after hospital admission were also excluded. Data collection and microbiology for atypical pathogens Data were collected using REDCap™ (Research Electronic Data Capture), an electronic data capture tool hosted on the UT Health server. After study enrolment, participating centers were allowed 7 days to complete electronic data entry and confirm microbiological results. Physicians taking care of CAP patients decided the microbiological work-up according to local standard operating procedures. Serology for atypical pathogens and urinary antigen test for L. pneumophila were performed by local hospital laboratories according to standard techniques. Atypical pathogens were considered: M. pneumoniae , C. pneumoniae , and L. pneumophila . Study groups Definition of CAP caused by atypical pathogens was based on species-specific serology or urinary antigen positivity. Patients tested for atypical pathogens were defined as having at least one of the following tests: urinary antigen test for L. pneumophila, serology for L. Pneumophila , C. pneumoniae, and M. pneumoniae . Study definitions CAP was deemed severe when patients were prescribed one of the following interventions: intensive care unit (ICU) admission, invasive or non-invasive mechanical ventilation, or vasopressor/inotrope administration during the first 24 h after hospital admission. Definition of immunodepression was based on the diagnosis of ≥1of the following medical conditions in the six-month period before hospital admission: hematological malignancy, asplenia, aplastic anemia, neutropenia, long-term exposure to biological drugs or steroids or chemotherapy or immunosuppressive therapy for hematological/solid organ transplantation other than lung transplant, HIV/AIDS, and congenital or genetic immunodepression. All site investigators were provided with a protocol including the above-mentioned clinical definitions. Statistical analysis Testing frequency of atypical pathogens was calculated on all CAP patients in the dataset. Prevalence of an atypical pathogen was computed based on positive results of serology and/or urinary antigen test for L. pneumophila performed during the first 24 h of hospital stay. Categorical variables, expressed as absolute frequencies and percentages, were compared between groups using the Chi-squared test. Regressions analyses were performed to compare prevalence and compute odds ratios (OR) with their 95% confidence interval (CI); furthermore, theywere performed to assess the relationship between atypical pathogen-related pneumonia and demographic, epidemiological, and clinical variables. Circular relation analysis using the Chi-squared test was performed to compare the prevalence between countries and continents. Statistical significance when P was &lt; 0.05. All statistical analyses were performed with IBM SPSS, Statistics for Mac, version 22.0, and STATA 13. Prevalence maps were created using Stat Planet software. Results Testing for atypical pathogens A total of 3702 hospitalized CAP patients were recruited in 54 countries across 6 continents. Among them, 1250 (33.8%) patients were tested for atypical pathogens: 1186 (32.0%) for L. pneumophila (either urinary antigen or serology), 251 (6.8%) for M. pneumoniae (serology), and 228 (6.1%) for C. pneumoniae (serology). Distribution of testing frequencies across countries is showed in Fig. 1a . Fig. 1 a ) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. b ) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure 1 is original and it was created using Stat Planet software with the information created from the study Full size image The frequency of patients tested for atypicals was significantly higher in Europe in comparison with the rest of the world (46.0% VS. 12.7%, P &lt; 0.0001). The lowest testing frequency was recorded in Africa and South America (5.8 and 5.0%, respectively). The highest frequencies of patients tested for atypicals in countries enrolling &gt; 100 CAP patients were detected in Spain (70.8%), Italy (63.8%), Portugal (43.3%), Germany (23.1%), and USA (21.4%) (Table 1 ). Data on testing for L. pneumophila , M. pneumoniae , and C. pneumoniae are reported in the additional files (Additional file 1 : Table A). Detection of L. pneumophila urinary antigen was the most prevalent test performed worldwide (32.0%). Table 1 Testing frequency for atypical pathogens (all) in hospitalized patients with community-acquired pneumonia across different continents and countries Full size table The frequencies of patients tested for atypical pathogens were lower among those with severe CAP in comparison with those with non-severe CAP (30.5% VS. 35.0% for atypical pathogens other than L. pneumophila , P = 0.009; 28.3% VS. 33.5% for L. pneumophila , P = 0.003). L. pneumophila testing was lower in ICU patients. Univariate analysis comparing characteristics of tested and non-tested patients is reported in Table 3 , column A. Prevalence of atypical pathogens At least one atypical pathogen was isolated in 63 (4.7%) patients out of those tested for atypicals. L. pneumophila was detected in 30 (2.5%), M. pneumoniae in 26 (10.3%), and C. pneumoniae in 8 (3.5%) patients. The prevalence of atypical pathogens ranged from 0.0 to 36.4% and from 0.0 to 66.7% across different continents and countries, see Fig. 1b . Italy showed the highest prevalence of atypical pathogens in comparison with the rest of the world (7.5% VS. 4.2%, P = 0.022), whereas Spain showed the lowest prevalence (2.2% VS. 6.5%, P = 0.001) (Table 2 ). Table 2 Prevalence of atypical pathogens in hospitalized patients with community-acquired pneumonia across different continents Full size table Patients with CAP caused by atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison with patients with CAP caused by other pathogens CAP (Table 3 , column B and Table 4 ). Table 3 Clinical characteristics of tested and non-tested patients for both all atypical pathogens and L. pneumophila (column A) and of patients with community-acquired pneumonia caused and not caused by atypical pathogen (column B) Full size table Table 4 Protective factors for atypical pathogens in hospitalized patients with community-acquired pneumonia Full size table Discussion This secondary analysis of the GLIMP database found that only a third of patients hospitalized for CAP were tested for atypical pathogens worldwide, with a large variability among continents and countries. Patients with severe CAP were less likely to be tested for all atypical pathogens. Furthermore, L. pneumophila testing frequency was lower in ICU patients. Among those tested for, the prevalence of CAP caused by atypical pathogens was low. Younger age, female gender, and having a less comorbidities (cardiovascular disease, chronic renal failure) were factors associated with CAP due to atypicals. The most frequent test for atypical pathogens performed in hospitalized patients with CAP was the Legionella urinary antigen (32.0%), followed by Legionella serology, whereas frequency of serological testing for any atypical pathogens was very low (6.8 and 6.1% for M. pneumoniae and C. pneumoniae , respectively). However, information on molecular biology was not retrieved in the GLIMP dataset based on missing recommendations by international guidelines [ 1 , 7 ]. Although molecular techniques was found helpful in the diagnosis of CAP caused by L. pneumophila , findings from different studies showed that single available tests were not reliable for the detection of M. pneumoniae and C. pneumoniae in CAP patients [ 9 , 10 , 11 ]. In addition, molecular studies carried out in large population groups found financial limitations and lack of standardization [ 6 , 12 , 13 ]. Finally, these results are intended to be a real-life snapshot of what it is really done in different countries worldwide; we deem that it is unrealistic a worldwide shift to PCR techniques considering that data presented here suggest that even the most common and affordable test, the urinary antigen for Legionella , is not routinely prescribed. One of the major implications of a poor standardized approach for atypical pathogen testing is the wide heterogeneity across continents and countries. In Europe, almost half of the patients in the GLIMP database was investigated for atypical pathogens, thus resulting in the highest testing frequency. However, among European countries a significant variability was found. For example, the testing frequency was higher in the Mediterranean countries than in Northern Europe, ranging from 10.7% in United Kingdom to 70.8% in Spain. This significant difference may be caused by several factors, including the importance given to atypical pathogens in relation with national epidemiological reports and the lack of interest for this microbiological work-up in countries where extensive empirical therapy is routinely offered to patients. Interestingly, although large differences in frequencies of testing were found, prevalence of atypical pathogens seems to be quite similar in Europe, ranging from 1.6 to 6.5%, with the only exception of Italy and Spain. Furthermore, our data did not suggest significant clinical differences between patients who underwent testing for atypical pathogens and those who did not. The recent guidelines for the management of CAP published by the European Respiratory Society suggest a comprehensive microbiological work-up in severe patients [ 1 ]. However, we found that severe CAP was not a relevant driver for testing. Same results were obtained for other severity indicators, such as ICU admission, invasive/non-invasive mechanical ventilation, and administration of vasopressors. The low frequency testing may be explained by the recommendation of several guidelines on broad empirical coverage in severe patients [ 1 , 14 , 15 , 16 ]. Notably, despite cost-effectiveness and ease of use of urinary antigen test, L. pneumophila testing frequency was also lower in ICU patients. These data are consistent with those showed by Singanayagam who demonstrated that pneumonia severity scores, such as PSI and CURB-65, are poor predictors of microbial etiology and that atypical pathogens are more prevalent in patients with less disease severity at their presentation [ 17 ]. The present study showed that the estimated prevalence of atypical pathogens in hospitalized CAP patients is low during a non-epidemic season (i.e., from March to June). The proportional distribution was heterogeneous and the majority of the reported cases were from Europe. Inter-continent differences suggest that prevalence is lower in Africa and South America. L. pneumophila and M. pneumoniae seem to be the most frequent pathogens worldwide. The prevalence of M. pneumoniae is highest in South America, whereas L. pneumophila did show a homogeneous geographical distribution. L. pneumophila prevalence was similar to that recorded by Viasus (5.4% among 3934 immunocompetent hospitalized CAP patients after a 15-year study) [ 18 ]. Conversely, our data might underestimate the high incidence of legionellosis (12%) in the US population as previously reported by Vergis [ 19 ]. The CAPO database reported on a prevalence for atypical pathogens ranging from 20 to 28% across 21 countries over a five-year period (epidemic seasons included) [ 6 ]. The Authors performed a very comprehensive microbiological work-up including PCR for atypicals for the majority of CAP patients, but it is unclear the proportion of cases diagnosed by serological or molecular techniques. National and regional epidemiological reports showed a prevalence ranging from 9 to 50% [ 20 , 21 , 22 , 23 , 24 ]. Singanayagam and Coworkers recently published a secondary analysis of four independent prospective CAP datasets with atypical pathogens accounting for a global frequency of 14% in patients with identified microbiological positivity [ 17 ]. Interestingly, most of these studies suggested that atypical pathogens are more relevant in the outpatient population [ 17 , 20 , 21 , 22 , 23 , 24 ]. The prevalence estimates on atypical microorganisms might be limited. Even if the combination of serology and molecular techniques was suggested to increase sensitivity, diagnostic tools only accounted on serology for atypical pathogens and urinary antigen for Legionella [ 1 , 25 ]. Then, prevalence estimation can depend on frequency and comprehensiveness of the microbiological work-up. Second, since patients have been enrolled on a single day in the months of March, April and May, most of data come from non-epidemic season in northern hemisphere, thus biasing a plausible estimation of atypical pathogen epidemiology. However, the low testing frequency underscores the poor emphasis given by physicians or local health authorities to the role of atypicals. Therefore, the controversy on empiric coverage for atypical pathogens should be addressed after a more adequate description of the epidemiological burden and a sensitization of attending physicians. Potential risk factors for atypical pathogens were also investigated. In this analysis cardiovascular disease as well as chronic renal failure act as protective factors for atypical etiology. Our understanding is that these results might be a function of age, being patients with atypical pneumonia younger than others. Conclusions In conclusion, this real-life study demonstrates that testing for atypical pathogens in hospitalized patients with CAP is not routinely performed worldwide. Testing for atypical pathogens is poorly standardized and a wide inter-country heterogeneity was found. Testing rates could not appropriately describe prevalence of atypicals in different settings. Further studies are needed to better assess the epidemiological burden and the utility of the current microbiological and clinical recommendations. Change history 13 October 2020 An amendment to this paper has been published and can be accessed via the original article. Abbreviations CAP: Community-acquired pneumonia GLIMP: Global Initiative for MRSA Pneumonia ICU: Intensive care unit References Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72. CAS Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. . Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8. CAS Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8. CAS Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300. CAS Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51. Acknowledgments GLIMP investigators Argentina—Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires, Argentina); Silvia Attorri (Hospital Luis Lagomaggiore, Mendoza, Argentina); Enrique Barimboim (Hospital Central de Mendoza, Argentina); Juan Pablo Caeiro, María I Garzón (Hospital Privado Universitario, Córdoba, Argentina); Victor Hugo Cambursano (V H Dr Cazaux A Servicio de Neumologia, Hospital Rawson, Córdoba, Argentina); Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas, Argentina); Julio Chertcoff , Florencia Lascar, Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital, Buenos Aires, Argentina); Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza, Argentina); Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires, Argentina); Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos, Vicente Lopez y Planes from General Rodriguez, Buenos Aires, Argentina); Sandra Lambert (Hospital El Cruce - Alta Complejidad en Red, Argentina); Gustavo Lopardo, Hospital Bernardo Houssay, Vicente López, Argentina); Carlos M Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires, Argentina); Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen, Argentina); Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos Dr Antonio A Cetrangolo, Argentina); Claudia Pensotti (Infectious Diseases and Infection Control Department, Buenos Aires, Clinica Privada Monte Grande, Argentina); Betiana Pereyra (Hospital San Roque, Córdoba, Argentina); Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D F Santojanni, Argentina); Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela, Argentina). Australia—Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg, Australia). Austria–Felix Lötsch, Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna, Austria). Belgium—Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium); Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp, Belgium); Camille A Francois (Anesthesia and critical care department, Erasme university hospital, Brussels, Belgium); Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium). Benin—Marcel Zannou Djimon, Jules Bashi, Dodo Roger (Centre Hospitalier Universitaire HKM of Cotonou, Benin). Brazil—Simone Aranha Nouér (Federal University of Rio de Janeiro, Rio de Janeiro, Brazil). Bulgaria—Peter Chipev, Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofi a, Bulgaria); Darina Miteva (UMHAT “St. Marina”, Varna, Bulgaria); Diana Petkova (University Hospital Varna, Bulgaria. Cameroon—Balkissou Adamou Dodo (Yaounde Jamot Hospital, Yaounde, Cameroon); Mbatchou Ngahane Bertrand Hugo (Douala General Hospital, Douala, Cameroon). China—Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing, China); Jin-fu Xu, (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University, China). Colombia— Carlos Andres Bustamante Rico, Ricardo Buitrago (Clinica Shaio, Bogota, Colombia); Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin, Colombia). Congo—Kayembe Ntumba Jean-Marie (Cliniques Universitaires de Kinshasa, DR Congo). Croatia—Vesna Vladic Carevic (Interne Medicine, Dubrovnik, Croatia); Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, Zagreb, Croatia); Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases, Zagreb, Croatia); Zinka Matkovic (University Hospital Dubrava, Zagreb, Croatia); Ivan Mitrecic (Karlovac general hospital, Karlovac, Croatia). Denmark—Marie-Laure Bouchy Jacobsson (Emergency Department in North Zealand Hospital – Hillerød, Denmark); Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital, Denmark); Uff e Christian HeitmannBødtger (Department of Pulmonology, Naestved Hospital, Denmark); Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde, Denmark); Andreas Vestergaard Jensen, Gertrud Baunbæk-knudsen, Pelle Trier Petersen and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød, Denmark). Egypt—Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University, Egypt); Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt); Hanaa Shafi ek (Chest diseases department, Faculty of Medicine, Alexandria University, Egypt); Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo, Egypt). France— Fabrice Bertrand (Critical care Unit, Robert Ballanger Hospital, Aulnay sous Bois, France); Christian Brun- Buisson (Univ Hospital Henri Mondor, 94000 Créteil, France); Etienne de Montmollin (Intensive care unit, Hôpital Delafontaine, Centre hospitalier de Saint-Denis, Saint-Denis, France); Muriel Fartoukh (Unité de réanimation médico-chirurgicale, Pôle Thorax Voies aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien, France); Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médicochirurgicale, Hôpital Louis Mourier, Colombes, France, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France); Pierre Tattevin (Infectious Diseases &amp; ICU, Pontchaillou University Hospital, Rennes, France). Germany—Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen, Aachen, Germany); Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany); Matthias Meisinger (Klinikum Niederlausitz GmbH, Klinik für Innere Medizin und Intensivmedizin, Senftenberg, Germany); Mathias W Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital, Germany); Jan Rupp (Department of Molecular and Infectious Diseases, University of Lübeck, Lübeck, Germany); Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg, Germany); Marc Spielmanns (Internal Medicine Department, Pulmonary rehabilitation and Department of Health, School of Medicine, University Witten- Herdecke, St Remigius-Hospital, Leverkusen, Germany). Ghana—Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi, Ghana). Greece—Katerina Dimakou (5th Rerpiratory Medicine Dpt, “SOTIRIA” Chest Hospital, Athens, Greece); Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens, Greece); Evdoxia Tsigou and Dimitrios Ampazis, Agioi Anargiroi Hospital, Kifi ssia, Athens, Greece). India—Mohit Bhatia (S S Hospital IMS BHU Varanasi, India); Raja Dhar (Fortis Hospitals, Kolkata, India); George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore, India); Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow, India); Parvaiz A Koul (Department of Internal &amp; Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar, India); P A Mahesh and B S Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore, India); Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala, India); Hirennappa B Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka, India). Iran—Keihan Golshani (Isfahan University of Medical Sciences, Iran). Ireland—Vera M Keatings (Letterkenny General Hospital, Co. Donegal, Ireland); Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization (MICRO), St James’s University Hospital, Trinity Centre for Health Sciences Dublin, Ireland). Israel—Yasmin Maor (Infectious Disease Unit, Affi liated to Tel Aviv University, Wolfson Medical Center, Holon, Israel); Jacob Strahilevitz (Department of Clinical Microbiology &amp; Infectious Diseases, Hadassah-Hebrew University, Jerusalem, Israel). Italy—Salvatore Battaglia (University of Palermo, Pneumologia DiBiMIS, Palermo, Italy); Maria Carrabba (Internal Medicine Department, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Italy); Piero Ceriana (Pulmonary rehabilitation, IRCCS Fondazione Maugeri, Pavia Italy); Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste, Italy); Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan, Italy); Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples, Italy); Marino De Rosa (UOC Pneumologia San Filippo Neri ASL RM E, Rome, Italy); Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena, Italy); Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria AO Ospedali dei Colli PO, Monaldi, Italy); Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, ASL 5 Oristano, Sardegna, Italy); Francesco Menzella (Department of Cardiac- Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS- Arcispedale Santa Maria Nuova, Reggio Emilia, Italy); Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S Anna Nuovo, Unità Operativa di Pneumologia, Como, Italy); Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital, Italy); Gerardo Palmiero (Respiratory Unity, Versilia Hospital, Azienda USL 12 Viareggio, Lido di Camaiore, Lucca, Italy); Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli, Italy); Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine, Italy); Claudio Sorino (Pulmonology Unit, AO Sant’Anna di Como, Italy); Gundi Steinhilber (Spedali Civili Brescia, UO Pneumologia e Fisiopatologia Respiratoria, Brescia, Italy); Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta, Italy). Japan—Kiyoyasu Kurahashi (Yokohama City University Medical Center, Japan). Lebanon—Zeina Aoun Bacha (Medicine school, St Joseph University, Beyrouth, Lebanon). Mexico—Daniel Barajas Ugalde (National Institute of Respiratory Diseases, Mexico); Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California, Mexico); José F Villegas (Hospital Universitario Monterrey, México). Montenegro—Milic Medenica, Hospital for Lung Diseases—Brezovik, Niksic, Montenegro). Netherlands—E M W van de Garde (Dept. Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein, Netherlands). Nepal—Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences, Nepal); Poojan Shrestha, Oxford University Clinical Research Unit, Patan Hospital, Nepal). New Zealand—Elliott Ridgeon (Medical Research Institute of New Zealand). Nigeria—Babatunde Ishola Awokola (Department of Family Medicine &amp; Primary Care, Lily Hospitals Limited, Warri, Nigeria); Ogonna N O Nwankwo (University of Calabar Teaching Hospital, Calabar, Nigeria); Adefuye Bolanle Olufunlola (Olabisi Onabanjo University teaching hospital, Sagamu, Ogun State, Nigeria); Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan, Nigeria); Kingsley N Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria). Pakistan—Muhammad Irfan (Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Karachi, Pakistan). Poland—Lukasz Minarowski (Department of Lung Diseaes and Tuberculosis, Medical University of Bialystok, Poland); Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec, Poland). Portugal—Felipe Froes (Hospital Pulido Valente - CHLN, Lisboa, Portugal); Pedro Leuschner (Centro Hospitalar do Porto, Porto, Portugal); Mariana Meireles, Cláudia Ferrão, Pedro Leuschner and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo, Abel Salazar, Porto, Portugal); Sofi a B Ravara (Faculty of Health Sciences, University of Beira Interior); Cova da Beira Hospital Center, Covilhã, Portugal). Moldova—Victoria Brocovschii (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Moldova); Chesov Ion (Clinic of Anesthesia and Intensive Care “Valeriu Ghrerg”, Institute of Emergency Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova); Doina Rusu (SMFU “N Testemitanu”, Chisinau, Moldova); Cristina Toma (Department of Pneumology &amp; Allergology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, Chisinau, Moldova). Romania—Daniela Chirita (Hospital Sfantul Stefan, Bucharest, Romania). Russia—Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S I Georgievsky, Russia); Anna Kaluzhenina (Volgograd State Medical University, Russia). Saudi Arabia—Abdullah Almotairi (King Fahad medical City (KFMC), Riyadh, Saudi Arabia); Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina, Saudi Arabia); Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh, Saudi Arabia); Amal Fathy (Pulmonary and respiratory critical care Medicine, Mansoura University Egypt, Affi liate at Taibah University, Saudi Arabia); Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh, Saudi Arabia); Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa, 31982, Saudi Arabia). Serbia—Nada Bogdanović (Pulmonary department of KHC Dr Dragiša Mišović, Belgrade, Serbia); Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia); Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade, Serbia). Spain—Luis Borderìas, Respiratoy and Sleep Unit, Hospital San Jorge, Huesca, Spain); Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at sant Joan Despí, Spain); Hugo Cabello Alarcón, Sant Hospital Seu de Urgell, Catalonia, Spain); Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona - Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Ciber de Enfermedades Respiratorias (CIBERES), Spain); Vicens Diaz-Brito and Xavier Casas (Infectious diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona, Spain); Alicia Encabo González (Hospital Complex of Pontevedra, Spain); Maria Luisa FernándezAlmira (Medicina Interna, Hospital Universitario Central de Asturias, Spain); Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, Spain. CIBER de Enfermedades Respiratorias, CIBERES, Bunyola, Spain); Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga, Spain); Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid, Spain); Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante, Spain); Elena Laserna Martínez (Hospital Mollet, Barcelona, Spain); Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid); Pedro J Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña CHUAC, INIBIC, Sergas, Universidade de A Coruña, Spain); Rosario Menéndez (Pneumology Service, Universitary and Polytechnic Hospital La Fe, Valencia, Spain); Ana Pando-Sandoval (Hospital Universitario Central de Asturias. Area de Gestion Clinica de Pulmon. Servicio de Neumologia, Oviedo, Spain); Cristina Prat Aymerich, Alicia Lacoma del la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, Spain; Universitat Autònoma de Barcelona; CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Spain); Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d›Hebron, Barcelona, Spain); Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia, Spain); Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona, Spain); Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain); Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo, Spain); Job FM van Boven (Hospital Universitari Son Espases, Palma de Mallorca, Spain); Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró, Spain). South Africa—Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa). South Korea—Ho Kee Yum (Inje Univ. Seoul Paik Hospital, South Korea). Togo—Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University hospital of Sylvanus Olympio, Lomé, Togo). Tunisia—Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security (I.F.S), Marsa, Tunis, Tunisia). Turkey—Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir, Turkey); Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul, Turkey); Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir, Turkey). Ukraine—Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa regional antituberculosis hospital, Vinnitsa, Ukraine). United Arab Emirates—Naheed Elahi (Dubai Hospital, UAE.); UK—Devesh J Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife, UK); Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann (University Hospitals of Leicester NHS Trust and University of Leicester, Leicester, UK); Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool, UK); Adam T Hill (Royal Infi rmary and University of Edinburgh, UK); Banu Rudran (The Royal London Hospital, Barts Health Trust, London, UK); Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, Eaglesham Road, East Kilbride, UK); Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds, UK). USA—Karen S Allen (University of Oklahoma Health Sciences Center, OK, USA); Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care and Sleep Medicine Baylor Scott &amp; White Health, TX, USA); Jessica Dietz (Fargo VA Health Care System, Fargo, ND, USA); Claire E Dysart and Susan M Kellie (Clement J Zablocki VA Medical Center, Milwaukee, WI, USA, Division of Infectious Diseases, University of New Mexico School of Medicine, Raymond G Murphy VA Medical Center, Albuquerque, NM, USA); Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, MI, USA); Mina Gaga (7th Resp Med Dept and Asthma Center, Athens Chest Hospital, USA); Thomas L Holland and Stephen P Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, NC, USA); Fayez Kheir (Department Pulmonary Diseases, Critical Care &amp; Environmental Medicine, Tulane University Health Sciences Center, New Orleans, LA, USA); Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, IL, USA); Manuel Lois (John Peter Smith Hospital, Fort Worth, TX, USA); Girish B Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook Winthrop University Hospital, Mineola, NY, USA); Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, USA); Katherine Reyes (Henry Ford Hospital, Detroit, IL, USA); William Rodriguez-Cintron (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, USA); Shigeki Saito (Tulane University, New Orleans, USA); Nilam J Soni, Julio Noda, Cecilia I Hinojosa, Stephanie M Levine, Luis F Angel, and Antonio Anzueto (Divisions of Hospital Medicine &amp; Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio, TX, USA); K Scott Whitlow, John Hipskind, and Kunal Sukhija (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, CA, USA); Richard G. Wunderink and Ray D Shah (Northwestern University Feinberg School of Medicine, Chicago, IL, USA). Zambia—Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka, Zambia). Ethics approval and consent to partecipate The coordinating center (University of Texas Health at San Antonio -UT Health- Texas, USA) received project approval by the Institutional Review Board (IRB# HSC20150184E). All participating centers followed their local law and regulations. Avaibility of data and materials The database used for the study is not public but it is available from the corresponding author on reasonable request. Funding The authors did not receive any funding for this study. Author information Authors and Affiliations Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory unit and Adult Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy Andrea Gramegna, Marta Di Pasquale, Francesco Blasi &amp; Stefano Aliberti Clinical Epidemiology and Medical Statistics Unit, Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy Giovanni Sotgiu Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Section of Respiratory Diseases, Ospedale L. Sacco, ASST Fatebenefratelli-Sacco, Milan, Italy Dejan Radovanovic Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Milan, Italy Silvia Terraneo Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA Luis F. Reyes &amp; Marcos I. Restrepo Intensive Care Unit, Hospital de Matarò, Consorci Sanitari del Maresme, Carretera de Cirera s/n, 08304 Matarò, Barcelona, Spain Ester Vendrell Internal Medicine Department, Centro Hospitalar do Porto, Porto, Portugal Joao Neves Department of Medical Specialties, Pneumology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda USL Reggio Emilia, Italy Francesco Menzella Authors Andrea Gramegna View author publications You can also search for this author in Giovanni Sotgiu View author publications You can also search for this author in Marta Di Pasquale View author publications You can also search for this author in Dejan Radovanovic View author publications You can also search for this author in Silvia Terraneo View author publications You can also search for this author in Luis F. Reyes View author publications You can also search for this author in Ester Vendrell View author publications You can also search for this author in Joao Neves View author publications You can also search for this author in Francesco Menzella View author publications You can also search for this author in Francesco Blasi View author publications You can also search for this author in Stefano Aliberti View author publications You can also search for this author in Marcos I. Restrepo View author publications You can also search for this author in Consortia on behalf of the GLIMP Study Group Contributions AG, SA and GS analyzed the dataset. AG, SA, GS, MDP, DR and ST interpreted the patient data. LFR took charge of Figs. EV, JN, FM, FB and MIR along with all the auothors read and approved the final manuscript. Corresponding author Correspondence to . Ethics declarations Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests for this study. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Additional file Table A: Tables with testing frequencies for specific atypical pathogens across continents (A1: Testing frequencies for C. pneumoniae across continents; A2: Testing frequencies for M. pneumoniae across continents; A3: Testing frequencies for L. pneumophila across continents).- Brief description of the data : a table in three parts reporting data about frequency of testing for different atypical pathogens across different continents. (DOC 50 kb) Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver () applies to the data made available in this article, unless otherwise stated. About this article Cite this article Gramegna, A., Sotgiu, G., Di Pasquale, M. et al. Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. BMC Infect Dis 18 , 677 (2018). https://doi.org/10.1186/s12879-018-3565-z Received : 28 May 2018 Accepted : 28 November 2018 Published : 18 December 2018 DOI : https://doi.org/10.1186/s12879-018-3565-z Share this article Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative Keywords CAP Atypical pathogens Epidemiology Download PDF Sections Figures References Abstract Background Methods Results Discussion Conclusions Change history Abbreviations References Acknowledgments Author information Ethics declarations Additional file Rights and permissions About this article Advertisement Fig. 1 View in article Full size image Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72. CAS Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12. Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418. Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13. Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72. Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. . Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5. von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62. Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9. Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8. CAS Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55. Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8. CAS Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306. Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306. Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300. CAS Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6. Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43. Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82. Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8. Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6. Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51. BMC Infectious Diseases ISSN: 1471-2334 Contact us General enquiries: Read more on our blogs Receive BMC newsletters Manage article alerts Policies Accessibility Press center Support and Contact Careers Follow BMC By using this website, you agree to our Terms and Conditions , , Privacy statement and Cookies policy. we use in the preference centre. © 2025 BioMed Central Ltd unless otherwise stated. Part of ."
      },
      "media": {
        "images": [
          {
            "src": "//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png",
            "data": "",
            "alt": "figure 1",
            "desc": "a ) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. b ) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure 1 is original and it was created using Stat Planet software with the information created from the study",
            "score": 6,
            "type": "image",
            "group_id": 2,
            "format": "png",
            "width": null
          },
          {
            "src": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png",
            "data": "",
            "alt": "figure 1",
            "desc": "Fig. 1 View in article Full size image",
            "score": 3,
            "type": "image",
            "group_id": 3,
            "format": "png",
            "width": null
          }
        ],
        "videos": [],
        "audio": [],
        "all_media": {
          "images": [
            {
              "src": "//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png",
              "data": "",
              "alt": "figure 1",
              "desc": "a ) Worldwide map on testing for atypical pathogens in hospitalized patients with community-acquired pneumonia (CAP) by country. Denominator: all CAP for each country. b ) Worldwide map on prevalence of atypical pathogens in community-acquired pneumonia (CAP) in hospitalized patients by country. Denominator: all CAP tested for atypical pathogens for each country. Figure 1 is original and it was created using Stat Planet software with the information created from the study",
              "score": 6,
              "type": "image",
              "group_id": 2,
              "format": "png",
              "width": null
            },
            {
              "src": "https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png",
              "data": "",
              "alt": "figure 1",
              "desc": "Fig. 1 View in article Full size image",
              "score": 3,
              "type": "image",
              "group_id": 3,
              "format": "png",
              "width": null
            }
          ],
          "videos": [],
          "audios": []
        }
      },
      "links": {
        "internal": [
          {
            "href": "https://www.biomedcentral.com/privacy-statement",
            "text": "privacy policy",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#main-content",
            "text": "Skip to main content",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com",
            "text": "",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/journals",
            "text": "Explore journals",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/getpublished",
            "text": "Get published",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/about",
            "text": "About BMC",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/login",
            "text": "Login",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/",
            "text": "BMC Infectious Diseases",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/about",
            "text": "About",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles",
            "text": "Articles",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/submission-guidelines",
            "text": "Submission Guidelines",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/join-our-editorial-board",
            "text": "Join the board",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/collections",
            "text": "Collections",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf",
            "text": "Download PDF",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Andrea-Gramegna-Aff1",
            "text": "Andrea Gramegna",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff1",
            "text": "1",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Giovanni-Sotgiu-Aff2",
            "text": "Giovanni Sotgiu",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff2",
            "text": "2",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Marta-Pasquale-Aff1",
            "text": "Marta Di Pasquale",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Dejan-Radovanovic-Aff3",
            "text": "Dejan Radovanovic",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff3",
            "text": "3",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Silvia-Terraneo-Aff4",
            "text": "Silvia Terraneo",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff4",
            "text": "4",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Luis_F_-Reyes-Aff5",
            "text": "Luis F. Reyes",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff5",
            "text": "5",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Ester-Vendrell-Aff6",
            "text": "Ester Vendrell",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff6",
            "text": "6",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Joao-Neves-Aff7",
            "text": "Joao Neves",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff7",
            "text": "7",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Francesco-Menzella-Aff8",
            "text": "Francesco Menzella",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff8",
            "text": "8",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Francesco-Blasi-Aff1",
            "text": "Francesco Blasi",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Stefano-Aliberti-Aff1",
            "text": "Stefano Aliberti",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Marcos_I_-Restrepo-Aff5",
            "text": "Marcos I. Restrepo",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#group-1",
            "text": "on behalf of the GLIMP Study Group",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#citeas",
            "text": "Cite this article",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/metrics",
            "text": "Metrics details",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05472-y",
            "text": "Correction",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#change-history",
            "text": "updated",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/peer-review",
            "text": "Peer Review reports",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1",
            "text": "1",
            "title": "Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR2",
            "text": "2",
            "title": "Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR3",
            "text": "3",
            "title": "Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR4",
            "text": "4",
            "title": "Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR5",
            "text": "5",
            "title": "Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6",
            "text": "6",
            "title": "Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7",
            "text": "7",
            "title": "Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n                    https://doi.org/10.1111/j.1469-0691.2011.03672.x.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8",
            "text": "8",
            "title": "Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n                    https://doi.org/10.1016/S1473-3099(16)30267-5\n                    \n                  .",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1",
            "text": "1a",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1",
            "text": "",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab1",
            "text": "1",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#MOESM1",
            "text": "1",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/1",
            "text": "Full size table",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3",
            "text": "3",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab2",
            "text": "2",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/2",
            "text": "Full size table",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab4",
            "text": "4",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/3",
            "text": "Full size table",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/4",
            "text": "Full size table",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR9",
            "text": "9",
            "title": "Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR10",
            "text": "10",
            "title": "von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR11",
            "text": "11",
            "title": "Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR12",
            "text": "12",
            "title": "Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR13",
            "text": "13",
            "title": "Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n                    https://doi.org/10.1186/s12879-016-1641-9.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR14",
            "text": "14",
            "title": "Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR15",
            "text": "15",
            "title": "Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR16",
            "text": "16",
            "title": "Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17",
            "text": "17",
            "title": "Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR18",
            "text": "18",
            "title": "Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR19",
            "text": "19",
            "title": "Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR20",
            "text": "20",
            "title": "Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR21",
            "text": "21",
            "title": "Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR22",
            "text": "22",
            "title": "Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR23",
            "text": "23",
            "title": "Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24",
            "text": "24",
            "title": "Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR25",
            "text": "25",
            "title": "Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D",
            "text": "CAS",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D",
            "text": "CAS",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D",
            "text": "CAS",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D",
            "text": "CAS",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Joao%20Neves",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo",
            "text": "View author publications",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/search?query=CAP&facet-discipline=\"Medicine%20%26%20Public%20Health\"",
            "text": "CAP",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/search?query=Atypical%20pathogens&facet-discipline=\"Medicine%20%26%20Public%20Health\"",
            "text": "Atypical pathogens",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/search?query=Epidemiology&facet-discipline=\"Medicine%20%26%20Public%20Health\"",
            "text": "Epidemiology",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Abs1",
            "text": "Abstract",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec1",
            "text": "Background",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec2",
            "text": "Methods",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec8",
            "text": "Results",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec11",
            "text": "Discussion",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec12",
            "text": "Conclusions",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#abbreviations",
            "text": "Abbreviations",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Bib1",
            "text": "References",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Ack1",
            "text": "Acknowledgments",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#author-information",
            "text": "Author information",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ethics",
            "text": "Ethics declarations",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec13",
            "text": "Additional file",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#rightslink",
            "text": "Rights and permissions",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#article-info",
            "text": "About this article",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Fig1",
            "text": "View in article",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://blogs.biomedcentral.com/",
            "text": "Read more on our blogs",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/login",
            "text": "Receive BMC newsletters",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/account",
            "text": "Manage article alerts",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/about/policies",
            "text": "Policies",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/accessibility",
            "text": "Accessibility",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/about/press-centre",
            "text": "Press center",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://support.biomedcentral.com/support/home",
            "text": "Support and Contact",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/about/jobs",
            "text": "Careers",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/terms-and-conditions",
            "text": "Terms and Conditions",
            "title": "",
            "base_domain": "biomedcentral.com"
          },
          {
            "href": "https://www.biomedcentral.com/cookies",
            "text": "Cookies",
            "title": "",
            "base_domain": "biomedcentral.com"
          }
        ],
        "external": [],
        "all_links": {
          "internal": [
            {
              "href": "https://www.biomedcentral.com/privacy-statement",
              "text": "privacy policy",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#main-content",
              "text": "Skip to main content",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com",
              "text": "",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/journals",
              "text": "Explore journals",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/getpublished",
              "text": "Get published",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/about",
              "text": "About BMC",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/login",
              "text": "Login",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/",
              "text": "BMC Infectious Diseases",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/about",
              "text": "About",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles",
              "text": "Articles",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/submission-guidelines",
              "text": "Submission Guidelines",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/join-our-editorial-board",
              "text": "Join the board",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/collections",
              "text": "Collections",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/s12879-018-3565-z.pdf",
              "text": "Download PDF",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Andrea-Gramegna-Aff1",
              "text": "Andrea Gramegna",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff1",
              "text": "1",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Giovanni-Sotgiu-Aff2",
              "text": "Giovanni Sotgiu",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff2",
              "text": "2",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Marta-Pasquale-Aff1",
              "text": "Marta Di Pasquale",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Dejan-Radovanovic-Aff3",
              "text": "Dejan Radovanovic",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff3",
              "text": "3",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Silvia-Terraneo-Aff4",
              "text": "Silvia Terraneo",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff4",
              "text": "4",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Luis_F_-Reyes-Aff5",
              "text": "Luis F. Reyes",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff5",
              "text": "5",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Ester-Vendrell-Aff6",
              "text": "Ester Vendrell",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff6",
              "text": "6",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Joao-Neves-Aff7",
              "text": "Joao Neves",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff7",
              "text": "7",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Francesco-Menzella-Aff8",
              "text": "Francesco Menzella",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Aff8",
              "text": "8",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Francesco-Blasi-Aff1",
              "text": "Francesco Blasi",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Stefano-Aliberti-Aff1",
              "text": "Stefano Aliberti",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#auth-Marcos_I_-Restrepo-Aff5",
              "text": "Marcos I. Restrepo",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#group-1",
              "text": "on behalf of the GLIMP Study Group",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#citeas",
              "text": "Cite this article",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/metrics",
              "text": "Metrics details",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-05472-y",
              "text": "Correction",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#change-history",
              "text": "updated",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/peer-review",
              "text": "Peer Review reports",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR1",
              "text": "1",
              "title": "Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27–72.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR2",
              "text": "2",
              "title": "Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, Nakamatsu R, Pena S, Guinn BE, Furmanek SP, Persaud AK, Raghuram A, Fernandez F, Beavin L, Bosson R, Fernandez-Botran R, Cavallazzi R, Bordon J, Valdivieso C, Schulte J, Carrico RM. University of Louisville Pneumonia Study Group. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017 Nov 13;65(11):1806–12.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR3",
              "text": "3",
              "title": "Eliakim-Raz N, Robenshtok E, Shefet D, Gafter-Gvili A, Vidal L, Paul M, Leibovici L. Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD004418.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR4",
              "text": "4",
              "title": "Arnold FW, Summersgill JT, Ramirez JA. Role of atypical pathogens in the etiology of community-acquired pneumonia. Semin Respir Crit Care Med. 2016 Dec;37(6):819–28 Epub 2016 Dec 13.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR5",
              "text": "5",
              "title": "Tao LL, Hu BJ, He LX, Wei L, Xie HM, Wang BQ, Li HY, Chen XH, Zhou CM, Deng WW. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012 Sep;125(17):2967–72.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR6",
              "text": "6",
              "title": "Arnold FW, Summersgill JT, Lajoie AS, Peyrani P, Marrie TJ, Rossi P, Blasi F, Fernandez P, File TM Jr, Rello J, Menendez R, Marzoratti L, Luna CM, Ramirez JA. Community-acquired pneumonia organization (CAPO) investigators. A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007 May 15;175(10):1086–93.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR7",
              "text": "7",
              "title": "Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Read R, Verheij TJ. Joint taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect. 2011 Nov;17(Suppl 6):E1–59. \n                    https://doi.org/10.1111/j.1469-0691.2011.03672.x.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR8",
              "text": "8",
              "title": "Aliberti S, Reyes LF, Faverio P, Sotgiu G, Dore S, Rodriguez AH, Soni NJ, Restrepo MI, investigators GLIMP. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. Lancet Infect Dis. 2016 Dec;16(12):1364–76. \n                    https://doi.org/10.1016/S1473-3099(16)30267-5\n                    \n                  .",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Fig1",
              "text": "1a",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/figures/1",
              "text": "",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab1",
              "text": "1",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#MOESM1",
              "text": "1",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/1",
              "text": "Full size table",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab3",
              "text": "3",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab2",
              "text": "2",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/2",
              "text": "Full size table",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#Tab4",
              "text": "4",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/3",
              "text": "Full size table",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/tables/4",
              "text": "Full size table",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR9",
              "text": "9",
              "title": "Martinez MA, Ruiz M, Zunino E, Luchsinger V, Avendano LF. Detection of mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol. 2008;57(Pt 12):1491–5.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR10",
              "text": "10",
              "title": "von BH, Welte T, Marre R, Suttorp N, Luck C, Ewig S. Mycoplasma pneumoniae pneumonia revisited within the German competence network for community-acquired pneumonia (CAPNETZ). BMC Infect Dis. 2009;9:62.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR11",
              "text": "11",
              "title": "Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR12",
              "text": "12",
              "title": "Welte T, Suttorp N, Marre R. CAPNETZ: community-acquired pneumonia competence network. Infection. 2004;32:234–8.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR13",
              "text": "13",
              "title": "Raeven VM, Spoorenberg SM, Boersma WG, van de Garde EM, Cannegieter SC, Voorn GP, Bos WJ, van Steenbergen JE, Alkmaar study group, Ovidius study group. Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infect Dis. 2016 Jun 17;16:299. \n                    https://doi.org/10.1186/s12879-016-1641-9.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR14",
              "text": "14",
              "title": "Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64: Suppl. 3, iii1–ii55.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR15",
              "text": "15",
              "title": "Yanagihara K, Kohno S, Matsusima T. Japanese guidelines for the management of community-acquired pneumonia. Int J Antimicrob Agents. 2001;18(Suppl. 1):S45–8.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR16",
              "text": "16",
              "title": "Working Group of the South African Thoracic Society. Management of community-acquired pneumonia in adults. S Afr Med J. 2007;97:1296–306.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR17",
              "text": "17",
              "title": "Singanayagam A, Aliberti S, Cillóniz C, et al. Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017;50:1602306.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR18",
              "text": "18",
              "title": "Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F, Carratalà J. Community- acquired legionella pneumophila pneumonia:a single- center experience with 214 hospitalized sporadic cases over 15 years. Medicine. 2012;92:51–60.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR19",
              "text": "19",
              "title": "Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J, Sarosi GA, Grayston JT, Summersgill J, Yu VL. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med. 2000 May 8;160(9):1294–300.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR20",
              "text": "20",
              "title": "Luchsinger V, Ruiz M, Zunino E, Martínez MA, Machado C, Piedra PA, Fasce R, Ulloa MT, Fink MC, Lara P, Gebauer M, Chávez F, Avendaño LF. Community- acquired pneumonia in Chile: the clinical relevance in the detection of viruses and atypical bacteria. Thorax. 2013;68:1000–6.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR21",
              "text": "21",
              "title": "Spoorenberg SM, Bos WJ, Heijligenberg R, Voorn PG, Grutters JC, Rijkers GT, van de Garde EM. Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis. BMC Infect Dis. 2014;14:335–43.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR22",
              "text": "22",
              "title": "Shibli F, Chazan B, Nitzan O, Flatau E, Edelstein H, Blondheim O, Raz R, Colodner R. Etiology of community-acquired pneumonia in hospitalized patients in northern Israel. Isr Med Assoc J. 2010;12:477–82.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ref-CR23",
              "text": "23",
              "title": "Chen K, Jia R, Li L, Yang C, Shi Y. The aetiology of community associated pneumonia in children in Nanjing, China and aetiological patternsassociated with age and season. BMC Public Health. 2015;15:113–8.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR24",
              "text": "24",
              "title": "Arancibia F, Cortes CP, Valdés M, Cerda J, Hernández A, Soto L, Torres A. Importance of legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago. Chile Chest. 2014;145:290–6.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z#ref-CR25",
              "text": "25",
              "title": "Templeton KE, Scheltinga SA, van den Eeden WC, Graffelman AW, van den Broek PJ, Claas EC. Improved diagnosis of the etiology of community- acquired pneumonia with real-time polymerase chain reaction. Clin Infect Dis. 2005;41:345–51.",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD2sXjtVWrs74%3D",
              "text": "CAS",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:STN:280:DC%2BD2czovVWhsg%3D%3D",
              "text": "CAS",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3MXntVWrsb4%3D",
              "text": "CAS",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/cas-redirect/1:CAS:528:DC%2BD3cXjslKnsLY%3D",
              "text": "CAS",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Andrea%20Gramegna",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Giovanni%20Sotgiu",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Marta%20Di%20Pasquale",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Dejan%20Radovanovic",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Silvia%20Terraneo",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Luis%20F.%20Reyes",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Ester%20Vendrell",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Joao%20Neves",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Francesco%20Menzella",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Francesco%20Blasi",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Stefano%20Aliberti",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/search?query=author%23Marcos%20I.%20Restrepo",
              "text": "View author publications",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/search?query=CAP&facet-discipline=\"Medicine%20%26%20Public%20Health\"",
              "text": "CAP",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/search?query=Atypical%20pathogens&facet-discipline=\"Medicine%20%26%20Public%20Health\"",
              "text": "Atypical pathogens",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/search?query=Epidemiology&facet-discipline=\"Medicine%20%26%20Public%20Health\"",
              "text": "Epidemiology",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Abs1",
              "text": "Abstract",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec1",
              "text": "Background",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec2",
              "text": "Methods",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec8",
              "text": "Results",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec11",
              "text": "Discussion",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec12",
              "text": "Conclusions",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#abbreviations",
              "text": "Abbreviations",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Bib1",
              "text": "References",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Ack1",
              "text": "Acknowledgments",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#author-information",
              "text": "Author information",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#ethics",
              "text": "Ethics declarations",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Sec13",
              "text": "Additional file",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#rightslink",
              "text": "Rights and permissions",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#article-info",
              "text": "About this article",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z/#Fig1",
              "text": "View in article",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://blogs.biomedcentral.com/",
              "text": "Read more on our blogs",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/login",
              "text": "Receive BMC newsletters",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/account",
              "text": "Manage article alerts",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/about/policies",
              "text": "Policies",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/accessibility",
              "text": "Accessibility",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/about/press-centre",
              "text": "Press center",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://support.biomedcentral.com/support/home",
              "text": "Support and Contact",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/about/jobs",
              "text": "Careers",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/terms-and-conditions",
              "text": "Terms and Conditions",
              "title": "",
              "base_domain": "biomedcentral.com"
            },
            {
              "href": "https://www.biomedcentral.com/cookies",
              "text": "Cookies",
              "title": "",
              "base_domain": "biomedcentral.com"
            }
          ],
          "external": []
        }
      },
      "structured_data": {},
      "json_ld": [],
      "microdata": {},
      "rdfa": {},
      "screenshot": null,
      "meta_tags": {},
      "page_title": "",
      "headers": {},
      "cookies": [],
      "performance_metrics": {},
      "content_analysis": {
        "sizes": {
          "raw_html_size": 475539,
          "cleaned_html_size": 89447,
          "markdown_size": 86943,
          "text_length": 61281
        },
        "counts": {
          "images_count": 2,
          "videos_count": 0,
          "internal_links_count": 120,
          "external_links_count": 0,
          "total_links_count": 120
        },
        "quality_indicators": {
          "has_title": true,
          "has_description": true,
          "has_images": true,
          "has_structured_data": false,
          "content_richness_score": 65
        }
      },
      "logos": [],
      "institution_hints": {
        "institution_type": "hospital",
        "detected_keywords": [
          "hospital",
          "medical",
          "health",
          "patient",
          "care",
          "treatment",
          "clinic",
          "emergency",
          "surgery"
        ],
        "contact_indicators": [],
        "social_media_present": false
      }
    },
    "content_quality_score": 65,
    "metadata": {
      "title": "Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective | BMC Infectious Diseases | Full Text",
      "description": "Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p &lt; 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.",
      "keywords": null,
      "author": null,
      "og:url": "https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-018-3565-z",
      "og:type": "article",
      "og:site_name": "BioMed Central",
      "og:title": "Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective - BMC Infectious Diseases",
      "og:description": "Background Empirical antibiotic coverage for atypical pathogens in community-acquired pneumonia (CAP) has long been debated, mainly because of a lack of epidemiological data. We aimed to assess both testing for atypical pathogens and their prevalence in hospitalized patients with CAP worldwide, especially in relation with disease severity. Methods A secondary analysis of the GLIMP database, an international, multicentre, point-prevalence study of adult patients admitted for CAP in 222 hospitals across 6 continents in 2015, was performed. The study evaluated frequency of testing for atypical pathogens, including L. pneumophila, M. pneumoniae, C. pneumoniae, and their prevalence. Risk factors for testing and prevalence for atypical pathogens were assessed through univariate analysis. Results Among 3702 CAP patients 1250 (33.8%) underwent at least one test for atypical pathogens. Testing varies greatly among countries and its frequency was higher in Europe than elsewhere (46.0% vs. 12.7%, respectively, p < 0.0001). Detection of L. pneumophila urinary antigen was the most common test performed worldwide (32.0%). Patients with severe CAP were less likely to be tested for both atypical pathogens considered together (30.5% vs. 35.0%, p = 0.009) and specifically for legionellosis (28.3% vs. 33.5%, p = 0.003) than the rest of the population. Similarly, L. pneumophila testing was lower in ICU patients. At least one atypical pathogen was isolated in 62 patients (4.7%), including M. pneumoniae (26/251 patients, 10.3%), L. pneumophila (30/1186 patients, 2.5%), and C. pneumoniae (8/228 patients, 3.5%). Patients with CAP due to atypical pathogens were significantly younger, showed less cardiovascular, renal, and metabolic comorbidities in comparison to adult patients hospitalized due to non-atypical pathogen CAP. Conclusions Testing for atypical pathogens in patients admitted for CAP in poorly standardized in real life and does not mirror atypical prevalence in different settings. Further evidence on the impact of atypical pathogens, expecially in the low-income countries, is needed to guidelines implementation.",
      "og:image": "https://static-content.springer.com/image/art%3A10.1186%2Fs12879-018-3565-z/MediaObjects/12879_2018_3565_Fig1_HTML.png"
    },
    "word_count": 10171,
    "size_bytes": 475539
  }
}